=== Generating (published_papers) === === Generating (research_interests) === === Generating (education) === === Generating (research_experience) === === Generating (misc) === === Generating (research_projects) === === Generating (books_etc) === === Generating (industrial_property_rights) === === Generating (awards) === === Generating (association_memberships) === === Generating (teaching_experience) === === Generating (committee_memberships) === === Generating (presentations) === ==== begin registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/published_papers.jsonl) ==== line:1, {"insert":{"user_id":"B000241782","type":"published_papers","id":"45827841"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/38485345","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405478","label":"url"}],"paper_title":{"en":"Effects of D-allose on ATP production and cell viability in neonatal rat cardiomyocytes.","ja":"Effects of D-allose on ATP production and cell viability in neonatal rat cardiomyocytes."},"authors":{"en":[{"name":"Chen Xi"},{"name":"Rahman Asadur"},{"name":"Akumwami Steeve"},{"name":"Morishita Asahiro"},{"name":"Kitada Kento"},{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"},{"name":"Nishiyama Akira"}],"ja":[{"name":"Chen Xi"},{"name":"Rahman Asadur"},{"name":"Akumwami Steeve"},{"name":"Morishita Asahiro"},{"name":"Kitada Kento"},{"name":"池田 康将"},{"name":"船本 雅文"},{"name":"Nishiyama Akira"}]},"description":{"en":"2-Deoxy-d-glucose (2DG) induces anticancer effects through glycolytic inhibition but it may raise the risk of arrhythmia. The rare monosaccharide d-allose also has anticancer properties, but its cardiac effects are unknown. We examined the effects of d-allose on adenosine triphosphate (ATP) production in neonatal rat cardiomyocytes. We showed that 25 mM d-allose selectively reduced glycolytic ATP, but had minimal impact on mitochondrial ATP, while 1 mM 2DG strongly inhibited both. Furthermore, d-allose had less impact on cell viability and was less cytotoxic than 2DG; neither compound caused apoptosis. Thus, d-allose selectively diminished glycolytic ATP production with no apparent effects on cardiomyocytes.","ja":"2-Deoxy-d-glucose (2DG) induces anticancer effects through glycolytic inhibition but it may raise the risk of arrhythmia. The rare monosaccharide d-allose also has anticancer properties, but its cardiac effects are unknown. We examined the effects of d-allose on adenosine triphosphate (ATP) production in neonatal rat cardiomyocytes. We showed that 25 mM d-allose selectively reduced glycolytic ATP, but had minimal impact on mitochondrial ATP, while 1 mM 2DG strongly inhibited both. Furthermore, d-allose had less impact on cell viability and was less cytotoxic than 2DG; neither compound caused apoptosis. Thus, d-allose selectively diminished glycolytic ATP production with no apparent effects on cardiomyocytes."},"publication_date":"2024-02-15","publication_name":{"en":"Journal of Pharmacological Sciences","ja":"Journal of Pharmacological Sciences"},"volume":"Vol.154","number":"No.4","starting_page":"274","ending_page":"278","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.jphs.2024.02.009"],"issn":["1347-8648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:2, {"insert":{"user_id":"B000241782","type":"published_papers","id":"44313632"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/119176","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/37973221","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406137","label":"url"}],"paper_title":{"en":"CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.","ja":"CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses."},"authors":{"en":[{"name":"Imanishi Masaki"},{"name":"Inoue Takahisa"},{"name":"Fukushima Keijo"},{"name":"Yamashita Ryosuke"},{"name":"Nakayama Ryo"},{"name":"Nojima Masataka"},{"name":"Kondo Kosuke"},{"name":"Gomi Yoshiki"},{"name":"Tsunematsu Honoka"},{"name":"Goto Kohei"},{"name":"Miyamoto Licht"},{"name":"Funamoto Masafumi"},{"name":"Denda Masaya"},{"name":"Ishizawa Keisuke"},{"name":"Otaka Akira"},{"name":"Fujino Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"今西 正樹"},{"name":"井上 貴久"},{"name":"福島 圭穣"},{"name":"山下 竜介"},{"name":"中山 涼"},{"name":"野島 雅孝"},{"name":"Kondo Kosuke"},{"name":"五味 義輝"},{"name":"常松 保乃加"},{"name":"後藤 廣平"},{"name":"宮本 理人"},{"name":"船本 雅文"},{"name":"傳田 将也"},{"name":"石澤 啓介"},{"name":"大髙 章"},{"name":"藤野 裕道"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"description":{"en":"A strong hypoxic environment has been observed in pancreatic ductal adenocarcinoma (PDAC) cells, which contributes to drug resistance, tumor progression, and metastasis. Therefore, we performed bioinformatics analyses to investigate potential targets for the treatment of PDAC. To identify potential genes as effective PDAC treatment targets, we selected all genes whose expression level was related to worse overall survival (OS) in The Cancer Genome Atlas (TCGA) database and selected only the genes that matched with the genes upregulated due to hypoxia in pancreatic cancer cells in the dataset obtained from the Gene Expression Omnibus (GEO) database. Although the extracted 107 hypoxia-responsive genes included the genes that were slightly enriched in angiogenic factors, TCGA data analysis revealed that the expression level of endothelial cell (EC) markers did not affect OS. Finally, we selected CA9 and PRELID2 as potential targets for PDAC treatment and elucidated that a CA9 inhibitor, U-104, suppressed pancreatic cancer cell growth more effectively than 5-fluorouracil (5-FU) and PRELID2 siRNA treatment suppressed the cell growth stronger than CA9 siRNA treatment. Thus, we elucidated that specific inhibition of PRELID2 as well as CA9, extracted via exhaustive bioinformatic analyses of clinical datasets, could be a more effective strategy for PDAC treatment.","ja":"A strong hypoxic environment has been observed in pancreatic ductal adenocarcinoma (PDAC) cells, which contributes to drug resistance, tumor progression, and metastasis. Therefore, we performed bioinformatics analyses to investigate potential targets for the treatment of PDAC. To identify potential genes as effective PDAC treatment targets, we selected all genes whose expression level was related to worse overall survival (OS) in The Cancer Genome Atlas (TCGA) database and selected only the genes that matched with the genes upregulated due to hypoxia in pancreatic cancer cells in the dataset obtained from the Gene Expression Omnibus (GEO) database. Although the extracted 107 hypoxia-responsive genes included the genes that were slightly enriched in angiogenic factors, TCGA data analysis revealed that the expression level of endothelial cell (EC) markers did not affect OS. Finally, we selected CA9 and PRELID2 as potential targets for PDAC treatment and elucidated that a CA9 inhibitor, U-104, suppressed pancreatic cancer cell growth more effectively than 5-fluorouracil (5-FU) and PRELID2 siRNA treatment suppressed the cell growth stronger than CA9 siRNA treatment. Thus, we elucidated that specific inhibition of PRELID2 as well as CA9, extracted via exhaustive bioinformatic analyses of clinical datasets, could be a more effective strategy for PDAC treatment."},"publication_date":"2023-10-17","publication_name":{"en":"Journal of Pharmacological Sciences","ja":"Journal of Pharmacological Sciences"},"volume":"Vol.153","number":"No.4","starting_page":"232","ending_page":"242","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.jphs.2023.10.003"],"issn":["1347-8648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:3, {"insert":{"user_id":"B000241782","type":"published_papers","id":"42962898"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118452","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/37524452","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=399186","label":"url"}],"paper_title":{"en":"TJ-17 (Goreisan) mitigates renal fibrosis in a mouse model of folic acid-induced chronic kidney disease.","ja":"TJ-17 (Goreisan) mitigates renal fibrosis in a mouse model of folic acid-induced chronic kidney disease."},"authors":{"en":[{"name":"Suenaga Aoi"},{"name":"Seto Yasuyuki"},{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"末永 あおい"},{"name":"瀬戸 靖幸"},{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"description":{"en":"TJ-17 may have a novel preventive effect against inflammation, oxidative stress, and fibrosis, contributing to innovation in the treatment of CKD.","ja":"We the preventive action of TJ-17 against acute kidney injury (AKI) transition to CKD in vivo using a folic acid (FA)-induced mouse model. Mice were treated with food containing TJ-17 at 48 h after FA intraperitoneal injection (AKI phase)."},"publication_date":"2023-07-08","publication_name":{"en":"Journal of Pharmacological Sciences","ja":"Journal of Pharmacological Sciences"},"volume":"Vol.153","number":"No.1","starting_page":"31","ending_page":"37","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.jphs.2023.07.001"],"issn":["1347-8648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:4, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/36940907","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397020","label":"url"}],"paper_title":{"en":"Pemafibrate inhibited renal dysfunction and fibrosis in a mouse model of adenine-induced chronic kidney disease.","ja":"Pemafibrate inhibited renal dysfunction and fibrosis in a mouse model of adenine-induced chronic kidney disease."},"authors":{"en":[{"name":"Horinouchi Yuya"},{"name":"Murashima Yuka"},{"name":"Yamada Yuto"},{"name":"Yoshioka Shun"},{"name":"Fukushima Keijo"},{"name":"Kure Takumi"},{"name":"Sasaki Naofumi"},{"name":"Imanishi Masaki"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Shinomiya Kazuaki"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"Murashima Yuka"},{"name":"Yamada Yuto"},{"name":"Yoshioka Shun"},{"name":"福島 圭穣"},{"name":"Kure Takumi"},{"name":"Sasaki Naofumi"},{"name":"今西 正樹"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"Shinomiya Kazuaki"},{"name":"池田 康将"}]},"description":{"en":"These results demonstrated the renoprotective effects of pemafibrate in CKD mice, confirming its potential as a therapeutic agent for renal disorders.","ja":"The risks associated with conventional fibrates (fenofibrate, bezafibrate) to the kidneys were evaluated using the Food and Drug Administration Adverse Event Reporting System. Pemafibrate (1 or 0.3 mg/kg/day) was administered daily using an oral sonde. Its renoprotective effects were examined in unilateral ureteral obstruction (UUO)-induced renal fibrosis model mice (UUO mice) and adenine-induced CKD model mice (CKD mice)."},"publication_date":"2023-03-18","publication_name":{"en":"Life Sciences","ja":"Life Sciences"},"volume":"Vol.321","starting_page":"121590","ending_page":"121590","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.lfs.2023.121590"],"issn":["1879-0631"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:5, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118258","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/36244745","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393955","label":"url"}],"paper_title":{"en":"Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.","ja":"Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus."},"authors":{"en":[{"name":"Hara Tomoyo"},{"name":"Uemoto Ryoko"},{"name":"Sekine Akiko"},{"name":"Mitsui Yukari"},{"name":"Masuda Shiho"},{"name":"Yamagami Hiroki"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Kuroda Akio"},{"name":"Ikeda Yasumasa"},{"name":"Endo Itsuro"},{"name":"Honda Soichi"},{"name":"Yoshimoto Katsuhiko"},{"name":"Kondo Akira"},{"name":"Tamaki Toshiaki"},{"name":"Matsumoto Toshio"},{"name":"Matsuhisa Munehide"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"原 倫世"},{"name":"Uemoto Ryoko"},{"name":"Sekine Akiko"},{"name":"Mitsui Yukari"},{"name":"桝田 志保"},{"name":"山上 紘規"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"黒田 暁生"},{"name":"池田 康将"},{"name":"遠藤 逸朗"},{"name":"Honda Soichi"},{"name":"吉本 勝彦"},{"name":"Kondo Akira"},{"name":"玉置 俊晃"},{"name":"松本 俊夫"},{"name":"松久 宗英"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"description":{"en":"Plasma HCII activity was inversely associated with clinical hepatic fibrosis indices including FIB-4 index, NFS and APRI and with the prevalence of advanced hepatic fibrosis in patients with T2DM. The results suggest that HCII can serve as a novel biomarker for assessment of hepatic fibrosis of NAFLD in patients with T2DM.","ja":"Multiple regression analysis including confounding factors showed that plasma HCII activity independently contributed to decreases in FIB-4 index (p<0.001), NFS (p<0.001) and APRI (p=0.004). In addition, logistic regression analysis for the prevalence of advanced hepatic fibrosis defined by the cutoff points of the clinical scores showed that plasma HCII activity was the sole and common negative factor for prevalence of advanced hepatic fibrosis (FIB-4 index: p=0.002, NFS: p=0.026 and APRI: p=0.012)."},"publication_date":"2022-10-14","publication_name":{"en":"Journal of Atherosclerosis and Thrombosis","ja":"Journal of Atherosclerosis and Thrombosis"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.5551/jat.63752"],"issn":["1880-3873"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:6, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118447","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/36172003","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=392443","label":"url"}],"paper_title":{"en":"Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study.","ja":"Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study."},"authors":{"en":[{"name":"Funamoto Masafumi"},{"name":"Sunagawa Yoichi"},{"name":"Katanasaka Yasufumi"},{"name":"Kato Toru"},{"name":"Funada Junichi"},{"name":"Ajiro Yoichi"},{"name":"Komiyama Maki"},{"name":"Akao Masaharu"},{"name":"Yasoda Akihiro"},{"name":"Yamakage Hajime"},{"name":"Satoh-Asahara Noriko"},{"name":"Wada Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Morimoto Tatsuya"},{"name":"Hasegawa Koji"}],"ja":[{"name":"船本 雅文"},{"name":"Sunagawa Yoichi"},{"name":"Katanasaka Yasufumi"},{"name":"Kato Toru"},{"name":"Funada Junichi"},{"name":"Ajiro Yoichi"},{"name":"Komiyama Maki"},{"name":"Akao Masaharu"},{"name":"Yasoda Akihiro"},{"name":"Yamakage Hajime"},{"name":"Satoh-Asahara Noriko"},{"name":"Wada Hiromichi"},{"name":"池田 康将"},{"name":"Morimoto Tatsuya"},{"name":"Hasegawa Koji"}]},"description":{"en":"' ratio, rather it significantly inhibited the increase in plasma BNP levels in patients with initial signs of hypertensive heart disease.","ja":"for interaction = 0.011)."},"publication_date":"2022-09-10","publication_name":{"en":"European Heart Journal Open","ja":"European Heart Journal Open"},"volume":"Vol.107","starting_page":"154457","ending_page":"154457","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1093/ehjopen/oeac057"],"issn":["2752-4191"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:7, {"insert":{"user_id":"B000241782","type":"published_papers","id":"37034545"},"force":{"see_also":[{"@id":"https://www.sciencedirect.com/science/article/pii/S0944711322002926","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/117134","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385621","label":"url"}],"paper_title":{"en":"The novel preventive effect of a Japanese ethical Kampo extract formulation TJ-90 (Seihaito) against cisplatin-induced nephrotoxicity","ja":"The novel preventive effect of a Japanese ethical Kampo extract formulation TJ-90 (Seihaito) against cisplatin-induced nephrotoxicity"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"},{"name":"Kishi Seiji"},{"name":"Imanishi Masaki"},{"name":"Aihara Ken-ichi"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"船本 雅文"},{"name":"岸 誠司"},{"name":"今西 正樹"},{"name":"粟飯原 賢一"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"publication_date":"2022-05-30","publication_name":{"en":"Phytomedicine","ja":"Phytomedicine"},"volume":"Vol.103","number":"No.8","starting_page":"154213","ending_page":"154213","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.phymed.2022.154213"],"issn":["0944-7113"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:8, {"insert":{"user_id":"B000241782","type":"published_papers","id":"32635735"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116131","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=375923","label":"url"}],"paper_title":{"en":"Role of ferroptosis in cisplatin-induced acute nephrotoxicity in mice","ja":"Role of ferroptosis in cisplatin-induced acute nephrotoxicity in mice"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Miyamoto Licht"},{"name":"Tasuku Hitayama"},{"name":"Nagasawa Hideko"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"宮本 理人"},{"name":"Tasuku Hitayama"},{"name":"永澤 秀子"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"publication_date":"2021-05-28","publication_name":{"en":"Journal of Trace Elements in Medicine and Biology","ja":"Journal of Trace Elements in Medicine and Biology"},"volume":"Vol.67","starting_page":"126798","ending_page":"126798","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.jtemb.2021.126798"],"issn":["0946-672X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:9, {"insert":{"user_id":"B000241782","type":"published_papers","id":"33322220"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116545","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34043882","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=376531","label":"url"}],"paper_title":{"en":"Plasma Heparin Cofactor II Activity Is Inversely Associated with Albuminuria and Its Annual Deterioration in Patients with Diabetes.","ja":"Plasma Heparin Cofactor II Activity Is Inversely Associated with Albuminuria and Its Annual Deterioration in Patients with Diabetes."},"authors":{"en":[{"name":"Hara Tomoyo"},{"name":"Uemoto Ryoko"},{"name":"Sekine Akiko"},{"name":"Mitsui Yukari"},{"name":"Masuda Shiho"},{"name":"Kurahashi Kiyoe"},{"name":"Yoshida Sumiko"},{"name":"Otoda Toshiki"},{"name":"Yuasa Tomoyuki"},{"name":"Kuroda Akio"},{"name":"Ikeda Yasumasa"},{"name":"Endo Itsuro"},{"name":"Honda Soichi"},{"name":"Yoshimoto Katsuhiko"},{"name":"Kondo Akira"},{"name":"Tamaki Toshiaki"},{"name":"Matsumoto Toshio"},{"name":"Matsuhisa Munehide"},{"name":"Abe Masahiro"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"原 倫世"},{"name":"Uemoto Ryoko"},{"name":"Sekine Akiko"},{"name":"Mitsui Yukari"},{"name":"桝田 志保"},{"name":"倉橋 清衛"},{"name":"吉田 守美子"},{"name":"乙田 敏城"},{"name":"湯浅 智之"},{"name":"黒田 暁生"},{"name":"池田 康将"},{"name":"遠藤 逸朗"},{"name":"Honda Soichi"},{"name":"吉本 勝彦"},{"name":"Kondo Akira"},{"name":"玉置 俊晃"},{"name":"松本 俊夫"},{"name":"松久 宗英"},{"name":"安倍 正博"},{"name":"粟飯原 賢一"}]},"description":{"en":"The plasma HCII activity was inversely and specifically associated with glomerular injury in patients with diabetes. The results suggest that HCII can serve as a novel predictive factor for early-stage DKD development, as represented by albuminuria.","ja":"The plasma HCII activity was inversely and specifically associated with glomerular injury in patients with diabetes. The results suggest that HCII can serve as a novel predictive factor for early-stage DKD development, as represented by albuminuria."},"publication_date":"2021-05-27","publication_name":{"en":"Journal of Diabetes Investigation","ja":"Journal of Diabetes Investigation"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1111/jdi.13602"],"issn":["2040-1124"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:10, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"http://repo.lib.tokushima-u.ac.jp/116038","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116038","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050851320431028352/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=390121","label":"url"}],"paper_title":{"en":"薬剤誘発性大動脈解離易発症モデルマウスを用いた薬効評価","ja":"薬剤誘発性大動脈解離易発症モデルマウスを用いた薬効評価"},"authors":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Aizawa Fuka"},{"name":"Zamami Yoshito"},{"name":"Hamano Hirofumi"},{"name":"Yagi Kenta"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"相澤 風花"},{"name":"座間味 義人"},{"name":"濱野 裕章"},{"name":"八木 健太"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"description":{"en":"Aortic dissection (or dissecting aortic aneurysm) is a condition in which the aortic wall is separated into two layers at the medial level to form a pseudocavity. The intima crack, called the ``entry'', allows blood to tear through the medial layer and flow in. The location of the ``entry'' and the extent of the dissection can cause a variety of serious complications, including rupture, cardiac tamponade, and obstruction of branched vessels. According to the Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection 2020, it is estimated that 61.4% of the onset of dissection die before arrival at the hospital, and 93% will die within 24 hours after the onset. It has been suggested that the morbidity rate has been increasing in recent years. Since many of them have a fatal prognosis, it is an important issue to prevent the onset itself. However, no effective therapeutic agent or preventive strategy has been established so far. The first reason is that it is extremely difficult to design clinical studies because aortic dissection traced the rapid onset and progression. The second is that the pathophysiology and preventive drug search are not sufficiently conducted even at the basic research level. Epidemiologically, the results of the International Registry of Aortic Dissection (IRAD) revealed that aging, hypertension, atherosclerosis, and hereditary connective tissue diseases are risk factors. The aortic aneurysm also shows similar pathological conditions caused by these risk factors. However, one of the major differences between aneurysm and dissection is the presence of aortic intima rupture. Therefore, we attempted to establish a mouse model developing dissection at a high rate by adding the endothelial dysfunction to a pharmacologically induced aortic aneurysm model mouse. Furthermore, we evaluated the efficacy of pitavastatin and several nutrients using our novel model mice and verified its usefulness as a model animal.","ja":"Aortic dissection (or dissecting aortic aneurysm) is a condition in which the aortic wall is separated into two layers at the medial level to form a pseudocavity. The intima crack, called the ``entry'', allows blood to tear through the medial layer and flow in. The location of the ``entry'' and the extent of the dissection can cause a variety of serious complications, including rupture, cardiac tamponade, and obstruction of branched vessels. According to the Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection 2020, it is estimated that 61.4% of the onset of dissection die before arrival at the hospital, and 93% will die within 24 hours after the onset. It has been suggested that the morbidity rate has been increasing in recent years. Since many of them have a fatal prognosis, it is an important issue to prevent the onset itself. However, no effective therapeutic agent or preventive strategy has been established so far. The first reason is that it is extremely difficult to design clinical studies because aortic dissection traced the rapid onset and progression. The second is that the pathophysiology and preventive drug search are not sufficiently conducted even at the basic research level. Epidemiologically, the results of the International Registry of Aortic Dissection (IRAD) revealed that aging, hypertension, atherosclerosis, and hereditary connective tissue diseases are risk factors. The aortic aneurysm also shows similar pathological conditions caused by these risk factors. However, one of the major differences between aneurysm and dissection is the presence of aortic intima rupture. Therefore, we attempted to establish a mouse model developing dissection at a high rate by adding the endothelial dysfunction to a pharmacologically induced aortic aneurysm model mouse. Furthermore, we evaluated the efficacy of pitavastatin and several nutrients using our novel model mice and verified its usefulness as a model animal."},"publication_date":"2021-04-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.77","number":"No.1,2","starting_page":"57","ending_page":"62","languages":["jpn"],"referee":true,"identifiers":{"issn":["0037-3699"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:11, {"insert":{"user_id":"B000241782","type":"published_papers","id":"32553169"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116301","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33910036","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=375760","label":"url"}],"paper_title":{"en":"Examination of the antiepileptic effects of valacyclovir using kindling mice- search for novel antiepileptic agents by drug repositioning using a large medical information database.","ja":"Examination of the antiepileptic effects of valacyclovir using kindling mice- search for novel antiepileptic agents by drug repositioning using a large medical information database."},"authors":{"en":[{"name":"Takahashi Shimon"},{"name":"Takechi Kenshi"},{"name":"Jozukuri Natsumi"},{"name":"Niimura Takahiro"},{"name":"Chuma Masayuki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Yanagawa Hiroaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"Takahashi Shimon"},{"name":"武智 研志"},{"name":"Jozukuri Natsumi"},{"name":"新村 貴博"},{"name":"中馬 真幸"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"楊河 宏章"},{"name":"石澤 啓介"}]},"description":{"en":"Despite the availability of more than 20 clinical antiepileptic drugs, approximately 30% of patients with epilepsy do not respond to antiepileptic drug treatment. Therefore, it is important to develop antiepileptic products that function via novel mechanisms. In the present study, we evaluated data from one of the largest global databases to identify drugs with antiepileptic effects, and subsequently attempted to understand the effect of the combination of antiepileptic drugs and valacyclovir in epileptic seizures using a kindling model. To induce kindling in mice, pentylenetetrazol at a dose of 40 mg/kg was administered once every 48 h. Valacyclovir was orally administered 30 min before antiepileptic drug injection in kindled mice, and behavioral seizures were monitored for 20 min following pentylenetetrazol administration. Additionally, c-Fos expression in the hippocampal dentate gyrus was measured in kindled mice. Valacyclovir showed inhibitory effects on pentylenetetrazol-induced kindled seizures. In addition, simultaneous use of levetiracetam and valacyclovir caused more potent inhibition of seizure activity, and neither valproic acid nor diazepam augmented the anti-seizure effect in kindled mice. Furthermore, kindled mice showed increased c-Fos levels in the dentate gyrus. The increase in c-Fos expression was significantly inhibited by the simultaneous use of levetiracetam and valacyclovir. The findings of the present study indicate that a combination of levetiracetam and valacyclovir had possible anticonvulsive effects on pentylenetetrazol-induced kindled epileptic seizures. These results suggest that valacyclovir may have an antiseizure effect in patients with epilepsy.","ja":"Despite the availability of more than 20 clinical antiepileptic drugs, approximately 30% of patients with epilepsy do not respond to antiepileptic drug treatment. Therefore, it is important to develop antiepileptic products that function via novel mechanisms. In the present study, we evaluated data from one of the largest global databases to identify drugs with antiepileptic effects, and subsequently attempted to understand the effect of the combination of antiepileptic drugs and valacyclovir in epileptic seizures using a kindling model. To induce kindling in mice, pentylenetetrazol at a dose of 40 mg/kg was administered once every 48 h. Valacyclovir was orally administered 30 min before antiepileptic drug injection in kindled mice, and behavioral seizures were monitored for 20 min following pentylenetetrazol administration. Additionally, c-Fos expression in the hippocampal dentate gyrus was measured in kindled mice. Valacyclovir showed inhibitory effects on pentylenetetrazol-induced kindled seizures. In addition, simultaneous use of levetiracetam and valacyclovir caused more potent inhibition of seizure activity, and neither valproic acid nor diazepam augmented the anti-seizure effect in kindled mice. Furthermore, kindled mice showed increased c-Fos levels in the dentate gyrus. The increase in c-Fos expression was significantly inhibited by the simultaneous use of levetiracetam and valacyclovir. The findings of the present study indicate that a combination of levetiracetam and valacyclovir had possible anticonvulsive effects on pentylenetetrazol-induced kindled epileptic seizures. These results suggest that valacyclovir may have an antiseizure effect in patients with epilepsy."},"publication_date":"2021-04-25","publication_name":{"en":"European Journal of Pharmacology","ja":"European Journal of Pharmacology"},"volume":"Vol.902","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.ejphar.2021.174099"],"issn":["1879-0712"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:12, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33845306","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374831","label":"url"}],"paper_title":{"en":"Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury.","ja":"Dual disruption of eNOS and ApoE gene accelerates kidney fibrosis and senescence after injury."},"authors":{"en":[{"name":"Nishimura Kenji"},{"name":"Taguchi Kensei"},{"name":"Kishi Seiji"},{"name":"Brooks Craig R"},{"name":"Ochi Arisa"},{"name":"Kadoya Hiroyuki"},{"name":"Ikeda Yasumasa"},{"name":"Miyoshi Masashi"},{"name":"Tamaki Masanori"},{"name":"Abe Hideharu"},{"name":"Aihara Ken-Ichi"},{"name":"Kashihara Naoki"},{"name":"Nagai Kojiro"}],"ja":[{"name":"西村 賢二"},{"name":"Taguchi Kensei"},{"name":"岸 誠司"},{"name":"Brooks Craig R"},{"name":"Ochi Arisa"},{"name":"Kadoya Hiroyuki"},{"name":"池田 康将"},{"name":"Miyoshi Masashi"},{"name":"田蒔 昌憲"},{"name":"Abe Hideharu"},{"name":"Aihara Ken-Ichi"},{"name":"Kashihara Naoki"},{"name":"Nagai Kojiro"}]},"description":{"en":"mice (DKO) were obtained by breeding. Unilateral ureteral obstruction (UUO) was performed on 8-10 week old male mice and the degree of renal tubular injury, fibrosis and kidney senescence were evaluated. DKO manifested elevated blood pressure, higher total cholesterol and lower HDL than WT. DKO showed sustained kidney injury molecule-1 protein expression. Kidney fibrosis was significantly higher in ApoEKO and DKO. mRNA expression of genes related to kidney fibrosis was the highest in DKO. The mRNA expression of Zinc-α2-Glycoprotein and heme oxygenase-1 were significantly decreased in DKO. Furthermore, mRNA expression of p53, p21 and p16 were increased both in ApoEKO and DKO, with DKO being the highest. Senescence associated β-gal positive tubule area was significantly increased in DKO. Increased DNA damage and target of rapamycin-autophagy spatial coupling compartments (TASCCs) formation was found in DKO. Mice with endothelial dysfunction and dyslipidemia developed kidney fibrosis and accelerated senescence even in young mice after injury. These data highlight the fact managing lifestyle-related diseases from a young age is important for CKD prevention.","ja":"mice (DKO) were obtained by breeding. Unilateral ureteral obstruction (UUO) was performed on 8-10 week old male mice and the degree of renal tubular injury, fibrosis and kidney senescence were evaluated. DKO manifested elevated blood pressure, higher total cholesterol and lower HDL than WT. DKO showed sustained kidney injury molecule-1 protein expression. Kidney fibrosis was significantly higher in ApoEKO and DKO. mRNA expression of genes related to kidney fibrosis was the highest in DKO. The mRNA expression of Zinc-α2-Glycoprotein and heme oxygenase-1 were significantly decreased in DKO. Furthermore, mRNA expression of p53, p21 and p16 were increased both in ApoEKO and DKO, with DKO being the highest. Senescence associated β-gal positive tubule area was significantly increased in DKO. Increased DNA damage and target of rapamycin-autophagy spatial coupling compartments (TASCCs) formation was found in DKO. Mice with endothelial dysfunction and dyslipidemia developed kidney fibrosis and accelerated senescence even in young mice after injury. These data highlight the fact managing lifestyle-related diseases from a young age is important for CKD prevention."},"publication_date":"2021-04-09","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.556","starting_page":"142","ending_page":"148","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2021.03.111"],"issn":["1090-2104"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:13, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30702859"},"force":{"see_also":[{"@id":"https://linkinghub.elsevier.com/retrieve/pii/S0085-2538(20)31411-3","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/115399","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33307103","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=372231","label":"url"}],"paper_title":{"en":"Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity","ja":"Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity"},"authors":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Goda Mitsuhiro"},{"name":"Fukushima Keijo"},{"name":"Kishi Seiji"},{"name":"Chuma Masayuki"},{"name":"Yamashita Michiko"},{"name":"Niimura Takahiro"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Horinouchi Yuya"},{"name":"Yuki Izawa-Ishizawa"},{"name":"Miyamoto Licht"},{"name":"Keisuke Ishizawa"},{"name":"Fujino Hiromichi"},{"name":"Tamaki Toshiaki"},{"name":"Aihara Ken-ichi"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"合田 光寛"},{"name":"福島 圭穣"},{"name":"岸 誠司"},{"name":"中馬 真幸"},{"name":"山下 理子"},{"name":"新村 貴博"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"堀ノ内 裕也"},{"name":"Yuki Izawa-Ishizawa"},{"name":"宮本 理人"},{"name":"Keisuke Ishizawa"},{"name":"藤野 裕道"},{"name":"玉置 俊晃"},{"name":"粟飯原 賢一"},{"name":"土屋 浩一郎"}]},"description":{"en":"Cisplatin is widely used as an anti-tumor drug for the treatment of solid tumors. Unfortunately, it causes kidney toxicity as a critical side effect, limiting its use, given that no preventive drug against cisplatin-induced kidney toxicity is currently available. Here, based on a repositioning analysis of the Food and Drug Administration Adverse Events Reporting System, we found that a previously developed drug, diphenhydramine, may provide a novel treatment for cisplatin-induced kidney toxicity. To confirm this, the actual efficacy of diphenhydramine was evaluated in in vitro and in vivo experiments. Diphenhydramine inhibited cisplatin-induced cell death in kidney proximal tubular cells. Mice administered cisplatin developed kidney injury with significant dysfunction (mean plasma creatinine: 0.43 vs 0.15 mg/dl) and showed augmented oxidative stress, increased apoptosis, elevated inflammatory cytokines, and MAPKs activation. However, most of these symptoms were suppressed by treatment with diphenhydramine. Furthermore, the concentration of cisplatin in the kidney was significantly attenuated in diphenhydramine-treated mice (mean platinum content: 70.0 vs 53.4 μg/g dry kidney weight). Importantly, diphenhydramine did not influence or interfere with the anti-tumor effect of cisplatin in any of the in vitro or in vivo experiments. In a selected cohort of 98 1:1 matched patients from a retrospective database of 1467 patients showed that patients with malignant cancer who had used diphenhydramine before cisplatin treatment exhibited significantly less acute kidney injury compared to ones who did not (6.1 % vs 22.4 %, respectively). Thus, diphenhydramine demonstrated efficacy as a novel preventive medicine against cisplatin-induced kidney toxicity.","ja":"Cisplatin is widely used as an anti-tumor drug for the treatment of solid tumors. Unfortunately, it causes kidney toxicity as a critical side effect, limiting its use, given that no preventive drug against cisplatin-induced kidney toxicity is currently available. Here, based on a repositioning analysis of the Food and Drug Administration Adverse Events Reporting System, we found that a previously developed drug, diphenhydramine, may provide a novel treatment for cisplatin-induced kidney toxicity. To confirm this, the actual efficacy of diphenhydramine was evaluated in in vitro and in vivo experiments. Diphenhydramine inhibited cisplatin-induced cell death in kidney proximal tubular cells. Mice administered cisplatin developed kidney injury with significant dysfunction (mean plasma creatinine: 0.43 vs 0.15 mg/dl) and showed augmented oxidative stress, increased apoptosis, elevated inflammatory cytokines, and MAPKs activation. However, most of these symptoms were suppressed by treatment with diphenhydramine. Furthermore, the concentration of cisplatin in the kidney was significantly attenuated in diphenhydramine-treated mice (mean platinum content: 70.0 vs 53.4 μg/g dry kidney weight). Importantly, diphenhydramine did not influence or interfere with the anti-tumor effect of cisplatin in any of the in vitro or in vivo experiments. In a selected cohort of 98 1:1 matched patients from a retrospective database of 1467 patients showed that patients with malignant cancer who had used diphenhydramine before cisplatin treatment exhibited significantly less acute kidney injury compared to ones who did not (6.1 % vs 22.4 %, respectively). Thus, diphenhydramine demonstrated efficacy as a novel preventive medicine against cisplatin-induced kidney toxicity."},"publication_date":"2021-04","publication_name":{"en":"Kidney International","ja":"Kidney International"},"volume":"Vol.99","number":"No.4","starting_page":"885","ending_page":"889","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.kint.2020.10.041"],"issn":["1523-1755"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:14, {"insert":{"user_id":"B000241782","type":"published_papers","id":"32199538"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33790099","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374808","label":"url"}],"paper_title":{"en":"Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.","ja":"Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study."},"authors":{"en":[{"name":"Hamano Hirofumi"},{"name":"Mitsuhashi Chisato"},{"name":"Suzuki Yoshiko"},{"name":"Zamami Yoshito"},{"name":"Tsujinaka Kaito"},{"name":"Okada Naoto"},{"name":"Niimura Takahiro"},{"name":"Hayama Tatsuya"},{"name":"Imai Toru"},{"name":"Ishida Shunsuke"},{"name":"Sakamoto Kumiko"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Yagi Kenta"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Shinomiya Kazuaki"},{"name":"Ikeda Yasumasa"},{"name":"Kirino Yasushi"},{"name":"Nakamura Toshimi"},{"name":"Yanagawa Hiroaki"},{"name":"Hamada Yasuhiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"濱野 裕章"},{"name":"Mitsuhashi Chisato"},{"name":"Suzuki Yoshiko"},{"name":"Zamami Yoshito"},{"name":"Tsujinaka Kaito"},{"name":"Okada Naoto"},{"name":"新村 貴博"},{"name":"Hayama Tatsuya"},{"name":"Imai Toru"},{"name":"Ishida Shunsuke"},{"name":"Sakamoto Kumiko"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Yagi Kenta"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Shinomiya Kazuaki"},{"name":"池田 康将"},{"name":"Kirino Yasushi"},{"name":"Nakamura Toshimi"},{"name":"楊河 宏章"},{"name":"Hamada Yasuhiro"},{"name":"Ishizawa Keisuke"}]},"description":{"en":"RAs in controlling multiple-day chemotherapy-induced nausea and vomiting.","ja":"RAs palonosetron in multiple-day chemotherapy-induced nausea and vomiting. The design of this study was a retrospective case-control study of patients who received a five-day cisplatin-based chemotherapy and were treated with aprepitant, dexamethasone, granisetron, and ramosetron or palonosetron. The patients were divided into two groups: patients given granisetron and ramosetron (the first-generation group), and those given palonosetron (palonosetron group). The percentage of patients with a complete response or total control was assessed. They were divided into three phases: 0-216 h (overall phase), 0-120 h (remedial phase), and 120-216 h (after phase). The remedial phase was further divided into 0-24 h (early phase) and 24-120 h (later phase). Moreover, the nutritional status of each patient was assessed by noting the patients' total calorie-intake per day and total parenteral nutrition. First-generation 5-HT"},"publication_date":"2021","publication_name":{"en":"Biological & Pharmaceutical Bulletin","ja":"Biological & Pharmaceutical Bulletin"},"volume":"Vol.44","number":"No.4","starting_page":"478","ending_page":"484","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/bpb.b20-00609"],"issn":["1347-5215"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:15, {"insert":{"user_id":"B000241782","type":"published_papers","id":"31136365"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116288","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33231381","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=372620","label":"url"}],"paper_title":{"en":"Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effect.","ja":"Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effect."},"authors":{"en":[{"name":"Yagi Kenta"},{"name":"Mitstui Marin"},{"name":"Zamami Yoshito"},{"name":"Niimura Takahiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Chuma Masayuki"},{"name":"Fukunaga Kimiko"},{"name":"Shibata Takahiro"},{"name":"Ishida Shunsuke"},{"name":"Sakurada Takumi"},{"name":"Okada Naoto"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Yanagawa Hiroaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"八木 健太"},{"name":"Mitstui Marin"},{"name":"座間味 義人"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"中馬 真幸"},{"name":"Fukunaga Kimiko"},{"name":"Shibata Takahiro"},{"name":"Ishida Shunsuke"},{"name":"Sakurada Takumi"},{"name":"岡田 直人"},{"name":"Hamano Hirofumi"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"楊河 宏章"},{"name":"石澤 啓介"}]},"description":{"en":"PPIs prevent hypertension in bevacizumab-treated patients but may reduce bevacizumab's anti-tumoral effects by inducing VEGF expression.","ja":"PPIs prevent hypertension in bevacizumab-treated patients but may reduce bevacizumab's anti-tumoral effects by inducing VEGF expression."},"publication_date":"2020-11-24","publication_name":{"en":"Cancer Medicine","ja":"Cancer Medicine"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.1002/cam4.3587"],"issn":["2045-7634"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:16, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/114409","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32430665","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85085484596&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=363775","label":"url"}],"paper_title":{"en":"Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice","ja":"Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Shiuchi Tetsuya"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Imanishi Masaki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"渡邊 大晃"},{"name":"志内 哲也"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"今西 正樹"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Iron accumulation affects obesity and diabetes, both of which are ameliorated by iron reduction. Ferritin, an iron-storage protein, plays a crucial role in iron metabolism. H-ferritin exerts its cytoprotective action by reducing toxicity via its ferroxidase activity. We investigated the role of macrophage H-ferritin in obesity and diabetes. Conditional macrophage-specific H-ferritin (Fth, also known as Fth1) knockout (LysM-Cre Fth KO) mice were used and divided into four groups: wild-type (WT) and LysM-Cre Fth KO mice with normal diet (ND), and WT and LysM-Cre Fth KO mice with high-fat diet (HFD). These mice were analysed for characteristics of obesity and diabetes, tissue iron content, inflammation, oxidative stress, insulin sensitivity and metabolic measurements. RAW264.7 macrophage cells were used for in vitro experiments. Iron concentration reduced, and mRNA expression of ferroportin increased, in macrophages from LysM-Cre Fth KO mice. HFD-induced obesity was lower in LysM-Cre Fth KO mice than in WT mice at 12 weeks (body weight: KO 34.6 ± 5.6 g vs WT 40.1 ± 5.2 g). mRNA expression of inflammatory cytokines and infiltrated macrophages and oxidative stress increased in the adipose tissue of HFD-fed WT mice, but was not elevated in HFD-fed LysM-Cre Fth KO mice. However, WT mice fed an HFD had elevated iron concentration in adipose tissue and spleen, which was not observed in LysM-Cre Fth KO mice fed an HFD (adipose tissue [μmol Fe/g protein]: KO 1496 ± 479 vs WT 2316 ± 866; spleen [μmol Fe/g protein]: KO 218 ± 54 vs WT 334 ± 83). Moreover, HFD administration impaired both glucose tolerance and insulin sensitivity in WT mice, which was ameliorated in LysM-Cre Fth KO mice. In addition, energy expenditure, mRNA expression of thermogenic genes, and body temperature were higher in KO mice with HFD than WT mice with HFD. In vitro experiments showed that iron content was reduced, and lipopolysaccharide-induced Tnf-α (also known as Tnf) mRNA upregulation was inhibited in a macrophage cell line transfected with Fth siRNA. Deletion of macrophage H-ferritin suppresses the inflammatory response by reducing intracellular iron levels, resulting in the prevention of HFD-induced obesity and diabetes. The findings from this study highlight macrophage iron levels as a potential therapeutic target for obesity and diabetes.","ja":"Iron accumulation affects obesity and diabetes, both of which are ameliorated by iron reduction. Ferritin, an iron-storage protein, plays a crucial role in iron metabolism. H-ferritin exerts its cytoprotective action by reducing toxicity via its ferroxidase activity. We investigated the role of macrophage H-ferritin in obesity and diabetes. Conditional macrophage-specific H-ferritin (Fth, also known as Fth1) knockout (LysM-Cre Fth KO) mice were used and divided into four groups: wild-type (WT) and LysM-Cre Fth KO mice with normal diet (ND), and WT and LysM-Cre Fth KO mice with high-fat diet (HFD). These mice were analysed for characteristics of obesity and diabetes, tissue iron content, inflammation, oxidative stress, insulin sensitivity and metabolic measurements. RAW264.7 macrophage cells were used for in vitro experiments. Iron concentration reduced, and mRNA expression of ferroportin increased, in macrophages from LysM-Cre Fth KO mice. HFD-induced obesity was lower in LysM-Cre Fth KO mice than in WT mice at 12 weeks (body weight: KO 34.6 ± 5.6 g vs WT 40.1 ± 5.2 g). mRNA expression of inflammatory cytokines and infiltrated macrophages and oxidative stress increased in the adipose tissue of HFD-fed WT mice, but was not elevated in HFD-fed LysM-Cre Fth KO mice. However, WT mice fed an HFD had elevated iron concentration in adipose tissue and spleen, which was not observed in LysM-Cre Fth KO mice fed an HFD (adipose tissue [μmol Fe/g protein]: KO 1496 ± 479 vs WT 2316 ± 866; spleen [μmol Fe/g protein]: KO 218 ± 54 vs WT 334 ± 83). Moreover, HFD administration impaired both glucose tolerance and insulin sensitivity in WT mice, which was ameliorated in LysM-Cre Fth KO mice. In addition, energy expenditure, mRNA expression of thermogenic genes, and body temperature were higher in KO mice with HFD than WT mice with HFD. In vitro experiments showed that iron content was reduced, and lipopolysaccharide-induced Tnf-α (also known as Tnf) mRNA upregulation was inhibited in a macrophage cell line transfected with Fth siRNA. Deletion of macrophage H-ferritin suppresses the inflammatory response by reducing intracellular iron levels, resulting in the prevention of HFD-induced obesity and diabetes. The findings from this study highlight macrophage iron levels as a potential therapeutic target for obesity and diabetes."},"publication_date":"2020-07-11","publication_name":{"en":"Diabetologia","ja":"Diabetologia"},"volume":"Vol.63","number":"No.8","starting_page":"1588","ending_page":"1602","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s00125-020-05153-0"],"issn":["1432-0428"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:17, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32307577","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366414","label":"url"}],"paper_title":{"en":"Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model.","ja":"Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model."},"authors":{"en":[{"name":"Imanishi Masaki"},{"name":"Yamakawa Yusuke"},{"name":"Fukushima Keijo"},{"name":"Ikuto Raiki"},{"name":"Maegawa Akiko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Kondo Masateru"},{"name":"Kishuku Masatoshi"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Fujino Hiromichi"},{"name":"Tsuneyama Koichi"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"Yamakawa Yusuke"},{"name":"福島 圭穣"},{"name":"生藤 来希"},{"name":"前川 晃子"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"近藤 正輝"},{"name":"木宿 昌俊"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"藤野 裕道"},{"name":"常山 幸一"},{"name":"石澤 啓介"}]},"description":{"en":"The roles of cancer-associated fibroblasts (CAFs) have been studied in the tumor progression, and CAFs are expected to become the new targets for cancer pharmacotherapies. CAFs contribute to tumor cell survival and proliferation, tumor angiogenesis, immune suppression, tumor inflammation, tumor cell invasion and metastasis, and extracellular matrix remodeling. However, detailed mechanisms of how CAFs function in the living system remain unclear. CAFs include α-smooth muscle actin, expressing activated fibroblasts similar to myofibroblasts, and are highly capable of producing collagen. Several reports have demonstrated the contributions of extracellular-signal-regulated kinase 5 (ERK5) in fibroblasts to the fibrotic processes; however, the roles of CAF-derived ERK5 remain unclear. To investigate the roles of CAF-derived ERK5 in the tumor progression, we created mice lacking the ERK5 gene specifically in fibroblasts. Colon-26 mouse colon cancer cells were implanted into the mice subcutaneously, and the histological analyses of the tumor tissue were performed after 2 weeks. Immunofluorescence analyses showed that recipient-derived fibroblasts existed within the tumor tissue. The present study demonstrated that fibroblast-specific ERK5 deficiency exacerbated tumor progression and it was accompanied with thicker tumor vessel formation and the increase in the number of activated fibroblasts. We combined the results of The Cancer Genome Atlas (TCGA) database analysis with our animal studies, and indicated that regulating ERK5 activity in CAFs or CAF invasion into the tumor tissue can be important strategies for the development of new targets in cancer pharmacotherapies.","ja":"The roles of cancer-associated fibroblasts (CAFs) have been studied in the tumor progression, and CAFs are expected to become the new targets for cancer pharmacotherapies. CAFs contribute to tumor cell survival and proliferation, tumor angiogenesis, immune suppression, tumor inflammation, tumor cell invasion and metastasis, and extracellular matrix remodeling. However, detailed mechanisms of how CAFs function in the living system remain unclear. CAFs include α-smooth muscle actin, expressing activated fibroblasts similar to myofibroblasts, and are highly capable of producing collagen. Several reports have demonstrated the contributions of extracellular-signal-regulated kinase 5 (ERK5) in fibroblasts to the fibrotic processes; however, the roles of CAF-derived ERK5 remain unclear. To investigate the roles of CAF-derived ERK5 in the tumor progression, we created mice lacking the ERK5 gene specifically in fibroblasts. Colon-26 mouse colon cancer cells were implanted into the mice subcutaneously, and the histological analyses of the tumor tissue were performed after 2 weeks. Immunofluorescence analyses showed that recipient-derived fibroblasts existed within the tumor tissue. The present study demonstrated that fibroblast-specific ERK5 deficiency exacerbated tumor progression and it was accompanied with thicker tumor vessel formation and the increase in the number of activated fibroblasts. We combined the results of The Cancer Genome Atlas (TCGA) database analysis with our animal studies, and indicated that regulating ERK5 activity in CAFs or CAF invasion into the tumor tissue can be important strategies for the development of new targets in cancer pharmacotherapies."},"publication_date":"2020-04-19","publication_name":{"en":"Naunyn-Schmiedeberg's Archives of Pharmacology","ja":"Naunyn-Schmiedeberg's Archives of Pharmacology"},"volume":"Vol.393","number":"No.7","starting_page":"1239","ending_page":"1250","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s00210-020-01859-5"],"issn":["1432-1912"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:18, {"insert":{"user_id":"B000241782","type":"published_papers","id":"33233710"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/32068412","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377797","label":"url"}],"paper_title":{"en":"Novel Hydrophilic Camptothecin Derivatives Conjugated to Branched Glycerol Trimer Suppress Tumor Growth without Causing Diarrhea in Murine Xenograft Models of Human Lung Cancer.","ja":"Novel Hydrophilic Camptothecin Derivatives Conjugated to Branched Glycerol Trimer Suppress Tumor Growth without Causing Diarrhea in Murine Xenograft Models of Human Lung Cancer."},"authors":{"en":[{"name":"Tsuchihashi Yuki"},{"name":"Abe Shinji"},{"name":"Miyamoto Licht"},{"name":"Tsunematsu Honoka"},{"name":"Izumi Toshihiro"},{"name":"Hatano Aya"},{"name":"Okuno Hiroko"},{"name":"Yamane Megumi"},{"name":"Yasuoka Takashi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"Tsuchihashi Yuki"},{"name":"阿部 真治"},{"name":"宮本 理人"},{"name":"Tsunematsu Honoka"},{"name":"Izumi Toshihiro"},{"name":"Hatano Aya"},{"name":"Okuno Hiroko"},{"name":"Yamane Megumi"},{"name":"Yasuoka Takashi"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"description":{"en":"Camptothecin possesses broad antitumor spectra on various cancers. In spite of its marked tumor-suppressing potency, camptothecin is too hydrophobic to be solved in water and therefore not currently in clinical use. CPT-11 (irinotecan) is one of the hydrophilic analogues of camptothecin and widely prescribed. However, its water solubility is still low and furthermore evokes severe diarrhea. Therefore, we designed and synthesized novel highly hydrophilic camptothecin derivatives by conjugating SN38 with branched glycerol trimer (SN38-BGL), which we have been developing as a unique strategy to endow hydrophobic molecule with much hydrophilicity, to maximize the benefit of CPT-11 and minimize the adverse effects. The SN38-BGLs exhibited equivalent or slightly stronger tumor-suppressing effects in murine xenograft human lung cancer models compared to CPT-11. However, neither early- nor late-onset diarrhea was observed when SN38-BGL was administered. Heights of villi in jejunum and ileum were bigger than those from CPT-11-treated mice, indicating that SN38-BGL is less harmful than CPT-11. Ex vivo digestion by liver microsome did not yield SN38 but a couple of other molecules against our expectations, which suggests the involvement of other active metabolites than SN38 and may explain the differences. Hence, SN38-BGLs can be a novel hydrophilic camptothecin derivative without causing severe diarrhea.","ja":"Camptothecin possesses broad antitumor spectra on various cancers. In spite of its marked tumor-suppressing potency, camptothecin is too hydrophobic to be solved in water and therefore not currently in clinical use. CPT-11 (irinotecan) is one of the hydrophilic analogues of camptothecin and widely prescribed. However, its water solubility is still low and furthermore evokes severe diarrhea. Therefore, we designed and synthesized novel highly hydrophilic camptothecin derivatives by conjugating SN38 with branched glycerol trimer (SN38-BGL), which we have been developing as a unique strategy to endow hydrophobic molecule with much hydrophilicity, to maximize the benefit of CPT-11 and minimize the adverse effects. The SN38-BGLs exhibited equivalent or slightly stronger tumor-suppressing effects in murine xenograft human lung cancer models compared to CPT-11. However, neither early- nor late-onset diarrhea was observed when SN38-BGL was administered. Heights of villi in jejunum and ileum were bigger than those from CPT-11-treated mice, indicating that SN38-BGL is less harmful than CPT-11. Ex vivo digestion by liver microsome did not yield SN38 but a couple of other molecules against our expectations, which suggests the involvement of other active metabolites than SN38 and may explain the differences. Hence, SN38-BGLs can be a novel hydrophilic camptothecin derivative without causing severe diarrhea."},"publication_date":"2020-03-04","publication_name":{"en":"Molecular Pharmaceutics","ja":"Molecular Pharmaceutics"},"volume":"Vol.17","number":"No.4","starting_page":"1049","ending_page":"1058","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1021/acs.molpharmaceut.9b00249"],"issn":["1543-8392"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:19, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/115530","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/31882204","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366415","label":"url"}],"paper_title":{"en":"Rho-associated protein kinase and cyclophilin a are involved in inorganic phosphate-induced calcification signaling in vascular smooth muscle cells.","ja":"Rho-associated protein kinase and cyclophilin a are involved in inorganic phosphate-induced calcification signaling in vascular smooth muscle cells."},"authors":{"en":[{"name":"Tsuda Tatsuya"},{"name":"Imanishi Masaki"},{"name":"Oogoshi Mizuho"},{"name":"Goda Mitsuhiro"},{"name":"Kihira Yoshitaka"},{"name":"Horinouchi Yuya"},{"name":"Zamami Yoshito"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Hashimoto Ichiro"},{"name":"Tamaki Toshiaki"},{"name":"Izawa-Ishizawa Yuki"}],"ja":[{"name":"津田 達也"},{"name":"今西 正樹"},{"name":"Oogoshi Mizuho"},{"name":"合田 光寛"},{"name":"木平 孝高"},{"name":"堀ノ内 裕也"},{"name":"座間味 義人"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"橋本 一郎"},{"name":"玉置 俊晃"},{"name":"石澤 有紀"}]},"description":{"en":"Arterial calcification, a risk factor of cardiovascular events, develops with differentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells. Cyclophilin A (CypA) is a peptidyl-prolyl isomerase involved in cardiovascular diseases such as atherosclerosis and aortic aneurysms, and rho-associated protein kinase (ROCK) is involved in the pathogenesis of vascular calcification. CypA is secreted in a ROCK activity-dependent manner and works as a mitogen via autocrine or paracrine mechanisms in VSMCs. We examined the involvement of the ROCK-CypA axis in VSMC calcification induced by inorganic phosphate (Pi), a potent cell mineralization initiator. We found that Pi stimulated ROCK activity, CypA secretion, extracellular signal-regulated protein kinase (ERK) 1/2 phosphorylation, and runt-related transcription factor 2 expression, resulting in calcium accumulation in rat aortic smooth muscle cells (RASMCs). The ROCK inhibitor Y-27632 significantly suppressed Pi-induced CypA secretion, ERK1/2 phosphorylation, and calcium accumulation. Recombinant CypA was found to be associated with increased calcium accumulation in RASMCs. Based on these results, we suggest that autocrine CypA is mediated by ROCK activity and is involved in Pi-induced ERK1/2 phosphorylation following calcification signaling in RASMCs.","ja":"Arterial calcification, a risk factor of cardiovascular events, develops with differentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells. Cyclophilin A (CypA) is a peptidyl-prolyl isomerase involved in cardiovascular diseases such as atherosclerosis and aortic aneurysms, and rho-associated protein kinase (ROCK) is involved in the pathogenesis of vascular calcification. CypA is secreted in a ROCK activity-dependent manner and works as a mitogen via autocrine or paracrine mechanisms in VSMCs. We examined the involvement of the ROCK-CypA axis in VSMC calcification induced by inorganic phosphate (Pi), a potent cell mineralization initiator. We found that Pi stimulated ROCK activity, CypA secretion, extracellular signal-regulated protein kinase (ERK) 1/2 phosphorylation, and runt-related transcription factor 2 expression, resulting in calcium accumulation in rat aortic smooth muscle cells (RASMCs). The ROCK inhibitor Y-27632 significantly suppressed Pi-induced CypA secretion, ERK1/2 phosphorylation, and calcium accumulation. Recombinant CypA was found to be associated with increased calcium accumulation in RASMCs. Based on these results, we suggest that autocrine CypA is mediated by ROCK activity and is involved in Pi-induced ERK1/2 phosphorylation following calcification signaling in RASMCs."},"publication_date":"2020-03","publication_name":{"en":"Journal of Pharmacological Sciences","ja":"Journal of Pharmacological Sciences"},"volume":"Vol.142","number":"No.3","starting_page":"109","ending_page":"115","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.jphs.2019.12.005"],"issn":["1347-8648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:20, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113812","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/31669099","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=360423","label":"url"}],"paper_title":{"en":"Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway","ja":"Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway"},"authors":{"en":[{"name":"Hamano Hirofumi"},{"name":"Niimura Takahiro"},{"name":"Horinouchi Yuya"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Goda Mitsuhiro"},{"name":"Imanishi Masaki"},{"name":"Chuma Masayuki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Fukushima Keijo"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"濱野 裕章"},{"name":"新村 貴博"},{"name":"堀ノ内 裕也"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"合田 光寛"},{"name":"今西 正樹"},{"name":"中馬 真幸"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"福島 圭穣"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"},{"name":"池田 康将"}]},"description":{"en":"Proton pump inhibitors (PPIs) have been used worldwide to treat gastrointestinal disorders. A recent study showed that long-term use of PPIs caused iron deficiency; however, it is unclear whether PPIs affect iron metabolism directly. We investigated the effect of PPIs on the peptide hepcidin, an important iron regulatory hormone. First, we used the FDA Adverse Event Reporting System database and analyzed the influence of PPIs. We found that PPIs, as well as H2 blockers, increased the odds ratio of iron-deficient anemia. Next, HepG2 cells were used to examine the action of PPIs and H2 blockers on hepcidin. PPIs augmented hepcidin expression, while H2 blockers did not. In fact, the PPI omeprazole increased hepcidin secretion, and omeprazole-induced hepcidin upregulation was inhibited by gene silencing or the pharmacological inhibition of the aryl hydrocarbon receptor. In mouse experiments, omeprazole also increased hepatic hepcidin mRNA expression and blood hepcidin levels. In mice treated with omeprazole, protein levels of duodenal and splenic ferroportin decreased. Taken together, PPIs directly affect iron metabolism by suppressing iron absorption through the inhibition of duodenal ferroportin via hepcidin upregulation. These findings provide a new insight into the molecular mechanism of PPI-induced iron deficiency.","ja":"Proton pump inhibitors (PPIs) have been used worldwide to treat gastrointestinal disorders. A recent study showed that long-term use of PPIs caused iron deficiency; however, it is unclear whether PPIs affect iron metabolism directly. We investigated the effect of PPIs on the peptide hepcidin, an important iron regulatory hormone. First, we used the FDA Adverse Event Reporting System database and analyzed the influence of PPIs. We found that PPIs, as well as H2 blockers, increased the odds ratio of iron-deficient anemia. Next, HepG2 cells were used to examine the action of PPIs and H2 blockers on hepcidin. PPIs augmented hepcidin expression, while H2 blockers did not. In fact, the PPI omeprazole increased hepcidin secretion, and omeprazole-induced hepcidin upregulation was inhibited by gene silencing or the pharmacological inhibition of the aryl hydrocarbon receptor. In mouse experiments, omeprazole also increased hepatic hepcidin mRNA expression and blood hepcidin levels. In mice treated with omeprazole, protein levels of duodenal and splenic ferroportin decreased. Taken together, PPIs directly affect iron metabolism by suppressing iron absorption through the inhibition of duodenal ferroportin via hepcidin upregulation. These findings provide a new insight into the molecular mechanism of PPI-induced iron deficiency."},"publication_date":"2020-01","publication_name":{"en":"Toxicology Letters","ja":"Toxicology Letters"},"volume":"Vol.318","starting_page":"86","ending_page":"91","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.toxlet.2019.10.016"],"issn":["1879-3169"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:21, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113746","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/31145863","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351099","label":"url"}],"paper_title":{"en":"Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress","ja":"Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Satoh Akiho"},{"name":"Horinouchi Yuya"},{"name":"Hamano Hirofumi"},{"name":"Watanabe Hiroaki"},{"name":"Imao Mizuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Tasuku Hirayama"},{"name":"Nagasawa Hideko"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"佐藤 明穂"},{"name":"堀ノ内 裕也"},{"name":"濱野 裕章"},{"name":"渡邉 大晃"},{"name":"今尾 瑞季"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"Tasuku Hirayama"},{"name":"永澤 秀子"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Skeletal muscle atrophy is caused by disruption in the homeostatic balance of muscle degeneration and regeneration under various pathophysiological conditions. We have previously reported that iron accumulation induces skeletal muscle atrophy a ubiquitin ligase-dependent pathway. However, the potential effect of iron accumulation on muscle regeneration remains unclear. To examine the effect of iron accumulation on myogenesis, we used a mouse model with cardiotoxin (CTX)-induced muscle regeneration and C2C12 mouse myoblast cells . In mice with iron overload, the skeletal muscles exhibited increased oxidative stress and decreased expression of satellite cell markers. Following CTX-induced muscle injury, these mice also displayed delayed muscle regeneration with a decrease in the size of regenerating myofibers, reduced expression of myoblast differentiation markers, and decreased phosphorylation of MAPK signaling pathways. , iron overload also suppressed the differentiation of C2C12 myoblast cells but the suppression could be reversed by superoxide scavenging using tempol. Excess iron inhibits myogenesis oxidative stress, leading to an imbalance in skeletal muscle homeostasis.-Ikeda, Y., Satoh, A., Horinouchi, Y., Hamano, H., Watanabe, H., Imao, M., Imanishi, M., Zamami, Y., Takechi, K., Izawa-Ishizawa, Y., Miyamoto, L., Hirayama, T., Nagasawa, H., Ishizawa, K., Aihara, K.-I., Tsuchiya, K., Tamaki, T. Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress.","ja":"Skeletal muscle atrophy is caused by disruption in the homeostatic balance of muscle degeneration and regeneration under various pathophysiological conditions. We have previously reported that iron accumulation induces skeletal muscle atrophy a ubiquitin ligase-dependent pathway. However, the potential effect of iron accumulation on muscle regeneration remains unclear. To examine the effect of iron accumulation on myogenesis, we used a mouse model with cardiotoxin (CTX)-induced muscle regeneration and C2C12 mouse myoblast cells . In mice with iron overload, the skeletal muscles exhibited increased oxidative stress and decreased expression of satellite cell markers. Following CTX-induced muscle injury, these mice also displayed delayed muscle regeneration with a decrease in the size of regenerating myofibers, reduced expression of myoblast differentiation markers, and decreased phosphorylation of MAPK signaling pathways. , iron overload also suppressed the differentiation of C2C12 myoblast cells but the suppression could be reversed by superoxide scavenging using tempol. Excess iron inhibits myogenesis oxidative stress, leading to an imbalance in skeletal muscle homeostasis.-Ikeda, Y., Satoh, A., Horinouchi, Y., Hamano, H., Watanabe, H., Imao, M., Imanishi, M., Zamami, Y., Takechi, K., Izawa-Ishizawa, Y., Miyamoto, L., Hirayama, T., Nagasawa, H., Ishizawa, K., Aihara, K.-I., Tsuchiya, K., Tamaki, T. Iron accumulation causes impaired myogenesis correlated with MAPK signaling pathway inhibition by oxidative stress."},"publication_date":"2019-08-01","publication_name":{"en":"The FASEB journal","ja":"The FASEB journal"},"volume":"Vol.33","number":"No.8","starting_page":"9551","ending_page":"9564","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1096/fj.201802724RR"],"issn":["1530-6860"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:22, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376210"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30062585","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=341569","label":"url"}],"paper_title":{"en":"Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database.","ja":"Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database."},"authors":{"en":[{"name":"Hamano Hirofumi"},{"name":"Mitsui Marin"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Nimura Takahiro"},{"name":"Okada Naoto"},{"name":"Fukushima Keijo"},{"name":"Imanishi Masaki"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kirino Yasushi"},{"name":"Nakamura Toshimi"},{"name":"Teraoka Kazuhiko"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Yanagawa Hiroaki"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"濱野 裕章"},{"name":"三井 茉綸"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"Nimura Takahiro"},{"name":"岡田 直人"},{"name":"福島 圭穣"},{"name":"今西 正樹"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"Kirino Yasushi"},{"name":"Nakamura Toshimi"},{"name":"寺岡 和彦"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"楊河 宏章"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"description":{"en":"These data indicate that oral alkalization drugs may reduce the frequency of neutropenia caused by irinotecan administration, making it possible to increase the dose safely.","ja":"These data indicate that oral alkalization drugs may reduce the frequency of neutropenia caused by irinotecan administration, making it possible to increase the dose safely."},"publication_date":"2019-03","publication_name":{"en":"Supportive Care in Cancer","ja":"Supportive Care in Cancer"},"volume":"Vol.27","number":"No.3","starting_page":"849","ending_page":"856","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s00520-018-4367-y"],"issn":["1433-7339"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:23, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30351343","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=347373","label":"url"}],"paper_title":{"en":"Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-induced Aortic Fibrosis.","ja":"Xanthine Oxidase Inhibition by Febuxostat in Macrophages Suppresses Angiotensin II-induced Aortic Fibrosis."},"authors":{"en":[{"name":"Kondo Masateru"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Ikuto Raiki"},{"name":"Murai Yoichi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"近藤 正輝"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"生藤 来希"},{"name":"村井 陽一"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"description":{"en":"Our results suggested that FEB ameliorates Ang II-induced aortic fibrosis via suppressing macrophage-derived TGF-1 expression.","ja":"Our results suggested that FEB ameliorates Ang II-induced aortic fibrosis via suppressing macrophage-derived TGF-1 expression."},"publication_date":"2019-02-12","publication_name":{"en":"American Journal of Hypertension","ja":"American Journal of Hypertension"},"volume":"Vol.32","number":"No.3","starting_page":"249","ending_page":"256","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1093/ajh/hpy157"],"issn":["1941-7225"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:24, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113264","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30303488","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=347382","label":"url"}],"paper_title":{"en":"Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses.","ja":"Development of a novel aortic dissection mouse model and evaluation of drug efficacy using in-vivo assays and database analyses."},"authors":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Hiroki Toya"},{"name":"Tomoko Nagao"},{"name":"Morishita Marin"},{"name":"Tsuneyama Koichi"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Takechi Kenshi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Yoshizumi Masanori"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"Morishita Marin"},{"name":"常山 幸一"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"武智 研志"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"吉栖 正典"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"description":{"en":"Aortic dissection is a life-threatening disease. At present, the only therapeutic strategies available are surgery and antihypertensive drugs. Moreover, the molecular mechanisms underlying the onset of aortic dissection are still unclear. We established a novel aortic dissection model in mice using pharmacologically induced endothelial dysfunction. We then used the Japanese Adverse Drug Event Report database to investigate the role of pitavastatin in preventing the onset of aortic dissection. To induce endothelial dysfunction, Nω-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, was administered to C57BL/6 mice. Three weeks later, angiotensin II (Ang II) and β-aminopropionitrile (BAPN), a lysyl oxidase inhibitor, were administered with osmotic mini-pumps. False lumen formation was used as the pathological determinant of aortic dissection. The incidences of aortic dissection and death from aneurysmal rupture were significantly higher in the Nω-nitro-L-arginine methyl ester, Ang II, and BAPN (LAB) group than they were in the Ang II and BAPN (AB) group.Pitavastatin was administered orally to LAB mice. It significantly lowered the incidences of dissection and rupture. It also decreased inflammation and medial degradation, both of which were exacerbated in the LAB group. The Japanese Adverse Drug Event Report database analysis indicated that there were 113 cases of aortic dissection out of 95 090 patients (0.12%) not receiving statins but only six cases out of 16 668 patients receiving statins (0.04%) (odds ratio: 0.30; P = 0.0043). Our results suggest that endothelial dysfunction is associated with the onset of aortic dissection and pitavastatin can help prevent this condition.","ja":"Aortic dissection is a life-threatening disease. At present, the only therapeutic strategies available are surgery and antihypertensive drugs. Moreover, the molecular mechanisms underlying the onset of aortic dissection are still unclear. We established a novel aortic dissection model in mice using pharmacologically induced endothelial dysfunction. We then used the Japanese Adverse Drug Event Report database to investigate the role of pitavastatin in preventing the onset of aortic dissection. To induce endothelial dysfunction, Nω-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, was administered to C57BL/6 mice. Three weeks later, angiotensin II (Ang II) and β-aminopropionitrile (BAPN), a lysyl oxidase inhibitor, were administered with osmotic mini-pumps. False lumen formation was used as the pathological determinant of aortic dissection. The incidences of aortic dissection and death from aneurysmal rupture were significantly higher in the Nω-nitro-L-arginine methyl ester, Ang II, and BAPN (LAB) group than they were in the Ang II and BAPN (AB) group.Pitavastatin was administered orally to LAB mice. It significantly lowered the incidences of dissection and rupture. It also decreased inflammation and medial degradation, both of which were exacerbated in the LAB group. The Japanese Adverse Drug Event Report database analysis indicated that there were 113 cases of aortic dissection out of 95 090 patients (0.12%) not receiving statins but only six cases out of 16 668 patients receiving statins (0.04%) (odds ratio: 0.30; P = 0.0043). Our results suggest that endothelial dysfunction is associated with the onset of aortic dissection and pitavastatin can help prevent this condition."},"publication_date":"2019-01","publication_name":{"en":"Journal of Hypertension","ja":"Journal of Hypertension"},"volume":"Vol.37","number":"No.1","starting_page":"73","ending_page":"83","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1097/HJH.0000000000001898"],"issn":["1473-5598"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:25, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376211"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30253416","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85054191604&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=354050","label":"url"}],"paper_title":{"en":"Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation.","ja":"Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation."},"authors":{"en":[{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Sakurada T"},{"name":"Kohara Y"},{"name":"Horinouchi Yuya"},{"name":"Sairyo E"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Fukushima Keijo"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Yoshizumi M"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"Sakurada T"},{"name":"Kohara Y"},{"name":"堀ノ内 裕也"},{"name":"Sairyo E"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"福島 圭穣"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"Yoshizumi M"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"description":{"en":"We have reported that nitrosonifedipine (NO-NIF), a photodegradation product of nifedipine, has strong antioxidant and endothelial protective effects, and can suppress several cardiovascular diseases in animal models. The objective of the present study was to investigate the effects of NO-NIF on aortic aneurysm formation. The mice were infused with β-aminopropionitrile for 2 weeks and angiotensin II for 6 weeks to induce aortic aneurysm formation. The oxidative stress was measured by dihydroethidium staining and nitrotyrosine staining. The expressions of inflammation-related genes were assessed by quantitative real-time PCR and immunohistochemical staining. To clarify the mechanisms of how NO-NIF suppresses vascular cell adhesion molecule (VCAM)-1, endothelial cells were used in in vitro system. NO-NIF suppressed pharmacologically induced the aortic aneurysm formation and aortic expansion without blood pressure changes. NO-NIF suppressed elastin degradation and matrix metalloproteinase-2 mRNA expression. NO-NIF suppressed the reactive oxygen species-cyclophilin A positive feedback loop. Upregulated mRNA expressions of inflammation-related genes and endothelial VCAM-1 were suppressed by NO-NIF co-treatment in aortae. NO-NIF has the potential to be a new, nifedipine-derived therapeutic drug for suppressing aortic aneurysm formation by directly improving aortic structure with its strong ability to reduce oxidative stress and inflammation.","ja":"We have reported that nitrosonifedipine (NO-NIF), a photodegradation product of nifedipine, has strong antioxidant and endothelial protective effects, and can suppress several cardiovascular diseases in animal models. The objective of the present study was to investigate the effects of NO-NIF on aortic aneurysm formation. The mice were infused with β-aminopropionitrile for 2 weeks and angiotensin II for 6 weeks to induce aortic aneurysm formation. The oxidative stress was measured by dihydroethidium staining and nitrotyrosine staining. The expressions of inflammation-related genes were assessed by quantitative real-time PCR and immunohistochemical staining. To clarify the mechanisms of how NO-NIF suppresses vascular cell adhesion molecule (VCAM)-1, endothelial cells were used in in vitro system. NO-NIF suppressed pharmacologically induced the aortic aneurysm formation and aortic expansion without blood pressure changes. NO-NIF suppressed elastin degradation and matrix metalloproteinase-2 mRNA expression. NO-NIF suppressed the reactive oxygen species-cyclophilin A positive feedback loop. Upregulated mRNA expressions of inflammation-related genes and endothelial VCAM-1 were suppressed by NO-NIF co-treatment in aortae. NO-NIF has the potential to be a new, nifedipine-derived therapeutic drug for suppressing aortic aneurysm formation by directly improving aortic structure with its strong ability to reduce oxidative stress and inflammation."},"publication_date":"2018-09-25","publication_name":{"en":"Pharmacology","ja":"Pharmacology"},"volume":"Vol.102","number":"No.5-6","starting_page":"281","ending_page":"286","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1159/000492577"],"issn":["1423-0313"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:26, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112445","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30022146","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=342025","label":"url"}],"paper_title":{"en":"Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis.","ja":"Renoprotective effects of a factor Xa inhibitor: fusion of basic research and a database analysis."},"authors":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Imanishi Masaki"},{"name":"Hamano Hirofumi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"今西 正樹"},{"name":"Hamano Hirofumi"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Renal tubulointerstitial injury, an inflammation-associated condition, is a major cause of chronic kidney disease (CKD). Levels of activated factor X (FXa), a blood coagulation factor, are increased in various inflammatory diseases. Therefore, we investigated the protective effects of an FXa inhibitor against renal tubulointerstitial injury using unilateral ureteral obstruction (UUO) mice (a renal tubulointerstitial fibrosis model) and the Food and Drug Administration Adverse Events Reporting System (FAERS) database. The renal expression levels of FX and the FXa receptors protease-activated receptor (PAR)-1 and PAR-2 were significantly higher in UUO mice than in sham-operated mice. UUO-induced tubulointerstitial fibrosis and extracellular matrix expression were suppressed in UUO mice treated with the FXa inhibitor edoxaban. Additionally, edoxaban attenuated UUO-induced macrophage infiltration and inflammatory molecule upregulation. In an analysis of the FAERS database, there were significantly fewer reports of tubulointerstitial nephritis for patients treated with FXa inhibitors than for patients not treated with inhibitors. These results suggest that FXa inhibitors exert protective effects against CKD by inhibiting tubulointerstitial fibrosis.","ja":"Renal tubulointerstitial injury, an inflammation-associated condition, is a major cause of chronic kidney disease (CKD). Levels of activated factor X (FXa), a blood coagulation factor, are increased in various inflammatory diseases. Therefore, we investigated the protective effects of an FXa inhibitor against renal tubulointerstitial injury using unilateral ureteral obstruction (UUO) mice (a renal tubulointerstitial fibrosis model) and the Food and Drug Administration Adverse Events Reporting System (FAERS) database. The renal expression levels of FX and the FXa receptors protease-activated receptor (PAR)-1 and PAR-2 were significantly higher in UUO mice than in sham-operated mice. UUO-induced tubulointerstitial fibrosis and extracellular matrix expression were suppressed in UUO mice treated with the FXa inhibitor edoxaban. Additionally, edoxaban attenuated UUO-induced macrophage infiltration and inflammatory molecule upregulation. In an analysis of the FAERS database, there were significantly fewer reports of tubulointerstitial nephritis for patients treated with FXa inhibitors than for patients not treated with inhibitors. These results suggest that FXa inhibitors exert protective effects against CKD by inhibiting tubulointerstitial fibrosis."},"publication_date":"2018-07-18","publication_name":{"en":"Scientific Reports","ja":"Scientific Reports"},"volume":"Vol.8","number":"No.1","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/s41598-018-29008-2"],"issn":["2045-2322"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:27, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376212"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/110922","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/28992067","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325682","label":"url"}],"paper_title":{"en":"The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease","ja":"The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease"},"authors":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publication_date":"2018-04","publication_name":{"en":"Nephrology, Dialysis, Transplantation","ja":"Nephrology, Dialysis, Transplantation"},"volume":"Vol.33","number":"No.4","starting_page":"586","ending_page":"597","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1093/ndt/gfx252"],"issn":["1460-2385"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:28, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112243","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/30282865","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=356163","label":"url"}],"paper_title":{"en":"Methanol extraction fraction from Citrus Sudachi peel exerts lipid reducing effects in cultured cells.","ja":"Methanol extraction fraction from Citrus Sudachi peel exerts lipid reducing effects in cultured cells."},"authors":{"en":[{"name":"Xu Wenting"},{"name":"Miyamoto Licht"},{"name":"Aihara Haruna"},{"name":"Yamaoka Tomomi"},{"name":"Tanaka Naonobu"},{"name":"Tsuchihashi Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"許 文婷"},{"name":"宮本 理人"},{"name":"粟飯原 遥奈"},{"name":"山岡 朋美"},{"name":"田中 直伸"},{"name":"土橋 有希"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"description":{"en":"Ectopic fat accumulation is associated with insulin resistance and type 2 diabetes mellitus. Citrus sudachi is an evergreen tree that is found mainly in Tokushima Prefecture in Japan. Previously, it was demonstrated that Citrus sudachi could inhibit the rising trend of blood glucose and fatty acid in human subjects. In the current study, we illustrated the function of methanol extracts from sudachi peel and investigated the mechanism of this effect. We got the five kinds of methanol extracts by using diaion HP-20, and those were named by hydrophobicity from M-F1 to M-F5. Among the 5 kinds of sudachi methanol extracts, only M-F4 significantly decreased the intracellular triglyceride of C2C12 cells. It augmented the AMPK activity and increased the transcription of PPARα and its downstream targets CPT-1b and UCP2. In conclusion, M-F4 improved the lipid metabolism possibly through AMPK, PPARα and their downstream targets like CPT-1b and UCP2. Furthermore, this extract may be useful for preventing obesity and diabetes related diseases. J. Med. Invest. 65:225-230, August, 2018.","ja":"Ectopic fat accumulation is associated with insulin resistance and type 2 diabetes mellitus. Citrus sudachi is an evergreen tree that is found mainly in Tokushima Prefecture in Japan. Previously, it was demonstrated that Citrus sudachi could inhibit the rising trend of blood glucose and fatty acid in human subjects. In the current study, we illustrated the function of methanol extracts from sudachi peel and investigated the mechanism of this effect. We got the five kinds of methanol extracts by using diaion HP-20, and those were named by hydrophobicity from M-F1 to M-F5. Among the 5 kinds of sudachi methanol extracts, only M-F4 significantly decreased the intracellular triglyceride of C2C12 cells. It augmented the AMPK activity and increased the transcription of PPARα and its downstream targets CPT-1b and UCP2. In conclusion, M-F4 improved the lipid metabolism possibly through AMPK, PPARα and their downstream targets like CPT-1b and UCP2. Furthermore, this extract may be useful for preventing obesity and diabetes related diseases. J. Med. Invest. 65:225-230, August, 2018."},"publication_date":"2018","publication_name":{"en":"The Journal of Medical Investigation : JMI","ja":"The Journal of Medical Investigation : JMI"},"volume":"Vol.65","number":"No.3.4","starting_page":"225","ending_page":"230","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2152/jmi.65.225"],"issn":["1349-6867"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:29, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376213"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/29607928","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=343011","label":"url"}],"paper_title":{"en":"Mechanisms of the pH- and Oxygen-Dependent Oxidation Activities of Artesunate.","ja":"Mechanisms of the pH- and Oxygen-Dependent Oxidation Activities of Artesunate."},"authors":{"en":[{"name":"Tsuda Katsunori"},{"name":"Miyamoto Licht"},{"name":"Hamano Shuichi"},{"name":"Morimoto Yuri"},{"name":"Kangawa Yumi"},{"name":"Fukue Chika"},{"name":"Kagawa Yoko"},{"name":"Horinouchi Yuya"},{"name":"Xu Wenting"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"津田 勝範"},{"name":"宮本 理人"},{"name":"濱野 修一"},{"name":"Morimoto Yuri"},{"name":"Kangawa Yumi"},{"name":"Fukue Chika"},{"name":"Kagawa Yoko"},{"name":"堀ノ内 裕也"},{"name":"Xu Wenting"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"description":{"en":"Artemisinin was discovered in 1971 as a constituent of the wormwood genus plant (Artemisia annua). This plant has been used as an herbal medicine to treat malaria since ancient times. The compound artemisinin has a sesquiterpene lactone bearing a peroxide group that offers its biological activity. In addition to anti-malarial activity, artemisinin derivatives have been reported to exert antitumor activity in cancer cells, and have attracted attention as potential anti-cancer drugs. Mechanisms that might explain the antitumor activities of artemisinin derivatives reportedly induction of apoptosis, angiogenesis inhibitory effects, inhibition of hypoxia-inducible factor-1 (HIF-1) activation, and direct DNA injury. Reactive oxygen species (ROS) generation is involved in many cases. However, little is known about the mechanism of ROS formation from artemisinin derivatives and what types of ROS are produced. Therefore, we investigated the iron-induced ROS formation mechanism by using artesunate, a water-soluble artemisinin derivative, which is thought to be the underlying mechanism involved in artesunate-mediated cell death. The ROS generated by the coexistence of iron(II), artesunate, and molecular oxygen was a hydroxyl radical or hydroxyl radical-like ROS. Artesunate can reduce iron(III) to iron(II), which enables generation of ROS irrespective of the iron valence. We found that reduction from iron(III) to iron(II) was activated in the acidic rather than the neutral region and was proportional to the hydrogen ion concentration.","ja":"Artemisinin was discovered in 1971 as a constituent of the wormwood genus plant (Artemisia annua). This plant has been used as an herbal medicine to treat malaria since ancient times. The compound artemisinin has a sesquiterpene lactone bearing a peroxide group that offers its biological activity. In addition to anti-malarial activity, artemisinin derivatives have been reported to exert antitumor activity in cancer cells, and have attracted attention as potential anti-cancer drugs. Mechanisms that might explain the antitumor activities of artemisinin derivatives reportedly induction of apoptosis, angiogenesis inhibitory effects, inhibition of hypoxia-inducible factor-1 (HIF-1) activation, and direct DNA injury. Reactive oxygen species (ROS) generation is involved in many cases. However, little is known about the mechanism of ROS formation from artemisinin derivatives and what types of ROS are produced. Therefore, we investigated the iron-induced ROS formation mechanism by using artesunate, a water-soluble artemisinin derivative, which is thought to be the underlying mechanism involved in artesunate-mediated cell death. The ROS generated by the coexistence of iron(II), artesunate, and molecular oxygen was a hydroxyl radical or hydroxyl radical-like ROS. Artesunate can reduce iron(III) to iron(II), which enables generation of ROS irrespective of the iron valence. We found that reduction from iron(III) to iron(II) was activated in the acidic rather than the neutral region and was proportional to the hydrogen ion concentration."},"publication_date":"2018","publication_name":{"en":"Biological & Pharmaceutical Bulletin","ja":"Biological & Pharmaceutical Bulletin"},"volume":"Vol.41","number":"No.4","starting_page":"555","ending_page":"563","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/bpb.b17-00855"],"issn":["1347-5215"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:30, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112397","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/29263333","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=335442","label":"url"}],"paper_title":{"en":"Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest.","ja":"Hydrocortisone administration was associated with improved survival in Japanese patients with cardiac arrest."},"authors":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Koyama Toshihiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyake Masashi"},{"name":"Koga Tadashi"},{"name":"Harada Keisaku"},{"name":"Ohshima Ayako"},{"name":"Imai Toru"},{"name":"Kondo Yutaka"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Hinotsu Shiro"},{"name":"Kano Mitsunobu R"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"Koyama Toshihiro"},{"name":"石澤 有紀"},{"name":"Miyake Masashi"},{"name":"Koga Tadashi"},{"name":"Harada Keisaku"},{"name":"Ohshima Ayako"},{"name":"Imai Toru"},{"name":"Kondo Yutaka"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"Hinotsu Shiro"},{"name":"Kano Mitsunobu R"},{"name":"石澤 啓介"}]},"description":{"en":"There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2% of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60-10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge.","ja":"There are few reports on hydrocortisone administration after cardiac arrest, and those that have been published included few subjects. This study aimed to evaluate the effect of hydrocortisone administration on the outcomes of patients who experienced cardiac arrest. We investigated the survival discharge rates and the length of hospital stay from cardiac arrest to discharge, stratified by use of hydrocortisone, using a Japanese health-insurance claims dataset that covers approximately 2% of the Japanese population. The study included the data of 2233 subjects who experienced either in-hospital or out-of-hospital cardiac arrest between January 2005 and May 2014. These patients were divided into two groups, based on the administration of hydrocortisone. We adjusted the baseline characteristics, medical treatment, and drug administration data of the two groups using propensity scores obtained via the inverse probability of treatment weighted method. The hydrocortisone group had a significantly higher survival discharge rate (13/61 [21.1%] vs. 240/2172 [11.0%], adjusted odds ratio: 4.2, 95% CI: 1.60-10.98, p = 0.004). In addition, the administration of hydrocortisone was independent predictor of survival to discharge (hazard ratio: 4.6, p < 0.001). The results demonstrate a correlation between hydrocortisone administration and the high rates of survival to discharge."},"publication_date":"2017-12-20","publication_name":{"en":"Scientific Reports","ja":"Scientific Reports"},"volume":"Vol.7","number":"No.1","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/s41598-017-17686-3"],"issn":["2045-2322"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:31, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/112368","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/28878231","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=329173","label":"url"}],"paper_title":{"en":"Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice","ja":"Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Hirofumi Hamano"},{"name":"Tasuku Hirayama"},{"name":"Kishi Seiji"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Nagasawa Hideko"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"濱野 裕章"},{"name":"Tasuku Hirayama"},{"name":"岸 誠司"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"永澤 秀子"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Increased proteinuria causes tubulointerstitial injury due to inflammation in chronic kidney disease (CKD). Iron restriction exhibits protective effects against renal dysfunction; however, its effects against protein overload-induced tubulointerstitial damage remain unclear. Here, we investigated dietary iron restriction effect on tubulointerstitial damage in mice with protein-overload tubulointerstitial injury. Renal tubulointerstitial injury in animal model was induced by intraperitoneal injection of an overdose of bovine serum albumin (BSA). We divided mice into three groups: normal saline + normal diet (ND), BSA + ND, and BSA + iron-restricted diet (IRD). BSA overload induced renal tubulointerstitial injury in the ND mice, which was ameliorated in the IRD mice. Inflammatory cytokines and extracellular matrix mRNA expression was upregulated in BSA + ND mice kidneys and was inhibited by IRD. BSA-induced increase in renal superoxide production, NADPH oxidase activity, and p22(phox) expression was diminished in the IRD mice. IRD suppression increased BSA-induced renal macrophage infiltration. Moreover, BSA mice exhibited nucleotide-binding oligomerisation domain-like receptor pyrin domain-containing protein (NLRP) inflammasome activation, which was inhibited by IRD. Ferrous iron increased in kidneys with BSA overload and was inhibited by IRD. Thus, iron restriction inhibited oxidative stress and inflammatory changes, contributing to the protective effect against BSA overload-induced tubulointerstitial injury.","ja":"Increased proteinuria causes tubulointerstitial injury due to inflammation in chronic kidney disease (CKD). Iron restriction exhibits protective effects against renal dysfunction; however, its effects against protein overload-induced tubulointerstitial damage remain unclear. Here, we investigated dietary iron restriction effect on tubulointerstitial damage in mice with protein-overload tubulointerstitial injury. Renal tubulointerstitial injury in animal model was induced by intraperitoneal injection of an overdose of bovine serum albumin (BSA). We divided mice into three groups: normal saline + normal diet (ND), BSA + ND, and BSA + iron-restricted diet (IRD). BSA overload induced renal tubulointerstitial injury in the ND mice, which was ameliorated in the IRD mice. Inflammatory cytokines and extracellular matrix mRNA expression was upregulated in BSA + ND mice kidneys and was inhibited by IRD. BSA-induced increase in renal superoxide production, NADPH oxidase activity, and p22(phox) expression was diminished in the IRD mice. IRD suppression increased BSA-induced renal macrophage infiltration. Moreover, BSA mice exhibited nucleotide-binding oligomerisation domain-like receptor pyrin domain-containing protein (NLRP) inflammasome activation, which was inhibited by IRD. Ferrous iron increased in kidneys with BSA overload and was inhibited by IRD. Thus, iron restriction inhibited oxidative stress and inflammatory changes, contributing to the protective effect against BSA overload-induced tubulointerstitial injury."},"publication_date":"2017-09-06","publication_name":{"en":"Scientific Reports","ja":"Scientific Reports"},"volume":"Vol.7","number":"No.1","starting_page":"10621","ending_page":"10621","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/s41598-017-11089-0"],"issn":["2045-2322"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:32, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376214"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/115483","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/28592707","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325954","label":"url"}],"paper_title":{"en":"Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice.","ja":"Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice."},"authors":{"en":[{"name":"Mitsuhashi Takeshi"},{"name":"Uemoto Ryoko"},{"name":"Ishikawa Kazue"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Matsumoto Toshio"},{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"Mitsuhashi Takeshi"},{"name":"Uemoto Ryoko"},{"name":"Ishikawa Kazue"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"松本 俊夫"},{"name":"赤池 雅史"},{"name":"粟飯原 賢一"}]},"description":{"en":"Pitavastatin exerts eNOS-independent protective effects against atherogenesis and hind-limb ischemia in mice, which may occur via modifications on key molecules such as AMPK and diverse molecules.","ja":"In Study 1, pitavastatin attenuated plaque formation and medial fibrosis of the aortic root with decreased macrophage infiltration in eNOS(-/-) ApoE(-/-) mice. PCR array analysis showed reductions in aortic gene expression of proatherogenic factors, including Ccl2 and Ccr2 in pitavastatin-treated double mutant mice. In addition, pitavastatin activated not only atherogenic p38MAPK and JNK but also anti-atherogenic ERK1/2 and ERK5 in the aorta of the double mutant mice. In Study 2, pitavastatin prolonged hind-limb survival after the surgery with increased BCL2-to-BAX protein ratio and inactivated JNK. Enhanced expression of anti-apoptotic genes, including Vegf, Api5, Atf5, Prdx2, and Dad1, was observed in the ischemic limb of pitavastatin-treated eNOS(-/-) mice. Furthermore, pitavastatin activated both aortic and skeletal muscle AMPK in the eNOS-deficient vascular injury models."},"publication_date":"2017-06-06","publication_name":{"en":"Journal of Atherosclerosis and Thrombosis","ja":"Journal of Atherosclerosis and Thrombosis"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.5551/jat.37747"],"issn":["1880-3873"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:33, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376215"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/110925","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/28502917","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325955","label":"url"}],"paper_title":{"en":"The Role of Heparin Cofactor in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice.","ja":"The Role of Heparin Cofactor in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice."},"authors":{"en":[{"name":"Kurahashi Kiyoe"},{"name":"Inoue Seika"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Morimoto Kana"},{"name":"Uemoto Ryoko"},{"name":"Ishikawa Kazue"},{"name":"Kondo Takeshi"},{"name":"Yuasa Tomoyuki"},{"name":"Endo Itsuro"},{"name":"Miyake Masato"},{"name":"Oyadomari Seiichi"},{"name":"Matsumoto Toshio"},{"name":"Abe Masahiro"},{"name":"Sakaue Hiroshi"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"倉橋 清衛"},{"name":"Inoue Seika"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"森本 佳奈"},{"name":"Uemoto Ryoko"},{"name":"Ishikawa Kazue"},{"name":"近藤 剛史"},{"name":"湯浅 智之"},{"name":"遠藤 逸朗"},{"name":"三宅 雅人"},{"name":"親泊 政一"},{"name":"松本 俊夫"},{"name":"安倍 正博"},{"name":"阪上 浩"},{"name":"粟飯原 賢一"}]},"description":{"en":"The present studies provide evidence to support the idea that HC plays an important role in the maintenance of glucose homeostasis by regulating insulin sensitivity in both humans and mice. Stimulators of HC production may serve as novel therapeutic tools for the treatment of type 2 diabetes.","ja":"The present studies provide evidence to support the idea that HC plays an important role in the maintenance of glucose homeostasis by regulating insulin sensitivity in both humans and mice. Stimulators of HC production may serve as novel therapeutic tools for the treatment of type 2 diabetes."},"publication_date":"2017-05-15","publication_name":{"en":"Journal of Atherosclerosis and Thrombosis","ja":"Journal of Atherosclerosis and Thrombosis"},"languages":["eng"],"referee":true,"identifiers":{"doi":["10.5551/jat.37739"],"issn":["1880-3873"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:34, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376216"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113749","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/28263291","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=322994","label":"url"}],"paper_title":{"en":"Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation","ja":"Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation"},"authors":{"en":[{"name":"Oshima Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Watanabe Hiroaki"},{"name":"Hamano Hirofumi"},{"name":"Kihira Yoshitaka"},{"name":"Kishi Seiji"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Hirayama Tasuku"},{"name":"Nagasawa Hideko"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"大島 啓亮"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"Watanabe Hiroaki"},{"name":"Hamano Hirofumi"},{"name":"木平 孝高"},{"name":"岸 誠司"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"Hirayama Tasuku"},{"name":"永澤 秀子"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Renal anemia is a major complication in chronic kidney disease (CKD). Iron supplementation, as well as erythropoiesis-stimulating agents, are widely used for treatment of renal anemia. However, excess iron causes oxidative stress via the Fenton reaction, and iron supplementation might damage remnant renal function including erythropoietin (EPO) production in CKD. EPO gene expression was suppressed in mice following direct iron treatment. Hypoxia-inducible factor-2 alpha (HIF-2α), a positive regulator of the EPO gene, was also diminished in the kidney of mice following iron treatment. Anemia-induced increase in renal EPO and HIF-2α expression was inhibited by iron treatment. In in vitro experiments using EPO-producing HepG2 cells, iron stimulation reduced the expression of the EPO gene, as well as HIF-2α. Moreover, iron treatment augmented oxidative stress, and iron-induced reduction of EPO and HIF-2α expression was restored by tempol, an antioxidant compound. HIF-2α interaction with the Epo promoter was inhibited by iron treatment, and was restored by tempol. These findings suggested that iron supplementation reduced EPO gene expression via an oxidative stress-HIF-2α-dependent signaling pathway.","ja":"Renal anemia is a major complication in chronic kidney disease (CKD). Iron supplementation, as well as erythropoiesis-stimulating agents, are widely used for treatment of renal anemia. However, excess iron causes oxidative stress via the Fenton reaction, and iron supplementation might damage remnant renal function including erythropoietin (EPO) production in CKD. EPO gene expression was suppressed in mice following direct iron treatment. Hypoxia-inducible factor-2 alpha (HIF-2α), a positive regulator of the EPO gene, was also diminished in the kidney of mice following iron treatment. Anemia-induced increase in renal EPO and HIF-2α expression was inhibited by iron treatment. In in vitro experiments using EPO-producing HepG2 cells, iron stimulation reduced the expression of the EPO gene, as well as HIF-2α. Moreover, iron treatment augmented oxidative stress, and iron-induced reduction of EPO and HIF-2α expression was restored by tempol, an antioxidant compound. HIF-2α interaction with the Epo promoter was inhibited by iron treatment, and was restored by tempol. These findings suggested that iron supplementation reduced EPO gene expression via an oxidative stress-HIF-2α-dependent signaling pathway."},"publication_date":"2017-03-06","publication_name":{"en":"Laboratory Investigation; a Journal of Technical Methods and Pathology","ja":"Laboratory Investigation; a Journal of Technical Methods and Pathology"},"volume":"Vol.97","number":"No.5","starting_page":"555","ending_page":"566","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/labinvest.2017.11"],"issn":["1530-0307"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:35, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376217"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/110118","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/28090711","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=323552","label":"url"}],"paper_title":{"en":"Topical Application of Nitrosonifedipine, a Novel Radical Scavenger, Ameliorates Ischemic Skin Flap Necrosis in a Mouse Model.","ja":"Topical Application of Nitrosonifedipine, a Novel Radical Scavenger, Ameliorates Ischemic Skin Flap Necrosis in a Mouse Model."},"authors":{"en":[{"name":"Fukunaga Yutaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Sairyo Eriko"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Abe Yoshiro"},{"name":"Hashimoto Ichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"福永 豊"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"Sairyo Eriko"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"安倍 吉郎"},{"name":"橋本 一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Ischemic skin flap necrosis can occur in random pattern flaps. An excess amount of reactive oxygen species is generated and causes necrosis in the ischemic tissue. Nitrosonifedipine (NO-NIF) has been demonstrated to possess potent radical scavenging ability. However, there has been no study on the effects of NO-NIF on ischemic skin flap necrosis. Therefore, they evaluated the potential of NO-NIF in ameliorating ischemic skin flap necrosis in a mouse model. A random pattern skin flap (1.0 × 3.0 cm) was elevated on the dorsum of C57BL/6 mice. NO-NIF was administered by topical injection immediately after surgery and every 24 hours thereafter. Flap survival was evaluated on postoperative day 7. Tissue samples from the skin flaps were harvested on postoperative days 1 and 3 to analyze oxidative stress, apoptosis and endothelial dysfunction. The viable area of the flap in the NO-NIF group was significantly increased (78.30 ± 7.041%) compared with that of the control group (47.77 ± 6.549%, p < 0.01). NO-NIF reduced oxidative stress, apoptosis and endothelial dysfunction, which were evidenced by the decrease of malondialdehyde, p22phox protein expression, number of apoptotic cells, phosphorylated p38 MAPK protein expression, and vascular cell adhesion molecule-1 protein expression while endothelial nitric oxide synthase protein expression was increased. In conclusion, they demonstrated that NO-NIF ameliorated ischemic skin flap necrosis by reducing oxidative stress, apoptosis, and endothelial dysfunction. NO-NIF is considered to be a candidate for the treatment of ischemic flap necrosis.","ja":"Ischemic skin flap necrosis can occur in random pattern flaps. An excess amount of reactive oxygen species is generated and causes necrosis in the ischemic tissue. Nitrosonifedipine (NO-NIF) has been demonstrated to possess potent radical scavenging ability. However, there has been no study on the effects of NO-NIF on ischemic skin flap necrosis. Therefore, they evaluated the potential of NO-NIF in ameliorating ischemic skin flap necrosis in a mouse model. A random pattern skin flap (1.0 × 3.0 cm) was elevated on the dorsum of C57BL/6 mice. NO-NIF was administered by topical injection immediately after surgery and every 24 hours thereafter. Flap survival was evaluated on postoperative day 7. Tissue samples from the skin flaps were harvested on postoperative days 1 and 3 to analyze oxidative stress, apoptosis and endothelial dysfunction. The viable area of the flap in the NO-NIF group was significantly increased (78.30 ± 7.041%) compared with that of the control group (47.77 ± 6.549%, p < 0.01). NO-NIF reduced oxidative stress, apoptosis and endothelial dysfunction, which were evidenced by the decrease of malondialdehyde, p22phox protein expression, number of apoptotic cells, phosphorylated p38 MAPK protein expression, and vascular cell adhesion molecule-1 protein expression while endothelial nitric oxide synthase protein expression was increased. In conclusion, they demonstrated that NO-NIF ameliorated ischemic skin flap necrosis by reducing oxidative stress, apoptosis, and endothelial dysfunction. NO-NIF is considered to be a candidate for the treatment of ischemic flap necrosis."},"publication_date":"2017-02-17","publication_name":{"en":"Wound Repair and Regeneration","ja":"Wound Repair and Regeneration"},"volume":"Vol.25","number":"No.2","starting_page":"217","ending_page":"223","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1111/wrr.12510"],"issn":["1524-475X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:36, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376218"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113750","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/27049128","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=306466","label":"url"}],"paper_title":{"en":"Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway","ja":"Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Imao Mizuki"},{"name":"Satoh Akiho"},{"name":"Watanabe Hiroaki"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"今尾 瑞季"},{"name":"佐藤 明穂"},{"name":"渡邉 大晃"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Skeletal muscle wasting or sarcopenia is a critical health problem. Skeletal muscle atrophy is induced by an excess of iron, which is an essential trace metal for all living organisms. Excessive amounts of iron catalyze the formation of highly toxic hydroxyl radicals via the Fenton reaction. However, the molecular mechanism of iron-induced skeletal muscle atrophy has remained unclear. In this study, 8-weeks-old C57BL6/J mice were divided into 2 groups: vehicle-treated group and the iron-injected group (10 mg iron·day-1·mouse-1) during 2 weeks. Mice in the iron-injected group showed an increase in the iron content of the skeletal muscle and serum and ferritin levels in the muscle, along with reduced skeletal muscle mass. The skeletal muscle showed elevated mRNA expression of the muscle atrophy-related E3 ubiquitin ligases, atrogin-1 and muscle ring finger-1(MuRF1), on days 7 and 14 of iron treatment. Moreover, iron-treated mice showed reduced phosphorylation of Akt and forkhead box O3 (FOXO3a) in skeletal muscles. Inhibition of FOXO3a using siRNA in vitro in C2C12 myotube cells inhibited iron-induced upregulation of atrogin-1 and MuRF1 and reversed the reduction in myotube diameters. Iron-load caused oxidative stress, and an oxidative stress inhibitor abrogated iron-induced muscle atrophy by reactivating the Akt-FOXO3 pathway. Iron-induced skeletal muscle atrophy is suggested to involve the E3 ubiquitin ligase mediated by the reduction of Akt-FOXO3a signaling by oxidative stress.","ja":"Skeletal muscle wasting or sarcopenia is a critical health problem. Skeletal muscle atrophy is induced by an excess of iron, which is an essential trace metal for all living organisms. Excessive amounts of iron catalyze the formation of highly toxic hydroxyl radicals via the Fenton reaction. However, the molecular mechanism of iron-induced skeletal muscle atrophy has remained unclear. In this study, 8-weeks-old C57BL6/J mice were divided into 2 groups: vehicle-treated group and the iron-injected group (10 mg iron·day-1·mouse-1) during 2 weeks. Mice in the iron-injected group showed an increase in the iron content of the skeletal muscle and serum and ferritin levels in the muscle, along with reduced skeletal muscle mass. The skeletal muscle showed elevated mRNA expression of the muscle atrophy-related E3 ubiquitin ligases, atrogin-1 and muscle ring finger-1(MuRF1), on days 7 and 14 of iron treatment. Moreover, iron-treated mice showed reduced phosphorylation of Akt and forkhead box O3 (FOXO3a) in skeletal muscles. Inhibition of FOXO3a using siRNA in vitro in C2C12 myotube cells inhibited iron-induced upregulation of atrogin-1 and MuRF1 and reversed the reduction in myotube diameters. Iron-load caused oxidative stress, and an oxidative stress inhibitor abrogated iron-induced muscle atrophy by reactivating the Akt-FOXO3 pathway. Iron-induced skeletal muscle atrophy is suggested to involve the E3 ubiquitin ligase mediated by the reduction of Akt-FOXO3a signaling by oxidative stress."},"publication_date":"2016-05","publication_name":{"en":"Journal of Trace Elements in Medicine and Biology","ja":"Journal of Trace Elements in Medicine and Biology"},"volume":"Vol.35","number":"No.5","starting_page":"66","ending_page":"76","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.jtemb.2016.01.011"],"issn":["1878-3252"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:37, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113751","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/26134126","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84946558014&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=294522","label":"url"}],"paper_title":{"en":"Bilirubin exerts pro-angiogenic effects through an Akt-eNOS-dependent pathway","ja":"Bilirubin exerts pro-angiogenic effects through an Akt-eNOS-dependent pathway"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Satoh Akiho"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"佐藤 明穂"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Low serum bilirubin levels are associated with the risk of cardiovascular diseases including peripheral artery disease. Bilirubin is known to exert its property such as antioxidant effect or the enhancement of flow-mediated vasodilation, however, bilirubin action on angiogenesis remains unclear. To investigate the molecular mechanism of bilirubin on angiogenic effect, we first employed C57BL/6J mice with unilateral hindlimb ischemia surgery and divided the mice into two groups (vehicle-treated group and bilirubin-treated group). The analysis of laser speckle blood flow demonstrated the enhancement of blood flow recovery in response to ischemia of mice with bilirubin treatment. The density of capillaries was significantly higher in ischemic-adductor muscles of bilirubin-treated mice. The phosphorylated levels of endothelial nitric oxide synthase (eNOS) and Akt were increased in ischemic skeletal muscles of mice with bilirubin treatment compared with vehicle treatment. In in vitro experiments by using human aortic endothelial cells, bilirubin augmented eNOS and Akt phosphorylation, cell proliferation, cell migration and tube formation. These bilirubin actions on endothelial cell activation were inhibited by LY294002, a phosphatidylinositol 3-kinase inhibitor. In conclusion, bilirubin promotes angiogenesis through endothelial cells activation via Akt-eNOS-dependent manner.","ja":"Low serum bilirubin levels are associated with the risk of cardiovascular diseases including peripheral artery disease. Bilirubin is known to exert its property such as antioxidant effect or the enhancement of flow-mediated vasodilation, however, bilirubin action on angiogenesis remains unclear. To investigate the molecular mechanism of bilirubin on angiogenic effect, we first employed C57BL/6J mice with unilateral hindlimb ischemia surgery and divided the mice into two groups (vehicle-treated group and bilirubin-treated group). The analysis of laser speckle blood flow demonstrated the enhancement of blood flow recovery in response to ischemia of mice with bilirubin treatment. The density of capillaries was significantly higher in ischemic-adductor muscles of bilirubin-treated mice. The phosphorylated levels of endothelial nitric oxide synthase (eNOS) and Akt were increased in ischemic skeletal muscles of mice with bilirubin treatment compared with vehicle treatment. In in vitro experiments by using human aortic endothelial cells, bilirubin augmented eNOS and Akt phosphorylation, cell proliferation, cell migration and tube formation. These bilirubin actions on endothelial cell activation were inhibited by LY294002, a phosphatidylinositol 3-kinase inhibitor. In conclusion, bilirubin promotes angiogenesis through endothelial cells activation via Akt-eNOS-dependent manner."},"publication_date":"2015-07-02","publication_name":{"en":"Hypertension Research","ja":"Hypertension Research"},"volume":"Vol.38","number":"No.11","starting_page":"733","ending_page":"740","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/hr.2015.74"],"issn":["1348-4214"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:38, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113753","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/25096756","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84937513465&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=280180","label":"url"}],"paper_title":{"en":"Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice","ja":"Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice"},"authors":{"en":[{"name":"Tajima Soichiro"},{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"Imao Mizuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Tajima Soichiro"},{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"今尾 瑞季"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Angiotensin II (ANG II) has been shown to affect iron metabolism through alteration of iron transporters, leading to increased cellular and tissue iron contents. Serum ferritin, a marker of body iron storage, is elevated in various cardiovascular diseases, including hypertension. However, the associated changes in iron absorption and the mechanism underlying increased iron content in a hypertensive state remain unclear. The C57BL6/J mice were treated with ANG II to generate a model of hypertension. Mice were divided into three groups: (1) control, (2) ANG II-treated, and (3) ANG II-treated and ANG II receptor blocker (ARB)-administered (ANG II-ARB) groups. Mice treated with ANG II showed increased serum ferritin levels compared to vehicle-treated control mice. In ANG II-treated mice, duodenal divalent metal transporter-1 and ferroportin (FPN) expression levels were increased and hepatic hepcidin mRNA expression and serum hepcidin concentration were reduced. The mRNA expression of bone morphogenetic protein 6 and CCAAT/enhancer-binding protein alpha, which are regulators of hepcidin, was also down-regulated in the livers of ANG II-treated mice. In terms of tissue iron content, macrophage iron content and renal iron content were increased by ANG II treatment, and these increases were associated with reduced expression of transferrin receptor 1 and FPN and increased expression of ferritin. These changes induced by ANG II treatment were ameliorated by the administration of an ARB. Angiotensin II (ANG II) altered the expression of duodenal iron transporters and reduced hepcidin levels, contributing to the alteration of body iron distribution.","ja":"Angiotensin II (ANG II) has been shown to affect iron metabolism through alteration of iron transporters, leading to increased cellular and tissue iron contents. Serum ferritin, a marker of body iron storage, is elevated in various cardiovascular diseases, including hypertension. However, the associated changes in iron absorption and the mechanism underlying increased iron content in a hypertensive state remain unclear. The C57BL6/J mice were treated with ANG II to generate a model of hypertension. Mice were divided into three groups: (1) control, (2) ANG II-treated, and (3) ANG II-treated and ANG II receptor blocker (ARB)-administered (ANG II-ARB) groups. Mice treated with ANG II showed increased serum ferritin levels compared to vehicle-treated control mice. In ANG II-treated mice, duodenal divalent metal transporter-1 and ferroportin (FPN) expression levels were increased and hepatic hepcidin mRNA expression and serum hepcidin concentration were reduced. The mRNA expression of bone morphogenetic protein 6 and CCAAT/enhancer-binding protein alpha, which are regulators of hepcidin, was also down-regulated in the livers of ANG II-treated mice. In terms of tissue iron content, macrophage iron content and renal iron content were increased by ANG II treatment, and these increases were associated with reduced expression of transferrin receptor 1 and FPN and increased expression of ferritin. These changes induced by ANG II treatment were ameliorated by the administration of an ARB. Angiotensin II (ANG II) altered the expression of duodenal iron transporters and reduced hepcidin levels, contributing to the alteration of body iron distribution."},"publication_date":"2015-07","publication_name":{"en":"European Journal of Nutrition","ja":"European Journal of Nutrition"},"volume":"Vol.54","number":"No.5","starting_page":"709","ending_page":"719","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s00394-014-0749-1"],"issn":["1436-6215"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:39, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/109948","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/25832631","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390001204631777920/","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84928951796&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=289231","label":"url"}],"paper_title":{"en":"Hypoxia decreases glucagon-like peptide-1 secretion from GLUTag cell line","ja":"Hypoxia decreases glucagon-like peptide-1 secretion from GLUTag cell line"},"authors":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Burentogtokh Ariunzaya"},{"name":"Itoh Mari"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"Burentogtokh Ariunzaya"},{"name":"Itoh Mari"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Glucagon-like peptide-1 (GLP-1), an incretin hormone, is secreted from L cells located in the intestinal epithelium. It is known that intestinal oxygen tension is decreased postprandially. In addition, we found that the expression of hypoxia-inducible factor-1α (HIF-1α), which accumulates in cells under hypoxic conditions, was significantly increased in the colons of mice with food intake, indicating that the oxygen concentration is likely reduced in the colon after eating. Therefore, we hypothesized that GLP-1 secretion is affected by oxygen tension. We found that forskolin-stimulated GLP-1 secretion from GLUTag cells, a model of intestinal L cells, is suppressed in hypoxia (1% O2). Forskolin-stimulated elevations of preproglucagon (ppGCG) and proprotein convertase 1/3 (PC1/3) mRNA expression were decreased under hypoxic conditions. The finding that H89, a protein kinase A (PKA) inhibitor, inhibited the forskolin-stimulated increase of ppGCG and PC1/3 indicated that the cAMP-PKA pathway is involved in the hypoxia-induced suppression of the genes. Hypoxia decreased hexokinase 2 mRNA and protein expression and increased lactate dehydrogenase A mRNA and protein expression. Concomitantly, lactate production was increased and ATP production was decreased. Together, the results indicate that hypoxia decreases glucose utilization for ATP production, which probably causes a decrease in cAMP production and in subsequent GLP-1 production. Our findings suggest that the postprandial decrease in oxygen tension in the intestine attenuates GLP-1 secretion.","ja":"Glucagon-like peptide-1 (GLP-1), an incretin hormone, is secreted from L cells located in the intestinal epithelium. It is known that intestinal oxygen tension is decreased postprandially. In addition, we found that the expression of hypoxia-inducible factor-1α (HIF-1α), which accumulates in cells under hypoxic conditions, was significantly increased in the colons of mice with food intake, indicating that the oxygen concentration is likely reduced in the colon after eating. Therefore, we hypothesized that GLP-1 secretion is affected by oxygen tension. We found that forskolin-stimulated GLP-1 secretion from GLUTag cells, a model of intestinal L cells, is suppressed in hypoxia (1% O2). Forskolin-stimulated elevations of preproglucagon (ppGCG) and proprotein convertase 1/3 (PC1/3) mRNA expression were decreased under hypoxic conditions. The finding that H89, a protein kinase A (PKA) inhibitor, inhibited the forskolin-stimulated increase of ppGCG and PC1/3 indicated that the cAMP-PKA pathway is involved in the hypoxia-induced suppression of the genes. Hypoxia decreased hexokinase 2 mRNA and protein expression and increased lactate dehydrogenase A mRNA and protein expression. Concomitantly, lactate production was increased and ATP production was decreased. Together, the results indicate that hypoxia decreases glucose utilization for ATP production, which probably causes a decrease in cAMP production and in subsequent GLP-1 production. Our findings suggest that the postprandial decrease in oxygen tension in the intestine attenuates GLP-1 secretion."},"publication_date":"2015-04","publication_name":{"en":"Biological & Pharmaceutical Bulletin","ja":"Biological & Pharmaceutical Bulletin"},"volume":"Vol.38","number":"No.4","starting_page":"514","ending_page":"521","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/bpb.b14-00612"],"issn":["1347-5215"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:40, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/40020377946/","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/25994136","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390282681302013696/","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84929747372&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=288751","label":"url"}],"paper_title":{"en":"A Long-Term High-Fat Diet Changes Iron Distribution in Body, Increasing Iron Accumulation Specifically in the Mouse Spleen","ja":"A Long-Term High-Fat Diet Changes Iron Distribution in Body, Increasing Iron Accumulation Specifically in the Mouse Spleen"},"authors":{"en":[{"name":"Yamano Noriko"},{"name":"Ikeda Yasumasa"},{"name":"Sakama Minoru"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Miyamoto Licht"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山野 範子"},{"name":"池田 康将"},{"name":"阪間 稔"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"宮本 理人"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Although iron is an essential trace metal, its presence in excess causes oxidative stress in the human body. Recent studies have indicated that iron storage is a risk factor for type 2 diabetes mellitus. Dietary iron restriction or iron chelation ameliorates symptoms of type 2 diabetes in mouse models. However, whether iron content in the body changes with the development of diabetes is unknown. Here, we investigated the dynamics of iron accumulation and changes in iron absorption-related genes in mice that developed obesity and diabetes by consuming a high-fat diet (HFD-fed mice). HFD-fed mice (18-20 wk) were compared with control mice for hematologic features, serum ferritin levels, and iron contents in the gastrocnemius muscle, heart, epididymal fat, testis, liver, duodenum, and spleen. In addition, the spleen was examined histologically. Iron absorption-related gene expression in the liver and duodenum was also examined. Hemoglobin and serum ferritin levels were increased in HFD-fed mice. The HFD-fed mice showed iron accumulation in the spleen, but not in the heart or liver. Increased percentages of the splenic red pulp and macrophages were observed in HFD-fed mice and iron accumulation in the spleen was found mainly in the splenic red pulp. The HFD-fed mice also showed decreased iron content in the duodenum. The mRNA expression of divalent metal transporter-1 (DMT-1), an iron absorption-related gene, was elevated in the duodenum of HFD-fed mice. These results indicate that iron accumulation (specifically accumulation in the spleen) is enhanced by the development of type 2 diabetes induced by HFD.","ja":"Although iron is an essential trace metal, its presence in excess causes oxidative stress in the human body. Recent studies have indicated that iron storage is a risk factor for type 2 diabetes mellitus. Dietary iron restriction or iron chelation ameliorates symptoms of type 2 diabetes in mouse models. However, whether iron content in the body changes with the development of diabetes is unknown. Here, we investigated the dynamics of iron accumulation and changes in iron absorption-related genes in mice that developed obesity and diabetes by consuming a high-fat diet (HFD-fed mice). HFD-fed mice (18-20 wk) were compared with control mice for hematologic features, serum ferritin levels, and iron contents in the gastrocnemius muscle, heart, epididymal fat, testis, liver, duodenum, and spleen. In addition, the spleen was examined histologically. Iron absorption-related gene expression in the liver and duodenum was also examined. Hemoglobin and serum ferritin levels were increased in HFD-fed mice. The HFD-fed mice showed iron accumulation in the spleen, but not in the heart or liver. Increased percentages of the splenic red pulp and macrophages were observed in HFD-fed mice and iron accumulation in the spleen was found mainly in the splenic red pulp. The HFD-fed mice also showed decreased iron content in the duodenum. The mRNA expression of divalent metal transporter-1 (DMT-1), an iron absorption-related gene, was elevated in the duodenum of HFD-fed mice. These results indicate that iron accumulation (specifically accumulation in the spleen) is enhanced by the development of type 2 diabetes induced by HFD."},"publication_date":"2015-03","publication_name":{"en":"Journal of Nutritional Science and Vitaminology","ja":"Journal of Nutritional Science and Vitaminology"},"volume":"Vol.61","number":"No.1","starting_page":"20","ending_page":"27","languages":["eng"],"referee":true,"identifiers":{"doi":["10.3177/jnsv.61.20"],"issn":["0301-4800"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:41, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/106145","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24623277","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84901457818&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=275488","label":"url"}],"paper_title":{"en":"Smooth muscle cell specific Hif-1 deficiency suppresses angiotensin II-induced vascular remodeling in mice","ja":"Smooth muscle cell specific Hif-1 deficiency suppresses angiotensin II-induced vascular remodeling in mice"},"authors":{"en":[{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ueno Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"Ueno Masaki"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Vascular remodelling is mediated by vascular smooth muscle cell (VSMC) proliferation and hypertrophy, both processes of which are linked to medial thickening and fibrosis. Here, we show that hypoxia-inducible factor-1α (Hif-1α) expressed in smooth muscle cells (SMCs) is involved in angiotensin II (Ang II)-induced vascular remodelling in an in vivo model. To clarify the role of Hif-1α in vascular remodelling, we created mice lacking the Hif-1α gene in SMCs (SMKO mice). Ang II infusion induced medial thickening and vascular fibrosis, accompanied by Hif-1α up-regulation, in the aortae of control mice, but not in those of SMKO mice. In accordance with those results, our in vitro studies showed that the deletion of SMC-derived Hif-1α suppressed the Ang II-induced hypertrophy of VSMCs, and our in vivo studies showed that the Ang II-induced expression of fibrosis-related genes in aortae was suppressed by SMC-specific Hif-1α deficiency. In addition, the SMC-specific Hif-1α deficiency suppressed Ang II-induced macrophage infiltration and Ang II-induced expression of inflammation-related genes in aortae. The superoxide production observed in the aortae of control mice with Ang II was suppressed in those of SMKO mice with Ang II, and this finding was consistent with the results of little Ang II-induced c-Src phosphorylation in SMKO mouse aortae. Loss- and gain-of-function analysis in in vitro experiments confirmed that VSMC-derived Hif-1α functions as an intrinsic modulator of vascular remodelling-related gene expression. Our results revealed that SMC-derived Hif-1α is a crucial mediator of Ang II-induced vascular remodelling.","ja":"Vascular remodelling is mediated by vascular smooth muscle cell (VSMC) proliferation and hypertrophy, both processes of which are linked to medial thickening and fibrosis. Here, we show that hypoxia-inducible factor-1α (Hif-1α) expressed in smooth muscle cells (SMCs) is involved in angiotensin II (Ang II)-induced vascular remodelling in an in vivo model. To clarify the role of Hif-1α in vascular remodelling, we created mice lacking the Hif-1α gene in SMCs (SMKO mice). Ang II infusion induced medial thickening and vascular fibrosis, accompanied by Hif-1α up-regulation, in the aortae of control mice, but not in those of SMKO mice. In accordance with those results, our in vitro studies showed that the deletion of SMC-derived Hif-1α suppressed the Ang II-induced hypertrophy of VSMCs, and our in vivo studies showed that the Ang II-induced expression of fibrosis-related genes in aortae was suppressed by SMC-specific Hif-1α deficiency. In addition, the SMC-specific Hif-1α deficiency suppressed Ang II-induced macrophage infiltration and Ang II-induced expression of inflammation-related genes in aortae. The superoxide production observed in the aortae of control mice with Ang II was suppressed in those of SMKO mice with Ang II, and this finding was consistent with the results of little Ang II-induced c-Src phosphorylation in SMKO mouse aortae. Loss- and gain-of-function analysis in in vitro experiments confirmed that VSMC-derived Hif-1α functions as an intrinsic modulator of vascular remodelling-related gene expression. Our results revealed that SMC-derived Hif-1α is a crucial mediator of Ang II-induced vascular remodelling."},"publication_date":"2014-06","publication_name":{"en":"Cardiovascular Research","ja":"Cardiovascular Research"},"volume":"Vol.102","number":"No.3","starting_page":"460","ending_page":"468","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1093/cvr/cvu061"],"issn":["0008-6363"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:42, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24599965","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84901845393&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273735","label":"url"}],"paper_title":{"en":"HIF-2α/ARNT complex regulates hair development via induction of p21Waf1/Cip1 and p27Kip1","ja":"HIF-2α/ARNT complex regulates hair development via induction of p21Waf1/Cip1 and p27Kip1"},"authors":{"en":[{"name":"Imamura Yuko"},{"name":"Tomita Shuhei"},{"name":"Imanishi Masaki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Imamura Yuko"},{"name":"冨田 修平"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"The hypoxia-inducible factors HIF-1α or HIF-2α form heterodimeric complexes with the aryl hydrocarbon receptor nuclear translocator (ARNT). HIF-1α/ARNT and HIF-2α/ARNT complexes activate hypoxia-inducible genes that play critical roles in angiogenesis, anaerobic metabolism, and other processes in response to O2 deprivation. HIF-2α is known to regulate the function and/or differentiation of stem cells by activating the POU domain transcription factor Oct4; however, the precise underlying mechanism is unknown. This study examined the role of HIF-2α/ARNT in hair development using conditional-knockout mice, in which Arnt was specifically deleted in keratinocytes. In wild-type mice, HIF-2α and ARNT were highly expressed in the precortex above the hair matrix, an area containing differentiating stem cells. An analysis of hair size and type in these mice showed that loss of ARNT decreased the production of zigzag hairs, corresponding to reduced expression of HIF-2α and induction of the mammalian cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27 (Kip1). The results suggest that the HIF-2α/ARNT complex regulates hair follicle differentiation via induction of p21(Waf1/Cip1) and possibly p27(Kip1), as p27(Kip1) expression was not altered in ARNT knockout mice. The findings provide insight into a possible mechanism underlying hair growth disorders and can be useful for future studies on hair follicle response to insults, such as chemotherapy and ionizing radiation.-Imamura, Y., Tomita, S., Imanishi, M., Kihira, Y., Ikeda, Y., Ishizawa, K., Tsuchiya, K., Tamaki, T. HIF-2α/ARNT complex regulates hair development via induction of p21(Waf1/Cip1) and p27(Kip1).","ja":"The hypoxia-inducible factors HIF-1α or HIF-2α form heterodimeric complexes with the aryl hydrocarbon receptor nuclear translocator (ARNT). HIF-1α/ARNT and HIF-2α/ARNT complexes activate hypoxia-inducible genes that play critical roles in angiogenesis, anaerobic metabolism, and other processes in response to O2 deprivation. HIF-2α is known to regulate the function and/or differentiation of stem cells by activating the POU domain transcription factor Oct4; however, the precise underlying mechanism is unknown. This study examined the role of HIF-2α/ARNT in hair development using conditional-knockout mice, in which Arnt was specifically deleted in keratinocytes. In wild-type mice, HIF-2α and ARNT were highly expressed in the precortex above the hair matrix, an area containing differentiating stem cells. An analysis of hair size and type in these mice showed that loss of ARNT decreased the production of zigzag hairs, corresponding to reduced expression of HIF-2α and induction of the mammalian cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27 (Kip1). The results suggest that the HIF-2α/ARNT complex regulates hair follicle differentiation via induction of p21(Waf1/Cip1) and possibly p27(Kip1), as p27(Kip1) expression was not altered in ARNT knockout mice. The findings provide insight into a possible mechanism underlying hair growth disorders and can be useful for future studies on hair follicle response to insults, such as chemotherapy and ionizing radiation.-Imamura, Y., Tomita, S., Imanishi, M., Kihira, Y., Ikeda, Y., Ishizawa, K., Tsuchiya, K., Tamaki, T. HIF-2α/ARNT complex regulates hair development via induction of p21(Waf1/Cip1) and p27(Kip1)."},"publication_date":"2014-06","publication_name":{"en":"The FASEB journal","ja":"The FASEB journal"},"volume":"Vol.28","number":"No.6","starting_page":"2517","ending_page":"2524","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1096/fj.13-244079"],"issn":["0892-6638"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:43, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376219"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/106138","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/25289325","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84897362750&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=286620","label":"url"}],"paper_title":{"en":"Overexpressed HIF-2α in Endothelial Cells Promotes Vascularization and Improves Random Pattern Skin Flap Survival.","ja":"Overexpressed HIF-2α in Endothelial Cells Promotes Vascularization and Improves Random Pattern Skin Flap Survival."},"authors":{"en":[{"name":"Morimoto Atsushi"},{"name":"Tomita Shuhei"},{"name":"Imanishi Masaki"},{"name":"Shioi Go"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Takaku Mitsuru"},{"name":"Hashimoto Ichiro"},{"name":"Ikeda Yasumasa"},{"name":"Nakanishi Hideki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"森本 篤志"},{"name":"冨田 修平"},{"name":"今西 正樹"},{"name":"Shioi Go"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"Takaku Mitsuru"},{"name":"橋本 一郎"},{"name":"池田 康将"},{"name":"中西 秀樹"},{"name":"玉置 俊晃"}]},"description":{"en":"Specific overexpression of HIF-2 in ECs promoted vascularization and enhanced skin flap survival in vivo in a mouse model.","ja":"Specific overexpression of HIF-2 in ECs promoted vascularization and enhanced skin flap survival in vivo in a mouse model."},"publication_date":"2014-05-07","publication_name":{"en":"Plastic and Reconstructive Surgery. Global Open","ja":"Plastic and Reconstructive Surgery. Global Open"},"volume":"Vol.2","number":"No.4","starting_page":"e132","ending_page":"e132","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1097/GOX.0000000000000083"],"issn":["2169-7574"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:44, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24705496","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84899440448&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=276331","label":"url"}],"paper_title":{"en":"Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation.","ja":"Deletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammation."},"authors":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Miyake Mariko"},{"name":"Hirata Manami"},{"name":"Hoshina Yoji"},{"name":"Kato Kana"},{"name":"Shirakawa Hitoshi"},{"name":"Sakaue Hiroshi"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"木平 孝高"},{"name":"Miyake Mariko"},{"name":"Hirata Manami"},{"name":"Hoshina Yoji"},{"name":"Kato Kana"},{"name":"Shirakawa Hitoshi"},{"name":"阪上 浩"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"description":{"en":"It is known that obese adipose tissues are hypoxic and express hypoxia-inducible factor (HIF)-1α. Although some studies have shown that the expression of HIF-1α in adipocytes induces glucose intolerance, the mechanisms are still not clear. In this study, we examined its effects on the development of type 2 diabetes by using adipocyte-specific HIF-1α knockout (ahKO) mice. ahKO mice showed improved glucose tolerance compared with wild type (WT) mice. Macrophage infiltration and mRNA levels of monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor α (TNFα) were decreased in the epididymal adipose tissues of high fat diet induced obese ahKO mice. The results indicated that the obesity-induced adipose tissue inflammation was suppressed in ahKO mice. In addition, in the ahKO mice, serum insulin levels were increased under the free-feeding but not the fasting condition, indicating that postprandial insulin secretion was enhanced. Serum glucagon-like peptide-1 (GLP-1) levels were also increased in the ahKO mice. Interestingly, adiponectin, whose serum levels were increased in the obese ahKO mice compared with the obese WT mice, stimulated GLP-1 secretion from cultured intestinal L cells. Therefore, insulin secretion may have been enhanced through the adiponectin-GLP-1 pathway in the ahKO mice. Our results suggest that the deletion of HIF-1α in adipocytes improves glucose tolerance by enhancing insulin secretion through the GLP-1 pathway and by reducing macrophage infiltration and inflammation in adipose tissue.","ja":"It is known that obese adipose tissues are hypoxic and express hypoxia-inducible factor (HIF)-1α. Although some studies have shown that the expression of HIF-1α in adipocytes induces glucose intolerance, the mechanisms are still not clear. In this study, we examined its effects on the development of type 2 diabetes by using adipocyte-specific HIF-1α knockout (ahKO) mice. ahKO mice showed improved glucose tolerance compared with wild type (WT) mice. Macrophage infiltration and mRNA levels of monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor α (TNFα) were decreased in the epididymal adipose tissues of high fat diet induced obese ahKO mice. The results indicated that the obesity-induced adipose tissue inflammation was suppressed in ahKO mice. In addition, in the ahKO mice, serum insulin levels were increased under the free-feeding but not the fasting condition, indicating that postprandial insulin secretion was enhanced. Serum glucagon-like peptide-1 (GLP-1) levels were also increased in the ahKO mice. Interestingly, adiponectin, whose serum levels were increased in the obese ahKO mice compared with the obese WT mice, stimulated GLP-1 secretion from cultured intestinal L cells. Therefore, insulin secretion may have been enhanced through the adiponectin-GLP-1 pathway in the ahKO mice. Our results suggest that the deletion of HIF-1α in adipocytes improves glucose tolerance by enhancing insulin secretion through the GLP-1 pathway and by reducing macrophage infiltration and inflammation in adipose tissue."},"publication_date":"2014-04-04","publication_name":{"en":"PLoS ONE","ja":"PLoS ONE"},"volume":"Vol.9","number":"No.4","starting_page":"e93856","ending_page":"e93856","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1371/journal.pone.0093856"],"issn":["1932-6203"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:45, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113752","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24586712","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84897786390&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274493","label":"url"}],"paper_title":{"en":"Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction","ja":"Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Ozono Iori"},{"name":"Tajima Soichro"},{"name":"Imao Mizuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"大園 伊織"},{"name":"Tajima Soichro"},{"name":"今尾 瑞季"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Renal fibrosis plays an important role in the onset and progression of chronic kidney diseases (CKD). Although several mechanisms underlying renal fibrosis and candidate drugs for its treatment have been identified, the effect of iron chelator on renal fibrosis remains unclear. In the present study, we examined the effect of an iron chelator, deferoxamine (DFO), on renal fibrosis in mice with surgically induced unilateral ureter obstruction (UUO). Mice were divided into 4 groups: UUO with vehicle, UUO with DFO, sham with vehicle, and sham with DFO. One week after surgery, augmented renal tubulointerstitial fibrosis and the expression of collagen I, III, and IV increased in mice with UUO; these changes were suppressed by DFO treatment. Similarly, UUO-induced macrophage infiltration of renal interstitial tubules was reduced in UUO mice treated with DFO. UUO-induced expression of inflammatory cytokines and extracellular matrix proteins was abrogated by DFO treatment. DFO inhibited the activation of the transforming growth factor-β1 (TGF-β1)-Smad3 pathway in UUO mice. UUO-induced NADPH oxidase activity and p22(phox) expression were attenuated by DFO. In the kidneys of UUO mice, divalent metal transporter 1, ferroportin, and ferritin expression was higher and transferrin receptor expression was lower than in sham-operated mice. Increased renal iron content was observed in UUO mice, which was reduced by DFO treatment. These results suggest that iron reduction by DFO prevents renal tubulointerstitial fibrosis by regulating TGF-β-Smad signaling, oxidative stress, and inflammatory responses.","ja":"Renal fibrosis plays an important role in the onset and progression of chronic kidney diseases (CKD). Although several mechanisms underlying renal fibrosis and candidate drugs for its treatment have been identified, the effect of iron chelator on renal fibrosis remains unclear. In the present study, we examined the effect of an iron chelator, deferoxamine (DFO), on renal fibrosis in mice with surgically induced unilateral ureter obstruction (UUO). Mice were divided into 4 groups: UUO with vehicle, UUO with DFO, sham with vehicle, and sham with DFO. One week after surgery, augmented renal tubulointerstitial fibrosis and the expression of collagen I, III, and IV increased in mice with UUO; these changes were suppressed by DFO treatment. Similarly, UUO-induced macrophage infiltration of renal interstitial tubules was reduced in UUO mice treated with DFO. UUO-induced expression of inflammatory cytokines and extracellular matrix proteins was abrogated by DFO treatment. DFO inhibited the activation of the transforming growth factor-β1 (TGF-β1)-Smad3 pathway in UUO mice. UUO-induced NADPH oxidase activity and p22(phox) expression were attenuated by DFO. In the kidneys of UUO mice, divalent metal transporter 1, ferroportin, and ferritin expression was higher and transferrin receptor expression was lower than in sham-operated mice. Increased renal iron content was observed in UUO mice, which was reduced by DFO treatment. These results suggest that iron reduction by DFO prevents renal tubulointerstitial fibrosis by regulating TGF-β-Smad signaling, oxidative stress, and inflammatory responses."},"publication_date":"2014-02-19","publication_name":{"en":"PLoS ONE","ja":"PLoS ONE"},"volume":"Vol.9","number":"No.2","starting_page":"e89355","ending_page":"e89355","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1371/journal.pone.0089355"],"issn":["1932-6203"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:46, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24489716","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84900332178&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=275165","label":"url"}],"paper_title":{"en":"Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects","ja":"Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects"},"authors":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Yamano Noriko"},{"name":"Urushihara Maki"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Fujii Shoko"},{"name":"Nuno Asami"},{"name":"Miyamoto Licht"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Kagami Shoji"},{"name":"Kobori Hiroyuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"山野 範子"},{"name":"漆原 真樹"},{"name":"Sakurada Takumi"},{"name":"今西 正樹"},{"name":"Fujii Shoko"},{"name":"Nuno Asami"},{"name":"宮本 理人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"香美 祥二"},{"name":"Kobori Hiroyuki"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Recently, we reported that NO-NIF has potential as a novel antioxidant with radical scavenging abilities and has the capacity to treat vascular dysfunction by exerting an endothelial protective effect. In the present study, we extended these findings by evaluating the efficacy of NO-NIF against DN and by clarifying the mechanisms of its antioxidative effect. In a model of type 2 DN (established in KKAy mice), NO-NIF administration reduced albuminuria and proteinuria as well as glomerular expansion without affecting glucose metabolism or systolic blood pressure. NO-NIF also suppressed renal and systemic oxidative stress and decreased the expression of intercellular adhesion molecule (ICAM)-1, a marker of endothelial cell injury, in the glomeruli of the KKAy mice. Similarly, NO-NIF reduced albuminuria, oxidative stress, and ICAM-1 expression in endothelial nitric oxide synthase (eNOS) knockout mice. Moreover, NO-NIF suppressed urinary angiotensinogen (AGT) excretion and intrarenal AGT protein expression in proximal tubular cells in the KKAy mice. On the other hand, hyperglycemia-induced mitochondrial superoxide production was not attenuated by NO-NIF in cultured endothelial cells. These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects.","ja":"Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Recently, we reported that NO-NIF has potential as a novel antioxidant with radical scavenging abilities and has the capacity to treat vascular dysfunction by exerting an endothelial protective effect. In the present study, we extended these findings by evaluating the efficacy of NO-NIF against DN and by clarifying the mechanisms of its antioxidative effect. In a model of type 2 DN (established in KKAy mice), NO-NIF administration reduced albuminuria and proteinuria as well as glomerular expansion without affecting glucose metabolism or systolic blood pressure. NO-NIF also suppressed renal and systemic oxidative stress and decreased the expression of intercellular adhesion molecule (ICAM)-1, a marker of endothelial cell injury, in the glomeruli of the KKAy mice. Similarly, NO-NIF reduced albuminuria, oxidative stress, and ICAM-1 expression in endothelial nitric oxide synthase (eNOS) knockout mice. Moreover, NO-NIF suppressed urinary angiotensinogen (AGT) excretion and intrarenal AGT protein expression in proximal tubular cells in the KKAy mice. On the other hand, hyperglycemia-induced mitochondrial superoxide production was not attenuated by NO-NIF in cultured endothelial cells. These findings suggest that NO-NIF prevents the progression of type 2 DN associated with endothelial dysfunction through selective antioxidative effects."},"publication_date":"2014-01-28","publication_name":{"en":"PLoS ONE","ja":"PLoS ONE"},"volume":"Vol.9","number":"No.1","starting_page":"e86335","ending_page":"e86335","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1371/journal.pone.0086335"],"issn":["1932-6203"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:47, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23723256","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=265044","label":"url"}],"paper_title":{"en":"Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.","ja":"Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling."},"authors":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Sumitomo-Ueda Yuka"},{"name":"Uemoto Ryoko"},{"name":"Ishikawa Kazue"},{"name":"Ise Takayuki"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Mouri Yasuhiro"},{"name":"Sakari Matomo"},{"name":"Matsumoto Takahiro"},{"name":"Takeyama Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Mitsuru"},{"name":"Sata Masataka"},{"name":"Walsh Kenneth"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"Sumitomo-Ueda Yuka"},{"name":"Uemoto Ryoko"},{"name":"Ishikawa Kazue"},{"name":"伊勢 孝之"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"毛利 安宏"},{"name":"盛 真友"},{"name":"松本 高広"},{"name":"Takeyama Ken-ichi"},{"name":"赤池 雅史"},{"name":"松本 満"},{"name":"佐田 政隆"},{"name":"Walsh Kenneth"},{"name":"Kato Shigeaki"},{"name":"松本 俊夫"}]},"description":{"en":"These results document a physiological role of AR in sex-independent angiogenic potency and provide evidence of novel cross-talk between the androgen/AR signaling and VEGF/kinase insert domain protein receptor signaling pathways.","ja":"These results document a physiological role of AR in sex-independent angiogenic potency and provide evidence of novel cross-talk between the androgen/AR signaling and VEGF/kinase insert domain protein receptor signaling pathways."},"publication_date":"2013-05-30","publication_name":{"en":"Circulation","ja":"Circulation"},"volume":"Vol.128","number":"No.1","starting_page":"60","ending_page":"71","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1161/CIRCULATIONAHA.113.001533"],"issn":["1524-4539"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:48, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23389454","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=261038","label":"url"}],"paper_title":{"en":"Dietary iron restriction inhibits progression of diabetic nephropathy in db/db mice.","ja":"Dietary iron restriction inhibits progression of diabetic nephropathy in db/db mice."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Excess iron causes oxidative stress through hydroxyl-radical production via Fenton/Haber-Weiss reactions. Recently, body iron reduction has been found to ameliorate diabetes. In the present study, we examined the protective effect of dietary iron restriction against diabetic nephropathy in the db/db mouse model of diabetic nephropathy using db/m mice as controls. The db/db mice were divided into 2 groups and fed a normal diet (ND) or a low iron diet (LID). Increasing urinary albumin excretion was observed in the ND db/db mice, but this was suppressed in db/db mice with LID. Histologically, the db/db mice in the ND group had increased glomerular volume and mesangial area compared to the LID group. Augmented deposition of extracellular matrices was decreased in db/db mice with LID. In terms of oxidative stress, increased superoxide production observed in the kidneys of the ND db/db mice was diminished in the LID group. NADPH oxidase activity and renal expression of NADPH oxidase components p22(phox) and NOX4 were augmented in the ND group, and this was abolished by LID. There were no differences in expression of renal iron importers, transferrin receptor, or divalent metal transporter-1 between db/m mice and db/db mice. The level of ferroportin, an iron exporter, increased in the kidneys of the db/db mice. Urinary iron excretion was significantly higher in ND db/db mice and was reduced in the LID group. These findings suggest that dietary iron restriction exerts a preventive effect on the progression of diabetic nephropathy partly due to the reduction of oxidative stress.","ja":"Excess iron causes oxidative stress through hydroxyl-radical production via Fenton/Haber-Weiss reactions. Recently, body iron reduction has been found to ameliorate diabetes. In the present study, we examined the protective effect of dietary iron restriction against diabetic nephropathy in the db/db mouse model of diabetic nephropathy using db/m mice as controls. The db/db mice were divided into 2 groups and fed a normal diet (ND) or a low iron diet (LID). Increasing urinary albumin excretion was observed in the ND db/db mice, but this was suppressed in db/db mice with LID. Histologically, the db/db mice in the ND group had increased glomerular volume and mesangial area compared to the LID group. Augmented deposition of extracellular matrices was decreased in db/db mice with LID. In terms of oxidative stress, increased superoxide production observed in the kidneys of the ND db/db mice was diminished in the LID group. NADPH oxidase activity and renal expression of NADPH oxidase components p22(phox) and NOX4 were augmented in the ND group, and this was abolished by LID. There were no differences in expression of renal iron importers, transferrin receptor, or divalent metal transporter-1 between db/m mice and db/db mice. The level of ferroportin, an iron exporter, increased in the kidneys of the db/db mice. Urinary iron excretion was significantly higher in ND db/db mice and was reduced in the LID group. These findings suggest that dietary iron restriction exerts a preventive effect on the progression of diabetic nephropathy partly due to the reduction of oxidative stress."},"publication_date":"2013-02-06","publication_name":{"en":"American Journal of Physiology, Renal Physiology","ja":"American Journal of Physiology, Renal Physiology"},"volume":"Vol.304","number":"No.7","starting_page":"F1028","ending_page":"F1036","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1152/ajprenal.00473.2012"],"issn":["1522-1466"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:49, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/113754","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23364610","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259318","label":"url"}],"paper_title":{"en":"Bovine milk-derived lactoferrin exerts proangiogenic effects in an Src-Akt-eNOS-dependent manner in response to ischemia","ja":"Bovine milk-derived lactoferrin exerts proangiogenic effects in an Src-Akt-eNOS-dependent manner in response to ischemia"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Lactoferrin (LF) exerts a variety of biological effects, including the promotion of angiogenesis by increasing the expression of angiogenesis-related genes and reducing blood pressure via a nitric oxide-dependent mechanism. In this study, we investigated the effects of LF on angiogenesis using C57BL/6J mice that received daily unilateral treatment with or without bovine milk-derived LF (bLF) after unilateral hindlimb surgery. The analysis of laser speckle blood flow showed that bLF treatment promoted blood flow recovery in response to ischemic hindlimb. The capillary density of ischemic adductor muscles and the phosphorylation of Src, Akt, and endothelial nitric oxide synthase (eNOS) were also significantly higher in bLF-treated mice than in vehicle-treated mice. Furthermore, bLF increased the phosphorylation levels of Src, Akt, and eNOS in in vitro experiments using human aortic endothelial cells. The action of bLF on eNOS phosphorylation was abolished by both LY294002, a phosphatidylinositol 3-kinase inhibitor, and 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo [3,4-d]pyrimidine (PP2), an Src inhibitor. Similarly, bLF-induced acceleration of tube formation, cell proliferation, and cell migration in human aortic endothelial cells were inhibited by LY294002 or PP2. Thus, bLF promotes vascular endothelial cell function via an Src Akt eNOS-dependent pathway, thereby contributing to revascularization in response to ischemia.","ja":"Lactoferrin (LF) exerts a variety of biological effects, including the promotion of angiogenesis by increasing the expression of angiogenesis-related genes and reducing blood pressure via a nitric oxide-dependent mechanism. In this study, we investigated the effects of LF on angiogenesis using C57BL/6J mice that received daily unilateral treatment with or without bovine milk-derived LF (bLF) after unilateral hindlimb surgery. The analysis of laser speckle blood flow showed that bLF treatment promoted blood flow recovery in response to ischemic hindlimb. The capillary density of ischemic adductor muscles and the phosphorylation of Src, Akt, and endothelial nitric oxide synthase (eNOS) were also significantly higher in bLF-treated mice than in vehicle-treated mice. Furthermore, bLF increased the phosphorylation levels of Src, Akt, and eNOS in in vitro experiments using human aortic endothelial cells. The action of bLF on eNOS phosphorylation was abolished by both LY294002, a phosphatidylinositol 3-kinase inhibitor, and 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo [3,4-d]pyrimidine (PP2), an Src inhibitor. Similarly, bLF-induced acceleration of tube formation, cell proliferation, and cell migration in human aortic endothelial cells were inhibited by LY294002 or PP2. Thus, bLF promotes vascular endothelial cell function via an Src Akt eNOS-dependent pathway, thereby contributing to revascularization in response to ischemia."},"publication_date":"2013-01","publication_name":{"en":"Journal of Cardiovascular Pharmacology","ja":"Journal of Cardiovascular Pharmacology"},"volume":"Vol.61","number":"No.5","starting_page":"423","ending_page":"429","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1097/FJC.0b013e318287d526"],"issn":["1533-4023"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:50, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23149861","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84872316103&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=257964","label":"url"}],"paper_title":{"en":"Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects","ja":"Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects"},"authors":{"en":[{"name":"Sakurada Takumi"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Fujii Shoko"},{"name":"Tominaga Erika"},{"name":"Tsuneishi Teppei"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Aihara Ken-ichi"},{"name":"Minakuchi Kazuo"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Sakurada Takumi"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"Fujii Shoko"},{"name":"Tominaga Erika"},{"name":"Tsuneishi Teppei"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"粟飯原 賢一"},{"name":"水口 和生"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Nifedipine is unstable under light and decomposes to a stable nitroso analog, nitrosonifedipine (NO-NIF). The ability of NO-NIF to block calcium channels is quite weak compared with that of nifedipine. Recently, we have demonstrated that NO-NIF reacts with unsaturated fatty acid leading to generate NO-NIF radical, which acquires radical scavenging activity. However, the effects of NO-NIF on the pathogenesis related with oxidative stress, such as atherosclerosis and hypertension, are unclear. In this study, we investigated the effects of NO-NIF on angiotensin II (Ang II)-induced vascular remodeling. Ang II-induced thickening and fibrosis of aorta were inhibited by NO-NIF in mice. NO-NIF decreased reactive oxygen species (ROS) in the aorta and urinary 8-hydroxy-20-deoxyguanosine. Ang II-stimulated mRNA expressions of p22(phox), CD68, F4/80, monocyte chemoattractant protein-1, and collagen I in the aorta were inhibited by NO-NIF. Moreover, NO-NIF inhibited Ang II-induced cell migration and proliferation of vascular smooth muscle cells (VSMCs). NO-NIF reduced Ang II-induced ROS to the control level detected by dihydroethidium staining and lucigenin chemiluminescence assay in VSMCs. NO-NIF suppressed phosphorylations of Akt and epidermal growth factor receptor induced by Ang II. However, NO-NIF had no effects on intracellular Ca(2+) increase and protein kinase C-δ phosphorylation induced by Ang II in VSMCs. The electron paramagnetic resonance spectra indicated the continuous generation of NO-NIF radical of reaction with cultured VSMCs. These findings suggest that NO-NIF improves Ang II-induced vascular remodeling via the attenuation of oxidative stress.","ja":"Nifedipine is unstable under light and decomposes to a stable nitroso analog, nitrosonifedipine (NO-NIF). The ability of NO-NIF to block calcium channels is quite weak compared with that of nifedipine. Recently, we have demonstrated that NO-NIF reacts with unsaturated fatty acid leading to generate NO-NIF radical, which acquires radical scavenging activity. However, the effects of NO-NIF on the pathogenesis related with oxidative stress, such as atherosclerosis and hypertension, are unclear. In this study, we investigated the effects of NO-NIF on angiotensin II (Ang II)-induced vascular remodeling. Ang II-induced thickening and fibrosis of aorta were inhibited by NO-NIF in mice. NO-NIF decreased reactive oxygen species (ROS) in the aorta and urinary 8-hydroxy-20-deoxyguanosine. Ang II-stimulated mRNA expressions of p22(phox), CD68, F4/80, monocyte chemoattractant protein-1, and collagen I in the aorta were inhibited by NO-NIF. Moreover, NO-NIF inhibited Ang II-induced cell migration and proliferation of vascular smooth muscle cells (VSMCs). NO-NIF reduced Ang II-induced ROS to the control level detected by dihydroethidium staining and lucigenin chemiluminescence assay in VSMCs. NO-NIF suppressed phosphorylations of Akt and epidermal growth factor receptor induced by Ang II. However, NO-NIF had no effects on intracellular Ca(2+) increase and protein kinase C-δ phosphorylation induced by Ang II in VSMCs. The electron paramagnetic resonance spectra indicated the continuous generation of NO-NIF radical of reaction with cultured VSMCs. These findings suggest that NO-NIF improves Ang II-induced vascular remodeling via the attenuation of oxidative stress."},"publication_date":"2013-01","publication_name":{"en":"Naunyn-Schmiedeberg's Archives of Pharmacology","ja":"Naunyn-Schmiedeberg's Archives of Pharmacology"},"volume":"Vol.386","number":"No.1","starting_page":"29","ending_page":"39","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1007/s00210-012-0810-7"],"issn":["1432-1912"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:51, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/23052181","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84867214872&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=256474","label":"url"}],"paper_title":{"en":"Angiotensin II receptor blocker improves tumor necrosis factor-α-induced cytotoxicity via antioxidative effect in human glomerular endothelial cells","ja":"Angiotensin II receptor blocker improves tumor necrosis factor-α-induced cytotoxicity via antioxidative effect in human glomerular endothelial cells"},"authors":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Miyamoto Licht"},{"name":"Fujii Shoko"},{"name":"Taira Hironori"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Shuichi"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"Sakurada Takumi"},{"name":"今西 正樹"},{"name":"宮本 理人"},{"name":"Fujii Shoko"},{"name":"Taira Hironori"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"濱野 修一"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Tumor necrosis factor-α (TNF-α) is known to involve the progression of renal dysfunction through its cytotoxicity and proinflammatory effects such as the induction of intercellular adhesion molecule (ICAM)-1 expression in vascular endothelial cells (ECs). Olmesartan, one of the angiotensin II type 1 receptor blockers (ARBs), has been reported to show protective effects on injured ECs by some causal factors of renal disorder other than angiotensin II. However, the effects of olmesartan on TNF-α-induced glomerular EC damage have not been investigated. In the present study, we investigated the effects of RNH-6270, an active metabolite of olmesartan, on TNF-α-induced human glomerular EC (HGEC) damage to clarify the renoprotective mechanisms of ARBs. Cultured HGECs were stimulated by TNF-α, and then cell viability and cytotoxicity were measured by MTT assay and lactate dehydrogenase release assay, respectively. TNF-α-induced oxidative stress was estimated by dihydroethidium assay and lucigenin chemiluminescence assay. ICAM-1 expression and the phosphorylations of mitogen-activated protein kinases were measured using Western blotting assay. RNH-6270 suppressed cell death and the increase in ICAM-1 expression induced by TNF-α via the inhibition of reactive oxygen species in HGECs. Our findings suggested that olmesartan might have protective effects against TNF-α-induced glomerular EC dysfunction.","ja":"Tumor necrosis factor-α (TNF-α) is known to involve the progression of renal dysfunction through its cytotoxicity and proinflammatory effects such as the induction of intercellular adhesion molecule (ICAM)-1 expression in vascular endothelial cells (ECs). Olmesartan, one of the angiotensin II type 1 receptor blockers (ARBs), has been reported to show protective effects on injured ECs by some causal factors of renal disorder other than angiotensin II. However, the effects of olmesartan on TNF-α-induced glomerular EC damage have not been investigated. In the present study, we investigated the effects of RNH-6270, an active metabolite of olmesartan, on TNF-α-induced human glomerular EC (HGEC) damage to clarify the renoprotective mechanisms of ARBs. Cultured HGECs were stimulated by TNF-α, and then cell viability and cytotoxicity were measured by MTT assay and lactate dehydrogenase release assay, respectively. TNF-α-induced oxidative stress was estimated by dihydroethidium assay and lucigenin chemiluminescence assay. ICAM-1 expression and the phosphorylations of mitogen-activated protein kinases were measured using Western blotting assay. RNH-6270 suppressed cell death and the increase in ICAM-1 expression induced by TNF-α via the inhibition of reactive oxygen species in HGECs. Our findings suggested that olmesartan might have protective effects against TNF-α-induced glomerular EC dysfunction."},"publication_date":"2012-12","publication_name":{"en":"Pharmacology","ja":"Pharmacology"},"volume":"Vol.90","number":"No.5-6","starting_page":"324","ending_page":"331","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1159/000343244"],"issn":["1423-0313"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:52, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/22904320","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253941","label":"url"}],"paper_title":{"en":"Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway","ja":"Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Iwase Takashi"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Sata Masataka"},{"name":"Akaike Masashi"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"岩瀬 俊"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"佐田 政隆"},{"name":"赤池 雅史"},{"name":"Kato Shigeaki"},{"name":"松本 俊夫"},{"name":"玉置 俊晃"}]},"description":{"en":"We previously clarified that heparin cofactor II (HCII), a serine proteinase inhibitor, exerts various protective actions on cardiovascular diseases in both experimental and clinical studies. In the present study, we aimed to clarify whether HCII participates in the regulation of angiogenesis. Male heterozygous HCII-deficient (HCII(+/-)) mice and male littermate wild-type (HCII(+/+)) mice at the age of 12-16 weeks were subjected to unilateral hindlimb ligation surgery. Laser speckle blood flow analysis showed that blood flow recovery in response to hindlimb ischemia was delayed in HCII(+/-) mice compared with that in HCII(+/+) mice. Capillary number, arteriole number, and endothelial nitric-oxide synthase (eNOS), AMP-activated protein kinase (AMPK), and liver kinase B1 (LKB1) phosphorylation in ischemic muscles were decreased in HCII(+/-) mice. Human purified HCII (h-HCII) administration almost restored blood flow recovery, capillary density, and arteriole number as well as phosphorylation levels of eNOS, AMPK, and LKB1 in ischemic muscles of HCII(+/-) mice. Although treatment with h-HCII increased phosphorylation levels of eNOS, AMPK, and LKB1 in human aortic endothelial cells (HAECs), the h-HCII-induced eNOS phosphorylation was abolished by compound C, an AMPK inhibitor, and by AMPK siRNA. In a similar fashion, tube formation, proliferation, and migration of HAECs were also promoted by h-HCII treatment and were abrogated by pretreatment with compound C. HCII potentiates the activation of vascular endothelial cells and the promotion of angiogenesis in response to hindlimb ischemia via an AMPK-eNOS signaling pathway. These findings suggest that HCII is a novel therapeutic target for treatment of patients with peripheral circulation insufficiency.","ja":"We previously clarified that heparin cofactor II (HCII), a serine proteinase inhibitor, exerts various protective actions on cardiovascular diseases in both experimental and clinical studies. In the present study, we aimed to clarify whether HCII participates in the regulation of angiogenesis. Male heterozygous HCII-deficient (HCII(+/-)) mice and male littermate wild-type (HCII(+/+)) mice at the age of 12-16 weeks were subjected to unilateral hindlimb ligation surgery. Laser speckle blood flow analysis showed that blood flow recovery in response to hindlimb ischemia was delayed in HCII(+/-) mice compared with that in HCII(+/+) mice. Capillary number, arteriole number, and endothelial nitric-oxide synthase (eNOS), AMP-activated protein kinase (AMPK), and liver kinase B1 (LKB1) phosphorylation in ischemic muscles were decreased in HCII(+/-) mice. Human purified HCII (h-HCII) administration almost restored blood flow recovery, capillary density, and arteriole number as well as phosphorylation levels of eNOS, AMPK, and LKB1 in ischemic muscles of HCII(+/-) mice. Although treatment with h-HCII increased phosphorylation levels of eNOS, AMPK, and LKB1 in human aortic endothelial cells (HAECs), the h-HCII-induced eNOS phosphorylation was abolished by compound C, an AMPK inhibitor, and by AMPK siRNA. In a similar fashion, tube formation, proliferation, and migration of HAECs were also promoted by h-HCII treatment and were abrogated by pretreatment with compound C. HCII potentiates the activation of vascular endothelial cells and the promotion of angiogenesis in response to hindlimb ischemia via an AMPK-eNOS signaling pathway. These findings suggest that HCII is a novel therapeutic target for treatment of patients with peripheral circulation insufficiency."},"publication_date":"2012-10","publication_name":{"en":"The Journal of Biological Chemistry","ja":"The Journal of Biological Chemistry"},"volume":"Vol.287","number":"No.41","starting_page":"34256","ending_page":"34263","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1074/jbc.M112.353532"],"issn":["1083-351X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:53, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/105965","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/22880134","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253920","label":"url"}],"paper_title":{"en":"Systemic Preconditioning by a Prolyl Hydroxylase Inhibitor Promotes Prevention of Skin Flap Necrosis via HIF-1-Induced Bone Marrow-Derived Cells.","ja":"Systemic Preconditioning by a Prolyl Hydroxylase Inhibitor Promotes Prevention of Skin Flap Necrosis via HIF-1-Induced Bone Marrow-Derived Cells."},"authors":{"en":[{"name":"Takaku Mitsuru"},{"name":"Tomita Shuhei"},{"name":"Kurobe Hirotsugu"},{"name":"Kihira Yoshitaka"},{"name":"Morimoto Atsushi"},{"name":"Higashida Mayuko"},{"name":"Ikeda Yasumasa"},{"name":"Ushiyama Akira"},{"name":"Hashimoto Ichiro"},{"name":"Nakanishi Hideki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Takaku Mitsuru"},{"name":"冨田 修平"},{"name":"黒部 裕嗣"},{"name":"木平 孝高"},{"name":"森本 篤志"},{"name":"Higashida Mayuko"},{"name":"池田 康将"},{"name":"Ushiyama Akira"},{"name":"橋本 一郎"},{"name":"中西 秀樹"},{"name":"玉置 俊晃"}]},"description":{"en":"We demonstrated that transient activation of the HIF signaling pathway by a single systemic DMOG treatment upregulates not only anti-apoptotic pathways but also enhances neovascularization with concomitant increase in the numbers of bone marrow-derived progenitor cells.","ja":"We demonstrated that transient activation of the HIF signaling pathway by a single systemic DMOG treatment upregulates not only anti-apoptotic pathways but also enhances neovascularization with concomitant increase in the numbers of bone marrow-derived progenitor cells."},"publication_date":"2012-08-07","publication_name":{"en":"PLoS ONE","ja":"PLoS ONE"},"volume":"Vol.7","number":"No.8","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1371/journal.pone.0042964"],"issn":["1932-6203"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:54, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/40019353020/","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/22792339","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84863827034&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=248250","label":"url"}],"paper_title":{"en":"Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes","ja":"Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Hepcidin, a liver-derived iron regulatory protein, plays a crucial role in iron metabolism. It is known that gender differences exist with respect to iron storage in the body; however, the effects of sex steroid hormones on iron metabolism are not completely understood. We focused on the effects of the female sex hormone estrogen on hepcidin expression. First, ovariectomized (OVX) and sham-operated mice were employed to investigate the effects of estrogen on hepcidin expression in an in vivo study. Hepcidin expression was decreased in the livers of OVX mice compared to the sham-operated mice. In OVX mice, bone morphologic protein-6 (BMP6), a regulator of hepcidin, was also found to be downregulated in the liver, whereas ferroportin (FPN), an iron export protein, was upregulated in the duodenum. Both serum and liver iron concentrations were elevated in OVX mice relative to their concentrations in sham-operated mice. In in vitro studies, 17β-estradiol (E(2)) increased the mRNA expression of hepcidin in HepG2 cells in a concentration-dependent manner. E(2)-induced hepatic hepcidin upregulation was not inhibited by ICI 182720, an inhibitor of the estrogen receptor; instead, hepcidin expression was increased by ICI 182720. E(2) and ICI 182720 exhibit agonist actions with G-protein coupled receptor 30 (GPR30), the 7-transmembrane estrogen receptor. G1, a GPR30 agonist, upregulated hepcidin expression, and GPR30 siRNA treatment abolished E(2)-induced hepcidin expression. BMP6 expression induced by E(2) was abolished by GPR30 silencing. Finally, both E(2) and G1 supplementation restored reduced hepatic hepcidin and BMP6 expression and reversed the augmentation of duodenal FPN expression in the OVX mice. In contrast, serum hepcidin was elevated in OVX mice, which was reversed in these mice with E(2) and G1. Thus, estrogen is involved in hepcidin expression via a GPR30-BMP6-dependent mechanism, providing new insight into the role of estrogen in iron metabolism.","ja":"Hepcidin, a liver-derived iron regulatory protein, plays a crucial role in iron metabolism. It is known that gender differences exist with respect to iron storage in the body; however, the effects of sex steroid hormones on iron metabolism are not completely understood. We focused on the effects of the female sex hormone estrogen on hepcidin expression. First, ovariectomized (OVX) and sham-operated mice were employed to investigate the effects of estrogen on hepcidin expression in an in vivo study. Hepcidin expression was decreased in the livers of OVX mice compared to the sham-operated mice. In OVX mice, bone morphologic protein-6 (BMP6), a regulator of hepcidin, was also found to be downregulated in the liver, whereas ferroportin (FPN), an iron export protein, was upregulated in the duodenum. Both serum and liver iron concentrations were elevated in OVX mice relative to their concentrations in sham-operated mice. In in vitro studies, 17β-estradiol (E(2)) increased the mRNA expression of hepcidin in HepG2 cells in a concentration-dependent manner. E(2)-induced hepatic hepcidin upregulation was not inhibited by ICI 182720, an inhibitor of the estrogen receptor; instead, hepcidin expression was increased by ICI 182720. E(2) and ICI 182720 exhibit agonist actions with G-protein coupled receptor 30 (GPR30), the 7-transmembrane estrogen receptor. G1, a GPR30 agonist, upregulated hepcidin expression, and GPR30 siRNA treatment abolished E(2)-induced hepcidin expression. BMP6 expression induced by E(2) was abolished by GPR30 silencing. Finally, both E(2) and G1 supplementation restored reduced hepatic hepcidin and BMP6 expression and reversed the augmentation of duodenal FPN expression in the OVX mice. In contrast, serum hepcidin was elevated in OVX mice, which was reversed in these mice with E(2) and G1. Thus, estrogen is involved in hepcidin expression via a GPR30-BMP6-dependent mechanism, providing new insight into the role of estrogen in iron metabolism."},"publication_date":"2012-07-11","publication_name":{"en":"PLoS ONE","ja":"PLoS ONE"},"volume":"Vol.7","number":"No.7","starting_page":"e40465","ending_page":"e40465","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1371/journal.pone.0040465"],"issn":["1932-6203"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:55, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=250567","label":"url"}],"paper_title":{"en":"ロスバスタチンによる脂質低下作用非依存的な形態的および機能的頸動脈硬化改善作用","ja":"ロスバスタチンによる脂質低下作用非依存的な形態的および機能的頸動脈硬化改善作用"},"authors":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ise Takayuki"},{"name":"Ikeda Yasumasa"},{"name":"倉橋 清衛"},{"name":"Kinouchi Mizuho"},{"name":"Endo Itsuro"},{"name":"Fujinaka Yuichi"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"伊勢 孝之"},{"name":"池田 康将"},{"name":"倉橋 清衛"},{"name":"木内 美瑞穂"},{"name":"遠藤 逸朗"},{"name":"藤中 雄一"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"publication_date":"2012-02-01","publication_name":{"en":"Progress in Medicine","ja":"Progress in Medicine"},"volume":"Vol.32","number":"No.2","starting_page":"315","ending_page":"320","languages":["jpn"],"referee":true,"identifiers":{"issn":["0287-3648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:56, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21917632","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=243340","label":"url"}],"paper_title":{"en":"Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice.","ja":"Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice."},"authors":{"en":[{"name":"Tajima Soichiro"},{"name":"Ikeda Yasumasa"},{"name":"Sawada Kaori"},{"name":"Yamano Noriko"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Tajima Soichiro"},{"name":"池田 康将"},{"name":"澤田 香織"},{"name":"山野 範子"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Iron is an essential trace metal for most organisms. However, excess iron causes oxidative stress through production of highly toxic hydroxyl radicals via the Fenton/Haber-Weiss reaction. Iron storage in the body is reported to be associated with fat accumulation and type 2 diabetes mellitus. We investigated the role of iron in adiposity by using KKAy mice and obese and diabetic model mice. Eight-week-old KKAy mice were divided into two groups and treated with deferoxamine (DFO), an iron chelator agent, or a vehicle for 2 wk. DFO treatment diminished fat iron concentration and serum ferritin levels in KKAy mice. Fat weight and adipocyte size were reduced significantly in DFO-treated mice compared with vehicle-treated mice. Macrophage infiltration into fat was also decreased in DFO-treated mice compared with vehicle-treated mice. Superoxide production and NADPH oxidase activity in fat, as well as urinary 8-hydroxy-2'-deoxyguanosine excretion, were decreased in KKAy mice after DFO treatment while p22(phox) expression in adipose tissue was diminished in such mice. Ferritin expression in the fat of DFO-treated KKAy mice was decreased. In addition, F4/80-positive cells also presented through both p22(phox) and ferritin expression. The mRNA expression levels of inflammatory cytokines were also reduced in fat tissue of DFO-treated mice. These findings suggest that reduction of iron levels ameliorates adipocyte hypertrophy via suppression of oxidative stress, inflammatory cytokines, and macrophage infiltration, thereby breaking a vicious cycle in obesity.","ja":"Iron is an essential trace metal for most organisms. However, excess iron causes oxidative stress through production of highly toxic hydroxyl radicals via the Fenton/Haber-Weiss reaction. Iron storage in the body is reported to be associated with fat accumulation and type 2 diabetes mellitus. We investigated the role of iron in adiposity by using KKAy mice and obese and diabetic model mice. Eight-week-old KKAy mice were divided into two groups and treated with deferoxamine (DFO), an iron chelator agent, or a vehicle for 2 wk. DFO treatment diminished fat iron concentration and serum ferritin levels in KKAy mice. Fat weight and adipocyte size were reduced significantly in DFO-treated mice compared with vehicle-treated mice. Macrophage infiltration into fat was also decreased in DFO-treated mice compared with vehicle-treated mice. Superoxide production and NADPH oxidase activity in fat, as well as urinary 8-hydroxy-2'-deoxyguanosine excretion, were decreased in KKAy mice after DFO treatment while p22(phox) expression in adipose tissue was diminished in such mice. Ferritin expression in the fat of DFO-treated KKAy mice was decreased. In addition, F4/80-positive cells also presented through both p22(phox) and ferritin expression. The mRNA expression levels of inflammatory cytokines were also reduced in fat tissue of DFO-treated mice. These findings suggest that reduction of iron levels ameliorates adipocyte hypertrophy via suppression of oxidative stress, inflammatory cytokines, and macrophage infiltration, thereby breaking a vicious cycle in obesity."},"publication_date":"2012-01","publication_name":{"en":"American Journal of Physiology, Endocrinology and Metabolism","ja":"American Journal of Physiology, Endocrinology and Metabolism"},"volume":"Vol.302","number":"No.1","starting_page":"E77","ending_page":"86","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1152/ajpendo.00033.2011"],"issn":["1522-1555"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:57, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21810481","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241773","label":"url"}],"paper_title":{"en":"Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes","ja":"Basic fibroblast growth factor regulates glucose metabolism through glucose transporter 1 induced by hypoxia-inducible factor-1α in adipocytes"},"authors":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"木平 孝高"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"description":{"en":"Hypoxia-inducible factor-1 (HIF-1), which is a transcription factor that enhances glycolysis in cells in response to hypoxia, is induced in hypertrophied adipocytes in obesity. Recent studies have shown that growth factors are able to induce HIF-1 by mechanisms independent of hypoxia. Since basic fibroblast growth factor (bFGF), an angiogenic factor, is concentrated in expanding adipose tissue, the possible effects of bFGF on regulation of HIF-1 in adipocytes were investigated. Treatment of differentiated 3T3-L1 adipocytes with bFGF induced HIF-1. Concomitantly, glucose transporter 1 (GLUT1), which is a target gene of HIF-1, was induced at both mRNA and protein levels and was translocated to the plasma membrane. A chromatin immunoprecipitation assay and an RNA interference study indicated that bFGF-induced HIF-1 directly upregulates GLUT1. In addition, it was observed that bFGF increases lactate production of adipocytes. This result indicates that bFGF reprograms the metabolism toward glycolysis. Intraperitoneal injection of bFGF into mice upregulated HIF-1 and GLUT1 in adipose tissues, suggesting that bFGF regulates the metabolism of adipocytes via HIF-1-GLUT1 regulation in vivo. We also found that bFGF inhibits insulin-induced phosphorylation of insulin receptor substrate-1 and Akt, suggesting that bFGF attenuates the insulin signal in adipocytes. Taken together, the findings suggest that bFGF has a harmful effect on the development of type 2 diabetes through metabolism reprogramming and attenuation of the insulin signal.","ja":"Hypoxia-inducible factor-1 (HIF-1), which is a transcription factor that enhances glycolysis in cells in response to hypoxia, is induced in hypertrophied adipocytes in obesity. Recent studies have shown that growth factors are able to induce HIF-1 by mechanisms independent of hypoxia. Since basic fibroblast growth factor (bFGF), an angiogenic factor, is concentrated in expanding adipose tissue, the possible effects of bFGF on regulation of HIF-1 in adipocytes were investigated. Treatment of differentiated 3T3-L1 adipocytes with bFGF induced HIF-1. Concomitantly, glucose transporter 1 (GLUT1), which is a target gene of HIF-1, was induced at both mRNA and protein levels and was translocated to the plasma membrane. A chromatin immunoprecipitation assay and an RNA interference study indicated that bFGF-induced HIF-1 directly upregulates GLUT1. In addition, it was observed that bFGF increases lactate production of adipocytes. This result indicates that bFGF reprograms the metabolism toward glycolysis. Intraperitoneal injection of bFGF into mice upregulated HIF-1 and GLUT1 in adipose tissues, suggesting that bFGF regulates the metabolism of adipocytes via HIF-1-GLUT1 regulation in vivo. We also found that bFGF inhibits insulin-induced phosphorylation of insulin receptor substrate-1 and Akt, suggesting that bFGF attenuates the insulin signal in adipocytes. Taken together, the findings suggest that bFGF has a harmful effect on the development of type 2 diabetes through metabolism reprogramming and attenuation of the insulin signal."},"publication_date":"2011-11","publication_name":{"en":"The International Journal of Biochemistry & Cell Biology","ja":"The International Journal of Biochemistry & Cell Biology"},"volume":"Vol.43","number":"No.11","starting_page":"1602","ending_page":"1611","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.biocel.2011.07.009"],"issn":["1878-5875"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:58, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376220"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21422726","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-79955046642&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=227811","label":"url"}],"paper_title":{"en":"Pathophysiological Response to Hypoxia From the Molecular Mechanisms of Malady to Drug Discovery: Inflammatory Responses of Hypoxia-Inducible Factor 1 (HIF-1) in T Cells Observed in Development of Vascular Remodeling","ja":"Pathophysiological Response to Hypoxia From the Molecular Mechanisms of Malady to Drug Discovery: Inflammatory Responses of Hypoxia-Inducible Factor 1 (HIF-1) in T Cells Observed in Development of Vascular Remodeling"},"authors":{"en":[{"name":"Tomita Shuhei"},{"name":"Kihira Yoshitaka"},{"name":"Imanishi Masaki"},{"name":"Fukuhara Yayoi"},{"name":"Imamura Yuko"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"冨田 修平"},{"name":"木平 孝高"},{"name":"今西 正樹"},{"name":"福原 弥生"},{"name":"今村 優子"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Recent studies have shown that the cellular immune response to the hypoxic microenvironment constructed by vascular remodeling development modulates the resulting pathologic alterations. A major mechanism mediating adaptive responses to reduced oxygen availability is the regulation of transcription by hypoxia-inducible factor 1 (HIF-1). Impairment of HIF-1-dependent inflammatory responses in T cells causes an augmented vascular remodeling induced by arterial injury, which is shown as prominent neointimal hyperplasia and increase in infiltration of inflammatory cells at the adventitia in mice lacking Hif-1α specifically in T cells. Studies to clarify the mechanism of augmented vascular remodeling in the mutant mice have shown enhanced production of cytokines in activated T cells and augmented antibody production in response to a T-dependent antigen in the mutant mice. This minireview shows that HIF-1α in T cells plays a crucial role in vascular inflammation and remodeling in response to cuff injury as a negative regulator of the T cell-mediated immune response and suggests potential new therapeutic strategies that target HIF-1α.","ja":"Recent studies have shown that the cellular immune response to the hypoxic microenvironment constructed by vascular remodeling development modulates the resulting pathologic alterations. A major mechanism mediating adaptive responses to reduced oxygen availability is the regulation of transcription by hypoxia-inducible factor 1 (HIF-1). Impairment of HIF-1-dependent inflammatory responses in T cells causes an augmented vascular remodeling induced by arterial injury, which is shown as prominent neointimal hyperplasia and increase in infiltration of inflammatory cells at the adventitia in mice lacking Hif-1α specifically in T cells. Studies to clarify the mechanism of augmented vascular remodeling in the mutant mice have shown enhanced production of cytokines in activated T cells and augmented antibody production in response to a T-dependent antigen in the mutant mice. This minireview shows that HIF-1α in T cells plays a crucial role in vascular inflammation and remodeling in response to cuff injury as a negative regulator of the T cell-mediated immune response and suggests potential new therapeutic strategies that target HIF-1α."},"publication_date":"2011-04","publication_name":{"en":"Journal of Pharmacological Sciences","ja":"Journal of Pharmacological Sciences"},"volume":"Vol.115","number":"No.4","starting_page":"433","ending_page":"439","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1254/jphs.10R22FM"],"issn":["1347-8648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:59, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376221"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21436601","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=220416","label":"url"}],"paper_title":{"en":"Pharmacology in health food: Metabolism of quercetin in vivo and its protective effect against arteriosclerosis","ja":"Pharmacology in health food: Metabolism of quercetin in vivo and its protective effect against arteriosclerosis"},"authors":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Yoshizumi Masanori"},{"name":"Kawai Yoshichika"},{"name":"Terao Junji"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"吉栖 正典"},{"name":"河合 慶親"},{"name":"寺尾 純二"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Quercetin, a member of the bioflavonoids family, has been proposed to have anti-atherogenic, anti-inflammatory, and anti-hypertensive properties leading to the beneficial effects against cardiovascular diseases. It was recently demonstrated that quercetin 3-O-β-D-glucuronide (Q3GA) is one of the major quercetin conjugates in human plasma, in which the aglycone could not be detected. Although most of the in vitro pharmacological studies have been carried out using only the quercetin aglycone form, experiments using Q3GA would be important to discover the preventive mechanisms of cardiovascular diseases by quercetin in vivo. Therefore we examined the effects of the chemically synthesized Q3GA, as an in vivo form, on vascular smooth muscle cell (VSMC) disorders related to the progression of arteriosclerosis. Platelet-derived growth factor-induced cell migration and proliferation were inhibited by Q3GA in VSMCs. Q3GA attenuated angiotensin II-induced VSMC hypertrophy via its inhibitory effect on JNK and the AP-1 signaling pathway. Q3GA scavenged 1,1-diphenyl-2-picrylhydrazyl radical measured by the electron paramagnetic resonance method. In addition, immunohistochemical studies with monoclonal antibody 14A2 targeting the Q3GA demonstrated that the positive staining specifically accumulates in human atherosclerotic lesions, but not in the normal aorta. These findings suggest Q3GA would be an active metabolite of quercetin in plasma and may have preventative effects on arteriosclerosis relevant to VSMC disorders.","ja":"Quercetin, a member of the bioflavonoids family, has been proposed to have anti-atherogenic, anti-inflammatory, and anti-hypertensive properties leading to the beneficial effects against cardiovascular diseases. It was recently demonstrated that quercetin 3-O-β-D-glucuronide (Q3GA) is one of the major quercetin conjugates in human plasma, in which the aglycone could not be detected. Although most of the in vitro pharmacological studies have been carried out using only the quercetin aglycone form, experiments using Q3GA would be important to discover the preventive mechanisms of cardiovascular diseases by quercetin in vivo. Therefore we examined the effects of the chemically synthesized Q3GA, as an in vivo form, on vascular smooth muscle cell (VSMC) disorders related to the progression of arteriosclerosis. Platelet-derived growth factor-induced cell migration and proliferation were inhibited by Q3GA in VSMCs. Q3GA attenuated angiotensin II-induced VSMC hypertrophy via its inhibitory effect on JNK and the AP-1 signaling pathway. Q3GA scavenged 1,1-diphenyl-2-picrylhydrazyl radical measured by the electron paramagnetic resonance method. In addition, immunohistochemical studies with monoclonal antibody 14A2 targeting the Q3GA demonstrated that the positive staining specifically accumulates in human atherosclerotic lesions, but not in the normal aorta. These findings suggest Q3GA would be an active metabolite of quercetin in plasma and may have preventative effects on arteriosclerosis relevant to VSMC disorders."},"publication_date":"2011-04","publication_name":{"en":"Journal of Pharmacological Sciences","ja":"Journal of Pharmacological Sciences"},"volume":"Vol.115","number":"No.4","starting_page":"466","ending_page":"470","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1254/jphs.10R38FM"],"issn":["1347-8648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:60, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376222"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21297301","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-79551489998&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=314653","label":"url"}],"paper_title":{"en":"Antioxidant effects of photodegradation product of nifedipine","ja":"Antioxidant effects of photodegradation product of nifedipine"},"authors":{"en":[{"name":"Horinouchi Yuya"},{"name":"Tsuchiya Koichiro"},{"name":"Taoka Chiaki"},{"name":"Tajima Soichiro"},{"name":"Kihira Yoshitaka"},{"name":"Matsuda Yuko"},{"name":"Shishido Kozo"},{"name":"Yoshida Masahiro"},{"name":"Hamano Shuichi"},{"name":"Kawazoe Kazuyoshi"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"土屋 浩一郎"},{"name":"Taoka Chiaki"},{"name":"Tajima Soichiro"},{"name":"木平 孝高"},{"name":"Matsuda Yuko"},{"name":"宍戸 宏造"},{"name":"吉田 昌裕"},{"name":"濱野 修一"},{"name":"川添 和義"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"description":{"en":"Recently, increasing evidence suggests that the antihypertensive drug nifedipine acts as a protective agent for endothelial cells, and that the activity is unrelated to its calcium channel blocking. Nifedipine is unstable under light and reportedly decomposes to a stable nitrosonifedipine (NO-NIF). NO-NIF has no antihypertensive effect, and it has been recognized as a contaminant of nifedipine. The present study for the first time demonstrated that NO-NIF changed to a NO-NIF radical in a time-dependent manner when it interacted with human umbilical vein endothelial cells (HUVECs). The electron paramagnetic resonance (EPR) signal of NO-NIF radicals in HUVECs showed an asymmetric pattern suggesting that the radicals were located in the membrane. The NO-NIF radicals had radical scavenging activity for 1,1-diphenyl-2-picrylhydrazyl, whereas neither NO-NIF nor nifedipine did. In addition, the NO-NIF radical more effectively quenched lipid peroxides than NO-NIF or nifedipine. Furthermore, NO-NIF attenuated the superoxide-derived free radicals in HUVECs stimulated with LY83583, and suppressed iron-nitrilotriacetic acid (Fe-NTA)-induced cytotoxicity in rat pheochromocytoma (PC12) cells. Our findings suggest that NO-NIF is a candidate for a new class of antioxidative drugs that protect cells against oxidative stress.","ja":"Recently, increasing evidence suggests that the antihypertensive drug nifedipine acts as a protective agent for endothelial cells, and that the activity is unrelated to its calcium channel blocking. Nifedipine is unstable under light and reportedly decomposes to a stable nitrosonifedipine (NO-NIF). NO-NIF has no antihypertensive effect, and it has been recognized as a contaminant of nifedipine. The present study for the first time demonstrated that NO-NIF changed to a NO-NIF radical in a time-dependent manner when it interacted with human umbilical vein endothelial cells (HUVECs). The electron paramagnetic resonance (EPR) signal of NO-NIF radicals in HUVECs showed an asymmetric pattern suggesting that the radicals were located in the membrane. The NO-NIF radicals had radical scavenging activity for 1,1-diphenyl-2-picrylhydrazyl, whereas neither NO-NIF nor nifedipine did. In addition, the NO-NIF radical more effectively quenched lipid peroxides than NO-NIF or nifedipine. Furthermore, NO-NIF attenuated the superoxide-derived free radicals in HUVECs stimulated with LY83583, and suppressed iron-nitrilotriacetic acid (Fe-NTA)-induced cytotoxicity in rat pheochromocytoma (PC12) cells. Our findings suggest that NO-NIF is a candidate for a new class of antioxidative drugs that protect cells against oxidative stress."},"publication_date":"2011-02","publication_name":{"en":"Chemical & Pharmaceutical Bulletin","ja":"Chemical & Pharmaceutical Bulletin"},"volume":"Vol.59","number":"No.2","starting_page":"208","ending_page":"214","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/cpb.59.208"],"issn":["1347-5223"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:61, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376223"},"force":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/130004465233/","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/72667","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21372496","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390001204242892288/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=223410","label":"url"}],"paper_title":{"en":"Protective effect of photodegradation product of nifedipine against tumor necrosis factor alpha-induced oxidative stress in human glomerular endothelial cells","ja":"Protective effect of photodegradation product of nifedipine against tumor necrosis factor alpha-induced oxidative stress in human glomerular endothelial cells"},"authors":{"en":[{"name":"Fukuhara Yayoi"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"Tajima Soichiro"},{"name":"Kihira Yoshitaka"},{"name":"Hamano Shuichi"},{"name":"Kawazoe Kazuyoshi"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"福原 弥生"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"Tajima Soichiro"},{"name":"木平 孝高"},{"name":"濱野 修一"},{"name":"川添 和義"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"description":{"en":"Recently, increasing evidence suggests that the antihypertensive drug nifedipine acts as a protective agent for endothelial cells, and that the activity is unrelated to its calcium channel blocking. Nitrosonifedipine (NO-NIF) is metabolically and photochemically produced from nifedipine, and NO-NIF has been recognized as a contaminant of nifedipine because it has no antihypertensive effect. Treatment of tumor necrosis factor-α (TNF-α) suppressed the cell viability and facilitated the expression of Inter-Cellular Adhesion Molecule 1(ICAM-1) in human glomerular endothelial cells (HGECs) though, pretreatment of NO-NIF significantly recovered the TNF-α-induced cell damage to the same extent as Trolox-C did, and suppressed the ICAM-1 expression in a concentration dependent manner. In addition, NO-NIF inhibited the cell toxicity induced by cumene hydroperoxide, which hampers the integrity of cell membrane through oxidative stress, as effective as Trolox-c. These data suggest that NO-NIF is a candidate for a new class of antioxidative drug that protect cells against oxidative stress in glomerular endothelial cells.","ja":"Recently, increasing evidence suggests that the antihypertensive drug nifedipine acts as a protective agent for endothelial cells, and that the activity is unrelated to its calcium channel blocking. Nitrosonifedipine (NO-NIF) is metabolically and photochemically produced from nifedipine, and NO-NIF has been recognized as a contaminant of nifedipine because it has no antihypertensive effect. Treatment of tumor necrosis factor-α (TNF-α) suppressed the cell viability and facilitated the expression of Inter-Cellular Adhesion Molecule 1(ICAM-1) in human glomerular endothelial cells (HGECs) though, pretreatment of NO-NIF significantly recovered the TNF-α-induced cell damage to the same extent as Trolox-C did, and suppressed the ICAM-1 expression in a concentration dependent manner. In addition, NO-NIF inhibited the cell toxicity induced by cumene hydroperoxide, which hampers the integrity of cell membrane through oxidative stress, as effective as Trolox-c. These data suggest that NO-NIF is a candidate for a new class of antioxidative drug that protect cells against oxidative stress in glomerular endothelial cells."},"publication_date":"2011-02","publication_name":{"en":"The Journal of Medical Investigation : JMI","ja":"The Journal of Medical Investigation : JMI"},"volume":"Vol.58","number":"No.1, 2","starting_page":"118","ending_page":"126","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2152/jmi.58.118"],"issn":["1349-6867"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:62, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21315355","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=222278","label":"url"}],"paper_title":{"en":"Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function.","ja":"Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Yoshida Sumiko"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"吉田 守美子"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"BACKGROUND: Deferoxamine (DFO), an iron chelator for disorders of excess iron, upregulates the expression of angiogenic factors, such as vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2), indicating that it affects angiogenesis. Herein, we clarify the effect and mechanism of action of DFO on angiogenesis. METHODS AND RESULTS: In an in vitro study, DFO increased endothelial nitric oxide synthesis (eNOS) phosphorylation in human aortic endothelial cells (HAECs), which were inhibited by the phosphatidylinositol 3-kinase inhibitor LY294002. Tube formation, cell proliferation, and cell migration in HAECs were promoted by DFO, which were significantly reduced by LY294002. In an in vivo study, DFO promoted blood flow recovery in response to the hindlimb ischemia in mice with unilateral hindlimb surgery. The density of capillaries and arterioles in ischemic muscle was higher in DFO-treated mice compared to vehicle-treated mice. Endothelial cell proliferation increased and oxidative stress and apoptosis decreased in ischemic muscles of DFO-treated mice. The phosphorylation of Akt and eNOS on the ischemic side was elevated and urinary nitric oxide/nitric dioxide (NOx) excretion was higher in DFO-treated mice compared to vehicle-treated mice. The effect of DFO on angiogenesis was abolished in eNOS-deficient mice with hindlimb ischemia. CONCLUSION: These findings indicate that DFO promotes revascularization via the activation of vascular endothelial cell function by an Akt-eNOS-dependent mechanism.","ja":"BACKGROUND: Deferoxamine (DFO), an iron chelator for disorders of excess iron, upregulates the expression of angiogenic factors, such as vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (COX-2), indicating that it affects angiogenesis. Herein, we clarify the effect and mechanism of action of DFO on angiogenesis. METHODS AND RESULTS: In an in vitro study, DFO increased endothelial nitric oxide synthesis (eNOS) phosphorylation in human aortic endothelial cells (HAECs), which were inhibited by the phosphatidylinositol 3-kinase inhibitor LY294002. Tube formation, cell proliferation, and cell migration in HAECs were promoted by DFO, which were significantly reduced by LY294002. In an in vivo study, DFO promoted blood flow recovery in response to the hindlimb ischemia in mice with unilateral hindlimb surgery. The density of capillaries and arterioles in ischemic muscle was higher in DFO-treated mice compared to vehicle-treated mice. Endothelial cell proliferation increased and oxidative stress and apoptosis decreased in ischemic muscles of DFO-treated mice. The phosphorylation of Akt and eNOS on the ischemic side was elevated and urinary nitric oxide/nitric dioxide (NOx) excretion was higher in DFO-treated mice compared to vehicle-treated mice. The effect of DFO on angiogenesis was abolished in eNOS-deficient mice with hindlimb ischemia. CONCLUSION: These findings indicate that DFO promotes revascularization via the activation of vascular endothelial cell function by an Akt-eNOS-dependent mechanism."},"publication_date":"2011-01-21","publication_name":{"en":"Atherosclerosis","ja":"Atherosclerosis"},"volume":"Vol.215","number":"No.2","starting_page":"339","ending_page":"347","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.atherosclerosis.2011.01.009"],"issn":["1879-1484"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:63, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21060209","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=226738","label":"url"}],"paper_title":{"en":"Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.","ja":"Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets."},"authors":{"en":[{"name":"Hashizume Shunji"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Ishikawa Kazue"},{"name":"Yoshida Sumiko"},{"name":"Ueda Yuka"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Aihara Ken-ichi"},{"name":"Abe Masahiro"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Hashizume Shunji"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"Ishikawa Kazue"},{"name":"吉田 守美子"},{"name":"上田 由佳"},{"name":"八木 秀介"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"粟飯原 賢一"},{"name":"安倍 正博"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"description":{"en":"Platelet-derived growth factor (PDGF)-BB plays a crucial role in atherosclerosis and vascular remodeling by promoting the migration and proliferation of vascular smooth muscle cells. The objective of this study was to clarify the pleiotropic effect of peroxisome proliferator-activated receptor α (PPARα) activators on PDGF-BB expression in megakaryocytes and platelets. The expression of PPARα in a human erythroleukemia (HEL) cells was clearly detected by reverse transcriptase-PCR and immunofluorescence microscopy. The expression level of PPARα in HEL cells was unchanged regardless of differentiation into megakaryocytic cells by treatment with phorbol 12-myristate 13 acetate (TPA). The TPA-induced expression of PDGF-B mRNA and PDGF-BB protein levels in culture media was significantly decreased by treatment with PPARα activators, Wy14643 and fenofibric acid, in a dose-dependent manner. PDGF-BB expression induced by inflammatory cytokines, including interleukin-1β or interleukin-6, was also significantly suppressed by treatment with PPARα activators. Immunohistochemistry of human bone marrow showed the expression of PPARα in both the nucleus and cytoplasm of megakaryocytes. In addition, PDGF-BB levels in platelets were significantly decreased from 1,800±870 to 1,470±840 pg/10(5) platelets (mean±SD, p<0.05) by treatment with 300 mg fenofibrate once daily for 4 weeks in 13 patients with dyslipidemia. Activation of PPARα in megakaryocytes reduces PDGF-BB expression in platelets. PPARα activators may exert vasculo-protective action through suppression of PDGF-BB production in a megakaryocyte/platelet pathway.","ja":"Platelet-derived growth factor (PDGF)-BB plays a crucial role in atherosclerosis and vascular remodeling by promoting the migration and proliferation of vascular smooth muscle cells. The objective of this study was to clarify the pleiotropic effect of peroxisome proliferator-activated receptor α (PPARα) activators on PDGF-BB expression in megakaryocytes and platelets. The expression of PPARα in a human erythroleukemia (HEL) cells was clearly detected by reverse transcriptase-PCR and immunofluorescence microscopy. The expression level of PPARα in HEL cells was unchanged regardless of differentiation into megakaryocytic cells by treatment with phorbol 12-myristate 13 acetate (TPA). The TPA-induced expression of PDGF-B mRNA and PDGF-BB protein levels in culture media was significantly decreased by treatment with PPARα activators, Wy14643 and fenofibric acid, in a dose-dependent manner. PDGF-BB expression induced by inflammatory cytokines, including interleukin-1β or interleukin-6, was also significantly suppressed by treatment with PPARα activators. Immunohistochemistry of human bone marrow showed the expression of PPARα in both the nucleus and cytoplasm of megakaryocytes. In addition, PDGF-BB levels in platelets were significantly decreased from 1,800±870 to 1,470±840 pg/10(5) platelets (mean±SD, p<0.05) by treatment with 300 mg fenofibrate once daily for 4 weeks in 13 patients with dyslipidemia. Activation of PPARα in megakaryocytes reduces PDGF-BB expression in platelets. PPARα activators may exert vasculo-protective action through suppression of PDGF-BB production in a megakaryocyte/platelet pathway."},"publication_date":"2011","publication_name":{"en":"Journal of Atherosclerosis and Thrombosis","ja":"Journal of Atherosclerosis and Thrombosis"},"volume":"Vol.18","number":"No.2","starting_page":"138","ending_page":"147","languages":["eng"],"referee":true,"identifiers":{"doi":["10.5551/jat.5868"],"issn":["1880-3873"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:64, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21107326","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=250559","label":"url"}],"paper_title":{"en":"Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors.","ja":"Plasma heparin cofactor II activity is inversely associated with left atrial volume and diastolic dysfunction in humans with cardiovascular risk factors."},"authors":{"en":[{"name":"Ise Takayuki"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Yamada Hirotsugu"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"伊勢 孝之"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"山田 博胤"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"description":{"en":"Thrombin has a crucial role in cardiac remodeling through protease-activated receptor-1 activation in cardiac fibroblasts and cardiomyocytes. As heparin cofactor II (HCII) inhibits the action of tissue thrombin in the cardiovascular system, it is possible that HCII counteracts the development of cardiac remodeling. We investigated the relationships between plasma HCII activity and surrogate markers of cardiac geometry, including left atrial volume index (LAVI), relative wall thickness (RWT) and left ventricular mass index, and deceleration time (DcT) and the ratio of peak E velocity to early diastolic mitral annulus velocity (E/e' ratio) as surrogate markers of left ventricular diastolic dysfunction measured using echocardiography in 304 Japanese elderly individuals without systolic heart failure (169 men and 135 women; mean age: 65.4 ± 11.8 years). Mean plasma HCII activity in all participants was 95.8 ± 17.0% and there was no difference between the mean plasma HCII activities in males and females. Multiple regression analysis revealed that there were significant inverse relationships between plasma HCII activity and LAVI (coefficient: -0.2302, P<0.001), between HCII activity and RWT (coefficient: -0.0007, P<0.05), between HCII activity and DcT (coefficient: -0.5189, P<0.05) and between HCII activity and E/e' ratio (coefficient: -0.0558, P<0.01). Plasma HCII activity was independently and inversely associated with the development of cardiac remodeling, including cardiac concentric change, left atrial enlargement and left ventricular diastolic dysfunction. These findings suggest that cardiac tissue thrombin inactivation by HCII is a novel therapeutic target for cardiac remodeling and atherosclerosis.","ja":"Thrombin has a crucial role in cardiac remodeling through protease-activated receptor-1 activation in cardiac fibroblasts and cardiomyocytes. As heparin cofactor II (HCII) inhibits the action of tissue thrombin in the cardiovascular system, it is possible that HCII counteracts the development of cardiac remodeling. We investigated the relationships between plasma HCII activity and surrogate markers of cardiac geometry, including left atrial volume index (LAVI), relative wall thickness (RWT) and left ventricular mass index, and deceleration time (DcT) and the ratio of peak E velocity to early diastolic mitral annulus velocity (E/e' ratio) as surrogate markers of left ventricular diastolic dysfunction measured using echocardiography in 304 Japanese elderly individuals without systolic heart failure (169 men and 135 women; mean age: 65.4 ± 11.8 years). Mean plasma HCII activity in all participants was 95.8 ± 17.0% and there was no difference between the mean plasma HCII activities in males and females. Multiple regression analysis revealed that there were significant inverse relationships between plasma HCII activity and LAVI (coefficient: -0.2302, P<0.001), between HCII activity and RWT (coefficient: -0.0007, P<0.05), between HCII activity and DcT (coefficient: -0.5189, P<0.05) and between HCII activity and E/e' ratio (coefficient: -0.0558, P<0.01). Plasma HCII activity was independently and inversely associated with the development of cardiac remodeling, including cardiac concentric change, left atrial enlargement and left ventricular diastolic dysfunction. These findings suggest that cardiac tissue thrombin inactivation by HCII is a novel therapeutic target for cardiac remodeling and atherosclerosis."},"publication_date":"2010-11-25","publication_name":{"en":"Hypertension Research","ja":"Hypertension Research"},"volume":"Vol.34","number":"No.2","starting_page":"225","ending_page":"231","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/hr.2010.211"],"issn":["1348-4214"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:65, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20861841","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219670","label":"url"}],"paper_title":{"en":"High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.","ja":"High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension."},"authors":{"en":[{"name":"Yagi Shusuke"},{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Iwase Takashi"},{"name":"Yoshida Sumiko"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Ishikawa Kazue"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"八木 秀介"},{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"岩瀬 俊"},{"name":"吉田 守美子"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"Ishikawa Kazue"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"description":{"en":"Cognitive impairment leading to dementia is associated with high prevalence of hypertension, decreased quality of life and poor prognosis. Aldosterone is known as a risk factor for cardiovascular and cerebrovascular diseases. In addition, mineral corticoid receptors are abundantly expressed in the hippocampus, which plays a pivotal role in cognitive function; however, it has not been determined whether plasma aldosterone level is associated with cognitive impairment in patients with hypertension. We enrolled 68 patients with essential hypertension and assessed their cardiovascular risk factors, including blood pressure, hyperlipidemia, diabetes mellitus, obesity, smoking, history of cerebral infarction, renal function, parameters of inflammation, oxidative stress and nitric oxide bioavailability, a parameter of cerebral blood flow and carotid plaque by ultrasound examination, plasma renin activity and plasma aldosterone concentration (PAC). The mini-mental state examination (MMSE) was used to evaluate cognitive function. The relevance of cardiovascular risk factors and MMSE score was statistically evaluated. Multiple regression analysis showed that age (P<0.01), PAC (P<0.01) and history of cerebral infarction (P<0.05) were inversely and independently associated with MMSE score. Mineral corticoid receptor antagonists, including spironolactone and eplerenone, increased MMSE score in seven patients with hypertension, but not in the controls. In conclusion, increased PAC is associated with impaired cognitive function and mineral corticoid receptor blockade may protect against not only cardiovascular mortality, but also cognitive impairment in patients with hypertension.Hypertension Research advance online publication, 23 September 2010; doi:10.1038/hr.2010.179.","ja":"Cognitive impairment leading to dementia is associated with high prevalence of hypertension, decreased quality of life and poor prognosis. Aldosterone is known as a risk factor for cardiovascular and cerebrovascular diseases. In addition, mineral corticoid receptors are abundantly expressed in the hippocampus, which plays a pivotal role in cognitive function; however, it has not been determined whether plasma aldosterone level is associated with cognitive impairment in patients with hypertension. We enrolled 68 patients with essential hypertension and assessed their cardiovascular risk factors, including blood pressure, hyperlipidemia, diabetes mellitus, obesity, smoking, history of cerebral infarction, renal function, parameters of inflammation, oxidative stress and nitric oxide bioavailability, a parameter of cerebral blood flow and carotid plaque by ultrasound examination, plasma renin activity and plasma aldosterone concentration (PAC). The mini-mental state examination (MMSE) was used to evaluate cognitive function. The relevance of cardiovascular risk factors and MMSE score was statistically evaluated. Multiple regression analysis showed that age (P<0.01), PAC (P<0.01) and history of cerebral infarction (P<0.05) were inversely and independently associated with MMSE score. Mineral corticoid receptor antagonists, including spironolactone and eplerenone, increased MMSE score in seven patients with hypertension, but not in the controls. In conclusion, increased PAC is associated with impaired cognitive function and mineral corticoid receptor blockade may protect against not only cardiovascular mortality, but also cognitive impairment in patients with hypertension.Hypertension Research advance online publication, 23 September 2010; doi:10.1038/hr.2010.179."},"publication_date":"2010-09-23","publication_name":{"en":"Hypertension Research","ja":"Hypertension Research"},"volume":"Vol.34","number":"No.1","starting_page":"74","ending_page":"78","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/hr.2010.179"],"issn":["1348-4214"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:66, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20660821","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219671","label":"url"}],"paper_title":{"en":"Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.","ja":"Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice."},"authors":{"en":[{"name":"Sumitomo-Ueda Yuka"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Uemoto Ryoko"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Ishikawa Kazue"},{"name":"Hirata Yoichiro"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Sumitomo-Ueda Yuka"},{"name":"粟飯原 賢一"},{"name":"Ise Takayuki"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"Uemoto Ryoko"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Ishikawa Kazue"},{"name":"Hirata Yoichiro"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"Kato Shigeaki"},{"name":"松本 俊夫"}]},"description":{"en":"Heparin cofactor II (HCII), a serine protease inhibitor, inhibits tissue thrombin action after binding with dermatan sulfate proteoglycans in the extracellular matrix of the vascular system. We previously reported that heterozygous HCII-deficient (HCII(+/-)) humans and mice demonstrate acceleration of vascular remodeling, including atherosclerosis. However, the action of HCII on cardiac remodeling never has been determined. HCII(+/+) and HCII(+/-) mice at age 25 weeks were infused with angiotensin II (Ang II; 2.0 mg/kg/d) for 2 weeks by an osmotic mini-pump. Echocardiography revealed acceleration of cardiac concentric remodeling in HCII(+/-) mice and larger left atrial volume in HCII(+/-) mice than in HCII(+/+) mice. Histopathologic studies showed more prominent interstitial fibrosis in both the left atrium and left ventricle in HCII(+/-) mice than in HCII(+/+) mice. Daily urinary excretion of 8-hydroxy-2'-deoxyguanosine, a parameter of oxidative stress, and dihydroethidium-positive spots, indicating superoxide production in the myocardium, were markedly increased in Ang II-treated HCII(+/-) mice compared to those in HCII(+/+) mice. Cardiac gene expression levels of atrial natriuretic peptides and brain natriuretic peptides, members of the natriuretic peptide family, Nox 4, Rac-1, and p67(phox) as components of NAD(P)H oxidase, and transforming growth factor-beta1 and procollagen III were more augmented in HCII(+/-) mice than in HCII(+/+) mice. However, administration of human HCII protein attenuated all of those abnormalities in Ang II-treated HCII(+/-) mice. Moreover, human HCII protein supplementation almost abolished cardiac fibrosis in Ang II-treated HCII(+/+) mice. The results indicate that HCII has a protective role against Ang II-induced cardiac remodeling through suppression of the NAD(P)H oxidase-transforming growth factor-beta1 pathway.","ja":"Heparin cofactor II (HCII), a serine protease inhibitor, inhibits tissue thrombin action after binding with dermatan sulfate proteoglycans in the extracellular matrix of the vascular system. We previously reported that heterozygous HCII-deficient (HCII(+/-)) humans and mice demonstrate acceleration of vascular remodeling, including atherosclerosis. However, the action of HCII on cardiac remodeling never has been determined. HCII(+/+) and HCII(+/-) mice at age 25 weeks were infused with angiotensin II (Ang II; 2.0 mg/kg/d) for 2 weeks by an osmotic mini-pump. Echocardiography revealed acceleration of cardiac concentric remodeling in HCII(+/-) mice and larger left atrial volume in HCII(+/-) mice than in HCII(+/+) mice. Histopathologic studies showed more prominent interstitial fibrosis in both the left atrium and left ventricle in HCII(+/-) mice than in HCII(+/+) mice. Daily urinary excretion of 8-hydroxy-2'-deoxyguanosine, a parameter of oxidative stress, and dihydroethidium-positive spots, indicating superoxide production in the myocardium, were markedly increased in Ang II-treated HCII(+/-) mice compared to those in HCII(+/+) mice. Cardiac gene expression levels of atrial natriuretic peptides and brain natriuretic peptides, members of the natriuretic peptide family, Nox 4, Rac-1, and p67(phox) as components of NAD(P)H oxidase, and transforming growth factor-beta1 and procollagen III were more augmented in HCII(+/-) mice than in HCII(+/+) mice. However, administration of human HCII protein attenuated all of those abnormalities in Ang II-treated HCII(+/-) mice. Moreover, human HCII protein supplementation almost abolished cardiac fibrosis in Ang II-treated HCII(+/+) mice. The results indicate that HCII has a protective role against Ang II-induced cardiac remodeling through suppression of the NAD(P)H oxidase-transforming growth factor-beta1 pathway."},"publication_date":"2010-07-26","publication_name":{"en":"Hypertension","ja":"Hypertension"},"volume":"Vol.56","number":"No.3","starting_page":"430","ending_page":"436","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1161/HYPERTENSIONAHA.110.152207"],"issn":["1524-4563"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:67, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20627295","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219706","label":"url"}],"paper_title":{"en":"Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function.","ja":"Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function."},"authors":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Uemoto Ryoko"},{"name":"Sumitomo-Ueda Yuka"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Nishio Susumu"},{"name":"Kawano Hiromi"},{"name":"Miki Junko"},{"name":"Yamada Hirotsugu"},{"name":"Hirata Yoichiro"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"Uemoto Ryoko"},{"name":"住友(上田) 由香"},{"name":"八木 秀介"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"西尾 進"},{"name":"河野 裕美"},{"name":"三木 淳子"},{"name":"山田 博胤"},{"name":"平田 陽一郎"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"description":{"en":"BACKGROUND: Dehydroepiandrosterone sulfate (DHEAS) is thought to be associated with life expectancy and anti-aging. However, its biological significance in atherosclerosis remains controversial. Therefore, the aim of this study was to determine whether DHEAS is associated with development of carotid atherosclerosis in subjects with cardiovascular risk factors. SUBJECTS AND METHODS: A total of 419 Japanese individuals (208 males and 211 females) were recruited from Tokushima University Hospital, Japan. In all subjects, maximum intima-media thickness (max-IMT) in all carotid arteries, and mean-IMT and mean blood flow volume (BFV) in the common carotid arteries (CCA) were measured by ultrasonography; endothelial function was assessed by flow-mediated vasodilation of the brachial artery (%FMD). Serum DHEAS and classical cardiovascular risk factors were also evaluated. Statistical significance was determined by multiple regression analysis to elucidate independent determinants of max-IMT, mean-IMT, mean CCA-BFV, and %FMD. RESULTS: Serum DHEAS levels were higher in males than in females. Multiple regression analysis revealed that DHEAS was an independent negative factor for both max-IMT and mean-IMT in males but not in females. In contrast, DHEAS was the sole positive factor for mean CCA-BFV in females but not in males. In addition, there was no significant relationship between %FMD and DHEAS regardless of sex and other confounding factors. CONCLUSION: Although DHEAS is not involved in endothelial function, DHEAS is inversely associated with sex-dependent diverse carotid atherosclerosis such as increased max-IMT and mean-IMT in males and decreased CCA-BFV in females.","ja":"BACKGROUND: Dehydroepiandrosterone sulfate (DHEAS) is thought to be associated with life expectancy and anti-aging. However, its biological significance in atherosclerosis remains controversial. Therefore, the aim of this study was to determine whether DHEAS is associated with development of carotid atherosclerosis in subjects with cardiovascular risk factors. SUBJECTS AND METHODS: A total of 419 Japanese individuals (208 males and 211 females) were recruited from Tokushima University Hospital, Japan. In all subjects, maximum intima-media thickness (max-IMT) in all carotid arteries, and mean-IMT and mean blood flow volume (BFV) in the common carotid arteries (CCA) were measured by ultrasonography; endothelial function was assessed by flow-mediated vasodilation of the brachial artery (%FMD). Serum DHEAS and classical cardiovascular risk factors were also evaluated. Statistical significance was determined by multiple regression analysis to elucidate independent determinants of max-IMT, mean-IMT, mean CCA-BFV, and %FMD. RESULTS: Serum DHEAS levels were higher in males than in females. Multiple regression analysis revealed that DHEAS was an independent negative factor for both max-IMT and mean-IMT in males but not in females. In contrast, DHEAS was the sole positive factor for mean CCA-BFV in females but not in males. In addition, there was no significant relationship between %FMD and DHEAS regardless of sex and other confounding factors. CONCLUSION: Although DHEAS is not involved in endothelial function, DHEAS is inversely associated with sex-dependent diverse carotid atherosclerosis such as increased max-IMT and mean-IMT in males and decreased CCA-BFV in females."},"publication_date":"2010-06-01","publication_name":{"en":"Atherosclerosis","ja":"Atherosclerosis"},"volume":"Vol.212","number":"No.1","starting_page":"310","ending_page":"315","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.atherosclerosis.2010.05.011"],"issn":["1879-1484"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:68, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20501642","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219675","label":"url"}],"paper_title":{"en":"Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.","ja":"Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Sato Takashi"},{"name":"Ishikawa Kazue"},{"name":"Ise Takayuki"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Ueda Yuka"},{"name":"Yoshida Sumiko"},{"name":"Azuma Hiroyuki"},{"name":"Walsh Kenneth"},{"name":"Tamaki Toshiaki"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"Sato Takashi"},{"name":"Ishikawa Kazue"},{"name":"Ise Takayuki"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Ueda Yuka"},{"name":"吉田 守美子"},{"name":"東 博之"},{"name":"Walsh Kenneth"},{"name":"玉置 俊晃"},{"name":"Kato Shigeaki"},{"name":"松本 俊夫"}]},"description":{"en":"Doxorubicin (Dox) has been used as a potent anticancer agent, but serious cardiotoxicity precludes its use in a wide range of patients. We have reported that the androgen-androgen receptor (AR) system plays important roles in cardiac growth and protection from angiotensin II-induced cardiac remodeling. The present study was undertaken to clarify whether the androgen-AR system exerts a cardioprotective effect against Dox-induced cardiotoxicity. Male AR knockout (ARKO) and age-matched littermate male wild-type (WT) mice at 25 wk of age were given ip injections of Dox (20 mg/kg) or a vehicle. The survival rate and left ventricular function in Dox-treated male ARKO mice were reduced compared with those in Dox-treated male WT mice. Electron microscopic study showed prominent vacuole formation of myocardial mitochondria in Dox-treated male ARKO mice. Cardiac oxidative stress and apoptosis of cardiomyocytes were increased more prominently by Dox treatment in male ARKO mice than in male WT mice. In addition, Dox-induced reduction in the expression of cardiac mitochondria transcription factor A (Tfam) and phosphorylation of serine-threonine kinase (Akt) was more pronounced in male ARKO mice than in male WT mice. In cardiac myoblast cells, testosterone up-regulated Akt phosphorylation and Tfam expression and exerted an antiapoptotic effect against Dox-induced cardiotoxicity. Collectively, the results demonstrate that Dox-induced cardiotoxicity is aggravated in male ARKO mice via exacerbation of mitochondrial damage and superoxide generation, leading to enhanced apoptosis of cardiomyocytes. Thus, the androgen-AR system is thought to counteract Dox-induced cardiotoxicity partly through activation of the Akt pathway and up-regulation of Tfam to protect cardiomyocytes from mitochondrial damage and apoptosis.","ja":"Doxorubicin (Dox) has been used as a potent anticancer agent, but serious cardiotoxicity precludes its use in a wide range of patients. We have reported that the androgen-androgen receptor (AR) system plays important roles in cardiac growth and protection from angiotensin II-induced cardiac remodeling. The present study was undertaken to clarify whether the androgen-AR system exerts a cardioprotective effect against Dox-induced cardiotoxicity. Male AR knockout (ARKO) and age-matched littermate male wild-type (WT) mice at 25 wk of age were given ip injections of Dox (20 mg/kg) or a vehicle. The survival rate and left ventricular function in Dox-treated male ARKO mice were reduced compared with those in Dox-treated male WT mice. Electron microscopic study showed prominent vacuole formation of myocardial mitochondria in Dox-treated male ARKO mice. Cardiac oxidative stress and apoptosis of cardiomyocytes were increased more prominently by Dox treatment in male ARKO mice than in male WT mice. In addition, Dox-induced reduction in the expression of cardiac mitochondria transcription factor A (Tfam) and phosphorylation of serine-threonine kinase (Akt) was more pronounced in male ARKO mice than in male WT mice. In cardiac myoblast cells, testosterone up-regulated Akt phosphorylation and Tfam expression and exerted an antiapoptotic effect against Dox-induced cardiotoxicity. Collectively, the results demonstrate that Dox-induced cardiotoxicity is aggravated in male ARKO mice via exacerbation of mitochondrial damage and superoxide generation, leading to enhanced apoptosis of cardiomyocytes. Thus, the androgen-AR system is thought to counteract Dox-induced cardiotoxicity partly through activation of the Akt pathway and up-regulation of Tfam to protect cardiomyocytes from mitochondrial damage and apoptosis."},"publication_date":"2010-05-25","publication_name":{"en":"Molecular Endocrinology","ja":"Molecular Endocrinology"},"volume":"Vol.24","number":"No.7","starting_page":"1338","ending_page":"1348","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1210/me.2009-0402"],"issn":["1944-9917"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:69, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376224"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20431588","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-77954369377&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=207897","label":"url"}],"paper_title":{"en":"Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells","ja":"Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells"},"authors":{"en":[{"name":"Tajima Soichiro"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Shono Masayuki"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Tajima Soichiro"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"庄野 正行"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"description":{"en":"Angiotensin II (Ang II)-induced endothelial injury, which is associated with atherosclerosis, is believed to be mediated by intracellular reactive oxygen species (ROS) through stimulation of nicotinamide adenine dinucleotide phosphate oxidase (NOX). Iron is essential for the amplification of oxidative stress. In this study, we investigated whether Ang II altered iron metabolism and whether the Ang II-induced endothelial injury is attributable to changes in iron metabolism of human glomerular endothelial cells (HGECs). When 90% iron-saturated human transferrin (90% Tf) was applied to HGECs without Ang II, the labile ferrous iron level was same as the effect of control in spite of a significant increase in the total cellular iron concentration. Treatment with Ang II and 30% Tf or 90% Tf significantly (P<0.01) increased the intracellular iron concentration, as well as labile ferrous iron and protein oxidation levels, compared with the effect of separate administration of each compound. Ang II treatment facilitated the protein expression of the Tf receptor, divalent metal transporter 1, and ferroportin 1 in a dose- and time-dependent manner. It was also found that simultaneous exposure of HGECs to Ang II and 90% Tf accelerated hydroxyl radical production, as shown by using an electron paramagnetic resonance spectrometer. These results suggest that Ang II not only induces production of ROS by NOX activation but also iron incorporation followed by an increase in labile iron in HGECs. Both of these events may participate in the progression of oxidative stress because of endothelial cell dysfunction through ferrous iron-mediated ROS generation.","ja":"Angiotensin II (Ang II)-induced endothelial injury, which is associated with atherosclerosis, is believed to be mediated by intracellular reactive oxygen species (ROS) through stimulation of nicotinamide adenine dinucleotide phosphate oxidase (NOX). Iron is essential for the amplification of oxidative stress. In this study, we investigated whether Ang II altered iron metabolism and whether the Ang II-induced endothelial injury is attributable to changes in iron metabolism of human glomerular endothelial cells (HGECs). When 90% iron-saturated human transferrin (90% Tf) was applied to HGECs without Ang II, the labile ferrous iron level was same as the effect of control in spite of a significant increase in the total cellular iron concentration. Treatment with Ang II and 30% Tf or 90% Tf significantly (P<0.01) increased the intracellular iron concentration, as well as labile ferrous iron and protein oxidation levels, compared with the effect of separate administration of each compound. Ang II treatment facilitated the protein expression of the Tf receptor, divalent metal transporter 1, and ferroportin 1 in a dose- and time-dependent manner. It was also found that simultaneous exposure of HGECs to Ang II and 90% Tf accelerated hydroxyl radical production, as shown by using an electron paramagnetic resonance spectrometer. These results suggest that Ang II not only induces production of ROS by NOX activation but also iron incorporation followed by an increase in labile iron in HGECs. Both of these events may participate in the progression of oxidative stress because of endothelial cell dysfunction through ferrous iron-mediated ROS generation."},"publication_date":"2010-04-30","publication_name":{"en":"Hypertension Research","ja":"Hypertension Research"},"volume":"Vol.33","number":"No.7","starting_page":"713","ending_page":"721","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1038/hr.2010.63"],"issn":["1348-4214"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:70, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20194307","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219677","label":"url"}],"paper_title":{"en":"Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.","ja":"Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury."},"authors":{"en":[{"name":"Yagi Shusuke"},{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ishikawa Kazue"},{"name":"Iwase Takashi"},{"name":"Ikeda Yasumasa"},{"name":"Soeki Takeshi"},{"name":"Yoshida Sumiko"},{"name":"Sumitomo-Ueda Yuka"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"八木 秀介"},{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"Ishikawa Kazue"},{"name":"岩瀬 俊"},{"name":"池田 康将"},{"name":"添木 武"},{"name":"吉田 守美子"},{"name":"Sumitomo-Ueda Yuka"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"description":{"en":"Activation of the renin-angiotensin system exacerbates atrial remodeling, leading to atrial fibrillation and thrombosis, especially in a condition with decreased NO bioavailability. Recently, it has been reported that statins reduce the incidence of atrial fibrillation through attenuation of atrial remodeling; however, the mechanisms have not been completely elucidated. Therefore, we aimed to clarify the beneficial effect of statin on atrial remodeling in condition with reduced NO bioavailability. Endothelial NO synthase(-/-) mice were sham operated or infused with angiotensin II (Ang II) via an osmotic minipump for 2 weeks, and Ang II-infused mice were divided into 3 treatment groups: pitavastatin, Tempol (a free radical scavenger), or vehicle. Echocardiography and electrocardiography showed that Ang II infusion caused left atrial enlargement and a high incidence of atrial fibrillation, whereas pitavastatin and Tempol prevented these abnormalities. In histological analysis, Ang II-induced atrial interstitial fibrosis, perivascular fibrosis, and cardiomyocyte hypertrophy were all attenuated by pitavastatin and Tempol. Immunohistochemical staining showed that Ang II downregulated thrombomodulin and tissue factor pathway inhibitor and upregulated tissue factor and plasminogen activator inhibitor 1 in the left atrium and that pitavastatin and Tempol corrected the thrombogenic condition. Moreover, pitavastatin and Tempol reduced Ang II-induced atrial superoxide production and atrial transforming growth factor-beta1 expression and Smad 2/3 phosphorylation. Atrial rac1-GTPase activity, known to activate NADPH oxidase, was attenuated by pitavastatin but not by Tempol. In conclusion, pitavastatin exerts endothelial NO synthase-independent protective actions against Ang II-induced atrial remodeling and atrial fibrillation with enhanced thrombogenicity through suppression of oxidant injury.","ja":"Activation of the renin-angiotensin system exacerbates atrial remodeling, leading to atrial fibrillation and thrombosis, especially in a condition with decreased NO bioavailability. Recently, it has been reported that statins reduce the incidence of atrial fibrillation through attenuation of atrial remodeling; however, the mechanisms have not been completely elucidated. Therefore, we aimed to clarify the beneficial effect of statin on atrial remodeling in condition with reduced NO bioavailability. Endothelial NO synthase(-/-) mice were sham operated or infused with angiotensin II (Ang II) via an osmotic minipump for 2 weeks, and Ang II-infused mice were divided into 3 treatment groups: pitavastatin, Tempol (a free radical scavenger), or vehicle. Echocardiography and electrocardiography showed that Ang II infusion caused left atrial enlargement and a high incidence of atrial fibrillation, whereas pitavastatin and Tempol prevented these abnormalities. In histological analysis, Ang II-induced atrial interstitial fibrosis, perivascular fibrosis, and cardiomyocyte hypertrophy were all attenuated by pitavastatin and Tempol. Immunohistochemical staining showed that Ang II downregulated thrombomodulin and tissue factor pathway inhibitor and upregulated tissue factor and plasminogen activator inhibitor 1 in the left atrium and that pitavastatin and Tempol corrected the thrombogenic condition. Moreover, pitavastatin and Tempol reduced Ang II-induced atrial superoxide production and atrial transforming growth factor-beta1 expression and Smad 2/3 phosphorylation. Atrial rac1-GTPase activity, known to activate NADPH oxidase, was attenuated by pitavastatin but not by Tempol. In conclusion, pitavastatin exerts endothelial NO synthase-independent protective actions against Ang II-induced atrial remodeling and atrial fibrillation with enhanced thrombogenicity through suppression of oxidant injury."},"publication_date":"2010-03-01","publication_name":{"en":"Hypertension","ja":"Hypertension"},"volume":"Vol.55","number":"No.4","starting_page":"918","ending_page":"923","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1161/HYPERTENSIONAHA.109.146076"],"issn":["1524-4563"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:71, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19812233","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=194522","label":"url"}],"paper_title":{"en":"Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner","ja":"Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner"},"authors":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Dorjsuren Narantungalag"},{"name":"Miki Erika"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Shuichi"},{"name":"Kawazoe Kazuyoshi"},{"name":"Minakuchi Kazuo"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"Dorjsuren Narantungalag"},{"name":"Miki Erika"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"濱野 修一"},{"name":"川添 和義"},{"name":"水口 和生"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Clinical studies have shown that angiotensin II (Ang II) type 1 (AT1) receptor blockers (ARBs) are able to provide renoprotection independent of their blood pressure lowering effects. ARBs also are reported to suppress oxidative stress, inflammation and certain other cellular responses in a receptor-independent manner. We investigated the effects of an ARB, olmesartan, on the cell migration induced by platelet-derived growth factor (PDGF), a major mitogen involved in the pathogenesis of glomerulonephritis in rat mesangial cells (RMCs). Cell migration was determined by a modified Boyden chamber assay. The intracellular signalling pathway was examined by western blotting. AT1 receptor expression was knocked down by small interfering RNAs. The intracellular reactive oxygen species (ROS) was measured by using a fluorescent probe. The O(2)(.-) scavenging activities were studied by the electron paramagnetic resonance-spin trapping method. PDGF-induced cell migration was inhibited by olmesartan in AT1 receptor knockdown RMCs. Olmesartan attenuated big mitogen-activated protein (MAP) kinase 1 (BMK1) and Src activation by PDGF in AT1 receptor knockdown RMCs. PDGF-induced BMK1 activation was suppressed by the Src family tyrosine kinase inhibitors, indicating that Src exists upstream of BMK1. The NADPH oxidase inhibitors inhibited not only PDGF-induced BMK1 and Src activation but also RMC migration. The elevation in ROS generation induced by PDGF was decreased by olmesartan. Olmesartan displayed neither directly ROS scavenging activity nor the inhibition of ROS-mediated intracellular signalling in RMCs. Olmesartan attenuates ROS generation by PDGF, leading to the subsequent inhibition of Src/ BMK1/migration in an AT1 receptor-independent manner in RMCs.","ja":"Clinical studies have shown that angiotensin II (Ang II) type 1 (AT1) receptor blockers (ARBs) are able to provide renoprotection independent of their blood pressure lowering effects. ARBs also are reported to suppress oxidative stress, inflammation and certain other cellular responses in a receptor-independent manner. We investigated the effects of an ARB, olmesartan, on the cell migration induced by platelet-derived growth factor (PDGF), a major mitogen involved in the pathogenesis of glomerulonephritis in rat mesangial cells (RMCs). Cell migration was determined by a modified Boyden chamber assay. The intracellular signalling pathway was examined by western blotting. AT1 receptor expression was knocked down by small interfering RNAs. The intracellular reactive oxygen species (ROS) was measured by using a fluorescent probe. The O(2)(.-) scavenging activities were studied by the electron paramagnetic resonance-spin trapping method. PDGF-induced cell migration was inhibited by olmesartan in AT1 receptor knockdown RMCs. Olmesartan attenuated big mitogen-activated protein (MAP) kinase 1 (BMK1) and Src activation by PDGF in AT1 receptor knockdown RMCs. PDGF-induced BMK1 activation was suppressed by the Src family tyrosine kinase inhibitors, indicating that Src exists upstream of BMK1. The NADPH oxidase inhibitors inhibited not only PDGF-induced BMK1 and Src activation but also RMC migration. The elevation in ROS generation induced by PDGF was decreased by olmesartan. Olmesartan displayed neither directly ROS scavenging activity nor the inhibition of ROS-mediated intracellular signalling in RMCs. Olmesartan attenuates ROS generation by PDGF, leading to the subsequent inhibition of Src/ BMK1/migration in an AT1 receptor-independent manner in RMCs."},"publication_date":"2010-02","publication_name":{"en":"Nephrology, Dialysis, Transplantation","ja":"Nephrology, Dialysis, Transplantation"},"volume":"Vol.25","number":"No.2","starting_page":"364","ending_page":"372","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1093/ndt/gfp520"],"issn":["1460-2385"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:72, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376225"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20005970","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=204466","label":"url"}],"paper_title":{"en":"Dietary nitrite ameliorates renal injury in l-NAME-induced hypertensive rats","ja":"Dietary nitrite ameliorates renal injury in l-NAME-induced hypertensive rats"},"authors":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Abe Shinji"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"阿部 真治"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"玉置 俊晃"}]},"description":{"en":"Nitric oxide (NO) has numerous important functions in the kidney, and long-term blockage of nitric oxide synthases in rats by L-NAME results in severe hypertension and progressive kidney damage. On the other hand, NO production seems to be low in patients with chronic kidney disease (CKD), and NO deficiency may play a role in CKD progression. In this review, we summarized the mechanisms of amelioration of renal injury induced by L-NAME treated rats by treatment of nitrite. First, we demonstrate whether orally-administrated nitrite-derived NO can shift to the circulation. When 3mg/kg body weight Na(15)NO(2) was orally administered to rats, an apparent EPR signal derived from Hb(15)NO (A(z)=23.4 gauss) appeared in the blood, indicating that orally ingested nitrite can be a source of NO in vivo. Next, in order to clarify the capacity of nitrite to prevent renal disease, we administered low-dose nitrite (LDN: 0.1mg of sodium nitrite in 1L of drinking water), medium-dose nitrite (MDN: 1mg sodium nitrite/L, which corresponds to the amount of nitrite ingested by vegetarians), or high-dose nitrite (HDN: 10mg sodium nitrite/L) to rats simultaneously with L-NAME (1 g l-NAME/L) for 8 weeks, then examined the blood NO level as a hemoglobin-NO adduct (iron-nitrosyl-hemoglobin) using electron paramagnetic resonance spectroscopy, urinary protein excretion, and renal histological changes at the end of the experiment. It was found that oral administration of MDN and HDN but not LDN increased the blood iron-nitrosyl-hemoglobin concentration to the normal level, ameliorated the L-NAME-induced proteinuria, and reduced renal histological damage. The findings demonstrate that chronic administration of a mid-level dietary dose of nitrite restores the circulating iron-nitrosyl-hemoglobin levels reduced by L-NAME and that maintenance of the circulating iron-nitrosyl-hemoglobin level in a controlled range protects against L-NAME-induced renal injury. Taking these findings together, we propose that dietary supplementation of nitrite is a potentially useful nonpharmacological strategy for maintaining circulating NO level in order to prevent or slow the progression of renal disease. It had been believed that nitrite could result in intragastric formation of nitrosamines, which had been linked to esophageal and other gastrointestinal cancers. However, there is no positive association between the intake of nitrate or nitrite and gastric and pancreatic cancer by recent researches. Furthermore, nitrate-derived NO formation pathway is a possible mechanism for the hypotensive effect of vegetable- and fruit-rich diets, which may explain, at least in part, the mechanism of the Dietary Approach to Stop Hypertension (DASH) diet-induced hypotensive and organ-protective effects. Further research is needed to investigate the interaction between nitrite-nitrate intakes and human health.","ja":"Nitric oxide (NO) has numerous important functions in the kidney, and long-term blockage of nitric oxide synthases in rats by L-NAME results in severe hypertension and progressive kidney damage. On the other hand, NO production seems to be low in patients with chronic kidney disease (CKD), and NO deficiency may play a role in CKD progression. In this review, we summarized the mechanisms of amelioration of renal injury induced by L-NAME treated rats by treatment of nitrite. First, we demonstrate whether orally-administrated nitrite-derived NO can shift to the circulation. When 3mg/kg body weight Na(15)NO(2) was orally administered to rats, an apparent EPR signal derived from Hb(15)NO (A(z)=23.4 gauss) appeared in the blood, indicating that orally ingested nitrite can be a source of NO in vivo. Next, in order to clarify the capacity of nitrite to prevent renal disease, we administered low-dose nitrite (LDN: 0.1mg of sodium nitrite in 1L of drinking water), medium-dose nitrite (MDN: 1mg sodium nitrite/L, which corresponds to the amount of nitrite ingested by vegetarians), or high-dose nitrite (HDN: 10mg sodium nitrite/L) to rats simultaneously with L-NAME (1 g l-NAME/L) for 8 weeks, then examined the blood NO level as a hemoglobin-NO adduct (iron-nitrosyl-hemoglobin) using electron paramagnetic resonance spectroscopy, urinary protein excretion, and renal histological changes at the end of the experiment. It was found that oral administration of MDN and HDN but not LDN increased the blood iron-nitrosyl-hemoglobin concentration to the normal level, ameliorated the L-NAME-induced proteinuria, and reduced renal histological damage. The findings demonstrate that chronic administration of a mid-level dietary dose of nitrite restores the circulating iron-nitrosyl-hemoglobin levels reduced by L-NAME and that maintenance of the circulating iron-nitrosyl-hemoglobin level in a controlled range protects against L-NAME-induced renal injury. Taking these findings together, we propose that dietary supplementation of nitrite is a potentially useful nonpharmacological strategy for maintaining circulating NO level in order to prevent or slow the progression of renal disease. It had been believed that nitrite could result in intragastric formation of nitrosamines, which had been linked to esophageal and other gastrointestinal cancers. However, there is no positive association between the intake of nitrate or nitrite and gastric and pancreatic cancer by recent researches. Furthermore, nitrate-derived NO formation pathway is a possible mechanism for the hypotensive effect of vegetable- and fruit-rich diets, which may explain, at least in part, the mechanism of the Dietary Approach to Stop Hypertension (DASH) diet-induced hypotensive and organ-protective effects. Further research is needed to investigate the interaction between nitrite-nitrate intakes and human health."},"publication_date":"2010-02","publication_name":{"en":"Nitric Oxide: Biology and Chemistry","ja":"Nitric Oxide: Biology and Chemistry"},"volume":"Vol.22","number":"No.2","starting_page":"98","ending_page":"103","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.niox.2009.12.002"],"issn":["1089-8611"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:73, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19966184","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219678","label":"url"}],"paper_title":{"en":"Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.","ja":"Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice."},"authors":{"en":[{"name":"Mihara Masatomo"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yoshida Sumiko"},{"name":"Kinouchi Mizuho"},{"name":"Kurahashi Kiyoe"},{"name":"Fujinaka Yuichi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Mihara Masatomo"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"吉田 守美子"},{"name":"木内 美瑞穂"},{"name":"Kurahashi Kiyoe"},{"name":"藤中 雄一"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"description":{"en":"The binding of thrombin to its receptor stimulates inflammatory cytokines including IL-6 and monocyte chemoattractant protein-1 (MCP-1); both are associated with the development of insulin resistance. Because increased adiposity enhanced the expression of coagulation factor VII that stimulates the coagulation pathway in adipose tissue, we tested whether the inhibition of thrombin action ameliorates insulin resistance in obese diabetic (Lpr(-/-):db/db) mice. The 4-wk administration of argatroban, a selective thrombin inhibitor, reduced fasting plasma glucose and ameliorated insulin resistance in these mice. It also reduced adipocyte size and macrophage infiltration into adipose tissue. The aberrant gene expression of MCP-1, IL-6, adiponectin, and factor VII and suppressed insulin receptor substrate-1-Akt signaling in adipose tissue of db/db mice were reversed by argatroban treatment. These results demonstrate that increased adiposity enhances the production of thrombin in adipose tissue by stimulating factor VII expression and suggest that increased thrombin activity in adipose tissue plays an important role in the development of insulin resistance via enhancing MCP-1 production, leading to macrophage infiltration and insulin receptor substrate-1-Akt pathway inactivation.","ja":"The binding of thrombin to its receptor stimulates inflammatory cytokines including IL-6 and monocyte chemoattractant protein-1 (MCP-1); both are associated with the development of insulin resistance. Because increased adiposity enhanced the expression of coagulation factor VII that stimulates the coagulation pathway in adipose tissue, we tested whether the inhibition of thrombin action ameliorates insulin resistance in obese diabetic (Lpr(-/-):db/db) mice. The 4-wk administration of argatroban, a selective thrombin inhibitor, reduced fasting plasma glucose and ameliorated insulin resistance in these mice. It also reduced adipocyte size and macrophage infiltration into adipose tissue. The aberrant gene expression of MCP-1, IL-6, adiponectin, and factor VII and suppressed insulin receptor substrate-1-Akt signaling in adipose tissue of db/db mice were reversed by argatroban treatment. These results demonstrate that increased adiposity enhances the production of thrombin in adipose tissue by stimulating factor VII expression and suggest that increased thrombin activity in adipose tissue plays an important role in the development of insulin resistance via enhancing MCP-1 production, leading to macrophage infiltration and insulin receptor substrate-1-Akt pathway inactivation."},"publication_date":"2009-12-04","publication_name":{"en":"Endocrinology","ja":"Endocrinology"},"volume":"Vol.151","number":"No.2","starting_page":"513","ending_page":"519","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1210/en.2009-0661"],"issn":["1945-7170"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:74, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376226"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19828446","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219698","label":"url"}],"paper_title":{"en":"Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction.","ja":"Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Sato Kaori"},{"name":"Pimentel David R"},{"name":"Sam Flora"},{"name":"Shaw Reuben J"},{"name":"Dyck Jason R B"},{"name":"Walsh Kenneth"}],"ja":[{"name":"池田 康将"},{"name":"Sato Kaori"},{"name":"Pimentel David R"},{"name":"Sam Flora"},{"name":"Shaw Reuben J"},{"name":"Dyck Jason R B"},{"name":"Walsh Kenneth"}]},"description":{"en":"LKB1 encodes a serine/threonine kinase, which functions upstream of the AMP-activated protein kinase (AMPK) superfamily. To clarify the role of LKB1 in heart, we generated and characterized cardiac myocyte-specific LKB1 knock-out (KO) mice using alpha-myosin heavy chain-Cre deletor strain. LKB1-KO mice displayed biatrial enlargement with atrial fibrillation and cardiac dysfunction at 4 weeks of age. Left ventricular hypertrophy was observed in LKB1-KO mice at 12 weeks but not 4 weeks of age. Collagen I and III mRNA expression was elevated in atria at 4 weeks, and atrial fibrosis was seen at 12 weeks. LKB1-KO mice displayed cardiac dysfunction and atrial fibrillation and died within 6 months of age. Indicative of a prohypertrophic environment, the phosphorylation of AMPK and eEF2 was reduced, whereas mammalian target of rapamycin (mTOR) phosphorylation and p70S6 kinase phosphorylation were increased in both the atria and ventricles of LKB1-deficient mice. Consistent with vascular endothelial growth factor mRNA and protein levels being significantly reduced in LKB1-KO mice, these mice also exhibited a reduction in capillary density of both atria and ventricles. In cultured cardiac myocytes, LKB1 silencing induced hypertrophy, which was ameliorated by the expression of a constitutively active form AMPK or by treatment with the inhibitor of mTOR, rapamycin. These findings indicate that LKB1 signaling in cardiac myocytes is essential for normal development of the atria and ventricles. Cardiac hypertrophy and dysfunction in LKB1-deficient hearts are associated with alterations in AMPK and mTOR/p70S6 kinase/eEF2 signaling and with a reduction in vascular endothelial growth factor expression and vessel rarefaction.","ja":"LKB1 encodes a serine/threonine kinase, which functions upstream of the AMP-activated protein kinase (AMPK) superfamily. To clarify the role of LKB1 in heart, we generated and characterized cardiac myocyte-specific LKB1 knock-out (KO) mice using alpha-myosin heavy chain-Cre deletor strain. LKB1-KO mice displayed biatrial enlargement with atrial fibrillation and cardiac dysfunction at 4 weeks of age. Left ventricular hypertrophy was observed in LKB1-KO mice at 12 weeks but not 4 weeks of age. Collagen I and III mRNA expression was elevated in atria at 4 weeks, and atrial fibrosis was seen at 12 weeks. LKB1-KO mice displayed cardiac dysfunction and atrial fibrillation and died within 6 months of age. Indicative of a prohypertrophic environment, the phosphorylation of AMPK and eEF2 was reduced, whereas mammalian target of rapamycin (mTOR) phosphorylation and p70S6 kinase phosphorylation were increased in both the atria and ventricles of LKB1-deficient mice. Consistent with vascular endothelial growth factor mRNA and protein levels being significantly reduced in LKB1-KO mice, these mice also exhibited a reduction in capillary density of both atria and ventricles. In cultured cardiac myocytes, LKB1 silencing induced hypertrophy, which was ameliorated by the expression of a constitutively active form AMPK or by treatment with the inhibitor of mTOR, rapamycin. These findings indicate that LKB1 signaling in cardiac myocytes is essential for normal development of the atria and ventricles. Cardiac hypertrophy and dysfunction in LKB1-deficient hearts are associated with alterations in AMPK and mTOR/p70S6 kinase/eEF2 signaling and with a reduction in vascular endothelial growth factor expression and vessel rarefaction."},"publication_date":"2009-12","publication_name":{"en":"The Journal of Biological Chemistry","ja":"The Journal of Biological Chemistry"},"volume":"Vol.284","number":"No.51","starting_page":"35839","ending_page":"35849","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1074/jbc.M109.057273"],"issn":["1083-351X"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:75, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/20058503","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219707","label":"url"}],"paper_title":{"en":"Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.","ja":"Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure."},"authors":{"en":[{"name":"Fujimura Mitsunori"},{"name":"Akaike Masashi"},{"name":"Iwase Takashi"},{"name":"Yoshida Sumiko"},{"name":"Sumitomo Yuka"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"Hashizume Shunji"},{"name":"Aihara Ken-ichi"},{"name":"Nishiuchi Takeshi"},{"name":"Yasumura Yoshio"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Fujimura Mitsunori"},{"name":"Akaike Masashi"},{"name":"Iwase Takashi"},{"name":"吉田 守美子"},{"name":"Sumitomo Yuka"},{"name":"Yagi Shusuke"},{"name":"池田 康将"},{"name":"Hashizume Shunji"},{"name":"粟飯原 賢一"},{"name":"Nishiuchi Takeshi"},{"name":"Yasumura Yoshio"},{"name":"松本 俊夫"}]},"description":{"en":"OBJECTIVE: The purpose of the present study was to determine whether change in plasma brain natriuretic peptide (BNP) level at an early phase of carvedilol therapy is a predictor of improvement in cardiac function and long-term prognosis in patients with systolic chronic heart failure (CHF). METHODS AND RESULTS: Neurohumoral factors and haemodynamics were examined in 64 patients with systolic CHF (left ventricular ejection fraction (LVEF) below 45%) before and one month (early phase) and 3 to 6 months (late phase) after the start of carvedilol therapy. These patients were followed up for a mean period of 57 months. Plasma BNP levels were already decreased in the early phase before improvement of LVEF in response to carvedilol therapy. Univariate and multivariate linear regression analyses showed that Delta log brain natriuretic peptide (BNP)E (= log BNP at baseline--log BNP at early phase) (P < 0.0001) was a significant independent predictor of improvement in LVEF in the late phase. Cardiac events occurred in I I patients during the follow-up period. In addition, multivariate Cox proportional hazards regression analysis showed that Delta log BNPE (P = 0.0045) and systolic blood pressure at baseline (P = -0.048) were significant independent predictors of the development of cardiac events. CONCLUSIONS: Decrease in plasma BNP level in the early phase of carvedilol therapy is a novel predictor of not only improvement of LVEF in the late phase but also prognosis in patients with systolic CHF.","ja":"OBJECTIVE: The purpose of the present study was to determine whether change in plasma brain natriuretic peptide (BNP) level at an early phase of carvedilol therapy is a predictor of improvement in cardiac function and long-term prognosis in patients with systolic chronic heart failure (CHF). METHODS AND RESULTS: Neurohumoral factors and haemodynamics were examined in 64 patients with systolic CHF (left ventricular ejection fraction (LVEF) below 45%) before and one month (early phase) and 3 to 6 months (late phase) after the start of carvedilol therapy. These patients were followed up for a mean period of 57 months. Plasma BNP levels were already decreased in the early phase before improvement of LVEF in response to carvedilol therapy. Univariate and multivariate linear regression analyses showed that Delta log brain natriuretic peptide (BNP)E (= log BNP at baseline--log BNP at early phase) (P < 0.0001) was a significant independent predictor of improvement in LVEF in the late phase. Cardiac events occurred in I I patients during the follow-up period. In addition, multivariate Cox proportional hazards regression analysis showed that Delta log BNPE (P = 0.0045) and systolic blood pressure at baseline (P = -0.048) were significant independent predictors of the development of cardiac events. CONCLUSIONS: Decrease in plasma BNP level in the early phase of carvedilol therapy is a novel predictor of not only improvement of LVEF in the late phase but also prognosis in patients with systolic CHF."},"publication_date":"2009-10","publication_name":{"en":"Acta Cardiologica","ja":"Acta Cardiologica"},"volume":"Vol.64","number":"No.5","starting_page":"589","ending_page":"595","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2143/AC.64.5.2042687"],"issn":["0001-5385"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:76, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19460854","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=193058","label":"url"}],"paper_title":{"en":"Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration","ja":"Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration"},"authors":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Dorjsuren Narantungalag"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Sugimoto Rika"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"Dorjsuren Narantungalag"},{"name":"石澤 有紀"},{"name":"Sugimoto Rika"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"description":{"en":"Adiponectin, an adipocyte-derived hormone, has been involved in metabolic syndrome, a known risk factor for the development of chronic kidney disease (CKD). Recent studies have demonstrated that plasma adiponectin levels are elevated when kidney function declines in patients with CKD. Excessive mesangial cell (MC) turnover is one of the important features of CKD. The aim of the present study is to elucidate the effects of adiponectin on platelet-derived growth factor (PDGF)-induced cell migration and intracellular signaling pathways, in cultured rat MCs (RMCs). PDGF-induced RMC migration was significantly inhibited by the pretreatment of adiponectin. Adiponectin alone had no effect on RMC migration. Big mitogen-activated protein (MAP) kinase 1 (BMK1), p38 MAP kinase, and Akt were activated by PDGF stimulation in a time- and concentration-dependent manner in RMC. Adiponectin alone did not affect BMK1, p38 MAP kinase, and Akt phosphorylations in RMC. PDGF-induced BMK1 and p38 MAP kinase phosphorylations were significantly attenuated by the pretreatment of adiponectin in RMCs. On the other hand, the phosphorylation of Akt by PDGF was not diminished by the pretreatment of adiponectin. Adiponectin had no effects on PDGF-receptor autophosphorylation by PDGF. We also confirmed that PDGF-induced RMC migration was significantly suppressed by siBMK1 transfection or SB203580, a p38 MAP kinase inhibitor. From these findings, it is implied that the elevated plasma adiponectin levels in patients with CKD might play a compensatory role aimed at counteracting renal dysfunction related to MC disorders.","ja":"Adiponectin, an adipocyte-derived hormone, has been involved in metabolic syndrome, a known risk factor for the development of chronic kidney disease (CKD). Recent studies have demonstrated that plasma adiponectin levels are elevated when kidney function declines in patients with CKD. Excessive mesangial cell (MC) turnover is one of the important features of CKD. The aim of the present study is to elucidate the effects of adiponectin on platelet-derived growth factor (PDGF)-induced cell migration and intracellular signaling pathways, in cultured rat MCs (RMCs). PDGF-induced RMC migration was significantly inhibited by the pretreatment of adiponectin. Adiponectin alone had no effect on RMC migration. Big mitogen-activated protein (MAP) kinase 1 (BMK1), p38 MAP kinase, and Akt were activated by PDGF stimulation in a time- and concentration-dependent manner in RMC. Adiponectin alone did not affect BMK1, p38 MAP kinase, and Akt phosphorylations in RMC. PDGF-induced BMK1 and p38 MAP kinase phosphorylations were significantly attenuated by the pretreatment of adiponectin in RMCs. On the other hand, the phosphorylation of Akt by PDGF was not diminished by the pretreatment of adiponectin. Adiponectin had no effects on PDGF-receptor autophosphorylation by PDGF. We also confirmed that PDGF-induced RMC migration was significantly suppressed by siBMK1 transfection or SB203580, a p38 MAP kinase inhibitor. From these findings, it is implied that the elevated plasma adiponectin levels in patients with CKD might play a compensatory role aimed at counteracting renal dysfunction related to MC disorders."},"publication_date":"2009-08","publication_name":{"en":"The Journal of Endocrinology","ja":"The Journal of Endocrinology"},"volume":"Vol.202","number":"No.2","starting_page":"309","ending_page":"316","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1677/JOE-08-0469"],"issn":["1479-6805"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:77, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376227"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19561137","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219710","label":"url"}],"paper_title":{"en":"Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.","ja":"Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease."},"authors":{"en":[{"name":"Summer Ross"},{"name":"Fiack Christopher A"},{"name":"Ikeda Yasumasa"},{"name":"Sato Kaori"},{"name":"Dwyer Daniel"},{"name":"Ouchi Noriyuki"},{"name":"Fine Alan"},{"name":"Farber Harrison W"},{"name":"Walsh Kenneth"}],"ja":[{"name":"Summer Ross"},{"name":"Fiack Christopher A"},{"name":"池田 康将"},{"name":"Sato Kaori"},{"name":"Dwyer Daniel"},{"name":"Ouchi Noriyuki"},{"name":"Fine Alan"},{"name":"Farber Harrison W"},{"name":"Walsh Kenneth"}]},"description":{"en":"Adiponectin (APN) is an adipocyte-derived factor that exists at high concentrations in serum and has anti-inflammatory and systemic vascular-protective properties. In this study, we investigated the role of APN in pulmonary vascular homeostasis. We found that APN localizes to the luminal side of blood vessels in lung and acts in vitro to block TNF-alpha-induced E-selectin upregulation in pulmonary artery endothelial cells. Targeted deletion of the APN gene in mice leads to a vascular phenotype in lung characterized by E-selectin upregulation and age-dependent increases in perivascular inflammatory cell infiltration and pulmonary arterial pressures. Taken together, these findings demonstrate an important role for APN in lung vascular homeostasis and suggest that APN-deficient states may contribute to the pathogenesis of inflammatory pulmonary vascular disease and to the development of pulmonary hypertension.","ja":"Adiponectin (APN) is an adipocyte-derived factor that exists at high concentrations in serum and has anti-inflammatory and systemic vascular-protective properties. In this study, we investigated the role of APN in pulmonary vascular homeostasis. We found that APN localizes to the luminal side of blood vessels in lung and acts in vitro to block TNF-alpha-induced E-selectin upregulation in pulmonary artery endothelial cells. Targeted deletion of the APN gene in mice leads to a vascular phenotype in lung characterized by E-selectin upregulation and age-dependent increases in perivascular inflammatory cell infiltration and pulmonary arterial pressures. Taken together, these findings demonstrate an important role for APN in lung vascular homeostasis and suggest that APN-deficient states may contribute to the pathogenesis of inflammatory pulmonary vascular disease and to the development of pulmonary hypertension."},"publication_date":"2009-06-26","publication_name":{"en":"American Journal of Physiology. Lung Cellular and Molecular Physiology","ja":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},"volume":"Vol.297","number":"No.3","starting_page":"L432","ending_page":"8","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1152/ajplung.90599.2008"],"issn":["1522-1504"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:78, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19403987","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219712","label":"url"}],"paper_title":{"en":"Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors.","ja":"Heparin cofactor II is an independent protective factor against peripheral arterial disease in elderly subjects with cardiovascular risk factors."},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Kurobe Hirotsugu"},{"name":"Takamori Nobuyuki"},{"name":"Ikeda Yasumasa"},{"name":"Sumitomo Yuka"},{"name":"Yoshida Sumiko"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Ishikawa Kazue"},{"name":"Sata Masataka"},{"name":"Kitagawa Tetsuya"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"黒部 裕嗣"},{"name":"Takamori Nobuyuki"},{"name":"池田 康将"},{"name":"Sumitomo Yuka"},{"name":"吉田 守美子"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Ishikawa Kazue"},{"name":"佐田 政隆"},{"name":"北川 哲也"},{"name":"松本 俊夫"}]},"description":{"en":"AIM: Heparin cofactor II (HCII) specifically inactivates thrombin action at the injured vascular wall. We have reported that HCII is a protective factor against coronary in-stent restenosis and carotid atherosclerosis; however, it is unclear whether there is any correlation between plasma HCII levels and the development of peripheral arterial disease (PAD). METHODS: Plasma HCII activity and the ankle brachial pressure index (ABI) were determined in 494 elderly subjects with cardiovascular risk factors. PAD was diagnosed by ABI below 0.9, and 62 subjects were diagnosed with PAD. The relationship between factors that affect cardiovascular events and the prevalence of PAD was statistically evaluated. RESULTS: Mean HCII activity in PAD subjects was significantly lower than in non-PAD subjects (87.5+/-19.7% v.s. 94.6+/-17.8%, p=0.009). Multivariate logistic regression analysis showed that age (odds ratio [OR]: 1.062, p=0.0016), current smoking (OR 3.028, p=0.002) and diabetes mellitus (OR 2.656, p=0.008) were independent and progressive determinants of PAD. In contrast, HCII was an independent inhibitory factor of PAD (OR: 0.982, p=0.048). CONCLUSIONS: Plasma HCII activity is inversely related to the prevalence of PAD. HCII may function as the sole protective factor against PAD in elderly people with cardiovascular risk factors.","ja":"AIM: Heparin cofactor II (HCII) specifically inactivates thrombin action at the injured vascular wall. We have reported that HCII is a protective factor against coronary in-stent restenosis and carotid atherosclerosis; however, it is unclear whether there is any correlation between plasma HCII levels and the development of peripheral arterial disease (PAD). METHODS: Plasma HCII activity and the ankle brachial pressure index (ABI) were determined in 494 elderly subjects with cardiovascular risk factors. PAD was diagnosed by ABI below 0.9, and 62 subjects were diagnosed with PAD. The relationship between factors that affect cardiovascular events and the prevalence of PAD was statistically evaluated. RESULTS: Mean HCII activity in PAD subjects was significantly lower than in non-PAD subjects (87.5+/-19.7% v.s. 94.6+/-17.8%, p=0.009). Multivariate logistic regression analysis showed that age (odds ratio [OR]: 1.062, p=0.0016), current smoking (OR 3.028, p=0.002) and diabetes mellitus (OR 2.656, p=0.008) were independent and progressive determinants of PAD. In contrast, HCII was an independent inhibitory factor of PAD (OR: 0.982, p=0.048). CONCLUSIONS: Plasma HCII activity is inversely related to the prevalence of PAD. HCII may function as the sole protective factor against PAD in elderly people with cardiovascular risk factors."},"publication_date":"2009-04-30","publication_name":{"en":"Journal of Atherosclerosis and Thrombosis","ja":"Journal of Atherosclerosis and Thrombosis"},"volume":"Vol.16","number":"No.2","starting_page":"127","ending_page":"134","languages":["eng"],"referee":true,"identifiers":{"doi":["10.5551/jat.E695"],"issn":["1880-3873"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:79, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/19196803","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219697","label":"url"}],"paper_title":{"en":"Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.","ja":"Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Sato Takashi"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Sumitomo Yuka"},{"name":"Ise Takayuki"},{"name":"Ishikawa Kazue"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"Sato Takashi"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Sumitomo Yuka"},{"name":"Ise Takayuki"},{"name":"Ishikawa Kazue"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}]},"description":{"en":"Age-related andropause promotes cardiovascular disease in males. Although we had previously reported that the androgen-androgen receptor (AR) system plays important roles in cardiac growth and remodeling, the system's involvement in vascular remodeling remains unclear. To clarify this role, 25-wk-old male AR knockout (ARKO) mice and littermate male wild-type (WT) mice were divided into two groups with and without angiotensin II (Ang II) administration (2.0 mg/kg . d) for 14 d, respectively. No morphological differences in the coronary artery and thoracic aorta were observed between the groups without Ang II. Ang II stimulation markedly increased medial thickness and perivascular fibrosis in ARKO mice, with enhanced TGF-beta1, collagen type I, and collagen type III gene expression in the aorta. Ang II stimulation also prominently increased superoxide production, lipid peroxidation, and gene expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase components in ARKO mice compared with WT mice. In addition, phosphorylation of c-Jun N-terminal kinase (JNK) and phosphorylated (Smad2/3) was remarkably enhanced in Ang II-treated ARKO mice compared with Ang II-treated WT mice. Notably, daily urinary nitric oxide (NO) metabolites excretion as a marker of NO bioavailability, aortic endothelial NO synthase expression and phosphorylation, and Akt phosphorylation were significantly reduced in ARKO mice compared with WT mice, regardless of Ang II stimulation. In conclusion, the androgen-AR system is required for the preservation of NO bioavailability through Akt-endothelial NO synthase system activation and exerts protective effects against Ang II-induced vascular remodeling by regulating oxidative stress, c-Jun N-terminal kinase (JNK) signaling, and the TGF-beta-phosphorylated Smad pathway.","ja":"Age-related andropause promotes cardiovascular disease in males. Although we had previously reported that the androgen-androgen receptor (AR) system plays important roles in cardiac growth and remodeling, the system's involvement in vascular remodeling remains unclear. To clarify this role, 25-wk-old male AR knockout (ARKO) mice and littermate male wild-type (WT) mice were divided into two groups with and without angiotensin II (Ang II) administration (2.0 mg/kg . d) for 14 d, respectively. No morphological differences in the coronary artery and thoracic aorta were observed between the groups without Ang II. Ang II stimulation markedly increased medial thickness and perivascular fibrosis in ARKO mice, with enhanced TGF-beta1, collagen type I, and collagen type III gene expression in the aorta. Ang II stimulation also prominently increased superoxide production, lipid peroxidation, and gene expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase components in ARKO mice compared with WT mice. In addition, phosphorylation of c-Jun N-terminal kinase (JNK) and phosphorylated (Smad2/3) was remarkably enhanced in Ang II-treated ARKO mice compared with Ang II-treated WT mice. Notably, daily urinary nitric oxide (NO) metabolites excretion as a marker of NO bioavailability, aortic endothelial NO synthase expression and phosphorylation, and Akt phosphorylation were significantly reduced in ARKO mice compared with WT mice, regardless of Ang II stimulation. In conclusion, the androgen-AR system is required for the preservation of NO bioavailability through Akt-endothelial NO synthase system activation and exerts protective effects against Ang II-induced vascular remodeling by regulating oxidative stress, c-Jun N-terminal kinase (JNK) signaling, and the TGF-beta-phosphorylated Smad pathway."},"publication_date":"2009-02-05","publication_name":{"en":"Endocrinology","ja":"Endocrinology"},"volume":"Vol.150","number":"No.6","starting_page":"2857","ending_page":"2864","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1210/en.2008-1254"],"issn":["1945-7170"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:80, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266433","label":"url"}],"paper_title":{"en":"アンジオテンシンII受容体拮抗薬バルサルタンのNO bioavailability改善効果に関する臨床的検討","ja":"アンジオテンシンII受容体拮抗薬バルサルタンのNO bioavailability改善効果に関する臨床的検討"},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Ueda Yuka"},{"name":"Yoshida Sumiko"},{"name":"Ise Takayuki"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"近藤 彰"},{"name":"田村 克也"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"上田 由佳"},{"name":"吉田 守美子"},{"name":"伊勢 孝之"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"近藤 彰"},{"name":"田村 克也"},{"name":"松本 俊夫"}]},"description":{"en":"バルサルタンの降圧作用,動脈硬化抑制作用および糖代謝改善作用に一酸化窒素(NO)のバイオアベイラビリティの改善効果が関与しているか検討した.高血圧治療目的で通院加療中の42例を対象とした.バルサルタン投与にて,BMIやリポプロテイン(a)を含む脂質プロファイルに有意な変化は認めなかったが,収縮期血圧,脈圧,baPWVおよびHbA1cは有意に低下した.投与3ヵ月後には投与前と比較して,NOのバイオアベイラビリティのマーカーである血清硝酸/亜硝酸イオン(NOx)は約1.5倍に増加した.血清NOxの増加が,他の測定因子にどのように影響を与えているか,単変量および多変量解析を用いて解析し,血清NOxの増加量は収縮期血圧の低下と脈圧の減少との間においてそれぞれ有意な相関がみられた.また,HbA1cはバルサルタン投与3ヵ月後に有意に低下していたが,その変化はNOxの増加量と有意な相関がみられた.","ja":"バルサルタンの降圧作用,動脈硬化抑制作用および糖代謝改善作用に一酸化窒素(NO)のバイオアベイラビリティの改善効果が関与しているか検討した.高血圧治療目的で通院加療中の42例を対象とした.バルサルタン投与にて,BMIやリポプロテイン(a)を含む脂質プロファイルに有意な変化は認めなかったが,収縮期血圧,脈圧,baPWVおよびHbA1cは有意に低下した.投与3ヵ月後には投与前と比較して,NOのバイオアベイラビリティのマーカーである血清硝酸/亜硝酸イオン(NOx)は約1.5倍に増加した.血清NOxの増加が,他の測定因子にどのように影響を与えているか,単変量および多変量解析を用いて解析し,血清NOxの増加量は収縮期血圧の低下と脈圧の減少との間においてそれぞれ有意な相関がみられた.また,HbA1cはバルサルタン投与3ヵ月後に有意に低下していたが,その変化はNOxの増加量と有意な相関がみられた."},"publication_date":"2009","publication_name":{"en":"Progress in Medicine","ja":"Progress in Medicine"},"volume":"Vol.29","number":"No.7","starting_page":"1777","ending_page":"1782","languages":["jpn"],"referee":true,"identifiers":{"issn":["0287-3648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:81, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/18552468","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219679","label":"url"}],"paper_title":{"en":"Infective endocarditis caused by lactobacillus.","ja":"Infective endocarditis caused by lactobacillus."},"authors":{"en":[{"name":"Yagi Shusuke"},{"name":"Akaike Masahi"},{"name":"Fujimura Mitsunori"},{"name":"Ise Takayuki"},{"name":"Yoshida Sumiko"},{"name":"Sumitomo Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Kurushima Atsushi"},{"name":"Ichikawa Youichi"},{"name":"Kitagawa Tetsuya"},{"name":"Kimura Takehiko"},{"name":"Nishiuchi Takeshi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"Akaike Masahi"},{"name":"Fujimura Mitsunori"},{"name":"Ise Takayuki"},{"name":"吉田 守美子"},{"name":"Sumitomo Yuka"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"Kurushima Atsushi"},{"name":"Ichikawa Youichi"},{"name":"北川 哲也"},{"name":"Kimura Takehiko"},{"name":"Nishiuchi Takeshi"},{"name":"松本 俊夫"}]},"description":{"en":"Lactobacillus (LB) is a gram-positive rod-shaped bacterium that inhabits the oral cavity, gastrointestinal tract, vagina and nasal cavity. Although LB plays a role in the prevention of infections caused by pathogenic bacteria, it causes some critical infectious diseases such as infective endocarditis (IE). IE due to LB is rare; however, early diagnosis and early treatment are important because of its high mortality rate. We report the onset of IE after otologic treatment in a heavy drinker of alcohol, the second case of IE due to LB in Japan.","ja":"Lactobacillus (LB) is a gram-positive rod-shaped bacterium that inhabits the oral cavity, gastrointestinal tract, vagina and nasal cavity. Although LB plays a role in the prevention of infections caused by pathogenic bacteria, it causes some critical infectious diseases such as infective endocarditis (IE). IE due to LB is rare; however, early diagnosis and early treatment are important because of its high mortality rate. We report the onset of IE after otologic treatment in a heavy drinker of alcohol, the second case of IE due to LB in Japan."},"publication_date":"2008-06-16","publication_name":{"en":"Internal Medicine","ja":"Internal Medicine"},"volume":"Vol.47","number":"No.12","starting_page":"1113","ending_page":"1116","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2169/internalmedicine.47.0744"],"issn":["1349-7235"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:82, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/18339320","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219699","label":"url"}],"paper_title":{"en":"Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes.","ja":"Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Ohashi Koji"},{"name":"Shibata Rei"},{"name":"Pimentel David R"},{"name":"Kihara Shinji"},{"name":"Ouchi Noriyuki"},{"name":"Walsh Kenneth"}],"ja":[{"name":"池田 康将"},{"name":"Ohashi Koji"},{"name":"Shibata Rei"},{"name":"Pimentel David R"},{"name":"Kihara Shinji"},{"name":"Ouchi Noriyuki"},{"name":"Walsh Kenneth"}]},"description":{"en":"The adipose-derived plasma protein, adiponectin (APN), has various protective effects on cardiovascular diseases. In this study, we show that endogenous APN is required for full cyclooxygenase-2 (COX-2) induction by ischemia-reperfusion injury in the heart in vivo. In rat neonatal cardiac myocytes, APN-induced COX-2 expression was reduced by treatment with a sphingosine kinase-1 (SphK-1) inhibitor or siRNA targeting SphK-1. Treatment with a sphingosine-1-phosphate (S1P) receptor antagonist also diminished COX-2 expression in response to APN stimulation. These findings suggest that APN is a physiological regulator of COX-2 signaling in the heart and that this regulation occurs in part via a SphK-1-S1P receptor dependent mechanism in cardiac myocytes.","ja":"The adipose-derived plasma protein, adiponectin (APN), has various protective effects on cardiovascular diseases. In this study, we show that endogenous APN is required for full cyclooxygenase-2 (COX-2) induction by ischemia-reperfusion injury in the heart in vivo. In rat neonatal cardiac myocytes, APN-induced COX-2 expression was reduced by treatment with a sphingosine kinase-1 (SphK-1) inhibitor or siRNA targeting SphK-1. Treatment with a sphingosine-1-phosphate (S1P) receptor antagonist also diminished COX-2 expression in response to APN stimulation. These findings suggest that APN is a physiological regulator of COX-2 signaling in the heart and that this regulation occurs in part via a SphK-1-S1P receptor dependent mechanism in cardiac myocytes."},"publication_date":"2008-03-11","publication_name":{"en":"FEBS Letters","ja":"FEBS Letters"},"volume":"Vol.582","number":"No.7","starting_page":"1147","ending_page":"1150","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.febslet.2008.03.002"],"issn":["0014-5793"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:83, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376228"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266819","label":"url"}],"paper_title":{"en":"高コレステロール血症患者に対するピタバスタチンの有効性 総合的脂質プロファイルに関する検討","ja":"高コレステロール血症患者に対するピタバスタチンの有効性 総合的脂質プロファイルに関する検討"},"authors":{"en":[{"name":"Akaike Masashi"},{"name":"小原 卓爾"},{"name":"日浅 光春"},{"name":"藤村 光則"},{"name":"加藤 みどり"},{"name":"横井 健治"},{"name":"小島 章裕"},{"name":"岡崎 誠司"},{"name":"井内 貴彦"},{"name":"井上 利彦"},{"name":"住友 由佳"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"}],"ja":[{"name":"赤池 雅史"},{"name":"小原 卓爾"},{"name":"日浅 光春"},{"name":"藤村 光則"},{"name":"加藤 みどり"},{"name":"横井 健治"},{"name":"小島 章裕"},{"name":"岡崎 誠司"},{"name":"井内 貴彦"},{"name":"井上 利彦"},{"name":"住友 由佳"},{"name":"八木 秀介"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"粟飯原 賢一"},{"name":"東 博之"}]},"description":{"en":"高コレステロール血症患者を対象にピタバスタチンを投与し,総合的脂質プロファイルへの影響について検討した.高コレステロール血症と診断され,ピタバスタチンを投与した87例を対象とした.ピタバスタチン投与によりTC,LDL-Cは有意に低下した.HDL-Cは有意な上昇,TGは有意な低下を認めた.ピタバスタチンを新規に投与した症例で,TC,LDL-Cは有意かつ良好な低下作用を認めた.また,HDL-Cは有意な上昇,TGは有意な低下作用を示した.Non HDL-Cは有意に低下し,LDL-C/HDL-C比は有意に減少した.動脈硬化指数は,いずれも有意に改善した.投与前後でLp(a)を測定した76例で,有意な変化は認めなかった.投与前後におけるALT,ASTの平均変化量に,有意な変化は認めなかった.CKも有意な変化は認めなかった.治療上,問題となる副作用は認めなかった.","ja":"高コレステロール血症患者を対象にピタバスタチンを投与し,総合的脂質プロファイルへの影響について検討した.高コレステロール血症と診断され,ピタバスタチンを投与した87例を対象とした.ピタバスタチン投与によりTC,LDL-Cは有意に低下した.HDL-Cは有意な上昇,TGは有意な低下を認めた.ピタバスタチンを新規に投与した症例で,TC,LDL-Cは有意かつ良好な低下作用を認めた.また,HDL-Cは有意な上昇,TGは有意な低下作用を示した.Non HDL-Cは有意に低下し,LDL-C/HDL-C比は有意に減少した.動脈硬化指数は,いずれも有意に改善した.投与前後でLp(a)を測定した76例で,有意な変化は認めなかった.投与前後におけるALT,ASTの平均変化量に,有意な変化は認めなかった.CKも有意な変化は認めなかった.治療上,問題となる副作用は認めなかった."},"publication_date":"2008","publication_name":{"en":"Progress in Medicine","ja":"Progress in Medicine"},"volume":"Vol.28","number":"No.11","starting_page":"2745","ending_page":"2751","languages":["jpn"],"referee":true,"identifiers":{"issn":["0287-3648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:84, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/17967781","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219713","label":"url"}],"paper_title":{"en":"Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.","ja":"Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency."},"authors":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Sumitomo Yuka"},{"name":"Yoshida Sumiko"},{"name":"Ise Takayuki"},{"name":"Iwase Takashi"},{"name":"Ishikawa Kazue"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"Sumitomo Yuka"},{"name":"吉田 守美子"},{"name":"Ise Takayuki"},{"name":"岩瀬 俊"},{"name":"Ishikawa Kazue"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}]},"description":{"en":"Angiotensin II (Ang II) plays a pivotal role in cardiovascular remodeling leading to hypertension, myocardial infarction, and stroke. Pitavastatin, an HMG-CoA reductase inihibitor, is known to have pleiotropic actions against the development of cardiovascular remodeling. The objectives of this study were to clarify the beneficial effects as well as the mechanism of action of pitavastatin against Ang II-induced organ damage. C57BL6/J mice at 10 weeks of age were infused with Ang II for 2 weeks and were simultaneously administered pitavastatin or a vehicle. Pitavastatin treatment improved Ang II-induced left ventricular hypertrophy and diastolic dysfunction and attenuated enhancement of cardiac fibrosis, cardiomyocyte hypertrophy, coronary perivascular fibrosis, and medial thickening. Ang II-induced oxidative stress, cardiac TGFbeta-1 expression, and Smad 2/3 phosphorylation were all attenuated by pitavastatin treatment. Pitavastatin also reduced Ang II-induced cardiac remodeling and diastolic dysfunction in eNOS-/- mice as in wild-type mice. In eNOS-/- mice, the Ang II-induced cardiac oxidative stress and TGF-beta-Smad 2/3 signaling pathway were enhanced, and pitavastatin treatment attenuated the enhanced oxidative stress and the signaling pathway. Moreover, pitavastatin treatment reduced the high mortality rate and improved renal insufficiency in Ang II-treated eNOS-/- mice, with suppression of glomerular oxidative stress and TGF-beta-Smad 2/3 signaling pathway. In conclusion, pitavastatin exerts eNOS-independent protective actions against Ang II-induced cardiovascular remodeling and renal insufficiency through inhibition of the TGF-beta-Smad 2/3 signaling pathway by suppression of oxidative stress.","ja":"Angiotensin II (Ang II) plays a pivotal role in cardiovascular remodeling leading to hypertension, myocardial infarction, and stroke. Pitavastatin, an HMG-CoA reductase inihibitor, is known to have pleiotropic actions against the development of cardiovascular remodeling. The objectives of this study were to clarify the beneficial effects as well as the mechanism of action of pitavastatin against Ang II-induced organ damage. C57BL6/J mice at 10 weeks of age were infused with Ang II for 2 weeks and were simultaneously administered pitavastatin or a vehicle. Pitavastatin treatment improved Ang II-induced left ventricular hypertrophy and diastolic dysfunction and attenuated enhancement of cardiac fibrosis, cardiomyocyte hypertrophy, coronary perivascular fibrosis, and medial thickening. Ang II-induced oxidative stress, cardiac TGFbeta-1 expression, and Smad 2/3 phosphorylation were all attenuated by pitavastatin treatment. Pitavastatin also reduced Ang II-induced cardiac remodeling and diastolic dysfunction in eNOS-/- mice as in wild-type mice. In eNOS-/- mice, the Ang II-induced cardiac oxidative stress and TGF-beta-Smad 2/3 signaling pathway were enhanced, and pitavastatin treatment attenuated the enhanced oxidative stress and the signaling pathway. Moreover, pitavastatin treatment reduced the high mortality rate and improved renal insufficiency in Ang II-treated eNOS-/- mice, with suppression of glomerular oxidative stress and TGF-beta-Smad 2/3 signaling pathway. In conclusion, pitavastatin exerts eNOS-independent protective actions against Ang II-induced cardiovascular remodeling and renal insufficiency through inhibition of the TGF-beta-Smad 2/3 signaling pathway by suppression of oxidative stress."},"publication_date":"2007-10-25","publication_name":{"en":"Circulation Research","ja":"Circulation Research"},"volume":"Vol.102","number":"No.1","starting_page":"68","ending_page":"76","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1161/CIRCRESAHA.107.163493"],"issn":["1524-4571"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:85, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376229"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/17938525","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219714","label":"url"}],"paper_title":{"en":"Improvement of cardiac diastolic function and prognosis after autologous peripheral blood stem cell transplantation in AL cardiac amyloidosis.","ja":"Improvement of cardiac diastolic function and prognosis after autologous peripheral blood stem cell transplantation in AL cardiac amyloidosis."},"authors":{"en":[{"name":"Yagi Shusuke"},{"name":"Akaike Masashi"},{"name":"Ozaki Shuji"},{"name":"Moriya Chikako"},{"name":"Takeuchi Kyoko"},{"name":"Hara Tomoko"},{"name":"Fujimura Mitsunori"},{"name":"Sumitomo Yuka"},{"name":"Iwase Takashi"},{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Kimura Takehiko"},{"name":"Nishiuchi Takeshi"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Yagi Shusuke"},{"name":"Akaike Masashi"},{"name":"Ozaki Shuji"},{"name":"Moriya Chikako"},{"name":"Takeuchi Kyoko"},{"name":"Hara Tomoko"},{"name":"Fujimura Mitsunori"},{"name":"Sumitomo Yuka"},{"name":"Iwase Takashi"},{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"Kimura Takehiko"},{"name":"Nishiuchi Takeshi"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"}]},"description":{"en":"AL amyloidosis is a disease in which immunoglobulin L chain is deposited in multiple organs, and the prognosis of cardiac amyloidosis is extremely poor. Although several treatments based on that for multiple myeloma, have been performed, there is no clear evidence that cardiac function is improved. We report a case of AL cardiac amyloidosis with moderate cardiac dysfunction for which we performed autologous peripheral blood stem cell transplantation (auto-PBSCT) in combination with high-dose melphalan therapy. This treatment resulted in significant improvement in cardiac function and good prognosis for about 3.5 years after the diagnosis. Therefore, auto-PBSCT is a possible option as up-front therapy for AL cardiac amyloidosis.","ja":"AL amyloidosis is a disease in which immunoglobulin L chain is deposited in multiple organs, and the prognosis of cardiac amyloidosis is extremely poor. Although several treatments based on that for multiple myeloma, have been performed, there is no clear evidence that cardiac function is improved. We report a case of AL cardiac amyloidosis with moderate cardiac dysfunction for which we performed autologous peripheral blood stem cell transplantation (auto-PBSCT) in combination with high-dose melphalan therapy. This treatment resulted in significant improvement in cardiac function and good prognosis for about 3.5 years after the diagnosis. Therefore, auto-PBSCT is a possible option as up-front therapy for AL cardiac amyloidosis."},"publication_date":"2007-10-15","publication_name":{"en":"Internal Medicine","ja":"Internal Medicine"},"volume":"Vol.46","number":"No.20","starting_page":"1705","ending_page":"1710","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2169/internalmedicine.46.0142"],"issn":["1349-7235"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:86, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"http://www.jci.org/cgi/content/abstract/117/6/1514","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/17549254","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=159074","label":"url"}],"paper_title":{"en":"Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice","ja":"Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice"},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Sata Masataka"},{"name":"Takamori Nobuyuki"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Sumitomo Yuka"},{"name":"Kawano Hirotaka"},{"name":"Yamada Takashi"},{"name":"Fukuda Toru"},{"name":"Matsumoto Takahiro"},{"name":"Sekine Keisuke"},{"name":"Sato Takashi"},{"name":"Nakamichi Yuko"},{"name":"Yamamoto Yoko"},{"name":"Yoshimura Kimihiro"},{"name":"Watanabe Tomoyuki"},{"name":"Nakamura Takashi"},{"name":"Oomizu Akimasa"},{"name":"Tsukada Minoru"},{"name":"Hayashi Hideki"},{"name":"Sudo Toshiki"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"佐田 政隆"},{"name":"Takamori Nobuyuki"},{"name":"Yagi Shusuke"},{"name":"岩瀬 俊"},{"name":"Sumitomo Yuka"},{"name":"Kawano Hirotaka"},{"name":"Yamada Takashi"},{"name":"Fukuda Toru"},{"name":"松本 高広"},{"name":"Sekine Keisuke"},{"name":"Sato Takashi"},{"name":"Nakamichi Yuko"},{"name":"Yamamoto Yoko"},{"name":"Yoshimura Kimihiro"},{"name":"Watanabe Tomoyuki"},{"name":"Nakamura Takashi"},{"name":"Oomizu Akimasa"},{"name":"Tsukada Minoru"},{"name":"Hayashi Hideki"},{"name":"Sudo Toshiki"},{"name":"Kato Shigeaki"},{"name":"松本 俊夫"}]},"description":{"en":"Heparin cofactor II (HCII) specifically inhibits thrombin action at sites of injured arterial wall, and patients with HCII deficiency exhibit advanced atherosclerosis. However, the in vivo effects and the molecular mechanism underlying the action of HCII during vascular remodeling remain elusive. To clarify the role of HCII in vascular remodeling, we generated HCII-deficient mice by gene targeting. In contrast to a previous report, HCII(-/-) mice were embryonically lethal. In HCII(+/-) mice, prominent intimal hyperplasia with increased cellular proliferation was observed after tube cuff and wire vascular injury. The number of protease-activated receptor-1-positive (PAR-1-positive) cells was increased in the thickened vascular wall of HCII(+/-) mice, suggesting enhanced thrombin action in this region. Cuff injury also increased the expression levels of inflammatory cytokines and chemokines in the vascular wall of HCII(+/-) mice. The intimal hyperplasia in HCII(+/-) mice with vascular injury was abrogated by human HCII supplementation. Furthermore, HCII deficiency caused acceleration of aortic plaque formation with increased PAR-1 expression and oxidative stress in apoE-KO mice. These results demonstrate that HCII protects against thrombin-induced remodeling of an injured vascular wall by inhibiting thrombin action and suggest that HCII is potentially therapeutic against atherosclerosis without causing coagulatory disturbance.","ja":"Heparin cofactor II (HCII) specifically inhibits thrombin action at sites of injured arterial wall, and patients with HCII deficiency exhibit advanced atherosclerosis. However, the in vivo effects and the molecular mechanism underlying the action of HCII during vascular remodeling remain elusive. To clarify the role of HCII in vascular remodeling, we generated HCII-deficient mice by gene targeting. In contrast to a previous report, HCII(-/-) mice were embryonically lethal. In HCII(+/-) mice, prominent intimal hyperplasia with increased cellular proliferation was observed after tube cuff and wire vascular injury. The number of protease-activated receptor-1-positive (PAR-1-positive) cells was increased in the thickened vascular wall of HCII(+/-) mice, suggesting enhanced thrombin action in this region. Cuff injury also increased the expression levels of inflammatory cytokines and chemokines in the vascular wall of HCII(+/-) mice. The intimal hyperplasia in HCII(+/-) mice with vascular injury was abrogated by human HCII supplementation. Furthermore, HCII deficiency caused acceleration of aortic plaque formation with increased PAR-1 expression and oxidative stress in apoE-KO mice. These results demonstrate that HCII protects against thrombin-induced remodeling of an injured vascular wall by inhibiting thrombin action and suggest that HCII is potentially therapeutic against atherosclerosis without causing coagulatory disturbance."},"publication_date":"2007-06-01","publication_name":{"en":"The Journal of Clinical Investigation","ja":"The Journal of Clinical Investigation"},"volume":"Vol.117","number":"No.6","starting_page":"1514","ending_page":"1526","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1172/JCI27095"],"issn":["0021-9738"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:87, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/16864946","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=164577","label":"url"}],"paper_title":{"en":"Intra-vascular ultrasound findings of diffuse coronary atherosclerotic change in systemic lupus erythematosus with secondary antiphospholipid syndrome","ja":"Intra-vascular ultrasound findings of diffuse coronary atherosclerotic change in systemic lupus erythematosus with secondary antiphospholipid syndrome"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Yagi, Shusuke"},{"name":"Yamaguchi, Hiroshi"},{"name":"Fujimura, Mitsunori"},{"name":"Hashizume, Shunji"},{"name":"Aihara, Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Azuma, Hiroyuki"},{"name":"Matsumoto, Toshio"}],"ja":[{"name":"池田 康将"},{"name":"Yagi, Shusuke"},{"name":"Yamaguchi, Hiroshi"},{"name":"Fujimura, Mitsunori"},{"name":"Hashizume, Shunji"},{"name":"Aihara, Ken-ichi"},{"name":"赤池 雅史"},{"name":"Azuma, Hiroyuki"},{"name":"Matsumoto, Toshio"}]},"description":{"en":"Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are autoimmune inflammatory diseases associated with juvenile atherosclerosis and thrombosis, respectively. A 44-year-old woman who had SLE with secondary APS had been treated with corticosteroid therapy, however, her inflammatory marker had never been within a normal range in her clinical course, and finally acute myocardial infarction was developed. Intra-vascular ultrasound also revealed diffuse coronary atherosclerosis progression for her age, which might result from SLE and APS, including vascular inflammation.","ja":"Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are autoimmune inflammatory diseases associated with juvenile atherosclerosis and thrombosis, respectively. A 44-year-old woman who had SLE with secondary APS had been treated with corticosteroid therapy, however, her inflammatory marker had never been within a normal range in her clinical course, and finally acute myocardial infarction was developed. Intra-vascular ultrasound also revealed diffuse coronary atherosclerosis progression for her age, which might result from SLE and APS, including vascular inflammation."},"publication_date":"2006-08","publication_name":{"en":"Circulation Journal","ja":"Circulation Journal"},"volume":"Vol.70","number":"No.8","starting_page":"1082","ending_page":"1085","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1253/circj.70.1082"],"issn":["1346-9843"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:88, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/16327955","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219717","label":"url"}],"paper_title":{"en":"Acute myocardial infarction in a patient with essential thrombocythemia who underwent successful stenting. A case report","ja":"Acute myocardial infarction in a patient with essential thrombocythemia who underwent successful stenting. A case report"},"authors":{"en":[{"name":"Watanabe Tomonori"},{"name":"Fujinaga Hiroyuki"},{"name":"Ikeda Yasumasa"},{"name":"HIgashi Teruo"},{"name":"Murakami Masaru"},{"name":"Kawahara Keiji"},{"name":"Hayashi Ikuo"},{"name":"Niki Toshiharu"},{"name":"Shigekiyo Toshio"},{"name":"Wakatsuki Tetsuzo"}],"ja":[{"name":"Watanabe Tomonori"},{"name":"Fujinaga Hiroyuki"},{"name":"池田 康将"},{"name":"HIgashi Teruo"},{"name":"Murakami Masaru"},{"name":"Kawahara Keiji"},{"name":"Hayashi Ikuo"},{"name":"Niki Toshiharu"},{"name":"Shigekiyo Toshio"},{"name":"若槻 哲三"}]},"description":{"en":"Essential thrombocythemia (ET) can cause systemic vascular thrombosis, but involvement of coronary arteries in the setting of ET is rare. This report describes a case of acute myocardial infarction (MI) in a patient with ET. A 67-year-old man with ET complained of severe acute chest pain. Emergent coronary angiography revealed subtotal thrombotic occlusion of the left main trunk (LMT) coronary artery. Coronary angioplasty and stenting were performed successfully. Coronary angiography 4 weeks later revealed no significant restenosis. The patient has done well after primary coronary stenting with the use of only an antiplatelet agent to treat the thrombocythemia.","ja":"Essential thrombocythemia (ET) can cause systemic vascular thrombosis, but involvement of coronary arteries in the setting of ET is rare. This report describes a case of acute myocardial infarction (MI) in a patient with ET. A 67-year-old man with ET complained of severe acute chest pain. Emergent coronary angiography revealed subtotal thrombotic occlusion of the left main trunk (LMT) coronary artery. Coronary angioplasty and stenting were performed successfully. Coronary angiography 4 weeks later revealed no significant restenosis. The patient has done well after primary coronary stenting with the use of only an antiplatelet agent to treat the thrombocythemia."},"publication_date":"2005-11","publication_name":{"en":"Angiology","ja":"Angiology"},"volume":"Vol.56","number":"No.6","starting_page":"771","ending_page":"774","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1177/000331970505600616"],"issn":["0003-3197"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:89, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/15961403","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241203","label":"url"}],"paper_title":{"en":"Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.","ja":"Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Sato Takashi"},{"name":"Akaike Masashi"},{"name":"Yoshizumi Masanori"},{"name":"Suzaki Yuki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Fujimura Mitsunori"},{"name":"Hashizume Shunji"},{"name":"Kato Midori"},{"name":"Yagi Shusuke"},{"name":"Tamaki Toshiaki"},{"name":"Kawano Hirotaka"},{"name":"Matsumoto Takahiro"},{"name":"Azuma Hiroyuki"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"Sato Takashi"},{"name":"赤池 雅史"},{"name":"吉栖 正典"},{"name":"Suzaki Yuki"},{"name":"石澤 有紀"},{"name":"Fujimura Mitsunori"},{"name":"Hashizume Shunji"},{"name":"Kato Midori"},{"name":"八木 秀介"},{"name":"玉置 俊晃"},{"name":"Kawano Hirotaka"},{"name":"松本 高広"},{"name":"東 博之"},{"name":"Kato Shigeaki"},{"name":"松本 俊夫"}]},"description":{"en":"Androgen has anabolic effects on cardiac myocytes and has been shown to enhance left ventricular enlargement and function. However, the physiological and patho-physiological roles of androgen in cardiac growth and cardiac stress-induced remodeling remains unclear. We aimed to clarify whether the androgen-nuclear androgen receptor (AR) system contributes to the cardiac growth and angiotensin II (Ang II)-stimulated cardiac remodeling by using systemic AR-null male mice. AR knock-out (ARKO) male mice, at 25 weeks of age, and age-matched wild-type (WT) male mice were treated with or without Ang II stimulation (2.0 mg/kg/day) for 2 weeks. ARKO mice with or without Ang II stimulation showed a significant reduction in the heart-to-body weight ratio compared with those of WT mice. In addition, echocardiographic analysis demonstrated impairments of both the concentric hypertrophic response and left ventricular function in Ang II-stimulated ARKO mice. Western blot analysis of the myocardium revealed that activation of extracellular signal-regulated kinases (ERK) 1/2 and ERK5 by Ang II stimulation were lower in ARKO mice than those of WT mice. Ang II stimulation caused more prominent cardiac fibrosis in ARKO mice than in WT mice with enhanced expression of types I and III collagen and transforming growth factor-beta1 genes and with increased Smad2 activation. These results suggest that, in male mice, the androgen-AR system participates in normal cardiac growth and modulates cardiac adaptive hypertrophy and fibrosis during the process of cardiac remodeling under hypertrophic stress.","ja":"Androgen has anabolic effects on cardiac myocytes and has been shown to enhance left ventricular enlargement and function. However, the physiological and patho-physiological roles of androgen in cardiac growth and cardiac stress-induced remodeling remains unclear. We aimed to clarify whether the androgen-nuclear androgen receptor (AR) system contributes to the cardiac growth and angiotensin II (Ang II)-stimulated cardiac remodeling by using systemic AR-null male mice. AR knock-out (ARKO) male mice, at 25 weeks of age, and age-matched wild-type (WT) male mice were treated with or without Ang II stimulation (2.0 mg/kg/day) for 2 weeks. ARKO mice with or without Ang II stimulation showed a significant reduction in the heart-to-body weight ratio compared with those of WT mice. In addition, echocardiographic analysis demonstrated impairments of both the concentric hypertrophic response and left ventricular function in Ang II-stimulated ARKO mice. Western blot analysis of the myocardium revealed that activation of extracellular signal-regulated kinases (ERK) 1/2 and ERK5 by Ang II stimulation were lower in ARKO mice than those of WT mice. Ang II stimulation caused more prominent cardiac fibrosis in ARKO mice than in WT mice with enhanced expression of types I and III collagen and transforming growth factor-beta1 genes and with increased Smad2 activation. These results suggest that, in male mice, the androgen-AR system participates in normal cardiac growth and modulates cardiac adaptive hypertrophy and fibrosis during the process of cardiac remodeling under hypertrophic stress."},"publication_date":"2005-06-16","publication_name":{"en":"The Journal of Biological Chemistry","ja":"The Journal of Biological Chemistry"},"volume":"Vol.280","number":"No.33","starting_page":"29661","ending_page":"29666","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1074/jbc.M411694200"],"issn":["0021-9258"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:90, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/16216591","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219716","label":"url"}],"paper_title":{"en":"Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression.","ja":"Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression."},"authors":{"en":[{"name":"Kato Midori"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Iuchi Takahiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Fujimura Mitsunori"},{"name":"Yoshida Tomonori"},{"name":"Yamaguchi Hiroshi"},{"name":"Hashizume Shunji"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Kato Midori"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"Iuchi Takahiko"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"Fujimura Mitsunori"},{"name":"Yoshida Tomonori"},{"name":"Yamaguchi Hiroshi"},{"name":"Hashizume Shunji"},{"name":"松本 俊夫"}]},"description":{"en":"OBJECTIVE: We hypothesized that aspirin may exhibit its anti-atherosclerotic effects via mechanisms other than cyclooxygenase inhibition in platelets. METHODS AND RESULTS: Using enhanced subtraction hybridization analysis, we found in human umbilical vein endothelial cells (HUVECs) that aspirin up-regulates the expression of aminopeptidase N (APN/CD13) mRNA and its surface protein levels in a dose-dependent manner. Enzymatic activity of APN/CD13 on HUVECs was increased approximately 1.5-fold by 1 mmol L(-1) of aspirin, and treatment with bestatin, an inhibitor for APN/CD13 metalloprotease activity, attenuated the enhanced activities of APN/CD13. Since activated thrombin receptor is reported to be inactivated by APN/CD13 in vitro, protective actions of aspirin on HUVECs by thrombin stimulation were examined, resulting in the suppression of endothelin-1 and reactive oxygen species productions in HUVECs. These inhibitory actions of aspirin were partially abrogated by bestatin. CONCLUSIONS: Aspirin may exert its anti-atherothrombotic effects in part via the inhibition of thrombin action by up-regulating APN/CD13 on endothelial cells.","ja":"OBJECTIVE: We hypothesized that aspirin may exhibit its anti-atherosclerotic effects via mechanisms other than cyclooxygenase inhibition in platelets. METHODS AND RESULTS: Using enhanced subtraction hybridization analysis, we found in human umbilical vein endothelial cells (HUVECs) that aspirin up-regulates the expression of aminopeptidase N (APN/CD13) mRNA and its surface protein levels in a dose-dependent manner. Enzymatic activity of APN/CD13 on HUVECs was increased approximately 1.5-fold by 1 mmol L(-1) of aspirin, and treatment with bestatin, an inhibitor for APN/CD13 metalloprotease activity, attenuated the enhanced activities of APN/CD13. Since activated thrombin receptor is reported to be inactivated by APN/CD13 in vitro, protective actions of aspirin on HUVECs by thrombin stimulation were examined, resulting in the suppression of endothelin-1 and reactive oxygen species productions in HUVECs. These inhibitory actions of aspirin were partially abrogated by bestatin. CONCLUSIONS: Aspirin may exert its anti-atherothrombotic effects in part via the inhibition of thrombin action by up-regulating APN/CD13 on endothelial cells."},"publication_date":"2005-04-15","publication_name":{"en":"Atherosclerosis","ja":"Atherosclerosis"},"volume":"Vol.183","number":"No.1","starting_page":"49","ending_page":"55","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.atherosclerosis.2005.03.003"],"issn":["0021-9150"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:91, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/15887482","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219701","label":"url"}],"paper_title":{"en":"Successful percutaneous coronary intervention for acute myocardial infarction caused by simultaneous occlusion of two major coronary arteries in patients with diabetes mellitus. A report of two cases.","ja":"Successful percutaneous coronary intervention for acute myocardial infarction caused by simultaneous occlusion of two major coronary arteries in patients with diabetes mellitus. A report of two cases."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Fujinaga Hiroyuki"},{"name":"Niki Toshiharu"}],"ja":[{"name":"池田 康将"},{"name":"Fujinaga Hiroyuki"},{"name":"Niki Toshiharu"}]},"description":{"en":"Percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) is a common therapeutic method. Although two or more culprit lesions are rarely observed simultaneously in AMI patients, we present two cases of AMI caused by simultaneous occlusion of two major coronary arteries, the left anterior descending and right coronary arteries. In both cases, emergency PCI for the two major vessels was successful. Both patients had type 2 diabetes mellitus, which might have contributed to simultaneous occlusion of the two coronary arteries.","ja":"Percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) is a common therapeutic method. Although two or more culprit lesions are rarely observed simultaneously in AMI patients, we present two cases of AMI caused by simultaneous occlusion of two major coronary arteries, the left anterior descending and right coronary arteries. In both cases, emergency PCI for the two major vessels was successful. Both patients had type 2 diabetes mellitus, which might have contributed to simultaneous occlusion of the two coronary arteries."},"publication_date":"2005-04","publication_name":{"en":"Acta Cardiologica","ja":"Acta Cardiologica"},"volume":"Vol.60","number":"No.2","starting_page":"225","ending_page":"228","languages":["eng"],"referee":true,"identifiers":{"doi":["10.2143/AC.60.2.2005037"],"issn":["0001-5385"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:92, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376230"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267166","label":"url"}],"paper_title":{"en":"アミオダロン肺合併症との鑑別を要したマイコプラズマ肺炎合併拡張型心筋症の1例","ja":"アミオダロン肺合併症との鑑別を要したマイコプラズマ肺炎合併拡張型心筋症の1例"},"authors":{"en":[{"name":"山口 普史"},{"name":"Ikeda Yasumasa"},{"name":"藤村 光則"},{"name":"森岡 将臣"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"},{"name":"稲山 真美"},{"name":"Hanibuchi Masaki"}],"ja":[{"name":"山口 普史"},{"name":"池田 康将"},{"name":"藤村 光則"},{"name":"森岡 将臣"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"松本 俊夫"},{"name":"稲山 真美"},{"name":"埴淵 昌毅"}]},"description":{"en":"52歳男.47歳時に拡張型心筋症と診断され,持続性心室頻拍でアミオダロン150mg/日を開始した.その後,心室頻拍が頻回となり,心臓電気生理学的検査で心室細動が誘発されたため除細動器植込み術を受け,アミオダロンは増量して継続していた.今回,乾性咳が出現し,胸部X線で左右下肺野にスリガラス状陰影を指摘された.検査所見では高度の炎症所見を認めたが,KL-6は正常範囲で,C型肝炎ウイルスとヒトT細胞性白血病ウイルスI型のキャリアであった.胸部CTでは両側下肺野を中心として壁の肥厚を伴う気管支拡張や小葉中心性の粒状・樹枝状の陰影が多発しており,周囲の肺野に淡い濃度上昇を認めた.アミオダロンの副作用か感染症かは判断できなかったが,アミオダロンは中止し,アンピシリンナトリウム・スルバクタムナトリウム合剤を開始すると共にサイトメガロウイルス高力価免疫グロブリン投与を行った.入院10日目にマイコプラズマ抗体異常高値が判明し,マイコプラズマ肺炎と診断しミノサイクリン100mg/日を開始した.その結果,炎症所見,画像所見は徐々に軽快し,アミオダロンも再開して退院となった","ja":"52歳男.47歳時に拡張型心筋症と診断され,持続性心室頻拍でアミオダロン150mg/日を開始した.その後,心室頻拍が頻回となり,心臓電気生理学的検査で心室細動が誘発されたため除細動器植込み術を受け,アミオダロンは増量して継続していた.今回,乾性咳が出現し,胸部X線で左右下肺野にスリガラス状陰影を指摘された.検査所見では高度の炎症所見を認めたが,KL-6は正常範囲で,C型肝炎ウイルスとヒトT細胞性白血病ウイルスI型のキャリアであった.胸部CTでは両側下肺野を中心として壁の肥厚を伴う気管支拡張や小葉中心性の粒状・樹枝状の陰影が多発しており,周囲の肺野に淡い濃度上昇を認めた.アミオダロンの副作用か感染症かは判断できなかったが,アミオダロンは中止し,アンピシリンナトリウム・スルバクタムナトリウム合剤を開始すると共にサイトメガロウイルス高力価免疫グロブリン投与を行った.入院10日目にマイコプラズマ抗体異常高値が判明し,マイコプラズマ肺炎と診断しミノサイクリン100mg/日を開始した.その結果,炎症所見,画像所見は徐々に軽快し,アミオダロンも再開して退院となった"},"publication_date":"2005","publication_name":{"en":"Progress in Medicine","ja":"Progress in Medicine"},"volume":"Vol.25","number":"No.Suppl.1","starting_page":"1552","ending_page":"1556","languages":["jpn"],"referee":true,"identifiers":{"issn":["0287-3648"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:93, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/80016878495/","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/15205460","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1362262945661168512/","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-4143096123&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219674","label":"url"}],"paper_title":{"en":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice","ja":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice"},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Yamashita Michiko"},{"name":"Sudo Toshiki"},{"name":"Hayashi Hideki"},{"name":"Yamada Yoshihisa"},{"name":"Endoh Fuminari"},{"name":"Fujimura Mitsunori"},{"name":"Yoshida Tomonori"},{"name":"Yamaguchi Hiroshi"},{"name":"Hashizume Shunji"},{"name":"Kato Midori"},{"name":"Yoshimura Kimihiro"},{"name":"Yamamoto Yoko"},{"name":"Kato Shigeaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"山下 理子"},{"name":"Sudo Toshiki"},{"name":"Hayashi Hideki"},{"name":"Yamada Yoshihisa"},{"name":"Endoh Fuminari"},{"name":"Fujimura Mitsunori"},{"name":"Yoshida Tomonori"},{"name":"Yamaguchi Hiroshi"},{"name":"Hashizume Shunji"},{"name":"加藤 みどり"},{"name":"Yoshimura Kimihiro"},{"name":"Yamamoto Yoko"},{"name":"Kato Shigeaki"},{"name":"松本 俊夫"}]},"description":{"en":"Vitamin D metabolites influence the expression of various genes involved in calcium homeostasis, cell differentiation, and regulation of the immune system. Expression of these genes is mediated by the activation of the nuclear vitamin D receptor (VDR). Previous studies have shown that a hormonally active form of vitamin D, 1alpha,25-dihydroxyvitamin D3, exerts anticoagulant effects in cultured monocytic cells. To clarify whether activation of VDR plays any antithrombotic actions in vivo, hemostatic/thrombogenic systems were examined in normocalcemic VDR knock-out (KO) mice on a high calcium diet and compared with wild type and hypocalcemic VDRKO mice that were fed a regular diet. Platelet aggregation was enhanced significantly in normocalcemic VDRKO mice compared with wild type and hypocalcemic VDRKO mice. Aortic endothelial nitric-oxide (NO) synthase expression and urinary NOx excretions were reduced in hypocalcemic VDRKO mice, but not in normocalcemic VDRKO mice. Northern blot and RT-PCR analyses revealed that the gene expression of antithrombin in the liver as well as that of thrombomodulin in the aorta, liver and kidney was down-regulated in hypo- and normocalcemic VDRKO mice. Whereas tissue factor mRNA expression in the liver and kidney was up-regulated in VDRKO mice regardless of plasma calcium level. Furthermore, VDRKO mice manifested an exacerbated multi-organ thrombus formation after exogenous lipopolysaccharide injection regardless of the calcemic conditions. These results demonstrate that activation of nuclear VDR elicits antithrombotic effects in vivo, and suggest that the VDR system may play a physiological role in the maintenance of antithrombotic homeostasis.","ja":"Vitamin D metabolites influence the expression of various genes involved in calcium homeostasis, cell differentiation, and regulation of the immune system. Expression of these genes is mediated by the activation of the nuclear vitamin D receptor (VDR). Previous studies have shown that a hormonally active form of vitamin D, 1alpha,25-dihydroxyvitamin D3, exerts anticoagulant effects in cultured monocytic cells. To clarify whether activation of VDR plays any antithrombotic actions in vivo, hemostatic/thrombogenic systems were examined in normocalcemic VDR knock-out (KO) mice on a high calcium diet and compared with wild type and hypocalcemic VDRKO mice that were fed a regular diet. Platelet aggregation was enhanced significantly in normocalcemic VDRKO mice compared with wild type and hypocalcemic VDRKO mice. Aortic endothelial nitric-oxide (NO) synthase expression and urinary NOx excretions were reduced in hypocalcemic VDRKO mice, but not in normocalcemic VDRKO mice. Northern blot and RT-PCR analyses revealed that the gene expression of antithrombin in the liver as well as that of thrombomodulin in the aorta, liver and kidney was down-regulated in hypo- and normocalcemic VDRKO mice. Whereas tissue factor mRNA expression in the liver and kidney was up-regulated in VDRKO mice regardless of plasma calcium level. Furthermore, VDRKO mice manifested an exacerbated multi-organ thrombus formation after exogenous lipopolysaccharide injection regardless of the calcemic conditions. These results demonstrate that activation of nuclear VDR elicits antithrombotic effects in vivo, and suggest that the VDR system may play a physiological role in the maintenance of antithrombotic homeostasis."},"publication_date":"2004-08-20","publication_name":{"en":"The Journal of Biological Chemistry","ja":"The Journal of Biological Chemistry"},"volume":"Vol.279","number":"No.34","starting_page":"35798","ending_page":"35802","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1074/jbc.M404865200"],"issn":["0021-9258"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:94, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376231"},"force":{"see_also":[{"@id":"http://circ.ahajournals.org/cgi/content/abstract/109/22/2761","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/15148272","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=262743","label":"url"}],"paper_title":{"en":"Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals.","ja":"Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals."},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Takamori Nobuyuki"},{"name":"Kanagawa Yasuhiko"},{"name":"Akaike Masashi"},{"name":"Fujimura Mitsunori"},{"name":"Yoshida Tomonori"},{"name":"Hashizume Shunji"},{"name":"Kato Midori"},{"name":"Yamaguchi Hiroshi"},{"name":"Kato Shuji"},{"name":"Ikeda Yasumasa"},{"name":"Arase Tomoko"},{"name":"Kondo Akira"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"Takamori Nobuyuki"},{"name":"Kanagawa Yasuhiko"},{"name":"赤池 雅史"},{"name":"Fujimura Mitsunori"},{"name":"Yoshida Tomonori"},{"name":"Hashizume Shunji"},{"name":"Kato Midori"},{"name":"Yamaguchi Hiroshi"},{"name":"Kato Shuji"},{"name":"池田 康将"},{"name":"Arase Tomoko"},{"name":"Kondo Akira"},{"name":"松本 俊夫"}]},"description":{"en":"Thrombin plays a crucial role in atherothrombotic changes. Because heparin cofactor II (HCII) inhibits thrombin actions after binding to dermatan sulfate at injured arterial walls, HCII may negatively regulate thrombin actions in vascular walls. We hypothesized that plasma HCII activity is a preventive factor against atherosclerotic changes, especially in elderly individuals who already have atherosclerotic vascular injuries. Maximum plaque thickness (MPT) in the carotid artery was measured by ultrasonography in 306 Japanese elderly individuals (154 men and 152 women; age, 40 to 91 years; 68.9+/-11.1 years, mean+/-SD). The relevance of cardiovascular risk factors including plasma HCII activity to the severity of MPT was statistically evaluated. Plasma HCII activity decreased with age. Simple linear regression analysis after adjustments for age and sex showed that lipoprotein(a), glycosylated hemoglobin A1c, and presence of diabetes mellitus significantly contributed to an increase in MPT values (r=0.119, P<0.05; r=0.196, P<0.001; and r=0.227, P<0.0001, respectively). In contrast, high-density lipoprotein (HDL) cholesterol and HCII activity were negatively correlated with MPT values (r=-0.117, P<0.05, and r=-0.202, P<0.0005, respectively). Multiple regression analysis revealed that plasma HCII activity and HDL cholesterol independently contributed to the suppression of MPT values and that the antiatherogenic contribution of HCII activity was stronger than that of HDL cholesterol (P<0.001 and P<0.05, respectively). These results suggest that HCII can be a novel and independent antiatherogenic factor. Moreover, HCII is a stronger predictive factor than HDL cholesterol against carotid atherosclerosis in elderly individuals.","ja":"Thrombin plays a crucial role in atherothrombotic changes. Because heparin cofactor II (HCII) inhibits thrombin actions after binding to dermatan sulfate at injured arterial walls, HCII may negatively regulate thrombin actions in vascular walls. We hypothesized that plasma HCII activity is a preventive factor against atherosclerotic changes, especially in elderly individuals who already have atherosclerotic vascular injuries. Maximum plaque thickness (MPT) in the carotid artery was measured by ultrasonography in 306 Japanese elderly individuals (154 men and 152 women; age, 40 to 91 years; 68.9+/-11.1 years, mean+/-SD). The relevance of cardiovascular risk factors including plasma HCII activity to the severity of MPT was statistically evaluated. Plasma HCII activity decreased with age. Simple linear regression analysis after adjustments for age and sex showed that lipoprotein(a), glycosylated hemoglobin A1c, and presence of diabetes mellitus significantly contributed to an increase in MPT values (r=0.119, P<0.05; r=0.196, P<0.001; and r=0.227, P<0.0001, respectively). In contrast, high-density lipoprotein (HDL) cholesterol and HCII activity were negatively correlated with MPT values (r=-0.117, P<0.05, and r=-0.202, P<0.0005, respectively). Multiple regression analysis revealed that plasma HCII activity and HDL cholesterol independently contributed to the suppression of MPT values and that the antiatherogenic contribution of HCII activity was stronger than that of HDL cholesterol (P<0.001 and P<0.05, respectively). These results suggest that HCII can be a novel and independent antiatherogenic factor. Moreover, HCII is a stronger predictive factor than HDL cholesterol against carotid atherosclerosis in elderly individuals."},"publication_date":"2004-06-08","publication_name":{"en":"Circulation","ja":"Circulation"},"volume":"Vol.109","number":"No.22","starting_page":"2761","ending_page":"2765","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1161/01.CIR.0000129968.46095.F3"],"issn":["1524-4539"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:95, {"insert":{"user_id":"B000241782","type":"published_papers","id":"30376232"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267183","label":"url"}],"paper_title":{"en":"ビタミンD-ビタミンD受容体システムは生体における血液凝固調節因子である","ja":"ビタミンD-ビタミンD受容体システムは生体における血液凝固調節因子である"},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"山口 普史"},{"name":"Ikeda Yasumasa"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"山口 普史"},{"name":"池田 康将"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"publication_date":"2003-11","publication_name":{"en":"第25回日本血栓止血学会学術集会","ja":"第25回日本血栓止血学会学術集会"},"volume":"Vol.14","number":"No.5","starting_page":"420","ending_page":"420","languages":["jpn"],"referee":true,"published_paper_type":"scientific_journal"},"priority":"input_data"} line:96, {"insert":{"user_id":"B000241782","type":"published_papers"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/11345202","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219673","label":"url"}],"paper_title":{"en":"Successful combination therapy--flunarizine,pentoxifylline, and cholestyramine--for spur cell anemia","ja":"Successful combination therapy--flunarizine,pentoxifylline, and cholestyramine--for spur cell anemia"},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"Abe Masahiro"},{"name":"Sugihara Takashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"安倍 正博"},{"name":"Sugihara Takashi"},{"name":"松本 俊夫"}]},"description":{"en":"Spur cell anemia, a hemolytic anemia observed in patients with alcoholic cirrhosis, is characterized by unusual erythrocyte morphology and an increased ratio of free cholesterol to phospholipid in the erythrocyte membrane. The prognosis of spur cell anemia is usually extremely poor, however, we describe here a patient with spur cell anemia who was successfully treated with combination therapy consisting of flunarizine, pentoxifylline, and cholestyramine. Initial therapy with flunarizine alone for 6 weeks did not significantly decrease the number of spur cells on peripheral blood smears. So pentoxifylline was added to the regimen. The patient recovered from the anemia, showed remarkable improvement with regard to the hyperbilirubinemia, and the changes were accompanied by a significant decrease in the number of spur cells in peripheral blood smears. To correct the hypercholesterolemia, cholestyramine was added to the regimen, which resulted in a reduction in the serum level of free cholesterol and an increase in the molar ratio of free cholesterol to phospholipid in erythrocyte membrane. However, 6 months later a skin eruption developed that was considered an adverse reaction to the drugs, so the flunarizine and pentoxifylline were discontinued. With cholestyramine therapy alone, the remission of spur cell anemia was maintained for more than 11 months. These observations suggest that non-invasive combination therapy with flunarizine, pentoxifylline, and cholestyramine is effective and valuable in the treatment of patients with spur cell anemia.","ja":"Spur cell anemia, a hemolytic anemia observed in patients with alcoholic cirrhosis, is characterized by unusual erythrocyte morphology and an increased ratio of free cholesterol to phospholipid in the erythrocyte membrane. The prognosis of spur cell anemia is usually extremely poor, however, we describe here a patient with spur cell anemia who was successfully treated with combination therapy consisting of flunarizine, pentoxifylline, and cholestyramine. Initial therapy with flunarizine alone for 6 weeks did not significantly decrease the number of spur cells on peripheral blood smears. So pentoxifylline was added to the regimen. The patient recovered from the anemia, showed remarkable improvement with regard to the hyperbilirubinemia, and the changes were accompanied by a significant decrease in the number of spur cells in peripheral blood smears. To correct the hypercholesterolemia, cholestyramine was added to the regimen, which resulted in a reduction in the serum level of free cholesterol and an increase in the molar ratio of free cholesterol to phospholipid in erythrocyte membrane. However, 6 months later a skin eruption developed that was considered an adverse reaction to the drugs, so the flunarizine and pentoxifylline were discontinued. With cholestyramine therapy alone, the remission of spur cell anemia was maintained for more than 11 months. These observations suggest that non-invasive combination therapy with flunarizine, pentoxifylline, and cholestyramine is effective and valuable in the treatment of patients with spur cell anemia."},"publication_date":"2001-04","publication_name":{"en":"International Journal of Hematology","ja":"International Journal of Hematology"},"volume":"Vol.73","number":"No.3","starting_page":"351","ending_page":"355","languages":["eng"],"referee":true,"identifiers":{"issn":["0925-5710"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} line:97, {"insert":{"user_id":"B000241782","type":"published_papers","id":"32199539"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116786","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33745535","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374809","label":"url"}],"paper_title":{"en":"The authors reply. Response to In Response to Diphenhydramine may be a Preventive Medicine Against Cisplatin- Induced Kidney Toxicity","ja":"The authors reply. Response to In Response to Diphenhydramine may be a Preventive Medicine Against Cisplatin- Induced Kidney Toxicity"},"authors":{"en":[{"name":"Hamano Hirofumi"},{"name":"Chuma Masayuki"},{"name":"Takechi Kenshi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"濱野 裕章"},{"name":"中馬 真幸"},{"name":"武智 研志"},{"name":"池田 康将"}]},"publication_date":"2021-04","publication_name":{"en":"Kidney International","ja":"Kidney International"},"volume":"Vol.99","number":"No.4","starting_page":"1026","ending_page":"1026","languages":["eng"],"identifiers":{"doi":["10.1016/j.kint.2021.01.009"],"issn":["1523-1755"]},"published_paper_type":"scientific_journal"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/published_papers.jsonl, IcEv-I4B7kacV6CWWPVe) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/misc.jsonl) ==== line:1, {"insert":{"user_id":"B000241782","type":"misc","id":"44050684"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/37914318","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404042","label":"url"}],"paper_title":{"en":"[A new attempt of integrated practice of basic medicine in Tokushima University].","ja":"基礎医学における実習統合化の新たな取り組み"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"}],"ja":[{"name":"池田 康将"},{"name":"船本 雅文"}]},"description":{"en":"The Japan Accreditation Council for Medical Education has strengthened the promotion of horizontal and vertical integration of medical education, assuring the quality of medical education in Japan from an international perspective. Pharmacology plays an important role as a central hub that connects basic medical education with clinical medical education. As part of promoting horizontal integration of medical education, Tokushima University has started a joint practice with three basic medical subjects such as Biochemistry, Physiology, and Pharmacology for 2nd grade medical students in 2019. Each subject is in charge of two or four items of practice, and a total 8 of items are performed for 10 days in integrated practice every year. This joint practice has become an official subject in 2022. We introduce our experiences of unique practices based on their advantages and limitations.","ja":"The Japan Accreditation Council for Medical Education has strengthened the promotion of horizontal and vertical integration of medical education, assuring the quality of medical education in Japan from an international perspective. Pharmacology plays an important role as a central hub that connects basic medical education with clinical medical education. As part of promoting horizontal integration of medical education, Tokushima University has started a joint practice with three basic medical subjects such as Biochemistry, Physiology, and Pharmacology for 2nd grade medical students in 2019. Each subject is in charge of two or four items of practice, and a total 8 of items are performed for 10 days in integrated practice every year. This joint practice has become an official subject in 2022. We introduce our experiences of unique practices based on their advantages and limitations."},"publication_date":"2023-11","publication_name":{"en":"Folia Pharmacologica Japonica","ja":"日本薬理学雑誌"},"volume":"Vol.158","number":"No.6","starting_page":"440","ending_page":"443","languages":["jpn"],"invited":true,"identifiers":{"doi":["10.1254/fpj.23017"],"issn":["0015-5691"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:2, {"insert":{"user_id":"B000241782","type":"misc","id":"43586166"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/119145","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403245","label":"url"}],"paper_title":{"en":"生命金属元素鉄の新たな役割と治療応用","ja":"生命金属元素鉄の新たな役割と治療応用"},"authors":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"publication_date":"2023-11","publication_name":{"en":"四国医学界雑誌","ja":"四国医学界雑誌"},"volume":"Vol.79","number":"No.5,6","languages":["jpn"],"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:3, {"insert":{"user_id":"B000241782","type":"misc","id":"43586167"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/118415","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403246","label":"url"}],"paper_title":{"en":"COVID - 19と循環器疾患との関連について","ja":"COVID - 19と循環器疾患との関連について"},"authors":{"en":[{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"池田 康将"}]},"publication_date":"2023-06-07","publication_name":{"en":"四国医学雑誌","ja":"四国医学雑誌"},"volume":"Vol.79","number":"No.1,2","starting_page":"37","ending_page":"42","languages":["jpn"],"invited":true,"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:4, {"insert":{"user_id":"B000241782","type":"misc","id":"41903674"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/37008337","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395079","label":"url"}],"paper_title":{"en":"Roles of histone acetylation sites in cardiac hypertrophy and heart failure.","ja":"Roles of histone acetylation sites in cardiac hypertrophy and heart failure."},"authors":{"en":[{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"description":{"en":"Heart failure results from various physiological and pathological stimuli that lead to cardiac hypertrophy. This pathological process is common in several cardiovascular diseases and ultimately leads to heart failure. The development of cardiac hypertrophy and heart failure involves reprogramming of gene expression, a process that is highly dependent on epigenetic regulation. Histone acetylation is dynamically regulated by cardiac stress. Histone acetyltransferases play an important role in epigenetic remodeling in cardiac hypertrophy and heart failure. The regulation of histone acetyltransferases serves as a bridge between signal transduction and downstream gene reprogramming. Investigating the changes in histone acetyltransferases and histone modification sites in cardiac hypertrophy and heart failure will provide new therapeutic strategies to treat these diseases. This review summarizes the association of histone acetylation sites and histone acetylases with cardiac hypertrophy and heart failure, with emphasis on histone acetylation sites.","ja":"Heart failure results from various physiological and pathological stimuli that lead to cardiac hypertrophy. This pathological process is common in several cardiovascular diseases and ultimately leads to heart failure. The development of cardiac hypertrophy and heart failure involves reprogramming of gene expression, a process that is highly dependent on epigenetic regulation. Histone acetylation is dynamically regulated by cardiac stress. Histone acetyltransferases play an important role in epigenetic remodeling in cardiac hypertrophy and heart failure. The regulation of histone acetyltransferases serves as a bridge between signal transduction and downstream gene reprogramming. Investigating the changes in histone acetyltransferases and histone modification sites in cardiac hypertrophy and heart failure will provide new therapeutic strategies to treat these diseases. This review summarizes the association of histone acetylation sites and histone acetylases with cardiac hypertrophy and heart failure, with emphasis on histone acetylation sites."},"publication_date":"2023-03-15","publication_name":{"en":"Frontiers in Cardiovascular Medicine","ja":"Frontiers in Cardiovascular Medicine"},"volume":"Vol.10","languages":["eng"],"identifiers":{"doi":["10.3389/fcvm.2023.1133611"],"issn":["2297-055X"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:5, {"insert":{"user_id":"B000241782","type":"misc","id":"36868137"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116403","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/35466128","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385327","label":"url"}],"paper_title":{"en":"The role of iron in obesity and diabetes.","ja":"The role of iron in obesity and diabetes."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"船本 雅文"},{"name":"土屋 浩一郎"}]},"description":{"en":"Iron is an essential trace metal for all life, but excess iron causes oxidative stress through catalyzing the toxic hydroxy-radical production via the Fenton reaction. The number of patients with obesity and diabetes has been increasing worldwide, and their onset and development are affected by diet. In both clinical and experimental studies, a high body iron content was associated with obesity and diabetes, and the reduction of body iron content to an appropriate level can ameliorate the status and development of obesity and diabetes. Macrophages play an essential role in the pathophysiology of obesity and diabetes, and in the metabolism and homeostasis of iron in the body. Recent studies demonstrated that macrophage polarization is related to adipocyte hypertrophy and insulin resistance through their capabilities of iron handling. Control of iron in macrophages is a potential therapeutic strategy for obesity and diabetes. J. Med. Invest. 69 : 1-7, February, 2022.","ja":"Iron is an essential trace metal for all life, but excess iron causes oxidative stress through catalyzing the toxic hydroxy-radical production via the Fenton reaction. The number of patients with obesity and diabetes has been increasing worldwide, and their onset and development are affected by diet. In both clinical and experimental studies, a high body iron content was associated with obesity and diabetes, and the reduction of body iron content to an appropriate level can ameliorate the status and development of obesity and diabetes. Macrophages play an essential role in the pathophysiology of obesity and diabetes, and in the metabolism and homeostasis of iron in the body. Recent studies demonstrated that macrophage polarization is related to adipocyte hypertrophy and insulin resistance through their capabilities of iron handling. Control of iron in macrophages is a potential therapeutic strategy for obesity and diabetes. J. Med. Invest. 69 : 1-7, February, 2022."},"publication_date":"2022-04","publication_name":{"en":"The Journal of Medical Investigation : JMI","ja":"The Journal of Medical Investigation : JMI"},"volume":"Vol.69","number":"No.1.2","starting_page":"1","ending_page":"7","languages":["eng"],"invited":true,"identifiers":{"doi":["10.2152/jmi.69.1"],"issn":["1349-6867"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:6, {"insert":{"user_id":"B000241782","type":"misc","id":"32244698"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116787","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34154707","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374867","label":"url"}],"paper_title":{"en":"Novel roles of HIF-PHIs in CKD: the link between iron metabolism, kidney function, and FGF23","ja":"Novel roles of HIF-PHIs in CKD: the link between iron metabolism, kidney function, and FGF23"},"authors":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"description":{"en":"Hanudel et al. investigated the effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors (HIF-PHIs) on iron metabolism in a chronic kidney disease (CKD) mouse model and showed that vadadustat, an HIF-PHI, exerted beneficial effects on anemia and iron disorders independently of erythroferrone. Vadadustat also inhibited the progression of CKD and the CKD-associated increase of plasma fibroblast growth factor 23 in CKD mice. This study provides new insights into the action of HIF-PIHs in CKD.","ja":"Hanudel et al. investigated the effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors (HIF-PHIs) on iron metabolism in a chronic kidney disease (CKD) mouse model and showed that vadadustat, an HIF-PHI, exerted beneficial effects on anemia and iron disorders independently of erythroferrone. Vadadustat also inhibited the progression of CKD and the CKD-associated increase of plasma fibroblast growth factor 23 in CKD mice. This study provides new insights into the action of HIF-PIHs in CKD."},"publication_date":"2021-07-01","publication_name":{"en":"Kidney International","ja":"Kidney International"},"volume":"Vol.100","number":"No.1","starting_page":"14","ending_page":"16","languages":["eng"],"invited":true,"identifiers":{"doi":["10.1016/j.kint.2021.04.030"],"issn":["1523-1755"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:7, {"insert":{"user_id":"B000241782","type":"misc","id":"30376240"},"force":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1520291856216639360/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=362208","label":"url"}],"paper_title":{"en":"Abnormal iron metabolism in kidney disease","ja":"鉄と腎:腎疾患と鉄代謝異常"},"authors":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"publication_date":"2020-02","publication_name":{"en":"Nephrology","ja":"腎臓内科"},"volume":"Vol.11","number":"No.2","starting_page":"146","ending_page":"152","languages":["jpn"],"identifiers":{"issn":["2435-1903"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:8, {"insert":{"user_id":"B000241782","type":"misc","id":"30376241"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=362569","label":"url"}],"paper_title":{"en":"序文(特集:必須微量金属研究のパラダイムシフト)","ja":"序文(特集:必須微量金属研究のパラダイムシフト)"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"深田 俊幸"}],"ja":[{"name":"池田 康将"},{"name":"深田 俊幸"}]},"publication_date":"2019-12","publication_name":{"en":"Folia Pharmacologica Japonica","ja":"日本薬理学雑誌"},"volume":"Vol.2019","number":"No.6","starting_page":"309","ending_page":"309","languages":["jpn"],"identifiers":{"issn":["0015-5691"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:9, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://ci.nii.ac.jp/naid/130007754372/","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1390001277399772544/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=361601","label":"url"}],"paper_title":{"en":"Body iron accumulation in obesity, diabetes and complications, and thepossibility of therapeutic application by iron regulation","ja":"肥満・糖尿病とその合併症における生体内鉄蓄積と鉄制限による治療応用への可能性"},"authors":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"description":{"en":"

Iron is an essential trace metal element for maintaining vital functions, and it is involved in hemoglobin synthesis, redox reaction, enzyme activity, cell proliferation and apoptosis in various cells. Iron deficient-related diseases represented anemia are well-known, on the other hand, iron overload disease has attracted little attention. Excessive iron produces hydroxyl radicals via Fenton/Haber-Weiss reaction, causing organ damage in hereditary iron overload diseases. Additionally, it has been clarified that iron accumulation is involved in the pathological conditions even in metabolic diseases thought to be unrelated to iron so far. Therefore, the role of iron in the living body has been raised attention again. Recent studies have reported that body iron content is associated with both obesity and diabetes, and iron might be an aggravating factor of obesity and diabetes. We have revealed that iron chelating agent reduced oxidative stress and inflammation, suppressing the development of adipose hypertrophy in KKAy mice. Dietary iron restriction also diminishes oxidative stress, leading to the inhibition of increased albuminuria excretion and glomerular lesions in db/db mice. In this review, we give an outline of the role of iron on obese and diabetes, and diabetic kidney disease, and present the possibility of application to treatment with iron regulation in those disorders.

","ja":"

鉄は生体内に最も多く存在する生命機能維持に必須の微量金属元素であり,赤血球のヘモグロビン合成,各種細胞における酸化還元反応,酵素活性,細胞増殖ならびにアポトーシスなどに関与する.そのため,貧血に代表される鉄欠乏疾患はよく知られているものの,鉄過剰疾患はあまり注目されてこなかった.過剰な鉄はフェントン/ハーバー・ワイス反応を介して酸化力が強力なヒドロキシルラジカルを生成し,遺伝性鉄過剰疾患における臓器障害の原因となるが,C型肝炎やアルツハイマー病などの従来は鉄と無関係と考えられていた疾患においても鉄が病態に関与していることが明らかとなり,生体内での鉄の役割が改めて注目されている.近年,生体内鉄量の増加が肥満ならびに糖尿病と関連することが示唆されており,鉄は肥満・糖尿病の増悪因子の可能性がある.しかし,肥満・糖尿病における鉄除去の効果については不明であった.我々は,肥満・糖尿病モデルKKAyマウスを用いて,鉄キレート剤投与が酸化ストレスや炎症を低減して,脂肪細胞肥大の進展が抑制されること,糖尿病性腎臓病モデルdb/dbマウスでは,食餌性鉄制限が酸化ストレスを減少して,アルブミン尿排泄増加や糸球体病変を抑制することで糖尿病性腎臓病の進行抑制につながることを報告した.本稿では,肥満・糖尿病とその合併症における鉄の役割と鉄制限による治療応用への可能性について,我々が明らかにした研究成果を含めて概説する.

"},"publication_date":"2019-12","publication_name":{"en":"Folia Pharmacologica Japonica","ja":"日本薬理学雑誌"},"volume":"Vol.154","number":"No.6","starting_page":"316","ending_page":"321","languages":["jpn"],"identifiers":{"doi":["10.1254/fpj.154.316"],"issn":["0015-5691"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:10, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://ci.nii.ac.jp/naid/120006464485/","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/111571","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050564288435540608/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=347857","label":"url"}],"paper_title":{"en":"The role of iron, a trace nutrient, on diabetes","ja":"糖尿病における微量栄養素「鉄」の役割"},"authors":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"description":{"en":"The nutrient balance is an important factor to keep healthy state in the body. In various nutrients, iron is a most abundant trace metal element. Iron-deficient anemia is often seen in the iron-related disorders, therefore, lots of functional food, drink, and nutritional supplement are widely provided and used to prevent iron deficiency. On the other hand, over iron intake induces excess iron status, causing increased oxidative stress production via catalyzing Fenton reaction. Recent evidences suggest that iron involves the pathological conditions of non-iron accumulating diseases, and the role of iron is noticed again.Diabetes is associated with poor prognosis to develop a variety of complications such as cardiovascular disease and diabetic kidney disease(DKD)in addition to diabetic retinopathy and neuropathy. Moreover, patients with diabetes often present reduced skeletal muscle mass, and it causes more impaired insulin resistance by diminishing glucose uptake. Recent studies have shown that iron content is associated with diabetic and obese condition, and high iron intake increases diabetes risk. We have clarified the favorable effect of iron reduction on obesity and DKD through diminishing oxidative stress. In addition, excess iron caused skeletal muscle atrophy and it was ameliorated by an anti-oxidant drug.Thus, iron plays an important role in diabetes and its complication through oxidative stress production. Further studies are clarifying an important role of trace nutrient including iron and so on, contributing to the development of new therapeutic strategy.","ja":"The nutrient balance is an important factor to keep healthy state in the body. In various nutrients, iron is a most abundant trace metal element. Iron-deficient anemia is often seen in the iron-related disorders, therefore, lots of functional food, drink, and nutritional supplement are widely provided and used to prevent iron deficiency. On the other hand, over iron intake induces excess iron status, causing increased oxidative stress production via catalyzing Fenton reaction. Recent evidences suggest that iron involves the pathological conditions of non-iron accumulating diseases, and the role of iron is noticed again.Diabetes is associated with poor prognosis to develop a variety of complications such as cardiovascular disease and diabetic kidney disease(DKD)in addition to diabetic retinopathy and neuropathy. Moreover, patients with diabetes often present reduced skeletal muscle mass, and it causes more impaired insulin resistance by diminishing glucose uptake. Recent studies have shown that iron content is associated with diabetic and obese condition, and high iron intake increases diabetes risk. We have clarified the favorable effect of iron reduction on obesity and DKD through diminishing oxidative stress. In addition, excess iron caused skeletal muscle atrophy and it was ameliorated by an anti-oxidant drug.Thus, iron plays an important role in diabetes and its complication through oxidative stress production. Further studies are clarifying an important role of trace nutrient including iron and so on, contributing to the development of new therapeutic strategy."},"publication_date":"2018-04-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.74","number":"No.1,2","starting_page":"13","ending_page":"20","languages":["jpn"],"identifiers":{"issn":["0037-3699"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:11, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/26522430","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84959258899&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=306912","label":"url"}],"paper_title":{"en":"Roles of the Androgen - Androgen Receptor System in Vascular Angiogenesis.","ja":"Roles of the Androgen - Androgen Receptor System in Vascular Angiogenesis."},"authors":{"en":[{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"}],"ja":[{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"粟飯原 賢一"}]},"publication_date":"2016-03","publication_name":{"en":"Journal of Atherosclerosis and Thrombosis","ja":"Journal of Atherosclerosis and Thrombosis"},"volume":"Vol.23","number":"No.3","starting_page":"257","ending_page":"265","languages":["eng"],"identifiers":{"doi":["10.5551/jat.31047"],"issn":["1880-3873"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:12, {"insert":{"user_id":"B000241782","type":"misc","id":"30376242"},"force":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/24882646","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=278303","label":"url"}],"paper_title":{"en":"Drug development for cardiorenal disease based on oxidative stress control","ja":"酸化ストレス制御を基盤とする新規心腎血管障害治療薬の開発"},"authors":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"SAKURADA TAKUMI"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"石澤 有紀"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"description":{"en":"Oxidative stress is a key factor involved in the pathogenesis and progression of cardiovascular disease (CVD) and chronic kidney disease (CKD). Reactive oxygen species (ROS), produced as a result of redox reactions in various cells, have been recognized as key chemical mediators causing cellular damage and organ dysfunction in CVD and CKD. Nifedipine, a well-known calcium channel blocker, is extremely sensitive to light which gets converted to its nitroso analog, nitrosonifedipine (NO-NIF) in the presence of ultraviolet and visible light. The so formed NO-NIF blocks calcium channel quite weakly compared to that of nifedipine. However, we elucidated for the first time that NO-NIF is converted to NO-NIF radical which acquires extremely strong antioxidant property via reaction with unsaturated fatty acid or endothelial cells. We have already reported that NO-NIF reduces the cytotoxicity of cumene hydroperoxide, which hampers the integrity of cell membrane through oxidative stress, in endothelial cells. Additionally, we demonstrated that NO-NIF restored acetylcholine-responsive vascular relaxation and suppressed intercellular adhesion molecule-1 expression in the aorta of N(ω)-nitro-L-arginine methyl ester-treated rats, a model of vascular endothelial dysfunction. Recently, we reported that NO-NIF ameliorates angiotensin II-induced vascular remodeling via antioxidative effects in vivo and in vitro. These observations point towards the plausible, unique role of NO-NIF as a novel antioxidant which improves vascular dysfunction for overcoming CVD and CKD and the same has been highlighted in this review.","ja":"Oxidative stress is a key factor involved in the pathogenesis and progression of cardiovascular disease (CVD) and chronic kidney disease (CKD). Reactive oxygen species (ROS), produced as a result of redox reactions in various cells, have been recognized as key chemical mediators causing cellular damage and organ dysfunction in CVD and CKD. Nifedipine, a well-known calcium channel blocker, is extremely sensitive to light which gets converted to its nitroso analog, nitrosonifedipine (NO-NIF) in the presence of ultraviolet and visible light. The so formed NO-NIF blocks calcium channel quite weakly compared to that of nifedipine. However, we elucidated for the first time that NO-NIF is converted to NO-NIF radical which acquires extremely strong antioxidant property via reaction with unsaturated fatty acid or endothelial cells. We have already reported that NO-NIF reduces the cytotoxicity of cumene hydroperoxide, which hampers the integrity of cell membrane through oxidative stress, in endothelial cells. Additionally, we demonstrated that NO-NIF restored acetylcholine-responsive vascular relaxation and suppressed intercellular adhesion molecule-1 expression in the aorta of N(ω)-nitro-L-arginine methyl ester-treated rats, a model of vascular endothelial dysfunction. Recently, we reported that NO-NIF ameliorates angiotensin II-induced vascular remodeling via antioxidative effects in vivo and in vitro. These observations point towards the plausible, unique role of NO-NIF as a novel antioxidant which improves vascular dysfunction for overcoming CVD and CKD and the same has been highlighted in this review."},"publication_date":"2014-06","publication_name":{"en":"Journal of the Pharmaceutical Society of Japan","ja":"薬学雑誌"},"volume":"Vol.134","number":"No.6","starting_page":"715","ending_page":"719","languages":["jpn"],"identifiers":{"doi":["10.1248/yakushi.13-00255-4"],"issn":["1347-5231"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:13, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=277203","label":"url"}],"paper_title":{"en":"抗酸化薬","ja":"抗酸化薬"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publication_date":"2014-04-10","publication_name":{"en":"腎・高血圧の最新治療","ja":"腎・高血圧の最新治療"},"volume":"Vol.3","number":"No.2","starting_page":"93","ending_page":"99","languages":["jpn"],"invited":true,"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:14, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/40019952227/","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1520290882774966784/","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-84892762387&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274418","label":"url"}],"paper_title":{"en":"Role of Dietary Essential Trace Metals in the Pathogenesis of Diabetes Mellitus","ja":"糖尿病と食事由来金属元素"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publication_date":"2013-12","publication_name":{"en":"Journal of the The Japan Diabetes Society","ja":"糖尿病"},"volume":"Vol.56","number":"No.12","starting_page":"919","ending_page":"921","languages":["jpn"],"invited":true,"identifiers":{"issn":["0021-437X"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:15, {"insert":{"user_id":"B000241782","type":"misc","id":"30376244"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=313674","label":"url"}],"paper_title":{"en":"Nitrosonifedipineはangiotensin IIによるマウス血管リモデリングを抑制する","ja":"Nitrosonifedipineはangiotensin IIによるマウス血管リモデリングを抑制する"},"authors":{"en":[{"name":"櫻田 巧"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"藤井 聖子"},{"name":"谷口 順平"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"櫻田 巧"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"藤井 聖子"},{"name":"谷口 順平"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publication_date":"2013-01-10","publication_name":{"en":"腎とフリーラジカル","ja":"腎とフリーラジカル"},"volume":"Vol.11","starting_page":"78","ending_page":"81","languages":["jpn"],"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:16, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/22792467","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=253919","label":"url"}],"paper_title":{"en":"Effects of Statins on Cardiorenal Syndrome.","ja":"Effects of Statins on Cardiorenal Syndrome."},"authors":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"description":{"en":"Cardiovascular disease and renal disease have a close relationship that forms a vicious cycle as a cardiorenal syndrome (CRS). Oxidative stress, endothelial dysfunction, and vascular inflammation could be therapeutic targets when the renin-angiotensin-aldosterone system is activated by accumulation of conventional cardiovascular risk factors; however, a strategy for management of CRS has not been established yet. Statins, HMG-CoA reductase inhibitors, have not only cholesterol-lowering effects but also pleiotropic effects on cardiovascular systems, including anti-inflammatory and antioxidant effects and improvement of nitric oxide bioavailability. Since recent studies have indicated that statins have beneficial effects on chronic kidney disease and heart failure as well as coronary artery disease in cholesterol-lowering-dependent/independent manners, treatment with statins might be a successful strategy for preventing deterioration of CRS.","ja":"Cardiovascular disease and renal disease have a close relationship that forms a vicious cycle as a cardiorenal syndrome (CRS). Oxidative stress, endothelial dysfunction, and vascular inflammation could be therapeutic targets when the renin-angiotensin-aldosterone system is activated by accumulation of conventional cardiovascular risk factors; however, a strategy for management of CRS has not been established yet. Statins, HMG-CoA reductase inhibitors, have not only cholesterol-lowering effects but also pleiotropic effects on cardiovascular systems, including anti-inflammatory and antioxidant effects and improvement of nitric oxide bioavailability. Since recent studies have indicated that statins have beneficial effects on chronic kidney disease and heart failure as well as coronary artery disease in cholesterol-lowering-dependent/independent manners, treatment with statins might be a successful strategy for preventing deterioration of CRS."},"publication_date":"2012-06-26","publication_name":{"en":"International Journal of Vascular Medicine","ja":"International Journal of Vascular Medicine"},"volume":"Vol.2012","starting_page":"162545","ending_page":"162545","languages":["eng"],"identifiers":{"doi":["10.1155/2012/162545"],"issn":["2090-2832"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:17, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=247531","label":"url"}],"paper_title":{"en":"Iron metabolism in the progression of adipocyte hypertrophy","ja":"Iron metabolism in the progression of adipocyte hypertrophy"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publication_date":"2012-06","publication_name":{"en":"The Cell","ja":"細胞"},"volume":"Vol.44","number":"No.6","starting_page":"282","ending_page":"286","languages":["jpn"],"invited":true,"identifiers":{"issn":["1346-7557"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:18, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/22493003","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246743","label":"url"}],"paper_title":{"en":"Effects of androgens on cardiovascular remodeling.","ja":"Effects of androgens on cardiovascular remodeling."},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"description":{"en":"Androgens, the male sex hormones, exert various biological effects on many target organs through the transcriptional effects of the nuclear androgen receptor (AR). ARs are expressed not only in classical target organs, such as the brain, genital organs, bone, and skeletal muscles, but also in the cardiovascular system. Because the female sex hormones estrogens are well known to protect against cardiovascular disease, sex has been considered to have a significant clinical impact on cardiovascular mortality. However, the influence of androgens on the cardiovascular system has not been fully elucidated. To clarify this issue, we analyzed the effects of administration of angiotensin II and doxorubicin, an anticancer agent, in a loading model in male wild-type and AR-deficient mice. In this review, we focus on the actions of androgens as potential targets for the prevention of cardiovascular diseases in males.","ja":"Androgens, the male sex hormones, exert various biological effects on many target organs through the transcriptional effects of the nuclear androgen receptor (AR). ARs are expressed not only in classical target organs, such as the brain, genital organs, bone, and skeletal muscles, but also in the cardiovascular system. Because the female sex hormones estrogens are well known to protect against cardiovascular disease, sex has been considered to have a significant clinical impact on cardiovascular mortality. However, the influence of androgens on the cardiovascular system has not been fully elucidated. To clarify this issue, we analyzed the effects of administration of angiotensin II and doxorubicin, an anticancer agent, in a loading model in male wild-type and AR-deficient mice. In this review, we focus on the actions of androgens as potential targets for the prevention of cardiovascular diseases in males."},"publication_date":"2012-04-05","publication_name":{"en":"The Journal of Endocrinology","ja":"The Journal of Endocrinology"},"languages":["eng"],"identifiers":{"doi":["10.1530/JOE-12-0126"],"issn":["1479-6805"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:19, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"http://ci.nii.ac.jp/naid/10029400903/","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1572543024868677632/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231192","label":"url"}],"paper_title":{"en":"The role of iron on cardiovascular disease and diabetes mellitus","ja":"循環器疾患と糖尿病における生体内鉄の意義"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Yamano Noriko"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"山野 範子"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publication_date":"2011-07-06","publication_name":{"en":"Japanese Journal of Circulation Research","ja":"血管"},"volume":"Vol.34","number":"No.2","starting_page":"75","ending_page":"85","languages":["jpn"],"identifiers":{"issn":["0911-4637"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:20, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"http://repo.lib.tokushima-u.ac.jp/110344","label":"url"},{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/110344","label":"url"},{"@id":"https://cir.nii.ac.jp/crid/1050564287418524160/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230705","label":"url"}],"paper_title":{"en":"Role of Hypoxia-Inducible Factor1a (HIF-1a) in T cells in development of vascular remodeling","ja":"生体の低酸素応答と病態 -血管リモデリングにおける転写因子HIFの関与-"},"authors":{"en":[{"name":"Tomita Shuhei"},{"name":"Imanishi Masaki"},{"name":"Sakurada Takumi"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"冨田 修平"},{"name":"今西 正樹"},{"name":"櫻田 巧"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"description":{"en":"Recent studies have shown that the cellular immune response to the hypoxic microenvironment constructed by vascular remodeling development modulates the resulting pathologic alterations. A major mechanism mediating adaptive responses to reduced oxygen availability is the regulation of transcription by hypoxia-inducible factor1(HIF‐1). Impairment of HIF‐1‐ dependent inflammatory responses in T cells causes an augmented vascular remodeling induced by arterial injury, which is shown as prominent neointimal hyperplasia and increase in infiltration of inflammatory cells at the adventitia in mice lacking Hif‐1α specifically in T cells. Studies to clarify the mechanism of augmented vascular remodeling in the mutant mice have shown enhanced production of cytokines in activated T cells and augmented antibody production in response to a T-dependent antigen in the mutant mice. This minireview shows that HIF‐1α in T cells plays a crucial role in vascular inflammation and remodeling in response to cuff injury as a negative regulator of the T cell-mediated immune response and suggests potential new therapeutic strategies that target HIF‐1α.","ja":"Recent studies have shown that the cellular immune response to the hypoxic microenvironment constructed by vascular remodeling development modulates the resulting pathologic alterations. A major mechanism mediating adaptive responses to reduced oxygen availability is the regulation of transcription by hypoxia-inducible factor1(HIF‐1). Impairment of HIF‐1‐ dependent inflammatory responses in T cells causes an augmented vascular remodeling induced by arterial injury, which is shown as prominent neointimal hyperplasia and increase in infiltration of inflammatory cells at the adventitia in mice lacking Hif‐1α specifically in T cells. Studies to clarify the mechanism of augmented vascular remodeling in the mutant mice have shown enhanced production of cytokines in activated T cells and augmented antibody production in response to a T-dependent antigen in the mutant mice. This minireview shows that HIF‐1α in T cells plays a crucial role in vascular inflammation and remodeling in response to cuff injury as a negative regulator of the T cell-mediated immune response and suggests potential new therapeutic strategies that target HIF‐1α."},"publication_date":"2011-04-25","publication_name":{"en":"Shikoku Acta Medica","ja":"四国医学雑誌"},"volume":"Vol.67","number":"No.1, 2","starting_page":"3","ending_page":"6","languages":["jpn"],"identifiers":{"issn":["0037-3699"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:21, {"insert":{"user_id":"B000241782","type":"misc"},"similar_merge":{"see_also":[{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/21234356","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=237315","label":"url"}],"paper_title":{"en":"Transforming Growth Factor-1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome.","ja":"Transforming Growth Factor-1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome."},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"description":{"en":"Transforming growth factor-1 (TGF-1) is a polypeptide member of the transforming growth factor superfamily of cytokines. It is a secreted protein that performs many cellular functions including control of cell growth, cell proliferation, cell differentiation and apoptosis. In the cardiovascular system, TGF-1 plays pivotal roles in the pathogenesis of hypertension, restenosis after percutaneous coronary intervention, atherosclerosis, cardiac hypertrophy and heart failure. In addition, TGF-1 has been shown to be increased in adipose tissue of obese subjects with insulin resistance. Furthermore, TGF-1 is a potent initiator of proliferation of renal mesangial cells leading to chronic kidney disease. Some currently available agents can manipulate TGF-1 expression leading to amelioration of cardiovascular diseases. Thus, an understanding of interactions between chronic kidney disease and metabolic syndrome and the development of cardiovascular diseases is an important issue, and attention should be given to TGF-1 as a crucial factor for regulation and modulation of those pathological conditions.","ja":"Transforming growth factor-1 (TGF-1) is a polypeptide member of the transforming growth factor superfamily of cytokines. It is a secreted protein that performs many cellular functions including control of cell growth, cell proliferation, cell differentiation and apoptosis. In the cardiovascular system, TGF-1 plays pivotal roles in the pathogenesis of hypertension, restenosis after percutaneous coronary intervention, atherosclerosis, cardiac hypertrophy and heart failure. In addition, TGF-1 has been shown to be increased in adipose tissue of obese subjects with insulin resistance. Furthermore, TGF-1 is a potent initiator of proliferation of renal mesangial cells leading to chronic kidney disease. Some currently available agents can manipulate TGF-1 expression leading to amelioration of cardiovascular diseases. Thus, an understanding of interactions between chronic kidney disease and metabolic syndrome and the development of cardiovascular diseases is an important issue, and attention should be given to TGF-1 as a crucial factor for regulation and modulation of those pathological conditions."},"publication_date":"2010-12-28","publication_name":{"en":"Cardiology Research and Practice","ja":"Cardiology Research and Practice"},"volume":"Vol.2011","starting_page":"175381","ending_page":"175381","languages":["eng"],"identifiers":{"doi":["10.4061/2011/175381"],"issn":["2090-0597"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} line:22, {"insert":{"user_id":"B000241782","type":"misc","id":"30376245"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266434","label":"url"}],"paper_title":{"en":"【慢性心不全の分子機構 新しい治療戦略を求めて】 性ステロイドと心保護作用","ja":"【慢性心不全の分子機構 新しい治療戦略を求めて】 性ステロイドと心保護作用"},"authors":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"松本 俊夫"}]},"publication_date":"2006","publication_name":{"en":"Cardioangiology","ja":"循環器科"},"volume":"Vol.59","number":"No.6","starting_page":"579","ending_page":"584","languages":["jpn"],"identifiers":{"issn":["0388-1911"]},"misc_type":"introduction_scientific_journal"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/misc.jsonl, KMEv-I4B7kacV6CWWfWf) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/books_etc.jsonl) ==== line:1, {"insert":{"user_id":"B000241782","type":"books_etc","id":"43609713"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=403288","label":"url"}],"book_title":{"en":"疾病の成り立ちと回復の促進 薬理学(第4版)(分担執筆 各論4・5・6)","ja":"疾病の成り立ちと回復の促進 薬理学(第4版)(分担執筆 各論4・5・6)"},"authors":{"en":[{"name":"Tamaki Toshiaki"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"玉置 俊晃"},{"name":"池田 康将"}]},"publication_date":"2023-10-10","languages":["jpn"]},"priority":"input_data"} line:2, {"insert":{"user_id":"B000241782","type":"books_etc","id":"30376233"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=347858","label":"url"}],"book_title":{"en":"8章 血液・造血器・リンパ系( 新しい薬理学)","ja":"8章 血液・造血器・リンパ系( 新しい薬理学)"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"}]},"publisher":{"en":"西村書店","ja":"西村書店"},"publication_date":"2018-05-15","languages":["jpn"]},"priority":"input_data"} line:3, {"insert":{"user_id":"B000241782","type":"books_etc","id":"30376234"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=289451","label":"url"}],"book_title":{"en":"Annual Review2015腎臓---腎疾患と鉄代謝異常---","ja":"Annual Review2015腎臓---腎疾患と鉄代謝異常---"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"publisher":{"en":"株式会社 中外医学社","ja":"株式会社 中外医学社"},"publication_date":"2015-01","languages":["jpn"]},"priority":"input_data"} line:4, {"insert":{"user_id":"B000241782","type":"books_etc","id":"30376235"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=305550","label":"url"}],"book_title":{"en":"ヒト腎糸球体内皮細胞における亜硝酸塩によるAMPK-eNOS活性化経路の検討","ja":"ヒト腎糸球体内皮細胞における亜硝酸塩によるAMPK-eNOS活性化経路の検討"},"authors":{"en":[{"name":"Miyamoto Licht"},{"name":"山根 萌"},{"name":"冨田 洋輔"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"山根 萌"},{"name":"冨田 洋輔"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"publisher":{"en":"TOKYO IGAKUSHA","ja":"株式会社 東京医学社"},"publication_date":"2014-10-01","languages":["jpn"]},"priority":"input_data"} line:5, {"insert":{"user_id":"B000241782","type":"books_etc","id":"30386898"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260808","label":"url"}],"book_title":{"en":"腎とフリーラジカル第11集 --- 脂肪組織肥大進展における鉄キレート剤の効果","ja":"腎とフリーラジカル第11集 --- 脂肪組織肥大進展における鉄キレート剤の効果"},"authors":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publisher":{"en":"TOKYO IGAKUSHA","ja":"株式会社 東京医学社"},"publication_date":"2013-01-10","languages":["jpn"]},"priority":"input_data"} line:6, {"insert":{"user_id":"B000241782","type":"books_etc","id":"30376238"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260807","label":"url"}],"book_title":{"en":"腎とフリーラジカル第11集 --- NitrosonifedipineはangiotensinⅡによるマウス血管リモデリングを抑制する","ja":"腎とフリーラジカル第11集 --- NitrosonifedipineはangiotensinⅡによるマウス血管リモデリングを抑制する"},"authors":{"en":[{"name":"Sakurada Takumi"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Fujii Shoko"},{"name":"Taniguchi Jumpei"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"櫻田 巧"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"藤井 聖子"},{"name":"谷口 順平"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"publisher":{"en":"TOKYO IGAKUSHA","ja":"株式会社 東京医学社"},"publication_date":"2013-01-10","languages":["jpn"]},"priority":"input_data"} line:7, {"insert":{"user_id":"B000241782","type":"books_etc","id":"30386899"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260806","label":"url"}],"book_title":{"en":"腎とフリーラジカル第11集 --- 亜硝酸塩による腎保護作用","ja":"腎とフリーラジカル第11集 --- 亜硝酸塩による腎保護作用"},"authors":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"},{"name":"Miyamoto Licht"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"石澤 啓介"},{"name":"宮本 理人"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"publisher":{"en":"TOKYO IGAKUSHA","ja":"株式会社 東京医学社"},"publication_date":"2013-01-10","languages":["jpn"]},"priority":"input_data"} line:8, {"insert":{"user_id":"B000241782","type":"books_etc","id":"30376239"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233714","label":"url"}],"book_title":{"en":"腎とフリーラジカル第10集 --- アンジオテンシンII刺激による細胞内遊離鉄を介した酸化ストレス増強機構","ja":"腎とフリーラジカル第10集 --- アンジオテンシンII刺激による細胞内遊離鉄を介した酸化ストレス増強機構"},"authors":{"en":[{"name":"田島 壮一郎"},{"name":"Tsuchiya Koichiro"},{"name":"濱本 磨以"},{"name":"久住 祥子"},{"name":"Horinouchi Yuya"},{"name":"八木 祐子"},{"name":"櫻田 巧"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"土屋 浩一郎"},{"name":"濱本 磨以"},{"name":"久住 祥子"},{"name":"堀ノ内 裕也"},{"name":"八木 祐子"},{"name":"櫻田 巧"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"publisher":{"en":"TOKYO IGAKUSHA","ja":"株式会社 東京医学社"},"publication_date":"2010-06-20","languages":["jpn"]},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/books_etc.jsonl, K8Ev-I4B7kacV6CWWvVn) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/awards.jsonl) ==== line:1, {"insert":{"user_id":"B000241782","type":"awards"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219694","label":"url"}],"award_name":{"en":"Young Investigator Award","ja":"Young Investigator Award"},"winners":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"association":{"en":"6thAnnual Conference Society for Heart and Vascular Metabolism","ja":"6thAnnual Conference Society for Heart and Vascular Metabolism"},"award_date":"2008-06"},"priority":"input_data"} line:2, {"insert":{"user_id":"B000241782","type":"awards"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219693","label":"url"}],"award_name":{"en":"New Investigator Travel Award","ja":"New Investigator Travel Award"},"winners":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"association":{"en":"American Heart Association BCVS conference","ja":"American Heart Association BCVS conference"},"award_date":"2009-07"},"priority":"input_data"} line:3, {"insert":{"user_id":"B000241782","type":"awards"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219688","label":"url"}],"award_name":{"en":"CVEM Young Investigator Award","ja":"若手研究奨励賞"},"winners":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"award_title":{"en":"LKB1遺伝子は心肥大と血管新生を制御する必須の因子である","ja":"LKB1遺伝子は心肥大と血管新生を制御する必須の因子である"},"association":{"en":"日本心血管内分泌代謝学会","ja":"日本心血管内分泌代謝学会"},"award_date":"2009-10-23"},"priority":"input_data"} line:4, {"insert":{"user_id":"B000241782","type":"awards"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219692","label":"url"}],"award_name":{"en":"青藍会賞","ja":"青藍会賞"},"winners":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"association":{"en":"徳島大学医学部医学科同窓会","ja":"徳島大学医学部医学科同窓会"},"award_date":"2010-07-20"},"priority":"input_data"} line:5, {"insert":{"user_id":"B000241782","type":"awards"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219691","label":"url"}],"award_name":{"en":"若手研究者学長表彰","ja":"若手研究者学長表彰"},"winners":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"association":{"en":"Tokushima University","ja":"徳島大学"},"award_date":"2010-11-19"},"priority":"input_data"} line:6, {"insert":{"user_id":"B000241782","type":"awards"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=249454","label":"url"}],"award_name":{"en":"財団法人博慈会 老人病研究所 優秀論文助成","ja":"財団法人博慈会 老人病研究所 優秀論文助成"},"winners":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"award_title":{"en":"Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes","ja":"Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes"},"award_date":"2012-01"},"priority":"input_data"} line:7, {"insert":{"user_id":"B000241782","type":"awards"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274343","label":"url"}],"award_name":{"en":"康楽會賞","ja":"康楽會賞"},"winners":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"award_title":{"en":"肥満・糖尿病とその合併症における鉄代謝変化と鉄制御による病態改善機構の解明","ja":"肥満・糖尿病とその合併症における鉄代謝変化と鉄制御による病態改善機構の解明"},"association":{"en":"The Koraku Foundation","ja":"財団法人 三木康楽会"},"award_date":"2014-01"},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/awards.jsonl, L8Ev-I4B7kacV6CWW_U1) ==== ==== begin registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/presentations.jsonl) ==== line:1, {"insert":{"user_id":"B000241782","type":"presentations","id":"45512727"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404863","label":"url"}],"presentation_title":{"en":"Kampo medicine, orengedokuto, suppresses Doxorubicin-induced cardiotoxicity","ja":"Kampo medicine, orengedokuto, suppresses Doxorubicin-induced cardiotoxicity"},"presenters":{"en":[{"name":"Amiho Muramatsu"},{"name":"Funamoto Masafumi"},{"name":"Miyako Ueno"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"村松 明美穂"},{"name":"船本 雅文"},{"name":"上野 実弥子"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"28th International Society of Cardiovascular Pharmacotherapy Annual Scientific Meeting","ja":"28th International Society of Cardiovascular Pharmacotherapy Annual Scientific Meeting"},"publication_date":"2023-11-24","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:2, {"insert":{"user_id":"B000241782","type":"presentations","id":"45512728"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404862","label":"url"}],"presentation_title":{"en":"Effects of high-absorption curcumin for the prevention of hypertensive heart disease","ja":"Effects of high-absorption curcumin for the prevention of hypertensive heart disease"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Yoichi Sunagawa"},{"name":"Yasufumi Katanasaka"},{"name":"Toru Kato"},{"name":"Yoichi Ajiro"},{"name":"Maki Komiyama"},{"name":"Masaharu Akao"},{"name":"Hajime Yamakage"},{"name":"Noriko Satoh-Asahara"},{"name":"Hiromichi Wada"},{"name":"Ikeda Yasumasa"},{"name":"Tatsuya Morimoto"},{"name":"Koji Hasegawa"}],"ja":[{"name":"船本 雅文"},{"name":"Yoichi Sunagawa"},{"name":"Yasufumi Katanasaka"},{"name":"Toru Kato"},{"name":"Yoichi Ajiro"},{"name":"Maki Komiyama"},{"name":"Masaharu Akao"},{"name":"Hajime Yamakage"},{"name":"Noriko Satoh-Asahara"},{"name":"Hiromichi Wada"},{"name":"池田 康将"},{"name":"Tatsuya Morimoto"},{"name":"Koji Hasegawa"}]},"event":{"en":"28th International Society of Cardiovascular Pharmacotherapy Annual Scientific Meeting","ja":"28th International Society of Cardiovascular Pharmacotherapy Annual Scientific Meeting"},"publication_date":"2023-11-24","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:3, {"insert":{"user_id":"B000241782","type":"presentations","id":"45529575"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404875","label":"url"}],"presentation_title":{"en":"Clinical trial for high-absorption curcumin, targeting p300-histonetransferase activity, in patients with hypertensive heart disease","ja":"Clinical trial for high-absorption curcumin, targeting p300-histonetransferase activity, in patients with hypertensive heart disease"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Yoichi Sunagawa"},{"name":"Yasufumi Katanasaka"},{"name":"Maki Komiyama"},{"name":"Masaharu Akao"},{"name":"Akihiro Yasoda"},{"name":"Hajime Yamakage"},{"name":"Noriko Satoh-Asahara"},{"name":"Hiromichi Wad"},{"name":"Ikeda Yasumasa"},{"name":"Tatsuya Morimoto"},{"name":"Koji Hasegawa"}],"ja":[{"name":"船本 雅文"},{"name":"Yoichi Sunagawa"},{"name":"Yasufumi Katanasaka"},{"name":"Maki Komiyama"},{"name":"Masaharu Akao"},{"name":"Akihiro Yasoda"},{"name":"Hajime Yamakage"},{"name":"Noriko Satoh-Asahara"},{"name":"Hiromichi Wad"},{"name":"池田 康将"},{"name":"Tatsuya Morimoto"},{"name":"Koji Hasegawa"}]},"event":{"en":"27TH ASIAN PACIFIC SOCIETY OF CARDIOLOGY CONGRESS","ja":"27TH ASIAN PACIFIC SOCIETY OF CARDIOLOGY CONGRESS"},"publication_date":"2023-07-13","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:4, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376246"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366407","label":"url"}],"presentation_title":{"en":"Development of therapeutic agents using drug discovery tools and large-scale medical information","ja":"Development of therapeutic agents using drug discovery tools and large-scale medical information"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Niimura Takahiro"},{"name":"Goda Mitsuhiro"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Fukushima Keijo"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"新村 貴博"},{"name":"合田 光寛"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"福島 圭穣"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"FIP2019","ja":"FIP2019"},"publication_date":"2019-09","languages":["eng"],"location":{"en":"Abu Dhabi","ja":"Abu Dhabi"},"is_international_presentation":true},"priority":"input_data"} line:5, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376247"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351098","label":"url"}],"presentation_title":{"en":"Utilizing Real-World Big Data in the Search for New Renoprotective Drugs","ja":"Utilizing Real-World Big Data in the Search for New Renoprotective Drugs"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Joint Hypertension 2018 Scientific Sessions","ja":"Joint Hypertension 2018 Scientific Sessions"},"publication_date":"2018-09-07","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:6, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376248"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=356785","label":"url"}],"presentation_title":{"en":"Drug repositioning for post cardiopulmonary resuscitation syndrome using large-scale medical claims","ja":"Drug repositioning for post cardiopulmonary resuscitation syndrome using large-scale medical claims"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Niimura Takahiro"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"Niimura Takahiro"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"FIP2018","ja":"FIP2018"},"publication_date":"2018-09-02","languages":["eng"],"location":{"en":"グラスゴー","ja":"グラスゴー"},"is_international_presentation":true},"priority":"input_data"} line:7, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=342033","label":"url"}],"presentation_title":{"en":"Renoprotective effects of edoxaban, a factor Xa inhibitor","ja":"Renoprotective effects of edoxaban, a factor Xa inhibitor"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"18th World Congress of Basic and Clinical Pharmacology","ja":"18th World Congress of Basic and Clinical Pharmacology"},"publication_date":"2018-07-03","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:8, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376249"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=354182","label":"url"}],"presentation_title":{"en":"The effect of quercetin on aortic aneurysms in mice","ja":"The effect of quercetin on aortic aneurysms in mice"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"suzuki kotoko"},{"name":"Horinouchi Yuya"},{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"鈴木 琴子"},{"name":"堀ノ内 裕也"},{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"},{"name":"池田 康将"}]},"event":{"en":"WCP2018","ja":"WCP2018"},"publication_date":"2018-07-02","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:9, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376250"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=354172","label":"url"}],"presentation_title":{"en":"Proton Pump Inhibitor Involves Abnormality of Iron Metabolism through Hepcidin Regulation","ja":"Proton Pump Inhibitor Involves Abnormality of Iron Metabolism through Hepcidin Regulation"},"presenters":{"en":[{"name":"濱野 裕章"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Zamami Yoshito"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"座間味 義人"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"event":{"en":"18th World Congress of Basic and Clinical Pharmacology","ja":"18th World Congress of Basic and Clinical Pharmacology"},"publication_date":"2018-07-02","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:10, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=342030","label":"url"}],"presentation_title":{"en":"Search for drugs that attenuate the anti tumor effect of bevacizumab using adverse event database","ja":"Search for drugs that attenuate the anti tumor effect of bevacizumab using adverse event database"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"18th World Congress of Basic and Clinical Pharmacology","ja":"18th World Congress of Basic and Clinical Pharmacology"},"publication_date":"2018-07-02","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:11, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=343016","label":"url"}],"presentation_title":{"en":"The effect of iron on skeletal muscle atrophy in chronic kidney disease.","ja":"The effect of iron on skeletal muscle atrophy in chronic kidney disease."},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Free Radical Biology and Medicine","ja":"Free Radical Biology and Medicine"},"publication_date":"2017-12","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:12, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=329364","label":"url"}],"presentation_title":{"en":"Indoxyl Sulfate Disturbs Normal Iron Metabolism via Hepcidin Upregulation in Chronic Kidney Disease","ja":"Indoxyl Sulfate Disturbs Normal Iron Metabolism via Hepcidin Upregulation in Chronic Kidney Disease"},"presenters":{"en":[{"name":"Hamano hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"ASN Kidney Week 2017 Annual Meeting","ja":"ASN Kidney Week 2017 Annual Meeting"},"publication_date":"2017-11-03","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:13, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327188","label":"url"}],"presentation_title":{"en":"Direct activated factor X inhibitor attenuates renal fibrosis on unilateral ureteral obstruction-induced nephrotoxicity.","ja":"Direct activated factor X inhibitor attenuates renal fibrosis on unilateral ureteral obstruction-induced nephrotoxicity."},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"53rd Congress of the European Societies of Toxicology (eurotox2017)","ja":"53rd Congress of the European Societies of Toxicology (eurotox2017)"},"publication_date":"2017-09","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:14, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327179","label":"url"}],"presentation_title":{"en":"FACTOR XA INHIBITOR ATTENUATES RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION","ja":"FACTOR XA INHIBITOR ATTENUATES RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"THE 13TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS(EACPT2017)","ja":"THE 13TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS(EACPT2017)"},"publication_date":"2017-06-25","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:15, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327178","label":"url"}],"presentation_title":{"en":"NITROSONIFEDIPINE, A NOVEL ANTIOXIDANT, AMELIORATES NEUROLOGICALSYMPTOMS AND PROLONGS THE SURVIVAL IN A MALIGNANT STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS","ja":"NITROSONIFEDIPINE, A NOVEL ANTIOXIDANT, AMELIORATES NEUROLOGICALSYMPTOMS AND PROLONGS THE SURVIVAL IN A MALIGNANT STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"田淵 正樹"},{"name":"Imanishi Masaki"},{"name":"Takata Mai"},{"name":"Sairyo Eriko"},{"name":"Zamami Yoshito"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"田淵 正樹"},{"name":"今西 正樹"},{"name":"高田 真衣"},{"name":"西良 恵理子"},{"name":"座間味 義人"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"27th European Meeting on Hypertension and Cardiovascular Protection","ja":"27th European Meeting on Hypertension and Cardiovascular Protection"},"publication_date":"2017-06-19","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:16, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327176","label":"url"}],"presentation_title":{"en":"THE EFFECTS OF FEBUXOSTAT ON ANGIOTENSIN II-INDUCED VASCULAR REMODELING","ja":"THE EFFECTS OF FEBUXOSTAT ON ANGIOTENSIN II-INDUCED VASCULAR REMODELING"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tanaka Kyohei"},{"name":"Ikutoh Raiki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"田中 恭平"},{"name":"生藤 来希"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"27th European Meeting on Hypertension and Cardiovascular Protection","ja":"27th European Meeting on Hypertension and Cardiovascular Protection"},"publication_date":"2017-06-18","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:17, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325802","label":"url"}],"presentation_title":{"en":"IRON RESTRICTION PREVENTS RENAL TUBULOINTERSTITIAL INJURY INDUCED BY ALBUMIN OVERLOAD IN MICE","ja":"IRON RESTRICTION PREVENTS RENAL TUBULOINTERSTITIAL INJURY INDUCED BY ALBUMIN OVERLOAD IN MICE"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"玉置 俊晃"}]},"event":{"en":"54th ERA-EDTA Congress","ja":"54th ERA-EDTA Congress"},"publication_date":"2017-06-05","languages":["eng"],"location":{"en":"Madrid","ja":"Madrid"},"is_international_presentation":true},"priority":"input_data"} line:18, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325801","label":"url"}],"presentation_title":{"en":"DIRECT FACTOR XA INHIBITOR PREVENTS RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION","ja":"DIRECT FACTOR XA INHIBITOR PREVENTS RENAL INTERSTITIAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTION"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"玉置 俊晃"}]},"event":{"en":"54th ERA-EDTA Congress","ja":"54th ERA-EDTA Congress"},"publication_date":"2017-06-04","languages":["eng"],"location":{"en":"Madrid","ja":"Madrid"},"is_international_presentation":true},"priority":"input_data"} line:19, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=328958","label":"url"}],"presentation_title":{"en":"Fragrance of aromatic oil from peels of Citrus sudachi causes adipose browning and ameliorates glucose and lipid metabolism","ja":"Fragrance of aromatic oil from peels of Citrus sudachi causes adipose browning and ameliorates glucose and lipid metabolism"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Keisuke Fukuta"},{"name":"Rie Takahashi"},{"name":"Kana Umemoto"},{"name":"Hiroko Okuno"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"Keisuke Fukuta"},{"name":"Rie Takahashi"},{"name":"Kana Umemoto"},{"name":"Hiroko Okuno"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"EMBO workshop","ja":"EMBO workshop"},"publication_date":"2017-05-24","languages":["eng"],"location":{"en":"Sitges, Spain","ja":"Sitges, Spain"},"is_international_presentation":true},"priority":"input_data"} line:20, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325803","label":"url"}],"presentation_title":{"en":"Indoxyl Sulfate Involves Abnormality of Iron Metabolism through Hepcidin Regulation","ja":"Indoxyl Sulfate Involves Abnormality of Iron Metabolism through Hepcidin Regulation"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"Watanabe Hiroaki"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Experimental Bioogy 2017","ja":"Experimental Bioogy 2017"},"publication_date":"2017-04-23","languages":["eng"],"location":{"en":"Chicago","ja":"Chicago"},"is_international_presentation":true},"priority":"input_data"} line:21, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333195","label":"url"}],"presentation_title":{"en":"A limonene-derivative from Sudachi peel activates sirt1 and improves lipid and glucose metabolism in high fat diet-fed mice.","ja":"A limonene-derivative from Sudachi peel activates sirt1 and improves lipid and glucose metabolism in high fat diet-fed mice."},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Haruna Aihara"},{"name":"Wenting Xu"},{"name":"Meina Jin"},{"name":"Yosuke Tomida"},{"name":"Tomomi Yamaoka"},{"name":"Tanaka Naonobu"},{"name":"Ikeda Yasumasa"},{"name":"Shigenaga Akira"},{"name":"Otaka Akira"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"土屋 浩一郎"},{"name":"Haruna Aihara"},{"name":"Wenting Xu"},{"name":"Meina Jin"},{"name":"Yosuke Tomida"},{"name":"Tomomi Yamaoka"},{"name":"田中 直伸"},{"name":"池田 康将"},{"name":"重永 章"},{"name":"大髙 章"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"欧州糖尿病学会","ja":"欧州糖尿病学会"},"publication_date":"2016-12-16","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:22, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327145","label":"url"}],"presentation_title":{"en":"Disruption of hypoxia-inducible factor-1a deteriorates renal ischemia-reperfusion injury through dysregulation of Kv2.2-induced apoptosis in tubules.","ja":"Disruption of hypoxia-inducible factor-1a deteriorates renal ischemia-reperfusion injury through dysregulation of Kv2.2-induced apoptosis in tubules."},"presenters":{"en":[{"name":"Kazuma Ota"},{"name":"Kihira Yoshitaka"},{"name":"Reina Kishibuchi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Kazuma Ota"},{"name":"木平 孝高"},{"name":"Reina Kishibuchi"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"ASN KIDNEY WEEK 2016","ja":"ASN KIDNEY WEEK 2016"},"publication_date":"2016-11-19","languages":["eng"],"location":{"en":"Chicago","ja":"Chicago"},"is_international_presentation":true},"priority":"input_data"} line:23, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327928","label":"url"}],"presentation_title":{"en":"(Pro)renin receptor-mediated ERK1/2 and Wnt signaling pathway in crescent glomerulonephritis.","ja":"(Pro)renin receptor-mediated ERK1/2 and Wnt signaling pathway in crescent glomerulonephritis."},"presenters":{"en":[{"name":"Urushihara Maki"},{"name":"Nagai T"},{"name":"Kondo Shuji"},{"name":"Tamaki Toshiaki"},{"name":"Ikeda Yasumasa"},{"name":"Kagami Shoji"}],"ja":[{"name":"漆原 真樹"},{"name":"Nagai T"},{"name":"近藤 秀治"},{"name":"玉置 俊晃"},{"name":"池田 康将"},{"name":"香美 祥二"}]},"event":{"en":"Kidney Week 2016","ja":"Kidney Week 2016"},"publication_date":"2016-11","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:24, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327819","label":"url"}],"presentation_title":{"en":"Search for a preventative therapy for Bevacizumab-induced hypertension using the drug repositioning approach","ja":"Search for a preventative therapy for Bevacizumab-induced hypertension using the drug repositioning approach"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Marin Mitsui"},{"name":"Hiroshi Moriguchi"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Hiromu Kawasaki"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"Marin Mitsui"},{"name":"Hiroshi Moriguchi"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"Hiromu Kawasaki"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"7th Scientific Meeting of Asian Society for Vascular Biology","ja":"7th Scientific Meeting of Asian Society for Vascular Biology"},"publication_date":"2016-10-27","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:25, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326752","label":"url"}],"presentation_title":{"en":"Topical Application of Nitrosonifedipine, a Novel Free Radical Scavenger, Ameliorate the Ischemic Skin Flap Necrosis","ja":"Topical Application of Nitrosonifedipine, a Novel Free Radical Scavenger, Ameliorate the Ischemic Skin Flap Necrosis"},"presenters":{"en":[{"name":"Fukunaga Yutaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Hashimoto Ichiro"}],"ja":[{"name":"福永 豊"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"橋本 一郎"}]},"event":{"en":"Plastic Surgery THE MEETING 2016","ja":"Plastic Surgery THE MEETING 2016"},"publication_date":"2016-09-24","languages":["eng"],"location":{"en":"Los Angeles","ja":"Los Angeles"},"is_international_presentation":true},"priority":"input_data"} line:26, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=317865","label":"url"}],"presentation_title":{"en":"Pleiotropic Effects of Pitavastatin against Vascular Stress in eNOS-deficient Mice","ja":"Pleiotropic Effects of Pitavastatin against Vascular Stress in eNOS-deficient Mice"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Abe Masahiro"}],"ja":[{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"安倍 正博"}]},"event":{"en":"The 10th Congress of the Asian-Pacific Society of Atherosclerosis and Vascular Diseases","ja":"The 10th Congress of the Asian-Pacific Society of Atherosclerosis and Vascular Diseases"},"publication_date":"2016-07-15","languages":["eng"],"location":{"en":"Tokyo","ja":"Tokyo"},"is_international_presentation":true},"priority":"input_data"} line:27, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326022","label":"url"}],"presentation_title":{"en":"The effects of pitavastatin, a lipid-lowering agent, against aortic dissection model mice induced by L-NAME, a nitric oxide synthase inhibitor.","ja":"The effects of pitavastatin, a lipid-lowering agent, against aortic dissection model mice induced by L-NAME, a nitric oxide synthase inhibitor."},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan.","ja":"The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan."},"publication_date":"2016-05-19","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:28, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326019","label":"url"}],"presentation_title":{"en":"The new insight of iron on tissue damage in metabolic disorders.","ja":"The new insight of iron on tissue damage in metabolic disorders."},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"玉置 俊晃"}]},"event":{"en":"The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan.","ja":"The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide/16th Annual Scientific Meeting of the Nitric Oxide Society of Japan."},"publication_date":"2016-05-19","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:29, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333157","label":"url"}],"presentation_title":{"en":"Dietary nitrite ameliorates glucose tolerance and hyperlipidemia in diet-induced obesity rats.","ja":"Dietary nitrite ameliorates glucose tolerance and hyperlipidemia in diet-induced obesity rats."},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Miyamoto Licht"},{"name":"Yosuke Tomida"},{"name":"Megumi Yamane"},{"name":"Katsunori Tsuda"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"宮本 理人"},{"name":"Yosuke Tomida"},{"name":"Megumi Yamane"},{"name":"Katsunori Tsuda"},{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"The 16th Annual Scientific Meeting of the Nitric Oxide Society of Japan / The 9th Internatinal Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide. (Seindai, Japan) 2016.5","ja":"The 16th Annual Scientific Meeting of the Nitric Oxide Society of Japan / The 9th Internatinal Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide. (Seindai, Japan) 2016.5"},"publication_date":"2016-05","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:30, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=310546","label":"url"}],"presentation_title":{"en":"The Involvement of Iron Supplementation on Erythropoietin Expression","ja":"The Involvement of Iron Supplementation on Erythropoietin Expression"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Oshima Keisuke"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"大島 啓亮"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Experimental Biology 2016","ja":"Experimental Biology 2016"},"publication_date":"2016-04-05","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:31, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201802264623612812","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333199","label":"url"}],"presentation_title":{"en":"スダチ果皮からの抗メタボリックシンドローム活性を有する物質の同定","ja":"スダチ果皮からの抗メタボリックシンドローム活性を有する物質の同定"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"粟飯原 遥奈"},{"name":"許文 てい"},{"name":"ジン 美娜"},{"name":"冨田 洋介"},{"name":"山岡 朋美"},{"name":"Tanaka Naonobu"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"粟飯原 遥奈"},{"name":"許文 てい"},{"name":"ジン 美娜"},{"name":"冨田 洋介"},{"name":"山岡 朋美"},{"name":"田中 直伸"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"Journal of the The Japan Diabetes Society","ja":"糖尿病"},"publication_date":"2016","languages":["jpn"],"promoter":{"en":"Japan Diabetes Society","ja":"社団法人 日本糖尿病学会"},"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":true},"priority":"input_data"} line:32, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333156","label":"url"}],"presentation_title":{"en":"11th IDF-WPR Congress 2016 & 8th AASD Scientific MeetingPosterEessentialoil fromsudachipealimprovesglucoseandlipidmetabolism","ja":"11th IDF-WPR Congress 2016 & 8th AASD Scientific MeetingPosterEessentialoil fromsudachipealimprovesglucoseandlipidmetabolism"},"presenters":{"en":[{"name":"Keisuke FUKUTA"},{"name":"Miyamoto Licht"},{"name":"Rie TAKAHASHI"},{"name":"Tamaki Toshiaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"Keisuke FUKUTA"},{"name":"宮本 理人"},{"name":"Rie TAKAHASHI"},{"name":"玉置 俊晃"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"publication_date":"2016","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:33, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=319264","label":"url"}],"presentation_title":{"en":"Dietary nitrite ameliorates glucose tolerance and hyperlipidemia in diet-induced obese rats","ja":"Dietary nitrite ameliorates glucose tolerance and hyperlipidemia in diet-induced obese rats"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Tsuchihashi Yuki"},{"name":"Tomida Yosuke"},{"name":"Yamane Megumi"},{"name":"Takenokuma Kazuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"Tsuchihashi Yuki"},{"name":"Tomida Yosuke"},{"name":"Yamane Megumi"},{"name":"Takenokuma Kazuya"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"The 6th International Conference on Food Factors","ja":"The 6th International Conference on Food Factors"},"publication_date":"2015-11-22","languages":["eng"],"location":{"en":"Seoul","ja":"Seoul"},"is_international_presentation":true},"priority":"input_data"} line:34, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=302608","label":"url"}],"presentation_title":{"en":"Bilirubin Enhances Ischimia-induced Angiogenesis Through Akt-eNOS-Dependent Signaling Pathway","ja":"Bilirubin Enhances Ischimia-induced Angiogenesis Through Akt-eNOS-Dependent Signaling Pathway"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Hirofumi Hamano"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Hirofumi Hamano"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association Scientific Sessions 2015","ja":"American Heart Association Scientific Sessions 2015"},"publication_date":"2015-11-10","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:35, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=319084","label":"url"}],"presentation_title":{"en":"リモネン誘導体によるsirt1活性化を介した脂質低下作用","ja":"リモネン誘導体によるsirt1活性化を介した脂質低下作用"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"粟飯原 遥奈"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"冨田 洋介"},{"name":"山岡 朋美"},{"name":"Tanaka Naonobu"},{"name":"Ikeda Yasumasa"},{"name":"Shigenaga Akira"},{"name":"Otaka Akira"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"粟飯原 遥奈"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"冨田 洋介"},{"name":"山岡 朋美"},{"name":"田中 直伸"},{"name":"池田 康将"},{"name":"重永 章"},{"name":"大髙 章"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本肥満学会,アジアオセアニア糖尿病学会","ja":"日本肥満学会,アジアオセアニア糖尿病学会"},"publication_date":"2015-10-02","location":{"en":"Nagoya","ja":"名古屋"},"is_international_presentation":true},"priority":"input_data"} line:36, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=319072","label":"url"}],"presentation_title":{"en":"Limonene-derivative Ameliorates Lipid Profiles by Upregulation of Sirt1 Activity and Expression in Cultured Cells and High Fat Diet-Fed Mice","ja":"Limonene-derivative Ameliorates Lipid Profiles by Upregulation of Sirt1 Activity and Expression in Cultured Cells and High Fat Diet-Fed Mice"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Aihara Haruna"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"Tomida Yosuke"},{"name":"Yamaoka Tomomi"},{"name":"Tanaka Naonobu"},{"name":"Ikeda Yasumasa"},{"name":"Shigenaga Akira"},{"name":"Otaka Akira"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"Aihara Haruna"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"Tomida Yosuke"},{"name":"Yamaoka Tomomi"},{"name":"田中 直伸"},{"name":"池田 康将"},{"name":"重永 章"},{"name":"大髙 章"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"American diabetes association","ja":"American diabetes association"},"publication_date":"2015-06-05","languages":["eng"],"location":{"en":"Boston","ja":"Boston"},"is_international_presentation":true},"priority":"input_data"} line:37, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=295193","label":"url"}],"presentation_title":{"en":"Novel aortic dissection model by pharmacologically-induced endothelial dysfunction","ja":"Novel aortic dissection model by pharmacologically-induced endothelial dysfunction"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Hiroki Toya"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"Hiroki Toya"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"17th International Congress on Atherosclerosis 2015","ja":"17th International Congress on Atherosclerosis 2015"},"publication_date":"2015-05-24","languages":["eng"],"location":{"en":"Amsterdam","ja":"Amsterdam"},"is_international_presentation":true},"priority":"input_data"} line:38, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=293235","label":"url"}],"presentation_title":{"en":"The Effects of Bilirubin on Angiogenesis in Mice with Hindlimb Ischemia","ja":"The Effects of Bilirubin on Angiogenesis in Mice with Hindlimb Ischemia"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Kanai Yusuke"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"金井 佑亮"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Experimental Biology 2015","ja":"Experimental Biology 2015"},"publication_date":"2015-03-29","languages":["eng"],"location":{"en":"Boston","ja":"Boston"},"is_international_presentation":true},"priority":"input_data"} line:39, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287104","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine ameliorates the progression of aortic aneurysms by exerting antioxidative effects","ja":"Nitrosonifedipine ameliorates the progression of aortic aneurysms by exerting antioxidative effects"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Yusuke Kohara"},{"name":"Takumi Sakurada"},{"name":"Hiroki Toya"},{"name":"Yutaka Iki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"Yusuke Kohara"},{"name":"Takumi Sakurada"},{"name":"Hiroki Toya"},{"name":"Yutaka Iki"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"ESC Congress 2014","ja":"ESC Congress 2014"},"publication_date":"2014-09-01","languages":["eng"],"location":{"en":"Barcelona","ja":"Barcelona"},"is_international_presentation":true},"priority":"input_data"} line:40, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=279279","label":"url"}],"presentation_title":{"en":"Ferritin induces IL-1 production through inflammasome activation via NF-B-dependent manner in macrophages","ja":"Ferritin induces IL-1 production through inflammasome activation via NF-B-dependent manner in macrophages"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Imao Mizuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"今尾 瑞季"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Experimental Biology 2014","ja":"Experimental Biology 2014"},"publication_date":"2014-04-28","languages":["eng"],"location":{"en":"San Diego","ja":"San Diego"},"is_international_presentation":true},"priority":"input_data"} line:41, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274315","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine prevents the progression of diabetic nephropathy via attenuating the expression of intrarenal angiotensinogen and oxidative stress","ja":"Nitrosonifedipine prevents the progression of diabetic nephropathy via attenuating the expression of intrarenal angiotensinogen and oxidative stress"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Yamano Noriko"},{"name":"Kobori Hiroyuki"},{"name":"Urushihara Maki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"山野 範子"},{"name":"Kobori Hiroyuki"},{"name":"漆原 真樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"High Blood Pressure Research 2013 Scientific Sessions","ja":"High Blood Pressure Research 2013 Scientific Sessions"},"publication_date":"2013-09-12","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:42, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=272065","label":"url"}],"presentation_title":{"en":"Androgen receptor promotes angiogenesis in response to ischemia via activation of VEGF receptor signaling pathway regardless of sex","ja":"Androgen receptor promotes angiogenesis in response to ischemia via activation of VEGF receptor signaling pathway regardless of sex"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"松本 俊夫"}]},"event":{"en":"ENDO 2013;The Endocrine Society's 95th Annual Meeting & Expo","ja":"ENDO 2013;The Endocrine Society's 95th Annual Meeting & Expo"},"publication_date":"2013-06-17","languages":["eng"],"location":{"en":"San Francisco","ja":"San Francisco"},"is_international_presentation":true},"priority":"input_data"} line:43, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274314","label":"url"}],"presentation_title":{"en":"Rho-kinase is involved in inorganic phosphate-induced ERK1/2 activation in vascular smooth muscle cells","ja":"Rho-kinase is involved in inorganic phosphate-induced ERK1/2 activation in vascular smooth muscle cells"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Doi Sakiko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土肥 紗希子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"World Biotechnology Congress 2013","ja":"World Biotechnology Congress 2013"},"publication_date":"2013-06-06","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:44, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274339","label":"url"}],"presentation_title":{"en":"The effect of dietary iron restriction against diabetic nephropathy in db/db mice","ja":"The effect of dietary iron restriction against diabetic nephropathy in db/db mice"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Experimental Biology 2013","ja":"Experimental Biology 2013"},"publication_date":"2013-04","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:45, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=264291","label":"url"}],"presentation_title":{"en":"Androgen Receptor is Required for Cellular Survival and Angiogenesis in Response to Ischemia via Activation of VEGF Receptor Signaling Pathway Regardless of Sex","ja":"Androgen Receptor is Required for Cellular Survival and Angiogenesis in Response to Ischemia via Activation of VEGF Receptor Signaling Pathway Regardless of Sex"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"American Heart Association Scientific Session 2012","ja":"American Heart Association Scientific Session 2012"},"publication_date":"2012-11-07","languages":["eng"],"promoter":{"en":"American Heart Association","ja":"American Heart Association"},"is_international_presentation":true},"priority":"input_data"} line:46, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259220","label":"url"}],"presentation_title":{"en":"Heparin Cofactor II Promotes Angiogenesis in Response to Ischemic Hindlimb via an AMPK-eNOS-dependent Manner","ja":"Heparin Cofactor II Promotes Angiogenesis in Response to Ischemic Hindlimb via an AMPK-eNOS-dependent Manner"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Sata Masataka"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"佐田 政隆"},{"name":"赤池 雅史"},{"name":"松本 俊夫"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association Scientific Sessions 2012","ja":"American Heart Association Scientific Sessions 2012"},"publication_date":"2012-11-07","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:47, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259219","label":"url"}],"presentation_title":{"en":"Deficiency of Hypoxia Inducible Factor-1a in SM-22a-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation","ja":"Deficiency of Hypoxia Inducible Factor-1a in SM-22a-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation"},"presenters":{"en":[{"name":"Maeda Yusaku"},{"name":"Tomita Shuhei"},{"name":"Murakami Masaki"},{"name":"Kurobe Hirotsugu"},{"name":"Imanishi Masaki"},{"name":"Yoshida Yasushi"},{"name":"Hirata Yoichiro"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Kitagawa Tetsuya"},{"name":"Sata Masataka"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"前田 悠作"},{"name":"冨田 修平"},{"name":"村上 正樹"},{"name":"黒部 裕嗣"},{"name":"今西 正樹"},{"name":"Yoshida Yasushi"},{"name":"Hirata Yoichiro"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"北川 哲也"},{"name":"佐田 政隆"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association Scientific Sessions 2012","ja":"American Heart Association Scientific Sessions 2012"},"publication_date":"2012-11-05","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:48, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259218","label":"url"}],"presentation_title":{"en":"Iron Restriction Prevents the Progression of Diabetic Nephropathy in db/db Mice","ja":"Iron Restriction Prevents the Progression of Diabetic Nephropathy in db/db Mice"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association Scientific Sessions 2012","ja":"American Heart Association Scientific Sessions 2012"},"publication_date":"2012-11-04","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:49, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259217","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible Factor-1a in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media","ja":"Hypoxia-inducible Factor-1a in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association Scientific Sessions 2012","ja":"American Heart Association Scientific Sessions 2012"},"publication_date":"2012-11-04","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:50, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=299876","label":"url"}],"presentation_title":{"en":"Eicosapentaenoic acid administration ameliorates cardiac remodeling in humans and protects against Ang II-induced cardiovascular remodeling via attenuation of oxidative stress in mice.","ja":"Eicosapentaenoic acid administration ameliorates cardiac remodeling in humans and protects against Ang II-induced cardiovascular remodeling via attenuation of oxidative stress in mice."},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"American Heart Association Scientific Sessions 2012","ja":"American Heart Association Scientific Sessions 2012"},"publication_date":"2012-11-03","languages":["eng"],"location":{"en":"ロサンゼルス","ja":"ロサンゼルス"},"is_international_presentation":true},"priority":"input_data"} line:51, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259216","label":"url"}],"presentation_title":{"en":"Protective Effects of Iron-Restricted Food against Diabetic Nephropathy in db/db Mice","ja":"Protective Effects of Iron-Restricted Food against Diabetic Nephropathy in db/db Mice"},"presenters":{"en":[{"name":"Enomoto Hideaki"},{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"榎本 英明"},{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association High Blood Pressure Research 2012","ja":"American Heart Association High Blood Pressure Research 2012"},"publication_date":"2012-09-20","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:52, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259215","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice","ja":"Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice"},"presenters":{"en":[{"name":"Fujii Shoko"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Nuno Asami"},{"name":"Suzuki Yuta"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"藤井 聖子"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"布 あさ美"},{"name":"鈴木 雄太"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association High Blood Pressure Research 2012","ja":"American Heart Association High Blood Pressure Research 2012"},"publication_date":"2012-09-20","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:53, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=256311","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible factor-1a deficiency in smooth muscle cell attenuates angiotensin -induced vascular remodeling in mice","ja":"Hypoxia-inducible factor-1a deficiency in smooth muscle cell attenuates angiotensin -induced vascular remodeling in mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"ISOTT (International Society on Oxygen Transport to Tissue) 2012","ja":"ISOTT (International Society on Oxygen Transport to Tissue) 2012"},"publication_date":"2012-08","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:54, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259213","label":"url"}],"presentation_title":{"en":"Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice","ja":"Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice"},"presenters":{"en":[{"name":"Sakurada Takumi"},{"name":"Ishizawa Keisuke"},{"name":"Fujii Shoko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Nuno Asami"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"櫻田 巧"},{"name":"石澤 啓介"},{"name":"藤井 聖子"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"布 あさ美"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Experimental Biology 2012","ja":"Experimental Biology 2012"},"publication_date":"2012-04-23","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:55, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266800","label":"url"}],"presentation_title":{"en":"Heparin cofactor II, a serine protease inhibitor, is a novel regulating factor for glucose metabolism and albuminuria","ja":"Heparin cofactor II, a serine protease inhibitor, is a novel regulating factor for glucose metabolism and albuminuria"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"Keystone Symposia: Complications of Diabetes: Mechanisms of Injury and Failure of Repair","ja":"Keystone Symposia: Complications of Diabetes: Mechanisms of Injury and Failure of Repair"},"publication_date":"2012-03-13","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:56, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246533","label":"url"}],"presentation_title":{"en":"Iron restriction prevents progression of diabetic nephropathy","ja":"Iron restriction prevents progression of diabetic nephropathy"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"KEYSTONE SYMPOSIA 40th ANNIVERSARY 1972-2012 Complications of Diabetes: Mechanisms of Injury and Failure of Repair","ja":"KEYSTONE SYMPOSIA 40th ANNIVERSARY 1972-2012 Complications of Diabetes: Mechanisms of Injury and Failure of Repair"},"publication_date":"2012-03-13","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:57, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332513","label":"url"}],"presentation_title":{"en":"Deficiency of Hypoxia Inducible Factor-1 in SM-22-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation","ja":"Deficiency of Hypoxia Inducible Factor-1 in SM-22-Expressing Bone Marrow-Derived Cells Alleviates Neointimal Formation Following Wire-induced Vascular Formation"},"presenters":{"en":[{"name":"Maeda Yusaku"},{"name":"Tomita Shuhei"},{"name":"Murakami Masaki"},{"name":"Kurobe Hirotsugu"},{"name":"Imanishi Masaki"},{"name":"Yoshida Yasushi"},{"name":"Hirata Yoichiro"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Kitagawa Tetsuya"},{"name":"Sata Masataka"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Maeda Yusaku"},{"name":"冨田 修平"},{"name":"Murakami Masaki"},{"name":"黒部 裕嗣"},{"name":"今西 正樹"},{"name":"Yoshida Yasushi"},{"name":"Hirata Yoichiro"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"北川 哲也"},{"name":"佐田 政隆"},{"name":"玉置 俊晃"}]},"event":{"en":"AHA SCIENTIFIC SESSIONS 2012","ja":"AHA SCIENTIFIC SESSIONS 2012"},"publication_date":"2012","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:58, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332511","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible Factor-1 in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media","ja":"Hypoxia-inducible Factor-1 in Vascular Smooth Muscle Cells Regulates Angiotensin -induced Vascular Remodeling and AT1 Receptor Expression in Mouse Aortic Media"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"AHA SCIENTIFIC SESSIONS 2012","ja":"AHA SCIENTIFIC SESSIONS 2012"},"publication_date":"2012","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:59, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332509","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice","ja":"Nitrosonifedipine, a Photodegradation Product of Nifedipine, Prevents the Progression of Diabetic Nephropathy in Type II Diabetic Mice"},"presenters":{"en":[{"name":"Shoko Fujii"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Nuno Asami"},{"name":"Suzuki Yuta"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Shoko Fujii"},{"name":"石澤 啓介"},{"name":"Sakurada Takumi"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"Nuno Asami"},{"name":"Suzuki Yuta"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"HIGH BLOOD PRESSURE RESEARCH 2012 SCIENTIFIC SESSIONS","ja":"HIGH BLOOD PRESSURE RESEARCH 2012 SCIENTIFIC SESSIONS"},"publication_date":"2012","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:60, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332508","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible factor-1 deficiency in smooth muscle cell attenuates angiotensin II-induced vascular remodeling in mice","ja":"Hypoxia-inducible factor-1 deficiency in smooth muscle cell attenuates angiotensin II-induced vascular remodeling in mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"The International Society on Oxygen Transport to Tissue 2012","ja":"The International Society on Oxygen Transport to Tissue 2012"},"publication_date":"2012","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:61, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332506","label":"url"}],"presentation_title":{"en":"Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice","ja":"Effects of nitrosonifedipine, a photodegradation product of nifedipine, on diabetic nephropathy in type II diabetic mice"},"presenters":{"en":[{"name":"Sakurada Takumi"},{"name":"Ishizawa Keisuke"},{"name":"Fujii Shoko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Nuno Asami"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Sakurada Takumi"},{"name":"石澤 啓介"},{"name":"Fujii Shoko"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"Nuno Asami"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"Experimental Biology 2012","ja":"Experimental Biology 2012"},"publication_date":"2012","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:62, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=244263","label":"url"}],"presentation_title":{"en":"Smooth Muscle Cell-Specific Hypoxia-Inducible Factor-1a Deficiency Attenuates Angiotensin II-Induced Vascular Remodeling in Mice","ja":"Smooth Muscle Cell-Specific Hypoxia-Inducible Factor-1a Deficiency Attenuates Angiotensin II-Induced Vascular Remodeling in Mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"AHA scientific sessions 2011","ja":"AHA scientific sessions 2011"},"publication_date":"2011-11-15","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:63, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241579","label":"url"}],"presentation_title":{"en":"Inhibition of Adipocyte Hypertrophy by Deferoxiamine Diabetic KKAy mice","ja":"Inhibition of Adipocyte Hypertrophy by Deferoxiamine Diabetic KKAy mice"},"presenters":{"en":[{"name":"Tajima Soichiro"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Tsuchiya Koichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Tajima Soichiro"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"土屋 浩一郎"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions","ja":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions"},"publication_date":"2011-09","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:64, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241577","label":"url"}],"presentation_title":{"en":"Glucose Metabolism of Adipocytes is Regulated by Basic Fibroblast Growth Factor via Hypoxia-inducible Factor-1a","ja":"Glucose Metabolism of Adipocytes is Regulated by Basic Fibroblast Growth Factor via Hypoxia-inducible Factor-1a"},"presenters":{"en":[{"name":"Yamaguchi Kazuyuki"},{"name":"Kihira Yoshitaka"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山口 一行"},{"name":"木平 孝高"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions","ja":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions"},"publication_date":"2011-09","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:65, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241576","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible Factor-1a Deficiency in Smooth Muscle Cells Suppresses Angiotensin -induced Vascular Remodeling in Mice","ja":"Hypoxia-inducible Factor-1a Deficiency in Smooth Muscle Cells Suppresses Angiotensin -induced Vascular Remodeling in Mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions","ja":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions"},"publication_date":"2011-09","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:66, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241575","label":"url"}],"presentation_title":{"en":"Heparin Cofactor Promotes Angiogenesis via an AMPK-eNOS Signaling Pathway","ja":"Heparin Cofactor Promotes Angiogenesis via an AMPK-eNOS Signaling Pathway"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tomita Shuhei"},{"name":"Sata Masataka"},{"name":"Akaike Masashi"},{"name":"Kato Shigeki"},{"name":"Matsumoto Toshio"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"冨田 修平"},{"name":"佐田 政隆"},{"name":"赤池 雅史"},{"name":"Kato Shigeki"},{"name":"松本 俊夫"},{"name":"玉置 俊晃"}]},"event":{"en":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions","ja":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions"},"publication_date":"2011-09","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:67, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241574","label":"url"}],"presentation_title":{"en":"Angiotensin -induced Vascular Remodeling is Improved by Nitrosonifedipine, a Possible New Class Drug Against Oxidative Stress","ja":"Angiotensin -induced Vascular Remodeling is Improved by Nitrosonifedipine, a Possible New Class Drug Against Oxidative Stress"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Fujii Shoko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"藤井 聖子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions","ja":"High Blood Pressure Research Scientific Sessions 2011 Scientific Sessions"},"publication_date":"2011-09","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:68, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242118","label":"url"}],"presentation_title":{"en":"Nitorosonifedipine is a new class drug to improves angiotensin II-induced vascular remodeling","ja":"Nitorosonifedipine is a new class drug to improves angiotensin II-induced vascular remodeling"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Fujii Shoko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"藤井 聖子"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"European Society of Cardiology Congress 2011","ja":"European Society of Cardiology Congress 2011"},"publication_date":"2011-08-28","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:69, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231987","label":"url"}],"presentation_title":{"en":"Characterization on mice lacking HIF1a gene in renal ischemia-reperfusion injury","ja":"Characterization on mice lacking HIF1a gene in renal ischemia-reperfusion injury"},"presenters":{"en":[{"name":"Tomita Shuhei"},{"name":"Kihira Yoshitaka"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"冨田 修平"},{"name":"木平 孝高"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"ISOTT (International Society on Oxygen Transport to Tissue) 2011","ja":"ISOTT (International Society on Oxygen Transport to Tissue) 2011"},"publication_date":"2011-07-25","languages":["eng"],"location":{"en":"Washington, D.C.","ja":"Washington, D.C."},"is_international_presentation":true},"priority":"input_data"} line:70, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=238678","label":"url"}],"presentation_title":{"en":"Estrogen action on iron metabolism","ja":"Estrogen action on iron metabolism"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"ENDO 2011: The 93rd Annual Meeting & Expo","ja":"ENDO 2011: The 93rd Annual Meeting & Expo"},"publication_date":"2011-06-04","languages":["eng"],"location":{"en":"Boston","ja":"Boston"},"is_international_presentation":true},"priority":"input_data"} line:71, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230754","label":"url"}],"presentation_title":{"en":"Increment intracellular labile iron enhances Angiotensin-induced intracellular adhesion molecule-1 (ICAM-1) expression in human glomerular endothelial cells","ja":"Increment intracellular labile iron enhances Angiotensin-induced intracellular adhesion molecule-1 (ICAM-1) expression in human glomerular endothelial cells"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tajima Soichiro"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kondo Shuji"},{"name":"Kagami Shoji"},{"name":"Tomita Shuhei"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"Tajima Soichiro"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"近藤 秀治"},{"name":"香美 祥二"},{"name":"冨田 修平"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"World congress of Nephrology 2011","ja":"World congress of Nephrology 2011"},"publication_date":"2011-04","languages":["eng"],"location":{"en":"Vancouver","ja":"Vancouver"},"is_international_presentation":true},"priority":"input_data"} line:72, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332504","label":"url"}],"presentation_title":{"en":"Smooth Muscle Cell-specific Hypoxia-inducible Factor-1a Deficiency Attenuates Angiotensin II-induced Vascular Remodeling In Mice","ja":"Smooth Muscle Cell-specific Hypoxia-inducible Factor-1a Deficiency Attenuates Angiotensin II-induced Vascular Remodeling In Mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"AHA SCIENTIFIC SESSIONS 2011","ja":"AHA SCIENTIFIC SESSIONS 2011"},"publication_date":"2011","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:73, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332503","label":"url"}],"presentation_title":{"en":"Angiotensin II-induced Vascular Remodeling Is Improved By Nitrosonifedipine, A Possible New Class Drug","ja":"Angiotensin II-induced Vascular Remodeling Is Improved By Nitrosonifedipine, A Possible New Class Drug"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Takumi Sakurada"},{"name":"Imanishi Masaki"},{"name":"Shoko Fujii"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"Takumi Sakurada"},{"name":"今西 正樹"},{"name":"Shoko Fujii"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS","ja":"HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS"},"publication_date":"2011","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:74, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332502","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible Factor-1 Deficiency In Smooth Muscle Cells Suppresses Angiotensin II-induced Vascular Remodeling In Mice","ja":"Hypoxia-inducible Factor-1 Deficiency In Smooth Muscle Cells Suppresses Angiotensin II-induced Vascular Remodeling In Mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS","ja":"HIGH BLOOD PRESSURE RESEARCH 2011 SCIENTIFIC SESSIONS"},"publication_date":"2011","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:75, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332501","label":"url"}],"presentation_title":{"en":"Nitorosonifedipine is a new class drug to improve angiotensin II-induced vascular remodeling","ja":"Nitorosonifedipine is a new class drug to improve angiotensin II-induced vascular remodeling"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Fujii Shoko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"Sakurada Takumi"},{"name":"今西 正樹"},{"name":"Fujii Shoko"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"ESC Congress 2011","ja":"ESC Congress 2011"},"publication_date":"2011","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:76, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=332500","label":"url"}],"presentation_title":{"en":"INCREMENT INTRACELLULAR LABILE IRON ENHANCES ANGIOTENSIN II-INDUCED INTRACELLULAR ADHESION MOLECULE-1 (ICAM-1) EXPRESSION IN HUMAN GLOMERULAR ENDOTHELIAL CELLS","ja":"INCREMENT INTRACELLULAR LABILE IRON ENHANCES ANGIOTENSIN II-INDUCED INTRACELLULAR ADHESION MOLECULE-1 (ICAM-1) EXPRESSION IN HUMAN GLOMERULAR ENDOTHELIAL CELLS"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tajima Soichiro"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kondo Shuji"},{"name":"Kagami Shoji"},{"name":"Tomita Shuhei"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"Tajima Soichiro"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"近藤 秀治"},{"name":"香美 祥二"},{"name":"冨田 修平"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"World Congress of Nephrology 2011","ja":"World Congress of Nephrology 2011"},"publication_date":"2011","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:77, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230755","label":"url"}],"presentation_title":{"en":"Global gene expression analyses in renal ischemia-reperfusion injury (IRI) from mice lucking Hif-1a gene","ja":"Global gene expression analyses in renal ischemia-reperfusion injury (IRI) from mice lucking Hif-1a gene"},"presenters":{"en":[{"name":"Tamaki Toshiaki"},{"name":"Yamaguchi Kunihisa"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Kondo Shuji"},{"name":"Kagami Shoji"},{"name":"Tomita Shuhei"}],"ja":[{"name":"玉置 俊晃"},{"name":"山口 邦久"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"近藤 秀治"},{"name":"香美 祥二"},{"name":"冨田 修平"}]},"event":{"en":"ASN RENAL WEEK 2010 EXHIBIT","ja":"ASN RENAL WEEK 2010 EXHIBIT"},"publication_date":"2010-11","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:78, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242133","label":"url"}],"presentation_title":{"en":"Antioxidant effects of photodegradation product of nifedipine","ja":"Antioxidant effects of photodegradation product of nifedipine"},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"Tajima Soichiro"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Yoshimura Yoshiyuki"},{"name":"Tomita Shuhei"},{"name":"Hamano Shuichi"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"Tajima Soichiro"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"吉村 好之"},{"name":"冨田 修平"},{"name":"濱野 修一"},{"name":"玉置 俊晃"}]},"event":{"en":"17th Annual Meeting of the Society for Free Radical Biology and Medicine (SFRBM 2010)","ja":"17th Annual Meeting of the Society for Free Radical Biology and Medicine (SFRBM 2010)"},"publication_date":"2010-11-20","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:79, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300298","label":"url"}],"presentation_title":{"en":"Androgen receptor is essential for cell survival and neovascularization after ischemia.","ja":"Androgen receptor is essential for cell survival and neovascularization after ischemia."},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"American Heart Association Scientific Sessions 2010","ja":"American Heart Association Scientific Sessions 2010"},"publication_date":"2010-11-13","languages":["eng"],"location":{"en":"Chicago","ja":"Chicago"},"is_international_presentation":true},"priority":"input_data"} line:80, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233258","label":"url"}],"presentation_title":{"en":"Androgen Receptor is Essential for Cell Survival and Neovascularization after Ischemia.","ja":"Androgen Receptor is Essential for Cell Survival and Neovascularization after Ischemia."},"presenters":{"en":[{"name":"Yoshida, S."},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Ise, T."},{"name":"Ueda Yuka"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto, T."}],"ja":[{"name":"Yoshida, S."},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"Ise, T."},{"name":"上田 由佳"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"Matsumoto, T."}]},"event":{"en":"American Heart Association 2010","ja":"American Heart Association 2010"},"publication_date":"2010-11","languages":["eng"],"location":{"en":"Chicago","ja":"Chicago"},"is_international_presentation":true},"priority":"input_data"} line:81, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230756","label":"url"}],"presentation_title":{"en":"Endothelial-targeted hypoxia-inducible factor-1b (HIF-1b) loss-of function alleviates the monocrotaline-induced pulmonary hypertension in mice","ja":"Endothelial-targeted hypoxia-inducible factor-1b (HIF-1b) loss-of function alleviates the monocrotaline-induced pulmonary hypertension in mice"},"presenters":{"en":[{"name":"Tomita Shuhei"},{"name":"Urata Masahisa"},{"name":"Fukuhara Yayoi"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Kitagawa Tetsuya"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"冨田 修平"},{"name":"Urata Masahisa"},{"name":"福原 弥生"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"北川 哲也"},{"name":"玉置 俊晃"}]},"event":{"en":"American Heart Association Scientific Sessions 2010","ja":"American Heart Association Scientific Sessions 2010"},"publication_date":"2010-11","languages":["eng"],"location":{"en":"Chicago","ja":"Chicago"},"is_international_presentation":true},"priority":"input_data"} line:82, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=215129","label":"url"}],"presentation_title":{"en":"Nitroso-nifedipine is a new class drug to protect endothelial function for overcoming organ damage","ja":"Nitroso-nifedipine is a new class drug to protect endothelial function for overcoming organ damage"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Fukuhara Yayoi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"福原 弥生"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"International Society of Hypertension 2010","ja":"International Society of Hypertension 2010"},"publication_date":"2010-09-28","languages":["eng"],"location":{"en":"Vancouver","ja":"Vancouver"},"is_international_presentation":true},"priority":"input_data"} line:83, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300291","label":"url"}],"presentation_title":{"en":"Androgen receptor participants in ischemia-induced tissue damage and angiogenesis in male mice","ja":"Androgen receptor participants in ischemia-induced tissue damage and angiogenesis in male mice"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"23rd Scientific Meeting of the International Society of Hypertension Vancouver","ja":"23rd Scientific Meeting of the International Society of Hypertension Vancouver"},"publication_date":"2010-09-26","languages":["eng"],"location":{"en":"Vancouver","ja":"Vancouver"},"is_international_presentation":true},"priority":"input_data"} line:84, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231194","label":"url"}],"presentation_title":{"en":"IRON DERIVATION AMELIORATES GLUCOSE TOLERANCE THROUGH REDUCTION OF OXIDATIVE STRESS AND INFLAMMATION IN DIABETIC KKAY MICE","ja":"IRON DERIVATION AMELIORATES GLUCOSE TOLERANCE THROUGH REDUCTION OF OXIDATIVE STRESS AND INFLAMMATION IN DIABETIC KKAY MICE"},"presenters":{"en":[{"name":"Tajima Soichiro"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Tsuchiya Koichiro"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Tajima Soichiro"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"土屋 浩一郎"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"2010 American Physiological Society Conference Inflammation, Immunity and Cardiovascular Disease","ja":"2010 American Physiological Society Conference Inflammation, Immunity and Cardiovascular Disease"},"publication_date":"2010-08","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:85, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=213734","label":"url"}],"presentation_title":{"en":"Basic fibroblast growth factor upregulates hypoxia inducible factor 1 and glucose transporter 1 in adipose cells","ja":"Basic fibroblast growth factor upregulates hypoxia inducible factor 1 and glucose transporter 1 in adipose cells"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"The 16th World Congress of Basic and Clinical Pharmacology (WorldPharma 2010)","ja":"The 16th World Congress of Basic and Clinical Pharmacology (WorldPharma 2010)"},"publication_date":"2010-07-17","languages":["eng"],"location":{"en":"Copenhagen","ja":"Copenhagen"},"is_international_presentation":true},"priority":"input_data"} line:86, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231196","label":"url"}],"presentation_title":{"en":"Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway","ja":"Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway"},"presenters":{"en":[{"name":"Tajima Soichiro"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"Tajima Soichiro"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"The 6th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide","ja":"The 6th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide"},"publication_date":"2010-06","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:87, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242134","label":"url"}],"presentation_title":{"en":"Metabolism of quercetin in vivo and its protective effect against cardiovascular diseases","ja":"Metabolism of quercetin in vivo and its protective effect against cardiovascular diseases"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"2nd International On-Board Symposium: Human Health, Energy and Environment","ja":"2nd International On-Board Symposium: Human Health, Energy and Environment"},"publication_date":"2010-05","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:88, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300287","label":"url"}],"presentation_title":{"en":"Plasma heparin cofactor II activity is an independent determinant for cardiac remodeling in subjects with cardiovascular risk factors","ja":"Plasma heparin cofactor II activity is an independent determinant for cardiac remodeling in subjects with cardiovascular risk factors"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Ryoko Uemoto"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Yoichiro Hirata"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"Ryoko Uemoto"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Yoichiro Hirata"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"20th International Society for Heart Research(ISHR)","ja":"20th International Society for Heart Research(ISHR)"},"publication_date":"2010-05-13","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:89, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300267","label":"url"}],"presentation_title":{"en":"Heparin cofactor II is a novel anticardiac remodeling factor against angiotensin II excess","ja":"Heparin cofactor II is a novel anticardiac remodeling factor against angiotensin II excess"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ise Takayuki"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Ryoko Uemoto"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Yoichiro Hirata"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"伊勢 孝之"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"Ryoko Uemoto"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Yoichiro Hirata"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"20th International Society for Heart Research(ISHR)","ja":"20th International Society for Heart Research(ISHR)"},"publication_date":"2010-05-13","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:90, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300264","label":"url"}],"presentation_title":{"en":"Exacerbation of cell survival and impaired neovascularization after hindlimb ischemia in male androgen receptor null mice","ja":"Exacerbation of cell survival and impaired neovascularization after hindlimb ischemia in male androgen receptor null mice"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"20th International Society for Heart Research(ISHR)","ja":"20th International Society for Heart Research(ISHR)"},"publication_date":"2010-05-13","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:91, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233211","label":"url"}],"presentation_title":{"en":"Exacerbation of Cell Survival and Impaired Neovascularization after Hindlimb Ischemia in Male Androgen Receptor Null Mice.","ja":"Exacerbation of Cell Survival and Impaired Neovascularization after Hindlimb Ischemia in Male Androgen Receptor Null Mice."},"presenters":{"en":[{"name":"Yoshida, S."},{"name":"Aihara, K."},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase, T."},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto, T."}],"ja":[{"name":"Yoshida, S."},{"name":"Aihara, K."},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"Iwase, T."},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"Matsumoto, T."}]},"event":{"en":"XXth World Congress of the International Society for Heart Research 2010","ja":"XXth World Congress of the International Society for Heart Research 2010"},"publication_date":"2010-05","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:92, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233209","label":"url"}],"presentation_title":{"en":"Glucocorticoid causes vascular endothelial dysfunction through activation of mineralocorticoid receptor.","ja":"Glucocorticoid causes vascular endothelial dysfunction through activation of mineralocorticoid receptor."},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Ishikawa, K."},{"name":"Yoshida, S."},{"name":"Ueda Yuka"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Matsumoto, T."},{"name":"Sata Masataka"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"Ishikawa, K."},{"name":"Yoshida, S."},{"name":"上田 由佳"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Matsumoto, T."},{"name":"佐田 政隆"}]},"event":{"en":"XXth World Congress of the International Society for Heart Research 2010","ja":"XXth World Congress of the International Society for Heart Research 2010"},"publication_date":"2010-05","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:93, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233208","label":"url"}],"presentation_title":{"en":"Plasma heparin cofactor II activity is an independent determinant for cardiac remodeling in subjects with cardiovascular risk factors.","ja":"Plasma heparin cofactor II activity is an independent determinant for cardiac remodeling in subjects with cardiovascular risk factors."},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ise, T."},{"name":"Ueda Yuka"},{"name":"Yoshida, S."},{"name":"Ikeda Yasumasa"},{"name":"Uemoto, R."},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Hirata, Y."},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto, T."}],"ja":[{"name":"粟飯原 賢一"},{"name":"Ise, T."},{"name":"上田 由佳"},{"name":"Yoshida, S."},{"name":"池田 康将"},{"name":"Uemoto, R."},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Hirata, Y."},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"Matsumoto, T."}]},"event":{"en":"XXth World Congress of the International Society for Heart Research 2010","ja":"XXth World Congress of the International Society for Heart Research 2010"},"publication_date":"2010-05","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:94, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233198","label":"url"}],"presentation_title":{"en":"Heparin cofactor II is a novel anticardiac remodeling factoragainst angiotensin II excess.","ja":"Heparin cofactor II is a novel anticardiac remodeling factoragainst angiotensin II excess."},"presenters":{"en":[{"name":"Ueda Yuka"},{"name":"Aihara Ken-ichi"},{"name":"Ise, T."},{"name":"Yoshida, S."},{"name":"Ikeda Yasumasa"},{"name":"Uemoto, R."},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Hirata, Y."},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto, T."}],"ja":[{"name":"上田 由佳"},{"name":"粟飯原 賢一"},{"name":"Ise, T."},{"name":"Yoshida, S."},{"name":"池田 康将"},{"name":"Uemoto, R."},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Hirata, Y."},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"Matsumoto, T."}]},"event":{"en":"XXth World Congress of the International Society for Heart Research 2010","ja":"XXth World Congress of the International Society for Heart Research 2010"},"publication_date":"2010-05","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:95, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231197","label":"url"}],"presentation_title":{"en":"Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway","ja":"Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"XX World Congress ISHR 2010 KYOTO","ja":"XX World Congress ISHR 2010 KYOTO"},"publication_date":"2010-05","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:96, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231198","label":"url"}],"presentation_title":{"en":"Amelioration of acute tubular necrosis in ischemic acute renal failure was impaired in mice lucking hypoxia inducible factor-1 gene","ja":"Amelioration of acute tubular necrosis in ischemic acute renal failure was impaired in mice lucking hypoxia inducible factor-1 gene"},"presenters":{"en":[{"name":"Tamaki Toshiaki"},{"name":"Yamaguchi Kunihisa"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"}],"ja":[{"name":"玉置 俊晃"},{"name":"山口 邦久"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"}]},"event":{"en":"ISN (International Society of Nephrology) nexus sympojium 2010","ja":"ISN (International Society of Nephrology) nexus sympojium 2010"},"publication_date":"2010-04","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:97, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=237936","label":"url"}],"presentation_title":{"en":"Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway","ja":"Deferoxamine, an iron chelator, promotes angiogenesis after ischemic hind limb through Akt-eNOS-dependent pathway"},"presenters":{"en":[{"name":"Tajima Souichiro"},{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"Tajima Souichiro"},{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"The 6th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide","ja":"The 6th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide"},"publication_date":"2010-04-15","languages":["eng"],"location":{"en":"Kyoto","ja":"Kyoto"},"is_international_presentation":true},"priority":"input_data"} line:98, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242151","label":"url"}],"presentation_title":{"en":"Effect of Angiotensin II on the intracellular labile iron concentration in HGECs","ja":"Effect of Angiotensin II on the intracellular labile iron concentration in HGECs"},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Tajima Soichiro"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yoshimura Yoshiyuki"},{"name":"Hamano Shuichi"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"Tajima Soichiro"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"吉村 好之"},{"name":"濱野 修一"},{"name":"玉置 俊晃"}]},"event":{"en":"16th Annual Meeting of the Society for Free Radical Biology and Medicine (SFRBM 2009)","ja":"16th Annual Meeting of the Society for Free Radical Biology and Medicine (SFRBM 2009)"},"publication_date":"2009-11-19","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:99, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300420","label":"url"}],"presentation_title":{"en":"Dehydroepiandrosterone sulfate is an endothelial function-independent protective factor against carotid atherosclerosis.","ja":"Dehydroepiandrosterone sulfate is an endothelial function-independent protective factor against carotid atherosclerosis."},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Kiyoe Kurahashi"},{"name":"Endo Itsuro"},{"name":"Fujinaka Yuichi"},{"name":"Susumu Nishio"},{"name":"Yamada Hirotsugu"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"八木 秀介"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"Kiyoe Kurahashi"},{"name":"遠藤 逸朗"},{"name":"藤中 雄一"},{"name":"Susumu Nishio"},{"name":"山田 博胤"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"Scientific Sessions 2009, American Heart Association","ja":"Scientific Sessions 2009, American Heart Association"},"publication_date":"2009-11-14","languages":["eng"],"location":{"en":"Florida","ja":"Florida"},"is_international_presentation":true},"priority":"input_data"} line:100, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376251"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=363569","label":"url"}],"presentation_title":{"en":"LKB1 gene in myocytes plays a critical role to regulate the coordinated cardiac growth and capillary development","ja":"LKB1 gene in myocytes plays a critical role to regulate the coordinated cardiac growth and capillary development"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Sato Kaori"},{"name":"Pimentel David"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Sam Flora"},{"name":"Tamaki Toshiaki"},{"name":"Walsh Kenneth"}],"ja":[{"name":"池田 康将"},{"name":"Sato Kaori"},{"name":"Pimentel David"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"Sam Flora"},{"name":"玉置 俊晃"},{"name":"Walsh Kenneth"}]},"event":{"en":"American Heart Association Scientific Sessions 2009","ja":"American Heart Association Scientific Sessions 2009"},"publication_date":"2009-11","languages":["eng"],"location":{"en":"Orlando","ja":"Orlando"},"is_international_presentation":true},"priority":"input_data"} line:101, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300365","label":"url"}],"presentation_title":{"en":"Pitavastatin, an HMG-CoA Reductase Inhibitor, Prevents Glucocorticoid-induced Hypertension through Ameliorating Imbalance of Oxidative Stress and Nitric Oxide Production","ja":"Pitavastatin, an HMG-CoA Reductase Inhibitor, Prevents Glucocorticoid-induced Hypertension through Ameliorating Imbalance of Oxidative Stress and Nitric Oxide Production"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Kazue Ishikawa"},{"name":"Yuka Sumitomo"},{"name":"Yoshida Sumiko"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"Kazue Ishikawa"},{"name":"Yuka Sumitomo"},{"name":"吉田 守美子"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"event":{"en":"American Heart Association Sessions 2008","ja":"American Heart Association Sessions 2008"},"publication_date":"2008-11-08","languages":["eng"],"location":{"en":"New Orleans","ja":"New Orleans"},"is_international_presentation":true},"priority":"input_data"} line:102, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300358","label":"url"}],"presentation_title":{"en":"Pitavastatin, an HMG-CoA Reductase Inhibitor, Prevents Glucocorticoid-induced Hypertension through Increased Nitric Oxide Production as a Pleiotropic Effect on Vascular Endothelial Cells","ja":"Pitavastatin, an HMG-CoA Reductase Inhibitor, Prevents Glucocorticoid-induced Hypertension through Increased Nitric Oxide Production as a Pleiotropic Effect on Vascular Endothelial Cells"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"Kazue Ishikawa"},{"name":"Ise Takayuki"},{"name":"Yoshida Sumiko"},{"name":"Yuka Sumitomo"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"八木 秀介"},{"name":"池田 康将"},{"name":"Kazue Ishikawa"},{"name":"伊勢 孝之"},{"name":"吉田 守美子"},{"name":"Yuka Sumitomo"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"}]},"event":{"en":"Hypertension 2008 18th Scientific Meeting of the European Society of Hypertension 22nd Scientific Meeting of the International Society of Hypertension","ja":"Hypertension 2008 18th Scientific Meeting of the European Society of Hypertension 22nd Scientific Meeting of the International Society of Hypertension"},"publication_date":"2008-06-14","languages":["eng"],"location":{"en":"Berlin","ja":"Berlin"},"is_international_presentation":true},"priority":"input_data"} line:103, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267208","label":"url"}],"presentation_title":{"en":"Heparin Cofactor II Deficiency Causes Accelerated Thrombosis and Atherosclerosis in Mice","ja":"Heparin Cofactor II Deficiency Causes Accelerated Thrombosis and Atherosclerosis in Mice"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Yuka Sumitomo"},{"name":"Sata Masataka"},{"name":"Shigeaki Kato"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Yuka Sumitomo"},{"name":"佐田 政隆"},{"name":"Shigeaki Kato"},{"name":"松本 俊夫"}]},"event":{"en":"American Heart Association Scientific Sessions 2006, Chicago, USA","ja":"American Heart Association Scientific Sessions 2006, Chicago, USA"},"publication_date":"2006-11","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:104, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267285","label":"url"}],"presentation_title":{"en":"Valsartan Enhances Nitric Oxide Bioavailability and Reduces Arterial Stiffness in Patients with Essential Hypertension","ja":"Valsartan Enhances Nitric Oxide Bioavailability and Reduces Arterial Stiffness in Patients with Essential Hypertension"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Mitsunori Fujimura"},{"name":"Shunji Hashizume"},{"name":"Iwase Takashi"},{"name":"Yagi Shusuke"},{"name":"Akira Kondo"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"Mitsunori Fujimura"},{"name":"Shunji Hashizume"},{"name":"岩瀬 俊"},{"name":"八木 秀介"},{"name":"Akira Kondo"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"The 21st Scientific Meeting of the International Society of Hypertension, 2006, Fukuoka, Japan","ja":"The 21st Scientific Meeting of the International Society of Hypertension, 2006, Fukuoka, Japan"},"publication_date":"2006-10","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:105, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267210","label":"url"}],"presentation_title":{"en":"Plasma Heparin Cofactor II Activity is a Predictor for Incidence of Peripheral Arterial Disease in Patients with Cardiovascular Risk Factors","ja":"Plasma Heparin Cofactor II Activity is a Predictor for Incidence of Peripheral Arterial Disease in Patients with Cardiovascular Risk Factors"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Kurobe Hirotsugu"},{"name":"Mitsunori Fujimura"},{"name":"Yagi Shusuke"},{"name":"Shunji Hashizume"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Nobuyuki Takamori"},{"name":"Kitagawa Tetsuya"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"黒部 裕嗣"},{"name":"Mitsunori Fujimura"},{"name":"八木 秀介"},{"name":"Shunji Hashizume"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"Nobuyuki Takamori"},{"name":"北川 哲也"},{"name":"松本 俊夫"}]},"event":{"en":"XIV International Symposium on Atherosclerosis, 2006 Rome, Italy","ja":"XIV International Symposium on Atherosclerosis, 2006 Rome, Italy"},"publication_date":"2006-06","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:106, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267209","label":"url"}],"presentation_title":{"en":"Argatroban, a synthetic thrombin antagonist, can reduce insulin resistance though thrombin inactivation in the db/db mouse model of type 2 diabetes mellitus","ja":"Argatroban, a synthetic thrombin antagonist, can reduce insulin resistance though thrombin inactivation in the db/db mouse model of type 2 diabetes mellitus"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Masatomo Mihara"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Matsushita Takaya"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Shunji Hashizume"},{"name":"Mitsunori Fujimura"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"Masatomo Mihara"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"松下 隆哉"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"Shunji Hashizume"},{"name":"Mitsunori Fujimura"},{"name":"松本 俊夫"}]},"event":{"en":"XIV International Symposium on Atherosclerosis, 2006 Rome, Italy","ja":"XIV International Symposium on Atherosclerosis, 2006 Rome, Italy"},"publication_date":"2006-06","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:107, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266585","label":"url"}],"presentation_title":{"en":"Heparin cofactor II is inversely related to the severity of carotid atherosclerosis","ja":"Heparin cofactor II is inversely related to the severity of carotid atherosclerosis"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Nobuyuki Takamori"},{"name":"Kanagawa Yasuhiko"},{"name":"Akaike Masashi"},{"name":"Mitsunori Fujimura"},{"name":"Tomonori Yoshida"},{"name":"Shunji Hashizume"},{"name":"Midori Kato"},{"name":"Ikeda Yasumasa"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"Nobuyuki Takamori"},{"name":"金川 泰彦"},{"name":"赤池 雅史"},{"name":"Mitsunori Fujimura"},{"name":"Tomonori Yoshida"},{"name":"Shunji Hashizume"},{"name":"Midori Kato"},{"name":"池田 康将"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"American Heart Association, Scientific Sessions 2003 Orland Florida USA","ja":"American Heart Association, Scientific Sessions 2003 Orland Florida USA"},"publication_date":"2003-11","languages":["eng"],"is_international_presentation":true},"priority":"input_data"} line:108, {"insert":{"user_id":"B000241782","type":"presentations","id":"46023528"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406118","label":"url"}],"presentation_title":{"en":"糖尿病合併心不全に対する漢方薬五苓散の抑制効果","ja":"糖尿病合併心不全に対する漢方薬五苓散の抑制効果"},"presenters":{"en":[{"name":"Hirose Shunji"},{"name":"Funamoto Masafumi"},{"name":"Yasuda Hidenori"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"広瀬 駿次"},{"name":"船本 雅文"},{"name":"安田 英紀"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第144回日本薬理学会近畿部会","ja":"第144回日本薬理学会近畿部会"},"publication_date":"2024-03-20","is_international_presentation":false},"priority":"input_data"} line:109, {"insert":{"user_id":"B000241782","type":"presentations","id":"46023529"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406117","label":"url"}],"presentation_title":{"en":"低重力下における消化管と骨髄における鉄動態の検討","ja":"低重力下における消化管と骨髄における鉄動態の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"},{"name":"Yasuda Hidenori"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"船本 雅文"},{"name":"安田 英紀"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"第144回日本薬理学会近畿部会","ja":"第144回日本薬理学会近畿部会"},"publication_date":"2024-03-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:110, {"insert":{"user_id":"B000241782","type":"presentations","id":"45587319"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=405070","label":"url"}],"presentation_title":{"en":"ドキソルビシン誘導性心毒性を抑制する漢方薬と作用機序の解明","ja":"ドキソルビシン誘導性心毒性を抑制する漢方薬と作用機序の解明"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Muramatsu Amiho"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"村松 明美穂"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":"第53回日本心脈管作動物質学会","ja":"第53回日本心脈管作動物質学会"},"publication_date":"2024-02-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:111, {"insert":{"user_id":"B000241782","type":"presentations","id":"46023530"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406188","label":"url"}],"presentation_title":{"en":"TCGAがんゲノムビッグデータによる膵がん悪性化因子の網羅的探索と腫瘍血管新生の寄与についての検討","ja":"TCGAがんゲノムビッグデータによる膵がん悪性化因子の網羅的探索と腫瘍血管新生の寄与についての検討"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Inoue Takahisa"},{"name":"Fukushima Keijo"},{"name":"Yoshiki GOMI"},{"name":"Yoshiya HIGAKI"},{"name":"Nojima Masataka"},{"name":"Kondoh Kohsuke"},{"name":"Takaya SAWAMURA"},{"name":"Yamashita Ryosuke"},{"name":"Nakayama Ryo"},{"name":"Tsunematsu Honoka"},{"name":"Kohei GOTOH"},{"name":"Miyamoto Licht"},{"name":"Funamoto Masafumi"},{"name":"Fujino Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"今西 正樹"},{"name":"井上 貴久"},{"name":"福島 圭穣"},{"name":"五味 義輝"},{"name":"檜垣 良也"},{"name":"野島 雅孝"},{"name":"近藤 宏祐"},{"name":"澤村 貴哉"},{"name":"山下 竜介"},{"name":"中山 涼"},{"name":"常松 保乃加"},{"name":"後藤 廣平"},{"name":"宮本 理人"},{"name":"船本 雅文"},{"name":"藤野 裕道"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第53回日本心脈管作動物質学会年会","ja":"第53回日本心脈管作動物質学会年会"},"publication_date":"2024-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:112, {"insert":{"user_id":"B000241782","type":"presentations","id":"44542750"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404777","label":"url"}],"presentation_title":{"en":"圧負荷心不全モデルマウスにおいて心収縮機能悪化をBRG1阻害剤 PFI-3は抑制した","ja":"圧負荷心不全モデルマウスにおいて心収縮機能悪化をBRG1阻害剤 PFI-3は抑制した"},"presenters":{"en":[{"name":"眞鍋 智弘"},{"name":"上原 渉"},{"name":"Funamoto Masafumi"},{"name":"山本 みずほ"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"浜辺 俊秀"},{"name":"川瀬 裕斗"},{"name":"鳴田 竜也"},{"name":"Ikeda Yasumasa"},{"name":"長谷川 浩二"},{"name":"森本 達也"}],"ja":[{"name":"眞鍋 智弘"},{"name":"上原 渉"},{"name":"船本 雅文"},{"name":"山本 みずほ"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"浜辺 俊秀"},{"name":"川瀬 裕斗"},{"name":"鳴田 竜也"},{"name":"池田 康将"},{"name":"長谷川 浩二"},{"name":"森本 達也"}]},"event":{"en":"第33回循環薬理学会","ja":"第33回循環薬理学会"},"publication_date":"2024-01-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:113, {"insert":{"user_id":"B000241782","type":"presentations","id":"44542751"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404775","label":"url"}],"presentation_title":{"en":"ドキソルビシン心毒性を抑制する簡保薬と作用機序の解明","ja":"ドキソルビシン心毒性を抑制する簡保薬と作用機序の解明"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Muramatsu Amiho"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"村松 明美穂"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":"第33回日本循環薬理学会","ja":"第33回日本循環薬理学会"},"publication_date":"2024-01-27","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:114, {"insert":{"user_id":"B000241782","type":"presentations","id":"44287793"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404363","label":"url"}],"presentation_title":{"en":"新規水溶性カンプトテシン誘導体,SN38-BGLによる,ヒト肺がん細胞移植モデルマウスにおける抗腫瘍効果と副作用の解析","ja":"新規水溶性カンプトテシン誘導体,SN38-BGLによる,ヒト肺がん細胞移植モデルマウスにおける抗腫瘍効果と副作用の解析"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Tsuchihashi Yuki"},{"name":"Abe Shinji"},{"name":"Izumi Toshihiro"},{"name":"Hatano Aya"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"土橋 有希"},{"name":"阿部 真治"},{"name":"和泉 俊尋"},{"name":"秦野 彩"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第97回日本薬理学会年会(神戸)","ja":"第97回日本薬理学会年会(神戸)"},"publication_date":"2023-12-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:115, {"insert":{"user_id":"B000241782","type":"presentations","id":"44287794"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404362","label":"url"}],"presentation_title":{"en":"慢性腎臓病に対する漢方薬五苓散の効果の検討","ja":"慢性腎臓病に対する漢方薬五苓散の効果の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aoi SUENAGA"},{"name":"Yasuyuki SETO"},{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"末永 あおい"},{"name":"瀬戸 靖幸"},{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"第97回日本薬理学会年会(神戸)","ja":"第97回日本薬理学会年会(神戸)"},"publication_date":"2023-12-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:116, {"insert":{"user_id":"B000241782","type":"presentations","id":"44287795"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404361","label":"url"}],"presentation_title":{"en":"漢方薬のドキソルビシン心毒性に対する効果の検討","ja":"漢方薬のドキソルビシン心毒性に対する効果の検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Muramatsu Amiho"},{"name":"Ueno Miyako"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"村松 明美穂"},{"name":"上野 実弥子"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":"第97回日本薬理学会年会(神戸)2023年12月16日","ja":"第97回日本薬理学会年会(神戸)2023年12月16日"},"publication_date":"2023-12-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:117, {"insert":{"user_id":"B000241782","type":"presentations","id":"44268481"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404327","label":"url"}],"presentation_title":{"en":"糖尿病性心筋症におけるエピジェネティック制御機構","ja":"糖尿病性心筋症におけるエピジェネティック制御機構"},"presenters":{"en":[{"name":"Hirose Shunji"},{"name":"Funamoto Masafumi"},{"name":"Muramatsu Amiho"},{"name":"Ueno Miyako"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"廣瀬 駿次"},{"name":"船本 雅文"},{"name":"村松 明美穂"},{"name":"上野 実弥子"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第97回日本薬理学会年会(神戸)","ja":"第97回日本薬理学会年会(神戸)"},"publication_date":"2023-12-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:118, {"insert":{"user_id":"B000241782","type":"presentations","id":"46023531"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406187","label":"url"}],"presentation_title":{"en":"藍含有成分はendothelin-1発現を制御して肺動脈血管リモデリングを形成させる","ja":"藍含有成分はendothelin-1発現を制御して肺動脈血管リモデリングを形成させる"},"presenters":{"en":[{"name":"Tsunematsu Honoka"},{"name":"Imanishi Masaki"},{"name":"Uemura Yuka"},{"name":"Yoshiya HIGAKI"},{"name":"Fukushima Keijo"},{"name":"Morisaki Miyu"},{"name":"Katsura Akari"},{"name":"Miyamoto Licht"},{"name":"Funamoto Masafumi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuneyama Koichi"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"常松 保乃加"},{"name":"今西 正樹"},{"name":"植村 宥香"},{"name":"檜垣 良也"},{"name":"福島 圭穣"},{"name":"森崎 実友"},{"name":"桂 明里"},{"name":"宮本 理人"},{"name":"船本 雅文"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"常山 幸一"},{"name":"土屋 浩一郎"}]},"event":{"en":"次世代を担う若手のための創薬・医療薬理シンポジウム2023","ja":"次世代を担う若手のための創薬・医療薬理シンポジウム2023"},"publication_date":"2023-08-25","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:119, {"insert":{"user_id":"B000241782","type":"presentations","id":"46023532"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406186","label":"url"}],"presentation_title":{"en":"PARP阻害剤は低酸素環境下において生じる5-FU治療効果の減弱を回復させる","ja":"PARP阻害剤は低酸素環境下において生じる5-FU治療効果の減弱を回復させる"},"presenters":{"en":[{"name":"Takaya SAWAMURA"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Yamashita Ryosuke"},{"name":"Kondoh Kohsuke"},{"name":"Nakayama Ryo"},{"name":"Yoshiki GOMI"},{"name":"Tsunematsu Honoka"},{"name":"Inoue Takahisa"},{"name":"Kohei GOTOH"},{"name":"Miyamoto Licht"},{"name":"Funamoto Masafumi"},{"name":"Fujino Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"澤村 貴哉"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"山下 竜介"},{"name":"近藤 宏祐"},{"name":"中山 涼"},{"name":"五味 義輝"},{"name":"常松 保乃加"},{"name":"井上 貴久"},{"name":"後藤 廣平"},{"name":"宮本 理人"},{"name":"船本 雅文"},{"name":"藤野 裕道"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"生体機能と創薬シンポジウム2023","ja":"生体機能と創薬シンポジウム2023"},"publication_date":"2023-08-24","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:120, {"insert":{"user_id":"B000241782","type":"presentations","id":"46023533"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406184","label":"url"}],"presentation_title":{"en":"亜硝酸塩が有するヒドロキシルラジカル消去活性の検討","ja":"亜硝酸塩が有するヒドロキシルラジカル消去活性の検討"},"presenters":{"en":[{"name":"Toyota Natsuki"},{"name":"Imanishi Masaki"},{"name":"Inoue Takahisa"},{"name":"Tsunematsu Honoka"},{"name":"Kohei GOTOH"},{"name":"Miyamoto Licht"},{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"豊田 菜月"},{"name":"今西 正樹"},{"name":"井上 貴久"},{"name":"常松 保乃加"},{"name":"後藤 廣平"},{"name":"宮本 理人"},{"name":"船本 雅文"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"生体機能と創薬シンポジウム2023","ja":"生体機能と創薬シンポジウム2023"},"publication_date":"2023-08-24","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:121, {"insert":{"user_id":"B000241782","type":"presentations","id":"46023534"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=406183","label":"url"}],"presentation_title":{"en":"TCGAがんゲノムビッグデータとGEOトランスクリプトームデータとの統合解析による膵がん治療標的候補遺伝子の探索","ja":"TCGAがんゲノムビッグデータとGEOトランスクリプトームデータとの統合解析による膵がん治療標的候補遺伝子の探索"},"presenters":{"en":[{"name":"Yoshiki GOMI"},{"name":"Imanishi Masaki"},{"name":"Inoue Takahisa"},{"name":"Fukushima Keijo"},{"name":"Yamashita Ryosuke"},{"name":"Nakayama Ryo"},{"name":"Nojima Masataka"},{"name":"Kondoh Kohsuke"},{"name":"Takaya SAWAMURA"},{"name":"Tsunematsu Honoka"},{"name":"Kohei GOTOH"},{"name":"Miyamoto Licht"},{"name":"Funamoto Masafumi"},{"name":"Fujino Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"五味 義輝"},{"name":"今西 正樹"},{"name":"井上 貴久"},{"name":"福島 圭穣"},{"name":"山下 竜介"},{"name":"中山 涼"},{"name":"野島 雅孝"},{"name":"近藤 宏祐"},{"name":"澤村 貴哉"},{"name":"常松 保乃加"},{"name":"後藤 廣平"},{"name":"宮本 理人"},{"name":"船本 雅文"},{"name":"藤野 裕道"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"生体機能と創薬シンポジウム2023","ja":"生体機能と創薬シンポジウム2023"},"publication_date":"2023-08-24","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:122, {"insert":{"user_id":"B000241782","type":"presentations","id":"44268482"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404321","label":"url"}],"presentation_title":{"en":"生命金属元素鉄の新たな役割と治療応用(教授就任記念講演)","ja":"生命金属元素鉄の新たな役割と治療応用(教授就任記念講演)"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"第267回徳島医学会学術集会","ja":"第267回徳島医学会学術集会"},"publication_date":"2023-08-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:123, {"insert":{"user_id":"B000241782","type":"presentations","id":"44268483"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404325","label":"url"}],"presentation_title":{"en":"ドキソルビシン心毒性に対する漢方薬効果の検討","ja":"ドキソルビシン心毒性に対する漢方薬効果の検討"},"presenters":{"en":[{"name":"Muramatsu Amiho"},{"name":"Funamoto Masafumi"},{"name":"Ueno Miyako"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"村松 明美穂"},{"name":"船本 雅文"},{"name":"上野 実弥子"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第7回黒潮カンファレンス(宮崎)","ja":"第7回黒潮カンファレンス(宮崎)"},"publication_date":"2023-07-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:124, {"insert":{"user_id":"B000241782","type":"presentations","id":"44268484"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404324","label":"url"}],"presentation_title":{"en":"病的心肥大と老化におけるマクロファージ鉄ストレスの役割の検討","ja":"病的心肥大と老化におけるマクロファージ鉄ストレスの役割の検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":",第7回黒潮カンファレンス(宮崎)","ja":",第7回黒潮カンファレンス(宮崎)"},"publication_date":"2023-07-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:125, {"insert":{"user_id":"B000241782","type":"presentations","id":"44268485"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404323","label":"url"}],"presentation_title":{"en":"黄連解毒湯を用いたcGAS/STING/IRF3経路を介したドキソルビシン誘導性心毒性に対する検討","ja":"黄連解毒湯を用いたcGAS/STING/IRF3経路を介したドキソルビシン誘導性心毒性に対する検討"},"presenters":{"en":[{"name":"Muramatsu Amiho"},{"name":"Funamoto Masafumi"},{"name":"上野 実弥子"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"村松 明美穂"},{"name":"船本 雅文"},{"name":"上野 実弥子"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第8回日本心血管協会(JCVA)学術集会(大分) 2023年6月10日","ja":"第8回日本心血管協会(JCVA)学術集会(大分) 2023年6月10日"},"publication_date":"2023-06-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:126, {"insert":{"user_id":"B000241782","type":"presentations","id":"44268486"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404322","label":"url"}],"presentation_title":{"en":"糖尿病性心筋症におけるエピジェネティックな老化制御機構の解明","ja":"糖尿病性心筋症におけるエピジェネティックな老化制御機構の解明"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Hirose Shunji"},{"name":"Muramatsu Amiho"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"廣瀬 駿次"},{"name":"村松 明美穂"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":"第8回日本心血管協会(JCVA)学術集会(大分)","ja":"第8回日本心血管協会(JCVA)学術集会(大分)"},"publication_date":"2023-06-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:127, {"insert":{"user_id":"B000241782","type":"presentations","id":"44268487"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=404326","label":"url"}],"presentation_title":{"en":"5-FUの膵がん細胞増殖抑制効果に対する低酸素―PARP活性化シグナルの役割","ja":"5-FUの膵がん細胞増殖抑制効果に対する低酸素―PARP活性化シグナルの役割"},"presenters":{"en":[{"name":"Kondoh Kohsuke"},{"name":"Imanishi Masaki"},{"name":"Yamashita Ryosuke"},{"name":"Fukushima Keijo"},{"name":"Nakayama Ryo"},{"name":"Tsunematsu Honoka"},{"name":"Inoue Takahisa"},{"name":"Kohei GOTOH"},{"name":"Miyamoto Licht"},{"name":"Funamoto Masafumi"},{"name":"Fujino Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"近藤 宏祐"},{"name":"今西 正樹"},{"name":"山下 竜介"},{"name":"福島 圭穣"},{"name":"中山 涼"},{"name":"常松 保乃加"},{"name":"井上 貴久"},{"name":"後藤 廣平"},{"name":"宮本 理人"},{"name":"船本 雅文"},{"name":"藤野 裕道"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第262回徳島医学会学術集会(徳島)","ja":"第262回徳島医学会学術集会(徳島)"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:128, {"insert":{"user_id":"B000241782","type":"presentations","id":"42249451"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395830","label":"url"}],"presentation_title":{"en":"慢性腎臓病に対する五苓散の効果","ja":"慢性腎臓病に対する五苓散の効果"},"presenters":{"en":[{"name":"Aoi SUENAGA"},{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"末永 あおい"},{"name":"船本 雅文"},{"name":"池田 康将"}]},"event":{"en":"第262回徳島医学会学術集会","ja":"第262回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:129, {"insert":{"user_id":"B000241782","type":"presentations","id":"42249452"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395829","label":"url"}],"presentation_title":{"en":"2型糖尿病による心筋症モデルマウスの検討","ja":"2型糖尿病による心筋症モデルマウスの検討"},"presenters":{"en":[{"name":"Hirose Shunji"},{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"廣瀬 駿次"},{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":"第262回徳島医学会学術集会","ja":"第262回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:130, {"insert":{"user_id":"B000241782","type":"presentations","id":"42249453"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395828","label":"url"}],"presentation_title":{"en":"黄連解毒湯を用いたドキソルビシン誘導性心毒性に対する検討","ja":"黄連解毒湯を用いたドキソルビシン誘導性心毒性に対する検討"},"presenters":{"en":[{"name":"Yasuyuki SETO"},{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"瀬戸 靖幸"},{"name":"船本 雅文"},{"name":"池田 康将"}]},"event":{"en":"第262回徳島医学会学術集会","ja":"第262回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:131, {"insert":{"user_id":"B000241782","type":"presentations","id":"42249454"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395827","label":"url"}],"presentation_title":{"en":"急性腎障害に対するマクロファージ鉄ストレスの役割の検討","ja":"急性腎障害に対するマクロファージ鉄ストレスの役割の検討"},"presenters":{"en":[{"name":"Itoh Tatsuki"},{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"伊藤 達紀"},{"name":"船本 雅文"},{"name":"池田 康将"}]},"event":{"en":"第262回徳島医学会学術集会","ja":"第262回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:132, {"insert":{"user_id":"B000241782","type":"presentations","id":"42249455"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=395826","label":"url"}],"presentation_title":{"en":"慢性腎臓病に対する五苓散の効果","ja":"慢性腎臓病に対する五苓散の効果"},"presenters":{"en":[{"name":"Aoi SUENAGA"},{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"末永 あおい"},{"name":"船本 雅文"},{"name":"池田 康将"}]},"event":{"en":"第262回徳島医学会学術集会","ja":"第262回徳島医学会学術集会"},"publication_date":"2023-02-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:133, {"insert":{"user_id":"B000241782","type":"presentations","id":"42412550"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397237","label":"url"}],"presentation_title":{"en":"5-FU膵がん細胞増殖抑制効果に対する低酸素-PARPシグナルの役割","ja":"5-FU膵がん細胞増殖抑制効果に対する低酸素-PARPシグナルの役割"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"山下 竜介"},{"name":"Fukushima Keijo"},{"name":"近藤 宏祐"},{"name":"中山 涼"},{"name":"常松 保乃加"},{"name":"井上 貴久"},{"name":"後藤 廣平"},{"name":"Funamoto Masafumi"},{"name":"Fujino Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"今西 正樹"},{"name":"山下 竜介"},{"name":"福島 圭穣"},{"name":"近藤 宏祐"},{"name":"中山 涼"},{"name":"常松 保乃加"},{"name":"井上 貴久"},{"name":"後藤 廣平"},{"name":"船本 雅文"},{"name":"藤野 裕道"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第52回心脈管作動物質学会","ja":"第52回心脈管作動物質学会"},"publication_date":"2023-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:134, {"insert":{"user_id":"B000241782","type":"presentations","id":"40615749"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393079","label":"url"}],"presentation_title":{"en":"New Attempt of Practice in Pharmacology Joint Practice with Basic Medical Departments in Tokushima University-","ja":"薬理学実習に対する新たな取り組み-徳島大学における複数基礎医学分野による統合実習について-"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"},{"name":"Sei Hiroyoshi"}],"ja":[{"name":"池田 康将"},{"name":"船本 雅文"},{"name":"勢井 宏義"}]},"event":{"en":"第96回日本薬理学会年会 教育企画シンボジウム","ja":"第96回日本薬理学会年会 教育企画シンボジウム"},"publication_date":"2022-11-30","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:135, {"insert":{"user_id":"B000241782","type":"presentations","id":"42991600"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=399378","label":"url"}],"presentation_title":{"en":"フィブラート系薬剤の腎保護効果に関する検討","ja":"フィブラート系薬剤の腎保護効果に関する検討"},"presenters":{"en":[{"name":"村嶋 優香"},{"name":"Horinouchi Yuya"},{"name":"山田 佑人"},{"name":"吉岡 駿"},{"name":"Fukushima Keijo"},{"name":"久禮 匠"},{"name":"佐々木 尚史"},{"name":"Fujino Hiromichi"},{"name":"四宮 一昭"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"村嶋 優香"},{"name":"堀ノ内 裕也"},{"name":"山田 佑人"},{"name":"吉岡 駿"},{"name":"福島 圭穣"},{"name":"久禮 匠"},{"name":"佐々木 尚史"},{"name":"藤野 裕道"},{"name":"四宮 一昭"},{"name":"池田 康将"}]},"event":{"en":"第61回 日本薬学会 中四国支部学術大会","ja":"第61回 日本薬学会 中四国支部学術大会"},"publication_date":"2022-11-05","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:136, {"insert":{"user_id":"B000241782","type":"presentations","id":"42412551"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397230","label":"url"}],"presentation_title":{"en":"低酸素がん微小環境におけるPARP活性化は5-FUによる膵がん細胞増殖抑制効果の減弱に寄与する","ja":"低酸素がん微小環境におけるPARP活性化は5-FUによる膵がん細胞増殖抑制効果の減弱に寄与する"},"presenters":{"en":[{"name":"山下 竜介"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"近藤 宏祐"},{"name":"中山 涼"},{"name":"常松 保乃加"},{"name":"井上 貴久"},{"name":"後藤 廣平"},{"name":"Funamoto Masafumi"},{"name":"Fujino Hiromichi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"山下 竜介"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"近藤 宏祐"},{"name":"中山 涼"},{"name":"常松 保乃加"},{"name":"井上 貴久"},{"name":"後藤 廣平"},{"name":"船本 雅文"},{"name":"藤野 裕道"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第142回日本薬理学会近畿部会","ja":"第142回日本薬理学会近畿部会"},"publication_date":"2022-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:137, {"insert":{"user_id":"B000241782","type":"presentations","id":"38625525"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386327","label":"url"}],"presentation_title":{"en":"心不全発症時におけるBRG1を介したヒストンのアセチル修飾部位の検討","ja":"心不全発症時におけるBRG1を介したヒストンのアセチル修飾部位の検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"清水 聡志"},{"name":"長谷川 浩二"},{"name":"Ikeda Yasumasa"},{"name":"森本 達也"}],"ja":[{"name":"船本 雅文"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"清水 聡志"},{"name":"長谷川 浩二"},{"name":"池田 康将"},{"name":"森本 達也"}]},"event":{"en":"第51回日本心脈管作動物質学会","ja":"第51回日本心脈管作動物質学会"},"publication_date":"2022-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:138, {"insert":{"user_id":"B000241782","type":"presentations","id":"37579754"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386166","label":"url"}],"presentation_title":{"en":"漢方薬の腎保作用の検討","ja":"漢方薬の腎保作用の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"}],"ja":[{"name":"池田 康将"},{"name":"船本 雅文"}]},"event":{"en":"第51回日本心脈管作動物質学会","ja":"第51回日本心脈管作動物質学会"},"publication_date":"2022-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:139, {"insert":{"user_id":"B000241782","type":"presentations","id":"37241242"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386122","label":"url"}],"presentation_title":{"en":"ドキソルビシン誘導性心毒性に対するオウゴン成分オウゴニンの効果検討","ja":"ドキソルビシン誘導性心毒性に対するオウゴン成分オウゴニンの効果検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":"第141回日本薬理学会近畿部会","ja":"第141回日本薬理学会近畿部会"},"publication_date":"2022-07","is_international_presentation":false},"priority":"input_data"} line:140, {"insert":{"user_id":"B000241782","type":"presentations","id":"40241751"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=392439","label":"url"}],"presentation_title":{"en":"慢性腎臓病に対するSPPARMαペマフィブラートの腎保護効果","ja":"慢性腎臓病に対するSPPARMαペマフィブラートの腎保護効果"},"presenters":{"en":[{"name":"山田 佑人"},{"name":"Horinouchi Yuya"},{"name":"吉岡 駿"},{"name":"村嶋 優香"},{"name":"久禮 匠"},{"name":"佐々木 尚史"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"四宮 一昭"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"山田 佑人"},{"name":"堀ノ内 裕也"},{"name":"吉岡 駿"},{"name":"村嶋 優香"},{"name":"久禮 匠"},{"name":"佐々木 尚史"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"四宮 一昭"},{"name":"池田 康将"}]},"event":{"en":"第141回日本薬理学会近畿部会","ja":"第141回日本薬理学会近畿部会"},"publication_date":"2022-07-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:141, {"insert":{"user_id":"B000241782","type":"presentations","id":"37241243"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386121","label":"url"}],"presentation_title":{"en":"急性腎障害におけるマクロファージ鉄ストレスの役割の検討","ja":"急性腎障害におけるマクロファージ鉄ストレスの役割の検討"},"presenters":{"en":[{"name":"Itoh Tatsuki"},{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"伊藤 達紀"},{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"},{"name":"池田 康将"}]},"event":{"en":"第141回日本薬理学会近畿部会","ja":"第141回日本薬理学会近畿部会"},"publication_date":"2022-07-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:142, {"insert":{"user_id":"B000241782","type":"presentations","id":"39491398"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387790","label":"url"}],"presentation_title":{"en":"The Interaction of the p300 with the BRG1 Increases the Acetylation levels of the H3K122 in Heart Failure","ja":"The Interaction of the p300 with the BRG1 Increases the Acetylation levels of the H3K122 in Heart Failure"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Yoichi Sunagawa"},{"name":"Yasufumi Katanasaka"},{"name":"Kana Shimizu"},{"name":"Satoshi Shimizu"},{"name":"Koji Hasegawa"},{"name":"Ikeda Yasumasa"},{"name":"Tatsuya Morimoto"}],"ja":[{"name":"船本 雅文"},{"name":"Yoichi Sunagawa"},{"name":"Yasufumi Katanasaka"},{"name":"Kana Shimizu"},{"name":"Satoshi Shimizu"},{"name":"Koji Hasegawa"},{"name":"池田 康将"},{"name":"Tatsuya Morimoto"}]},"event":{"en":"第95回日本薬理学会年会","ja":"第95回日本薬理学会年会"},"publication_date":"2022-03-09","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:143, {"insert":{"user_id":"B000241782","type":"presentations","id":"36868138"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=385328","label":"url"}],"presentation_title":{"en":"漢方薬の新規腎保護作用の検討","ja":"漢方薬の新規腎保護作用の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Funamoto Masafumi"},{"name":"Imanishi Masaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"船本 雅文"},{"name":"今西 正樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"第95回日本薬理学会年会","ja":"第95回日本薬理学会年会"},"publication_date":"2022-03-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:144, {"insert":{"user_id":"B000241782","type":"presentations","id":"42921399"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=398904","label":"url"}],"presentation_title":{"en":"心不全期にp300/BRG1複合体がH3K122のアセチル化レベルを増加させた","ja":"心不全期にp300/BRG1複合体がH3K122のアセチル化レベルを増加させた"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"清水 聡志"},{"name":"長谷川 浩二"},{"name":"Ikeda Yasumasa"},{"name":"森本 達也"}],"ja":[{"name":"船本 雅文"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"清水 聡志"},{"name":"長谷川 浩二"},{"name":"池田 康将"},{"name":"森本 達也"}]},"event":{"en":"第95回日本薬理学会年会","ja":"第95回日本薬理学会年会"},"publication_date":"2022-03-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:145, {"insert":{"user_id":"B000241782","type":"presentations","id":"39491399"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387789","label":"url"}],"presentation_title":{"en":"生薬由来化合物のオウゴニンによるドキソルビシンの心毒性に対する効果検討","ja":"生薬由来化合物のオウゴニンによるドキソルビシンの心毒性に対する効果検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"池田 康将"}]},"event":{"en":"第31回日本循環薬理学会","ja":"第31回日本循環薬理学会"},"publication_date":"2021-12-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:146, {"insert":{"user_id":"B000241782","type":"presentations","id":"39491400"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387788","label":"url"}],"presentation_title":{"en":"ドキソルビシンの心毒性に対する生薬由来化合物オウゴニンの効果検討","ja":"ドキソルビシンの心毒性に対する生薬由来化合物オウゴニンの効果検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"Ikeda Yasumasa"}],"ja":[{"name":"船本 雅文"},{"name":"池田 康将"}]},"event":{"en":"第140回日本薬理学会近畿部会","ja":"第140回日本薬理学会近畿部会"},"publication_date":"2021-11-13","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:147, {"insert":{"user_id":"B000241782","type":"presentations","id":"39491401"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387786","label":"url"}],"presentation_title":{"en":"心肥大期から心不全期におけるヒストンのアセチル化修飾部位の検討","ja":"心肥大期から心不全期におけるヒストンのアセチル化修飾部位の検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"宮崎 雄輔"},{"name":"清水 聡史"},{"name":"長谷川 浩二"},{"name":"Ikeda Yasumasa"},{"name":"森本 達也"}],"ja":[{"name":"船本 雅文"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"宮崎 雄輔"},{"name":"清水 聡史"},{"name":"長谷川 浩二"},{"name":"池田 康将"},{"name":"森本 達也"}]},"event":{"en":"第5回黒潮カンファレンス","ja":"第5回黒潮カンファレンス"},"publication_date":"2021-09-18","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:148, {"insert":{"user_id":"B000241782","type":"presentations","id":"39491402"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387784","label":"url"}],"presentation_title":{"en":"心不全発症時におけるヒストンのアセチル化修飾部位の検討","ja":"心不全発症時におけるヒストンのアセチル化修飾部位の検討"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"宮崎 雄輔"},{"name":"清水 聡史"},{"name":"長谷川 浩二"},{"name":"Ikeda Yasumasa"},{"name":"森本 達也"}],"ja":[{"name":"船本 雅文"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"宮崎 雄輔"},{"name":"清水 聡史"},{"name":"長谷川 浩二"},{"name":"池田 康将"},{"name":"森本 達也"}]},"event":{"en":"第263回徳島医学会学術集会","ja":"第263回徳島医学会学術集会"},"publication_date":"2021-08-29","languages":["jpn"],"location":{"en":"徳島","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:149, {"insert":{"user_id":"B000241782","type":"presentations","id":"39491403"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387787","label":"url"}],"presentation_title":{"en":"心不全発症におけるヒストンのアセチル化修飾部位の変化を介した転写制御機構の解明","ja":"心不全発症におけるヒストンのアセチル化修飾部位の変化を介した転写制御機構の解明"},"presenters":{"en":[{"name":"Funamoto Masafumi"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"宮崎 雄輔"},{"name":"清水 聡史"},{"name":"長谷川 浩二"},{"name":"Ikeda Yasumasa"},{"name":"森本 達也"}],"ja":[{"name":"船本 雅文"},{"name":"砂川 陽一"},{"name":"刀坂 泰史"},{"name":"清水 果奈"},{"name":"宮崎 雄輔"},{"name":"清水 聡史"},{"name":"長谷川 浩二"},{"name":"池田 康将"},{"name":"森本 達也"}]},"event":{"en":"第28回市大フォーラム","ja":"第28回市大フォーラム"},"publication_date":"2021-08-17","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:150, {"insert":{"user_id":"B000241782","type":"presentations","id":"33127477"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=376903","label":"url"}],"presentation_title":{"en":"シスプラチン誘発性腎毒性における鉄依存性細胞死の役割の検討","ja":"シスプラチン誘発性腎毒性における鉄依存性細胞死の役割の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Miyamoto Licht"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"宮本 理人"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第64回日本腎臓学会学術集会","ja":"第64回日本腎臓学会学術集会"},"publication_date":"2021-06-19","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:151, {"insert":{"user_id":"B000241782","type":"presentations","id":"31837422"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374257","label":"url"}],"presentation_title":{"en":"Identification of a candidate drug for the prevention of cisplatin-induced nephrotoxicity by a database analysis -basic research-clinical study","ja":"シスプラチン起因性腎障害の予防薬の探索・同定"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Goda Mitsuhiro"},{"name":"Fukushima Keijo"},{"name":"Kishi Seiji"},{"name":"Chuma Masayuki"},{"name":"Zamami Yoshito"},{"name":"Miyamoto Licht"},{"name":"石澤 啓介"},{"name":"Fujino Hiromichi"},{"name":"Aihara Ken-ichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"合田 光寛"},{"name":"福島 圭穣"},{"name":"岸 誠司"},{"name":"中馬 真幸"},{"name":"座間味 義人"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"藤野 裕道"},{"name":"粟飯原 賢一"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第94回日本薬理学会年会","ja":"第94回日本薬理学会年会"},"publication_date":"2021-03-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:152, {"insert":{"user_id":"B000241782","type":"presentations","id":"31837423"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374256","label":"url"}],"presentation_title":{"en":"シスプラチン起因性腎障害を予防する既存薬の同定","ja":"シスプラチン起因性腎障害を予防する既存薬の同定"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Goda Mitsuhiro"},{"name":"Fukushima Keijo"},{"name":"Kishi Seiji"},{"name":"石澤 啓介"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"合田 光寛"},{"name":"福島 圭穣"},{"name":"岸 誠司"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第63回日本腎臓学会学術総会","ja":"第63回日本腎臓学会学術総会"},"publication_date":"2020-08-19","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:153, {"insert":{"user_id":"B000241782","type":"presentations","id":"33428529"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=380808","label":"url"}],"presentation_title":{"en":"薬剤誘発性急性大動脈疾患に対するケルセチンの抑制効果","ja":"薬剤誘発性急性大動脈疾患に対するケルセチンの抑制効果"},"presenters":{"en":[{"name":"Kondoh Masateru"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Suzuki Kotoko"},{"name":"Matsuoka Rie"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"近藤 正輝"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"鈴木 琴子"},{"name":"松岡 里英"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第137回日本薬理学会近畿部会","ja":"第137回日本薬理学会近畿部会"},"publication_date":"2020-06-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:154, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376252"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=363776","label":"url"}],"presentation_title":{"en":"The involvement of ferroptosis on cisplatin-induced nephrotoxicity","ja":"シスプラチン腎障害における鉄依存性細胞死の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"}]},"event":{"en":"第93回日本薬理学会年会","ja":"第93回日本薬理学会年会"},"publication_date":"2020-03-17","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:155, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376253"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=371395","label":"url"}],"presentation_title":{"en":"Chronic exposure to hypoxia facilitates chemotherapy sensitivity with downregulation of MDR1","ja":"Chronic exposure to hypoxia facilitates chemotherapy sensitivity with downregulation of MDR1"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Yagi Yuko"},{"name":"Hatano Aya"},{"name":"Ikeda Yasumasa"},{"name":"Abe Shinji"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"Yagi Yuko"},{"name":"Hatano Aya"},{"name":"池田 康将"},{"name":"阿部 真治"},{"name":"Tamaki Toshiaki"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本薬理学会","ja":"日本薬理学会"},"publication_date":"2020-03-16","is_international_presentation":false},"priority":"input_data"} line:156, {"insert":{"user_id":"B000241782","type":"presentations","id":"31973234"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374496","label":"url"}],"presentation_title":{"en":"血管平滑筋細胞石灰化シグナルにおけるRhoキナーゼーサイクロフィリンA経路の関与","ja":"血管平滑筋細胞石灰化シグナルにおけるRhoキナーゼーサイクロフィリンA経路の関与"},"presenters":{"en":[{"name":"Tsuda Tatsuya"},{"name":"Goda Mitsuhiro"},{"name":"Horinouchi Yuya"},{"name":"Zamami Yoshito"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Hashimoto Ichiro"},{"name":"Izawa-Ishizawa Yuki"}],"ja":[{"name":"津田 達也"},{"name":"合田 光寛"},{"name":"堀ノ内 裕也"},{"name":"座間味 義人"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"橋本 一郎"},{"name":"石澤 有紀"}]},"event":{"en":"第260回 徳島医学会学術集会(令和元年度冬期)","ja":"第260回 徳島医学会学術集会(令和元年度冬期)"},"publication_date":"2020-02-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:157, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376254"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=363198","label":"url"}],"presentation_title":{"en":"シスプラチン誘発性腎障害を予防する既存薬物の同定","ja":"シスプラチン誘発性腎障害を予防する既存薬物の同定"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Goda Mitsuhiro"},{"name":"Fukushima Keijo"},{"name":"Kishi Seiji"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Zamami Yoshito"},{"name":"Horinouchi Yuya"},{"name":"Miyamoto Licht"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"合田 光寛"},{"name":"福島 圭穣"},{"name":"岸 誠司"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"座間味 義人"},{"name":"堀ノ内 裕也"},{"name":"宮本 理人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第260回徳島医学会学術集会(令和元年度冬期)","ja":"第260回徳島医学会学術集会(令和元年度冬期)"},"publication_date":"2020-02-02","is_international_presentation":false},"priority":"input_data"} line:158, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376255"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=360686","label":"url"}],"presentation_title":{"en":"シスプラチン腎障害における鉄依存性細胞死の役割の検討","ja":"シスプラチン腎障害における鉄依存性細胞死の役割の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"}]},"event":{"en":"第23回日本心血管内分泌代謝学会学術総会【CVMW2019 心血管代謝週間 】","ja":"第23回日本心血管内分泌代謝学会学術総会【CVMW2019 心血管代謝週間 】"},"publication_date":"2019-12-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:159, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376256"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366400","label":"url"}],"presentation_title":{"en":"大規模医療情報データベースを活用したシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証","ja":"大規模医療情報データベースを活用したシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証"},"presenters":{"en":[{"name":"Goda Mitsuhiro"},{"name":"Kanda Masaya"},{"name":"前川 晃子"},{"name":"Niimura Takahiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"Takechi Kenshi"},{"name":"Hamano Hirofumi"},{"name":"Okada Naoto"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Yanagawa Hiroaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"合田 光寛"},{"name":"神田 将哉"},{"name":"前川 晃子"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"武智 研志"},{"name":"濱野 裕章"},{"name":"岡田 直人"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"楊河 宏章"},{"name":"石澤 啓介"}]},"event":{"en":"第40回日本臨床薬理学会学術総会","ja":"第40回日本臨床薬理学会学術総会"},"publication_date":"2019-12","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:160, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376257"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366399","label":"url"}],"presentation_title":{"en":"抗がん剤誘発末梢神経障害の予防薬開発を目的とした医療ビッグデータ解析および基礎研究","ja":"抗がん剤誘発末梢神経障害の予防薬開発を目的とした医療ビッグデータ解析および基礎研究"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Naitoh Yutaroh"},{"name":"川尻 雄大"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"内藤 優太朗"},{"name":"川尻 雄大"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第40回日本臨床薬理学会学術総会","ja":"第40回日本臨床薬理学会学術総会"},"publication_date":"2019-12","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:161, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376258"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=360685","label":"url"}],"presentation_title":{"en":"シスプラチン腎障害における鉄依存性細胞死の検討","ja":"シスプラチン腎障害における鉄依存性細胞死の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Hamano Hirofumi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"濱野 裕章"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第29回日本循環薬理学会/第55回高血圧関連疾患モデル学会 合同学会","ja":"第29回日本循環薬理学会/第55回高血圧関連疾患モデル学会 合同学会"},"publication_date":"2019-11-29","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:162, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376259"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364007","label":"url"}],"presentation_title":{"en":"慢性腎不全関連サルコペニアにおける鉄代謝異常","ja":"慢性腎不全関連サルコペニアにおける鉄代謝異常"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第6回日本サルコペニア・フレイル学会大会","ja":"第6回日本サルコペニア・フレイル学会大会"},"publication_date":"2019-11-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:163, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376260"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=371289","label":"url"}],"presentation_title":{"en":"スダチ果皮香気成分由来物質による糖脂質代謝の影響","ja":"スダチ果皮香気成分由来物質による糖脂質代謝の影響"},"presenters":{"en":[{"name":"近藤 友宏"},{"name":"Miyamoto Licht"},{"name":"福田 恵介"},{"name":"高橋 梨恵"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"近藤 友宏"},{"name":"宮本 理人"},{"name":"福田 恵介"},{"name":"高橋 梨恵"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第58回 中国四国支部学術大会","ja":"第58回 中国四国支部学術大会"},"publication_date":"2019-11-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:164, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376261"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364008","label":"url"}],"presentation_title":{"en":"プロトンポンプ阻害剤はヘプシジンを介して鉄代謝異常に関与する","ja":"プロトンポンプ阻害剤はヘプシジンを介して鉄代謝異常に関与する"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"Teraoka Kazuhiko"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"石澤 啓介"}]},"event":{"en":"第29回日本医療薬学会年会","ja":"第29回日本医療薬学会年会"},"publication_date":"2019-11-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:165, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376262"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366402","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニング手法を用いたシスプラチン誘発腎障害に対する新規予防薬探索","ja":"ドラッグリポジショニング手法を用いたシスプラチン誘発腎障害に対する新規予防薬探索"},"presenters":{"en":[{"name":"Goda Mitsuhiro"},{"name":"神田 将哉"},{"name":"前川 晃子"},{"name":"Yoshida Ami"},{"name":"Niimura Takahiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"Takechi Kenshi"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"合田 光寛"},{"name":"神田 将哉"},{"name":"前川 晃子"},{"name":"吉田 愛美"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"武智 研志"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第29回日本循環薬理学会・第55回高血圧関連疾患モデル学会 合同学術集会","ja":"第29回日本循環薬理学会・第55回高血圧関連疾患モデル学会 合同学術集会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:166, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376263"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366401","label":"url"}],"presentation_title":{"en":"大規模医療情報を活用した抗がん剤誘発心筋症予防薬の探索","ja":"大規模医療情報を活用した抗がん剤誘発心筋症予防薬の探索"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Saito Hiroumi"},{"name":"神田 将哉"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"齊藤 広海"},{"name":"神田 将哉"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第29回日本循環薬理学会・第55回高血圧関連疾患モデル学会 合同学術集会","ja":"第29回日本循環薬理学会・第55回高血圧関連疾患モデル学会 合同学術集会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:167, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376264"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366398","label":"url"}],"presentation_title":{"en":"ケルセチンによる薬剤誘発性急性大動脈疾患発症抑制効果の検討","ja":"ケルセチンによる薬剤誘発性急性大動脈疾患発症抑制効果の検討"},"presenters":{"en":[{"name":"鈴木 琴子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"近藤 正輝"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Horinouchi Yuya"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"鈴木 琴子"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"近藤 正輝"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"堀ノ内 裕也"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:168, {"insert":{"user_id":"B000241782","type":"presentations","id":"30496236"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366396","label":"url"}],"presentation_title":{"en":"大規模医療情報データベースを活用したドキソルビシン誘発心筋炎に対する予防薬の探索","ja":"大規模医療情報データベースを活用したドキソルビシン誘発心筋炎に対する予防薬の探索"},"presenters":{"en":[{"name":"Saito Hiroumi"},{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Kanda Masaya"},{"name":"Goda Mitsuhiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"齊藤 広海"},{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"神田 将哉"},{"name":"合田 光寛"},{"name":"石澤 有紀"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:169, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376267"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366395","label":"url"}],"presentation_title":{"en":"大規模医療情報データベースを活用したオキサリプラチン誘発末梢神経障害に対する予防薬探索","ja":"大規模医療情報データベースを活用したオキサリプラチン誘発末梢神経障害に対する予防薬探索"},"presenters":{"en":[{"name":"内藤 優太朗"},{"name":"Zamami Yoshito"},{"name":"Niimura Takahiro"},{"name":"川尻 雄大"},{"name":"相澤 風花"},{"name":"Nishiuchi Shiori"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"島添 隆雄"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"内藤 優太朗"},{"name":"座間味 義人"},{"name":"新村 貴博"},{"name":"川尻 雄大"},{"name":"相澤 風花"},{"name":"西内 栞"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"島添 隆雄"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:170, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376268"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366394","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニングによる大規模医療情報データベースを用いた新規抗てんかん薬の探索研究","ja":"ドラッグリポジショニングによる大規模医療情報データベースを用いた新規抗てんかん薬の探索研究"},"presenters":{"en":[{"name":"Natsumi JOHZUKURI"},{"name":"Takahashi Shimon"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Hamano Hirofumi"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"定作 奈津美"},{"name":"高橋 志門"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"濱野 裕章"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:171, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376269"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366393","label":"url"}],"presentation_title":{"en":"シスプラチンと各種5-HT3受容体拮抗薬の併用による腎機能への影響","ja":"シスプラチンと各種5-HT3受容体拮抗薬の併用による腎機能への影響"},"presenters":{"en":[{"name":"村井 陽一"},{"name":"Goda Mitsuhiro"},{"name":"神田 将哉"},{"name":"Niimura Takahiro"},{"name":"Yoshida Ami"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"Hamano Hirofumi"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"村井 陽一"},{"name":"合田 光寛"},{"name":"神田 将哉"},{"name":"新村 貴博"},{"name":"吉田 愛美"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"濱野 裕章"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:172, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376270"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366390","label":"url"}],"presentation_title":{"en":"シスプラチン誘発腎障害に対する各種 5-HT3 受容体拮抗薬の影響","ja":"シスプラチン誘発腎障害に対する各種 5-HT3 受容体拮抗薬の影響"},"presenters":{"en":[{"name":"Kanda Masaya"},{"name":"Goda Mitsuhiro"},{"name":"Niimura Takahiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"Hamano Hirofumi"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"Teraoka Kazuhiko"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"神田 将哉"},{"name":"合田 光寛"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"濱野 裕章"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"石澤 啓介"}]},"event":{"en":"第29回日本医療薬学会年会","ja":"第29回日本医療薬学会年会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Fukuoka","ja":"福岡"},"is_international_presentation":false},"priority":"input_data"} line:173, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376271"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366389","label":"url"}],"presentation_title":{"en":"ビッグデータを活用した新規抗てんかん薬の検討","ja":"ビッグデータを活用した新規抗てんかん薬の検討"},"presenters":{"en":[{"name":"定作 奈津美"},{"name":"Takahashi Shimon"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"定作 奈津美"},{"name":"高橋 志門"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"第29回日本医療薬学会年会","ja":"第29回日本医療薬学会年会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"Fukuoka","ja":"福岡"},"is_international_presentation":false},"priority":"input_data"} line:174, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376272"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366363","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニング手法を用いたバンコマイシン関連腎障害の予防薬探索とその有用性の検討","ja":"ドラッグリポジショニング手法を用いたバンコマイシン関連腎障害の予防薬探索とその有用性の検討"},"presenters":{"en":[{"name":"Chuma Masayuki"},{"name":"Goda Mitsuhiro"},{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"濱野 裕章"},{"name":"石田 俊介"},{"name":"Niimura Takahiro"},{"name":"Kondoh Masateru"},{"name":"Bandoh Takashi"},{"name":"Okada Naoto"},{"name":"Fukushima Keijo"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Yanagawa Hiroaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"中馬 真幸"},{"name":"合田 光寛"},{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 有紀"},{"name":"濱野 裕章"},{"name":"石田 俊介"},{"name":"新村 貴博"},{"name":"近藤 正輝"},{"name":"坂東 貴司"},{"name":"岡田 直人"},{"name":"福島 圭穣"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"楊河 宏章"},{"name":"石澤 啓介"}]},"event":{"en":"第13回日本腎臓病薬物療法学会学術集会・総会","ja":"第13回日本腎臓病薬物療法学会学術集会・総会"},"publication_date":"2019-11","languages":["jpn"],"location":{"en":"熊本市","ja":"熊本市"},"is_international_presentation":false},"priority":"input_data"} line:175, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376273"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=360541","label":"url"}],"presentation_title":{"en":"心血管病におけるアンドロゲン受容体の意義","ja":"心血管病におけるアンドロゲン受容体の意義"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Abe Masahiro"}],"ja":[{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"安倍 正博"}]},"event":{"en":"第30回 日本性機能学会学術総会","ja":"第30回 日本性機能学会学術総会"},"publication_date":"2019-09-21","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:176, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376274"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=359579","label":"url"}],"presentation_title":{"en":"心血管病における性機能障害と男性ホルモンの心血管保護作用","ja":"心血管病における性機能障害と男性ホルモンの心血管保護作用"},"presenters":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"佐田 政隆"}]},"event":{"en":"日本性機能学会第30回学術集会,シンポジウム","ja":"日本性機能学会第30回学術集会,シンポジウム"},"publication_date":"2019-09-21","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:177, {"insert":{"user_id":"B000241782","type":"presentations","id":"30496237"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366388","label":"url"}],"presentation_title":{"en":"医療ビッグデータ解析と基礎研究を融合した抗がん剤誘発末梢神経障害の予防薬開発","ja":"医療ビッグデータ解析と基礎研究を融合した抗がん剤誘発末梢神経障害の予防薬開発"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Niimura Takahiro"},{"name":"Naitoh Yutaroh"},{"name":"川尻 雄大"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"新村 貴博"},{"name":"内藤 優太朗"},{"name":"川尻 雄大"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム2019","ja":"次世代を担う創薬・医療薬理シンポジウム2019"},"publication_date":"2019-08","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:178, {"insert":{"user_id":"B000241782","type":"presentations","id":"30496238"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366387","label":"url"}],"presentation_title":{"en":"医療ビッグデータ解析と基礎研究を融合した抗がん剤誘発末梢神経障害の予防薬開発","ja":"医療ビッグデータ解析と基礎研究を融合した抗がん剤誘発末梢神経障害の予防薬開発"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Niimura Takahiro"},{"name":"内藤 優太朗"},{"name":"川尻 雄大"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"新村 貴博"},{"name":"内藤 優太朗"},{"name":"川尻 雄大"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"生体機能と創薬シンポジウム2019","ja":"生体機能と創薬シンポジウム2019"},"publication_date":"2019-08","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:179, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376277"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366386","label":"url"}],"presentation_title":{"en":"大規模医療情報データベースを活用したドキソルビシン誘発心筋炎にたいする予防薬の探索","ja":"大規模医療情報データベースを活用したドキソルビシン誘発心筋炎にたいする予防薬の探索"},"presenters":{"en":[{"name":"齊藤 広海"},{"name":"Zamami Yoshito"},{"name":"Niimura Takahiro"},{"name":"Kanda Masaya"},{"name":"Goda Mitsuhiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"齊藤 広海"},{"name":"座間味 義人"},{"name":"新村 貴博"},{"name":"神田 将哉"},{"name":"合田 光寛"},{"name":"石澤 有紀"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第30回霧島神経薬理フォーラム","ja":"第30回霧島神経薬理フォーラム"},"publication_date":"2019-08","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:180, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376278"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366385","label":"url"}],"presentation_title":{"en":"大規模医療情報を用いたニコランジルの心肺停止後予後改善効果の検討","ja":"大規模医療情報を用いたニコランジルの心肺停止後予後改善効果の検討"},"presenters":{"en":[{"name":"新村 貴博"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム","ja":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム"},"publication_date":"2019-07","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:181, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376279"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366383","label":"url"}],"presentation_title":{"en":"オキサリプラチン誘発末梢神経障害の予防薬探索を目的としたドラッグリポジショニング研究","ja":"オキサリプラチン誘発末梢神経障害の予防薬探索を目的としたドラッグリポジショニング研究"},"presenters":{"en":[{"name":"Naitoh Yutaroh"},{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"内藤 優太朗"},{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム","ja":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム"},"publication_date":"2019-07","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:182, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376280"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366382","label":"url"}],"presentation_title":{"en":"医療ビッグデータ解析を活用したドキソルビシン誘発心筋炎に対する予防薬探索研究","ja":"医療ビッグデータ解析を活用したドキソルビシン誘発心筋炎に対する予防薬探索研究"},"presenters":{"en":[{"name":"齊藤 広海"},{"name":"新村 貴博"},{"name":"Zamami Yoshito"},{"name":"Kanda Masaya"},{"name":"Goda Mitsuhiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"齊藤 広海"},{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"神田 将哉"},{"name":"合田 光寛"},{"name":"石澤 有紀"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム","ja":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム"},"publication_date":"2019-07","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:183, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376281"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366381","label":"url"}],"presentation_title":{"en":"大規模医療情報データベースを活用した新規抗てんかん薬の探索研究","ja":"大規模医療情報データベースを活用した新規抗てんかん薬の探索研究"},"presenters":{"en":[{"name":"Natsumi JOHZUKURI"},{"name":"Takahashi Shimon"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"定作 奈津美"},{"name":"高橋 志門"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム","ja":"医療薬学フォーラム2019/第27回クリニカルファーマシーシンポジウム"},"publication_date":"2019-07","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:184, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376282"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366380","label":"url"}],"presentation_title":{"en":"医療ビッグデータを活用したシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証","ja":"医療ビッグデータを活用したシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証"},"presenters":{"en":[{"name":"Goda Mitsuhiro"},{"name":"斉家 和仁"},{"name":"Maegawa Akiko"},{"name":"Kanda Masaya"},{"name":"Yoshida Ami"},{"name":"Murai Yoichi"},{"name":"Niimura Takahiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"Takechi Kenshi"},{"name":"Hamano Hirofumi"},{"name":"Okada Naoto"},{"name":"Fukushima Keijo"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Yanagawa Hiroaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"合田 光寛"},{"name":"斉家 和仁"},{"name":"前川 晃子"},{"name":"神田 将哉"},{"name":"吉田 愛美"},{"name":"村井 陽一"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"武智 研志"},{"name":"濱野 裕章"},{"name":"岡田 直人"},{"name":"福島 圭穣"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"楊河 宏章"},{"name":"石澤 啓介"}]},"event":{"en":"第4回中四国臨床薬理学会","ja":"第4回中四国臨床薬理学会"},"publication_date":"2019-07","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:185, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376283"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366379","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニング手法を用いたオキサリプラチン誘発末梢神経障害の予防薬探索","ja":"ドラッグリポジショニング手法を用いたオキサリプラチン誘発末梢神経障害の予防薬探索"},"presenters":{"en":[{"name":"新村 貴博"},{"name":"Zamami Yoshito"},{"name":"川尻 雄大"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"川尻 雄大"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第4回中四国臨床薬理学会","ja":"第4回中四国臨床薬理学会"},"publication_date":"2019-07","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:186, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376284"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366378","label":"url"}],"presentation_title":{"en":"薬剤誘発性急性大動脈疾患に対するケルセチンの効果","ja":"薬剤誘発性急性大動脈疾患に対するケルセチンの効果"},"presenters":{"en":[{"name":"Suzuki Kotoko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Kondoh Masateru"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Horinouchi Yuya"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"鈴木 琴子"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"近藤 正輝"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"堀ノ内 裕也"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第135回日本薬理学会近畿部会","ja":"第135回日本薬理学会近畿部会"},"publication_date":"2019-06","languages":["jpn"],"location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:187, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376285"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366356","label":"url"}],"presentation_title":{"en":"医療ビッグデータ解析と基礎研究を融合した薬剤性副作用の機序解明および治療薬の開発","ja":"医療ビッグデータ解析と基礎研究を融合した薬剤性副作用の機序解明および治療薬の開発"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"第29回日本医療薬学会年会 シンポジウム13","ja":"第29回日本医療薬学会年会 シンポジウム13"},"publication_date":"2019-03","languages":["jpn"],"location":{"en":"福岡市","ja":"福岡市"},"is_international_presentation":false},"priority":"input_data"} line:188, {"insert":{"user_id":"B000241782","type":"presentations","id":"30496240"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366353","label":"url"}],"presentation_title":{"en":"向精神薬の副作用対策を基盤とした臨床研究とその活用","ja":"向精神薬の副作用対策を基盤とした臨床研究とその活用"},"presenters":{"en":[{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"石田 俊介"},{"name":"坂東 寛"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Yanagawa Hiroaki"}],"ja":[{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"石田 俊介"},{"name":"坂東 寛"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"楊河 宏章"}]},"event":{"en":"第139回日本薬学会年会 一般シンポジウムS48","ja":"第139回日本薬学会年会 一般シンポジウムS48"},"publication_date":"2019-03-23","languages":["jpn"],"location":{"en":"千葉市","ja":"千葉市"},"is_international_presentation":false},"priority":"input_data"} line:189, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376288"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366355","label":"url"}],"presentation_title":{"en":"キサンチンオキシダーゼ阻害剤による新規血管線維化抑制機構の検討","ja":"キサンチンオキシダーゼ阻害剤による新規血管線維化抑制機構の検討"},"presenters":{"en":[{"name":"近藤 正輝"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"近藤 正輝"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会第139年会 大学院生シンポジウムGS03","ja":"日本薬学会第139年会 大学院生シンポジウムGS03"},"publication_date":"2019-03-22","languages":["jpn"],"location":{"en":"千葉市","ja":"千葉市"},"is_international_presentation":false},"priority":"input_data"} line:190, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376289"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351094","label":"url"}],"presentation_title":{"en":"慢性腎不全関連骨格筋萎縮における鉄代謝異常","ja":"慢性腎不全関連骨格筋萎縮における鉄代謝異常"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第92回日本薬理学会年会","ja":"第92回日本薬理学会年会"},"publication_date":"2019-03-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:191, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376290"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351091","label":"url"}],"presentation_title":{"en":"Iron accumulation negatively regulates skeletal muscle myogenesis","ja":"鉄蓄積は骨格筋分化を抑制する"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Satoh Akiho"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"佐藤 明穂"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第92回日本薬理学会年会","ja":"第92回日本薬理学会年会"},"publication_date":"2019-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:192, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376291"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351034","label":"url"}],"presentation_title":{"en":"疾患における鉄の意義と治療応用","ja":"疾患における鉄の意義と治療応用"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"第92回日本薬理学会年会 シンポジウム2:必須微量金属研究のパラダイムシフト","ja":"第92回日本薬理学会年会 シンポジウム2:必須微量金属研究のパラダイムシフト"},"publication_date":"2019-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:193, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376292"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=359558","label":"url"}],"presentation_title":{"en":"Significance of SGLT2 in glucagon secretion from α-TC cells","ja":"Significance of SGLT2 in glucagon secretion from α-TC cells"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Suguru Nakayama"},{"name":"Aya Hatano"},{"name":"Mana Hattori"},{"name":"Haruka Inoue"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"Suguru Nakayama"},{"name":"Aya Hatano"},{"name":"Mana Hattori"},{"name":"Haruka Inoue"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本薬理学会","ja":"日本薬理学会"},"publication_date":"2019-03-14","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:194, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376293"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366377","label":"url"}],"presentation_title":{"en":"ビッグデータを用いたシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証","ja":"ビッグデータを用いたシスプラチン誘発腎障害に対する新規予防薬の探索とその有効性の検証"},"presenters":{"en":[{"name":"Goda Mitsuhiro"},{"name":"Kanda Masaya"},{"name":"Niimura Takahiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"濱野 裕章"},{"name":"生田 賢治"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Kirino Yasushi"},{"name":"中村 敏己"},{"name":"Teraoka Kazuhiko"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"合田 光寛"},{"name":"神田 将哉"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"濱野 裕章"},{"name":"生田 賢治"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会第139年会","ja":"日本薬学会第139年会"},"publication_date":"2019-03","languages":["jpn"],"location":{"en":"Chiba","ja":"千葉"},"is_international_presentation":false},"priority":"input_data"} line:195, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376294"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366376","label":"url"}],"presentation_title":{"en":"シスプラチン誘発腎障害に対する新規予防薬の有効性の基礎的検証","ja":"シスプラチン誘発腎障害に対する新規予防薬の有効性の基礎的検証"},"presenters":{"en":[{"name":"Goda Mitsuhiro"},{"name":"Kanda Masaya"},{"name":"Niimura Takahiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"濱野 裕章"},{"name":"生田 賢治"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Kirino Yasushi"},{"name":"中村 敏己"},{"name":"Teraoka Kazuhiko"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"合田 光寛"},{"name":"神田 将哉"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"濱野 裕章"},{"name":"生田 賢治"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"石澤 啓介"}]},"event":{"en":"日本臨床腫瘍薬学会学術大会2019","ja":"日本臨床腫瘍薬学会学術大会2019"},"publication_date":"2019-03","languages":["jpn"],"location":{"en":"Sapporo","ja":"札幌"},"is_international_presentation":false},"priority":"input_data"} line:196, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376295"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366375","label":"url"}],"presentation_title":{"en":"シスプラチン誘発腎障害に対する新規予防薬の有効性の検証","ja":"シスプラチン誘発腎障害に対する新規予防薬の有効性の検証"},"presenters":{"en":[{"name":"Goda Mitsuhiro"},{"name":"神田 将哉"},{"name":"新村 貴博"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"濱野 裕章"},{"name":"生田 賢治"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"合田 光寛"},{"name":"神田 将哉"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"濱野 裕章"},{"name":"生田 賢治"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第92回日本薬理学会年会","ja":"第92回日本薬理学会年会"},"publication_date":"2019-03","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:197, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376296"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366373","label":"url"}],"presentation_title":{"en":"薬物誘発性大動脈瘤または大動脈解離モデルマウスに対するケルセチンの効果","ja":"薬物誘発性大動脈瘤または大動脈解離モデルマウスに対するケルセチンの効果"},"presenters":{"en":[{"name":"鈴木 琴子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kondoh Masateru"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Horinouchi Yuya"},{"name":"Takechi Kenshi"},{"name":"Goda Mitsuhiro"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"鈴木 琴子"},{"name":"石澤 有紀"},{"name":"近藤 正輝"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"堀ノ内 裕也"},{"name":"武智 研志"},{"name":"合田 光寛"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"石澤 啓介"}]},"event":{"en":"第92回日本薬理学会年会","ja":"第92回日本薬理学会年会"},"publication_date":"2019-03","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:198, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376297"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366372","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニング手法を用いたオキサリプラチン誘発末梢神経障害の予防薬探索","ja":"ドラッグリポジショニング手法を用いたオキサリプラチン誘発末梢神経障害の予防薬探索"},"presenters":{"en":[{"name":"新村 貴博"},{"name":"Zamami Yoshito"},{"name":"川尻 雄大"},{"name":"Goda Mitsuhiro"},{"name":"Okada Naoto"},{"name":"萱野 純史"},{"name":"小山 敏広"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"小林 大介"},{"name":"島添 隆雄"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"川尻 雄大"},{"name":"合田 光寛"},{"name":"岡田 直人"},{"name":"萱野 純史"},{"name":"小山 敏広"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"小林 大介"},{"name":"島添 隆雄"},{"name":"石澤 啓介"}]},"event":{"en":"第92回日本薬理学会年会 学生セッション","ja":"第92回日本薬理学会年会 学生セッション"},"publication_date":"2019-03","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:199, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376298"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366371","label":"url"}],"presentation_title":{"en":"大規模医療情報データベースを活用した抗がん剤誘発副作用に対する予防薬の探索","ja":"大規模医療情報データベースを活用した抗がん剤誘発副作用に対する予防薬の探索"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Niimura Takahiro"},{"name":"川尻 雄大"},{"name":"Goda Mitsuhiro"},{"name":"Okada Naoto"},{"name":"Hamano Hirofumi"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"島添 隆雄"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"新村 貴博"},{"name":"川尻 雄大"},{"name":"合田 光寛"},{"name":"岡田 直人"},{"name":"濱野 裕章"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"島添 隆雄"},{"name":"石澤 啓介"}]},"event":{"en":"第92回日本薬理学会年会 年会企画シンポジウム","ja":"第92回日本薬理学会年会 年会企画シンポジウム"},"publication_date":"2019-03","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:200, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376299"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351093","label":"url"}],"presentation_title":{"en":"マクロファージフェリチン欠損は肥満・糖尿病における脂肪炎症を抑制する","ja":"マクロファージフェリチン欠損は肥満・糖尿病における脂肪炎症を抑制する"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Hamano Hirofumi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"濱野 裕章"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第48回日本心脈管作動物質学会","ja":"第48回日本心脈管作動物質学会"},"publication_date":"2019-02-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:201, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376300"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351092","label":"url"}],"presentation_title":{"en":"肥満・糖尿病における鉄制御の意義","ja":"肥満・糖尿病における鉄制御の意義"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"第48回日本心脈管作動物質学会 シンポジウム4:心疾患腎代謝疾患の制御因子としての微量金属栄養素「鉄」の新たな展開","ja":"第48回日本心脈管作動物質学会 シンポジウム4:心疾患腎代謝疾患の制御因子としての微量金属栄養素「鉄」の新たな展開"},"publication_date":"2019-02-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:202, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376301"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=356877","label":"url"}],"presentation_title":{"en":"唾液中の硝酸イオンが口腔細菌に与える影響について·","ja":"唾液中の硝酸イオンが口腔細菌に与える影響について·"},"presenters":{"en":[{"name":"藤本 望"},{"name":"村田 梨菜"},{"name":"Murakami Keiji"},{"name":"Fujii Hideki"},{"name":"Miyamoto Licht"},{"name":"井上 貴久"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Hamano Shuichi"}],"ja":[{"name":"藤本 望"},{"name":"村田 梨菜"},{"name":"村上 圭史"},{"name":"藤猪 英樹"},{"name":"宮本 理人"},{"name":"井上 貴久"},{"name":"土屋 浩一郎"},{"name":"池田 康将"},{"name":"石澤 有紀"},{"name":"濱野 修一"}]},"event":{"en":"第42回徳島県医学検査学会","ja":"第42回徳島県医学検査学会"},"publication_date":"2018-12-09","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:203, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376302"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366352","label":"url"}],"presentation_title":{"en":"大規模医療情報データベースおよび遺伝子発現データベースを活用した薬剤性心筋炎に対する予防薬の探索","ja":"大規模医療情報データベースおよび遺伝子発現データベースを活用した薬剤性心筋炎に対する予防薬の探索"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Saito Hiroumi"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"齊藤 広海"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"第28回日本医療薬学会年会 シンポジウム","ja":"第28回日本医療薬学会年会 シンポジウム"},"publication_date":"2018-11-25","languages":["jpn"],"location":{"en":"神戸市","ja":"神戸市"},"is_international_presentation":false},"priority":"input_data"} line:204, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376303"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351095","label":"url"}],"presentation_title":{"en":"リアルワールドビッグデータを活用した新規腎保護薬の探索","ja":"リアルワールドビッグデータを活用した新規腎保護薬の探索"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Hamano Hirofumi"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"濱野 裕章"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第28回日本医療薬学会年会","ja":"第28回日本医療薬学会年会"},"publication_date":"2018-11-25","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:205, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376304"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366351","label":"url"}],"presentation_title":{"en":"救急・集中治療領域において大規模医療情報データベースを活用したトランスレーショナルリサーチ","ja":"救急・集中治療領域において大規模医療情報データベースを活用したトランスレーショナルリサーチ"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"新村 貴博"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"Teraoka Kazuhiko"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"新村 貴博"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"石澤 啓介"}]},"event":{"en":"第29回霧島神経薬理フォーラム","ja":"第29回霧島神経薬理フォーラム"},"publication_date":"2018-11-24","languages":["jpn"],"location":{"en":"神戸市","ja":"神戸市"},"is_international_presentation":false},"priority":"input_data"} line:206, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376305"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=356843","label":"url"}],"presentation_title":{"en":"亜硝酸塩による脂肪組織への抗肥満的な影響","ja":"亜硝酸塩による脂肪組織への抗肥満的な影響"},"presenters":{"en":[{"name":"井上 陽加"},{"name":"Miyamoto Licht"},{"name":"服部 真奈"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"井上 陽加"},{"name":"宮本 理人"},{"name":"服部 真奈"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第134回日本薬理学会近畿部会","ja":"第134回日本薬理学会近畿部会"},"publication_date":"2018-11-23","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:207, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376306"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351096","label":"url"}],"presentation_title":{"en":"慢性腎不全関連サルコペニアにおける鉄の関与","ja":"慢性腎不全関連サルコペニアにおける鉄の関与"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Goda Mitsuhiro"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"合田 光寛"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第134回日本薬理学会近畿部会","ja":"第134回日本薬理学会近畿部会"},"publication_date":"2018-11-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:208, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376307"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=356823","label":"url"}],"presentation_title":{"en":"シスプラチン誘発腎障害に対する脂質異常症治療薬の影響","ja":"シスプラチン誘発腎障害に対する脂質異常症治療薬の影響"},"presenters":{"en":[{"name":"斉家 和仁"},{"name":"Goda Mitsuhiro"},{"name":"伊勢 諒"},{"name":"新村 貴博"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Chuma Masayuki"},{"name":"Okada Naoto"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"演野 裕章"},{"name":"Horinouchi Yuya"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"斉家 和仁"},{"name":"合田 光寛"},{"name":"伊勢 諒"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"中馬 真幸"},{"name":"岡田 直人"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"演野 裕章"},{"name":"堀ノ内 裕也"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2018-11-10","languages":["jpn"],"location":{"en":"Tottori","ja":"鳥取"},"is_international_presentation":false},"priority":"input_data"} line:209, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376308"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=356804","label":"url"}],"presentation_title":{"en":"大腸がん増大におけるがん関連線維芽細胞由来ERKSの役割","ja":"大腸がん増大におけるがん関連線維芽細胞由来ERKSの役割"},"presenters":{"en":[{"name":"生藤 来希"},{"name":"Imanishi Masaki"},{"name":"山川 祐介"},{"name":"Fukushima Keijo"},{"name":"前川 晃子"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"生藤 来希"},{"name":"今西 正樹"},{"name":"山川 祐介"},{"name":"福島 圭穣"},{"name":"前川 晃子"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"}]},"event":{"en":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第57回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2018-11-10","languages":["jpn"],"location":{"en":"Tottori","ja":"鳥取"},"is_international_presentation":false},"priority":"input_data"} line:210, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376309"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351097","label":"url"}],"presentation_title":{"en":"リアルワールドデータを活用した新規腎保護薬の探索","ja":"リアルワールドデータを活用した新規腎保護薬の探索"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Fujino Hiromichi"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"石澤 有紀"},{"name":"藤野 裕道"},{"name":"玉置 俊晃"}]},"event":{"en":"第48回日本腎臓学会西部学術大会","ja":"第48回日本腎臓学会西部学術大会"},"publication_date":"2018-09-29","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:211, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=346366","label":"url"}],"presentation_title":{"en":"シンポジウム1「腎疾患(CKD)の治療と研究の最前線」慢性腎臓病における鉄代謝の意義と治療応用","ja":"シンポジウム1「腎疾患(CKD)の治療と研究の最前線」慢性腎臓病における鉄代謝の意義と治療応用"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"第48回日本腎臓学会西部学術大会","ja":"第48回日本腎臓学会西部学術大会"},"publication_date":"2018-09-29","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:212, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376310"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=354144","label":"url"}],"presentation_title":{"en":"マクロファージ鉄の肥満・糖尿病における役割 第42回日本鉄バイオサイエンス学会学術集会 2018/9/2 石川県 金沢医科大学病院北辰講堂","ja":"マクロファージ鉄の肥満・糖尿病における役割 第42回日本鉄バイオサイエンス学会学術集会 2018/9/2 石川県 金沢医科大学病院北辰講堂"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Hamano Hirofumi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"濱野 裕章"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第42回日本鉄バイオサイエンス学会学術集会","ja":"第42回日本鉄バイオサイエンス学会学術集会"},"publication_date":"2018-09-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:213, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376311"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366350","label":"url"}],"presentation_title":{"en":"大規模医療情報を活用した新規心肺蘇生後脳症治療薬の探索","ja":"大規模医療情報を活用した新規心肺蘇生後脳症治療薬の探索"},"presenters":{"en":[{"name":"新村 貴博"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Goda Mitsuhiro"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"合田 光寛"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"第29回霧島神経薬理フォーラム","ja":"第29回霧島神経薬理フォーラム"},"publication_date":"2018-08-18","languages":["jpn"],"location":{"en":"由布市","ja":"由布市"},"is_international_presentation":false},"priority":"input_data"} line:214, {"insert":{"user_id":"B000241782","type":"presentations","id":"31973235"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374500","label":"url"}],"presentation_title":{"en":"第40回徳島医学会賞受賞講演 動脈硬化性疾患発症に対するケルセチンの効果","ja":"第40回徳島医学会賞受賞講演 動脈硬化性疾患発症に対するケルセチンの効果"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Kagimoto Yu"},{"name":"Imanishi Masaki"},{"name":"Iwata Yusuke"},{"name":"Suzuki Kotoko"},{"name":"Horinouchi Yuya"},{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"鍵本 優有"},{"name":"今西 正樹"},{"name":"岩田 悠佑"},{"name":"鈴木 琴子"},{"name":"堀ノ内 裕也"},{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"event":{"en":"第257回 徳島医学会学術集会(平成30年度夏季)","ja":"第257回 徳島医学会学術集会(平成30年度夏季)"},"publication_date":"2018-08","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:215, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376312"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=366343","label":"url"}],"presentation_title":{"en":"医療情報データベースを活用した抗がん剤誘発副作用に対する予防薬の探索研究","ja":"医療情報データベースを活用した抗がん剤誘発副作用に対する予防薬の探索研究"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"新村 貴博"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"新村 貴博"},{"name":"石澤 有紀"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"第21回日本医薬品情報学会総会・学術大会","ja":"第21回日本医薬品情報学会総会・学術大会"},"publication_date":"2018-07-01","languages":["jpn"],"location":{"en":"鈴鹿市","ja":"鈴鹿市"},"is_international_presentation":false},"priority":"input_data"} line:216, {"insert":{"user_id":"B000241782","type":"presentations","id":"31973236"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=374491","label":"url"}],"presentation_title":{"en":"Angiotensin II誘発性心臓線維化は線維芽細胞特異的ERK5欠損マウスにおいて亢進される","ja":"Angiotensin II誘発性心臓線維化は線維芽細胞特異的ERK5欠損マウスにおいて亢進される"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Kondoh Masateru"},{"name":"山川 裕介"},{"name":"生藤 来希"},{"name":"村井 陽一"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Chuma Masayuki"},{"name":"Horinouchi Yuya"},{"name":"Fukushima Keijo"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"近藤 正輝"},{"name":"山川 裕介"},{"name":"生藤 来希"},{"name":"村井 陽一"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"中馬 真幸"},{"name":"堀ノ内 裕也"},{"name":"福島 圭穣"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"}]},"event":{"en":"第133回日本薬理学会近畿部会","ja":"第133回日本薬理学会近畿部会"},"publication_date":"2018-06","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:217, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376313"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=356706","label":"url"}],"presentation_title":{"en":"抗マラリア薬artesunateからの鉄依存活性酸素生成メカニズムの検討","ja":"抗マラリア薬artesunateからの鉄依存活性酸素生成メカニズムの検討"},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Miyamoto Licht"},{"name":"Hamano Shuichi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"津田 勝範"}],"ja":[{"name":"土屋 浩一郎"},{"name":"宮本 理人"},{"name":"濱野 修一"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"津田 勝範"}]},"event":{"en":"第71回日本酸化ストレス学会,第18回日本NO学会 合同学術集会","ja":"第71回日本酸化ストレス学会,第18回日本NO学会 合同学術集会"},"publication_date":"2018-05-17","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:218, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=346367","label":"url"}],"presentation_title":{"en":"シンポジウム2:「心血管系のNO/活性酸素と臨床応用展開」心腎血管代謝疾患における鉄の新たな知見","ja":"シンポジウム2:「心血管系のNO/活性酸素と臨床応用展開」心腎血管代謝疾患における鉄の新たな知見"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"第18回日本NO学会学術集会・第71回日本酸化ストレス学会学術集会合同大会","ja":"第18回日本NO学会学術集会・第71回日本酸化ストレス学会学術集会合同大会"},"publication_date":"2018-05-17","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:219, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339271","label":"url"}],"presentation_title":{"en":"有害事象自発報告データベースを活用したベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究","ja":"有害事象自発報告データベースを活用したベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Mitsui Marin"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Fukushima Keijo"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"三井 茉綸"},{"name":"石澤 有紀"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"福島 圭穣"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会第138年会","ja":"日本薬学会第138年会"},"publication_date":"2018-03-28","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:220, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339270","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニング手法を用いた心肺蘇生後脳症治療薬の探索","ja":"ドラッグリポジショニング手法を用いた心肺蘇生後脳症治療薬の探索"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会第138年会","ja":"日本薬学会第138年会"},"publication_date":"2018-03-28","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:221, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338853","label":"url"}],"presentation_title":{"en":"Factor Xa Inhibitor Exerts a Protective Effect against Renal Injury","ja":"Factor Xa Inhibitor Exerts a Protective Effect against Renal Injury"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"玉置 俊晃"}]},"event":{"en":"第82回日本循環器学会学術集会","ja":"第82回日本循環器学会学術集会"},"publication_date":"2018-03-25","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:222, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338851","label":"url"}],"presentation_title":{"en":"大規模医療情報データベース解析と基礎研究の融合による新規腎保護薬の探索","ja":"大規模医療情報データベース解析と基礎研究の融合による新規腎保護薬の探索"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Hamano Hirofumi"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"濱野 裕章"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第256回 徳島医学会学術集会(平成29年度冬期)","ja":"第256回 徳島医学会学術集会(平成29年度冬期)"},"publication_date":"2018-02-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:223, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338850","label":"url"}],"presentation_title":{"en":"マウス大動脈瘤形成に対するケルセチンの効果","ja":"マウス大動脈瘤形成に対するケルセチンの効果"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Kagimoto Yu"},{"name":"Imanishi Masaki"},{"name":"Iwata Yusuke"},{"name":"Horinouchi Yuya"},{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"鍵本 優有"},{"name":"今西 正樹"},{"name":"岩田 悠佑"},{"name":"堀ノ内 裕也"},{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"event":{"en":"第256回 徳島医学会学術集会(平成29年度冬期)","ja":"第256回 徳島医学会学術集会(平成29年度冬期)"},"publication_date":"2018-02-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:224, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338849","label":"url"}],"presentation_title":{"en":"Febuxostatの尿酸合成抑制作用とは独立した血管線維化抑制機構の解明","ja":"Febuxostatの尿酸合成抑制作用とは独立した血管線維化抑制機構の解明"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Kondoh Masateru"},{"name":"Tanaka Kyohei"},{"name":"Ikutoh Raiki"},{"name":"Murai Yoichi"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"近藤 正輝"},{"name":"田中 恭平"},{"name":"生藤 来希"},{"name":"村井 陽一"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第256回 徳島医学会学術集会(平成29年度冬期)","ja":"第256回 徳島医学会学術集会(平成29年度冬期)"},"publication_date":"2018-02-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:225, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338848","label":"url"}],"presentation_title":{"en":"てんかん誘発性精神症状の行動学的解析および治療薬の探索と作用機序の解明","ja":"てんかん誘発性精神症状の行動学的解析および治療薬の探索と作用機序の解明"},"presenters":{"en":[{"name":"Takechi Kenshi"},{"name":"Zamami Yoshito"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"},{"name":"Yanagawa Hiroaki"}],"ja":[{"name":"武智 研志"},{"name":"座間味 義人"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"},{"name":"楊河 宏章"}]},"event":{"en":"第256回 徳島医学会学術集会(平成29年度冬期)","ja":"第256回 徳島医学会学術集会(平成29年度冬期)"},"publication_date":"2018-02-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:226, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338846","label":"url"}],"presentation_title":{"en":"大規模医療情報を活用した心肺停止患者に対するニコランジルの有効性に関する検討","ja":"大規模医療情報を活用した心肺停止患者に対するニコランジルの有効性に関する検討"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第256回 徳島医学会学術集会(平成29年度冬期)","ja":"第256回 徳島医学会学術集会(平成29年度冬期)"},"publication_date":"2018-02-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:227, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=336471","label":"url"}],"presentation_title":{"en":"糖尿病における微量栄養素「鉄」の役割","ja":"糖尿病における微量栄養素「鉄」の役割"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"第256回徳島医学会市民公開シンポジウム 「加齢で起こる病気の検査と治療薬」","ja":"第256回徳島医学会市民公開シンポジウム 「加齢で起こる病気の検査と治療薬」"},"publication_date":"2018-02-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:228, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338845","label":"url"}],"presentation_title":{"en":"第Xa因子阻害剤の腎保護効果","ja":"第Xa因子阻害剤の腎保護効果"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第47回日本心脈管作動物質学会","ja":"第47回日本心脈管作動物質学会"},"publication_date":"2018-02-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:229, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=345611","label":"url"}],"presentation_title":{"en":"食後生じるAMPKの新たな翻訳後修飾を介した代謝制御機構","ja":"食後生じるAMPKの新たな翻訳後修飾を介した代謝制御機構"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"梅本 果奈"},{"name":"上島 沙弥香"},{"name":"友成 奈央実"},{"name":"土橋 有希"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"梅本 果奈"},{"name":"上島 沙弥香"},{"name":"友成 奈央実"},{"name":"土橋 有希"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"心脈管作動物質学会","ja":"心脈管作動物質学会"},"publication_date":"2018-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:230, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339293","label":"url"}],"presentation_title":{"en":"医療ビッグデータを活用した腎保護薬の探索","ja":"医療ビッグデータを活用した腎保護薬の探索"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Fujino Hiromichi"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"石澤 有紀"},{"name":"藤野 裕道"},{"name":"玉置 俊晃"}]},"event":{"en":"2017年度 肥満・糖尿病クラスター・ミニリトリート","ja":"2017年度 肥満・糖尿病クラスター・ミニリトリート"},"publication_date":"2018-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:231, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339296","label":"url"}],"presentation_title":{"en":"第Xa因子阻害薬の腎保護効果","ja":"第Xa因子阻害薬の腎保護効果"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fukushima Keijo"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Zamami Yoshito"},{"name":"Fujino Hiromichi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"福島 圭穣"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"座間味 義人"},{"name":"藤野 裕道"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第10回 心・血管クラスター・ミニリトリート","ja":"第10回 心・血管クラスター・ミニリトリート"},"publication_date":"2017","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:232, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=340506","label":"url"}],"presentation_title":{"en":"Actinomyces spp. による硝酸イオンの還元と生理作用の検討","ja":"Actinomyces spp. による硝酸イオンの還元と生理作用の検討"},"presenters":{"en":[{"name":"Betsushiyo Masahiro"},{"name":"村上 圭史"},{"name":"藤猪 英樹"},{"name":"Tsuda Katsunori"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Hamano Shuichi"}],"ja":[{"name":"別所 将弘"},{"name":"村上 圭史"},{"name":"藤猪 英樹"},{"name":"津田 勝範"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"濱野 修一"}]},"event":{"en":"第41回徳島県医学検査学会","ja":"第41回徳島県医学検査学会"},"publication_date":"2017-12-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:233, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338844","label":"url"}],"presentation_title":{"en":"大規模医療情報を活用した薬剤性腎障害に対する予防薬の探索","ja":"大規模医療情報を活用した薬剤性腎障害に対する予防薬の探索"},"presenters":{"en":[{"name":"Hino Sakiko"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"日野 咲季子"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"西日本医学生学術フォーラム2017","ja":"西日本医学生学術フォーラム2017"},"publication_date":"2017-12-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:234, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338843","label":"url"}],"presentation_title":{"en":"マウス大動脈瘤形成に対するケルセチンの効果","ja":"マウス大動脈瘤形成に対するケルセチンの効果"},"presenters":{"en":[{"name":"Iwata Yusuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kagimoto Yu"},{"name":"Suzuki Kotoko"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"岩田 悠佑"},{"name":"石澤 有紀"},{"name":"鍵本 優有"},{"name":"鈴木 琴子"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"event":{"en":"西日本医学生学術フォーラム2017","ja":"西日本医学生学術フォーラム2017"},"publication_date":"2017-12-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:235, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338842","label":"url"}],"presentation_title":{"en":"ケルセチンによる動脈硬化性疾患発症に対する予防効果の検討","ja":"ケルセチンによる動脈硬化性疾患発症に対する予防効果の検討"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Kagimoto Yu"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Suzuki Kotoko"},{"name":"Iwata Yusuke"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"石澤 有紀"},{"name":"鍵本 優有"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"鈴木 琴子"},{"name":"岩田 悠佑"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第27回日本循環薬理学会","ja":"第27回日本循環薬理学会"},"publication_date":"2017-12-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:236, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339294","label":"url"}],"presentation_title":{"en":"大規模医療情報を用いて新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究","ja":"大規模医療情報を用いて新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第38回日本臨床薬理学会学術総会","ja":"第38回日本臨床薬理学会学術総会"},"publication_date":"2017-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:237, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376314"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339272","label":"url"}],"presentation_title":{"en":"臨床薬理学集中講座修了後の研究活動∼大規模医療情報を活用したドラッグリポジショニング研究を中心に∼","ja":"臨床薬理学集中講座修了後の研究活動∼大規模医療情報を活用したドラッグリポジショニング研究を中心に∼"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Niimura Takahiro"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"新村 貴博"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第38回日本臨床薬理学会学術総会 臨床薬理学集中講座フォローアップ・セミナー","ja":"第38回日本臨床薬理学会学術総会 臨床薬理学集中講座フォローアップ・セミナー"},"publication_date":"2017-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:238, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338841","label":"url"}],"presentation_title":{"en":"肥満・糖尿病におけるマクロファージ鉄制御機構の検討","ja":"肥満・糖尿病におけるマクロファージ鉄制御機構の検討"},"presenters":{"en":[{"name":"Watanabe Hiroaki"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"渡邉 大晃"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第132回日本薬理学会近畿部会","ja":"第132回日本薬理学会近畿部会"},"publication_date":"2017-11-24","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:239, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339421","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニングを切り口とした心肺蘇生後症候群治療薬の探索研究","ja":"ドラッグリポジショニングを切り口とした心肺蘇生後症候群治療薬の探索研究"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"小山 敏広"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"小山 敏広"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第27回日本医療薬学会年会","ja":"第27回日本医療薬学会年会"},"publication_date":"2017-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:240, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=339417","label":"url"}],"presentation_title":{"en":"大規模医療情報を活用して心肺停止患者の生存率向上を志向したドラッグリポジショニング研究","ja":"大規模医療情報を活用して心肺停止患者の生存率向上を志向したドラッグリポジショニング研究"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"小山 敏広"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Niimura Takahiro"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"小山 敏広"},{"name":"石澤 有紀"},{"name":"新村 貴博"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"桐野 靖"},{"name":"中村 敏己"},{"name":"寺岡 和彦"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第27回日本医療薬学会年会","ja":"第27回日本医療薬学会年会"},"publication_date":"2017-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:241, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338840","label":"url"}],"presentation_title":{"en":"有害事象自発報告データベースを基にしたベバシズマブと相互作用を起こす薬剤の探索研究","ja":"有害事象自発報告データベースを基にしたベバシズマブと相互作用を起こす薬剤の探索研究"},"presenters":{"en":[{"name":"Mitsui Marin"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Niimura Takahiro"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"三井 茉綸"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"新村 貴博"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:242, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338839","label":"url"}],"presentation_title":{"en":"心肺停止患者の予後に与えるニコランジルの影響-大規模レセプト情報を用いた検討","ja":"心肺停止患者の予後に与えるニコランジルの影響-大規模レセプト情報を用いた検討"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:243, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338838","label":"url"}],"presentation_title":{"en":"大規模医療情報を活用して新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究","ja":"大規模医療情報を活用して新規心肺蘇生後症候群治療薬の開発を志向したドラッグリポジショニング研究"},"presenters":{"en":[{"name":"Urushizaki Shiori"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Niimura Takahiro"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"漆崎 汐里"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"新村 貴博"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:244, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338837","label":"url"}],"presentation_title":{"en":"急性大動脈解離易発症マウスにおけるquercetinの効果","ja":"急性大動脈解離易発症マウスにおけるquercetinの効果"},"presenters":{"en":[{"name":"Kagimoto Yu"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Hosohka Mayuko"},{"name":"Saito Naoko"},{"name":"Suzuki Kotoko"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"鍵本 優有"},{"name":"石澤 有紀"},{"name":"細岡 真由子"},{"name":"斎藤 尚子"},{"name":"鈴木 琴子"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:245, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338836","label":"url"}],"presentation_title":{"en":"フェブキソスタットの尿酸合成抑制剤作用とは独立した血管線維化抑制作用の検討","ja":"フェブキソスタットの尿酸合成抑制剤作用とは独立した血管線維化抑制作用の検討"},"presenters":{"en":[{"name":"Tanaka Kyohei"},{"name":"Imanishi Masaki"},{"name":"Kondoh Masateru"},{"name":"Ikutoh Raiki"},{"name":"Murai Yoichi"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"田中 恭平"},{"name":"今西 正樹"},{"name":"近藤 正輝"},{"name":"生藤 来希"},{"name":"村井 陽一"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:246, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338835","label":"url"}],"presentation_title":{"en":"肥満・糖尿病におけるマクロファージ鉄の役割の検討","ja":"肥満・糖尿病におけるマクロファージ鉄の役割の検討"},"presenters":{"en":[{"name":"Watanabe Hiroaki"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"渡邊 大晃"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第56回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2017-10-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:247, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325805","label":"url"}],"presentation_title":{"en":"慢性腎臓病における尿毒素蓄積によるヘプシジン制御と鉄代謝破綻のメカニズムの解明","ja":"慢性腎臓病における尿毒素蓄積によるヘプシジン制御と鉄代謝破綻のメカニズムの解明"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第41回日本鉄バイオサイエンス学会学術集会","ja":"第41回日本鉄バイオサイエンス学会学術集会"},"publication_date":"2017-09-23","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:248, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325804","label":"url"}],"presentation_title":{"en":"鉄摂取制限による尿細管間質障害の抑制効果の検討","ja":"鉄摂取制限による尿細管間質障害の抑制効果の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Hamano Hirofumi"},{"name":"平山 祐"},{"name":"Kishi Seiji"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Nagasawa Hideko"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"濱野 裕章"},{"name":"平山 祐"},{"name":"岸 誠司"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"永澤 秀子"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第41回日本鉄バイオサイエンス学会学術集会","ja":"第41回日本鉄バイオサイエンス学会学術集会"},"publication_date":"2017-09-23","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:249, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=340507","label":"url"}],"presentation_title":{"en":"食後のエネルギー代謝調節を担うAMPK活性制御機構","ja":"食後のエネルギー代謝調節を担うAMPK活性制御機構"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Umemoto Kana"},{"name":"Ueshima Sayaka"},{"name":"Tomonari Naomi"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"梅本 果奈"},{"name":"上島 沙弥香"},{"name":"友成 奈央実"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"次世代を担う創薬医療薬理シンポジウム2017","ja":"次世代を担う創薬医療薬理シンポジウム2017"},"publication_date":"2017-08-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:250, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338834","label":"url"}],"presentation_title":{"en":"慢性腎不全における尿毒素蓄積はヘプシジンを介した鉄代謝恒常性破綻に関与する","ja":"慢性腎不全における尿毒素蓄積はヘプシジンを介した鉄代謝恒常性破綻に関与する"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邊 大晃"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"大阪市大フォーラム","ja":"大阪市大フォーラム"},"publication_date":"2017-08-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:251, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=329719","label":"url"}],"presentation_title":{"en":"心肺蘇生後症候群治療薬の開発を目的としたドラッグリポジショニング研究-大規模医療情報を活用した検討-","ja":"心肺蘇生後症候群治療薬の開発を目的としたドラッグリポジショニング研究-大規模医療情報を活用した検討-"},"presenters":{"en":[{"name":"Niimura Takahiro"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Fukushima Keijo"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"新村 貴博"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"福島 圭穣"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第255回 徳島医学会学術集会","ja":"第255回 徳島医学会学術集会"},"publication_date":"2017-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:252, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=338833","label":"url"}],"presentation_title":{"en":"有害事象自発報告データベースを切り口としたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究","ja":"有害事象自発報告データベースを切り口としたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"桐野 靖"},{"name":"Mitsui Marin"},{"name":"Urushizaki Shiori"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"桐野 靖"},{"name":"三井 茉綸"},{"name":"漆崎 汐里"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム","ja":"医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム"},"publication_date":"2017-07-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:253, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327183","label":"url"}],"presentation_title":{"en":"経口FXa阻害剤の腎線維化抑制効果","ja":"経口FXa阻害剤の腎線維化抑制効果"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム","ja":"医療薬学フォーラム2017 第25回クリニカルファーマシーシンポジウム"},"publication_date":"2017-07-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:254, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327187","label":"url"}],"presentation_title":{"en":"第Xa因子阻害剤は腎間質線維化を抑制する","ja":"第Xa因子阻害剤は腎間質線維化を抑制する"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第131回 日本薬理学会近畿部会","ja":"第131回 日本薬理学会近畿部会"},"publication_date":"2017-06-30","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:255, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327186","label":"url"}],"presentation_title":{"en":"インドキシル硫酸蓄積はヘプシジン制御を介して鉄代謝恒常性破綻に関与する","ja":"インドキシル硫酸蓄積はヘプシジン制御を介して鉄代謝恒常性破綻に関与する"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邊 大晃"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第131回 日本薬理学会近畿部会","ja":"第131回 日本薬理学会近畿部会"},"publication_date":"2017-06-30","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:256, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325799","label":"url"}],"presentation_title":{"en":"Inhibitory effect of dietary iron restriction on albumin-induced renal tubulointerstitial injury","ja":"鉄摂取制限はタンパク過剰負荷による尿細管間質障害を軽減する"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"玉置 俊晃"}]},"event":{"en":"第60回日本腎臓学会学術総会","ja":"第60回日本腎臓学会学術総会"},"publication_date":"2017-05-28","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:257, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327182","label":"url"}],"presentation_title":{"en":"インドキシル硫酸はヘプシジンを介した鉄代謝異常に関与する","ja":"インドキシル硫酸はヘプシジンを介した鉄代謝異常に関与する"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第60回日本腎臓学会学術総会","ja":"第60回日本腎臓学会学術総会"},"publication_date":"2017-05-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:258, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327181","label":"url"}],"presentation_title":{"en":"FXa阻害剤は腎間質線維化を抑制する","ja":"FXa阻害剤は腎間質線維化を抑制する"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第60回日本腎臓学会学術総会","ja":"第60回日本腎臓学会学術総会"},"publication_date":"2017-05-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:259, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=345614","label":"url"}],"presentation_title":{"en":"A limonene-derivative purified from Sudachi peel upregulates sirt1 and improves lipid /glucose metabolism in HFD-fed mice.","ja":"A limonene-derivative purified from Sudachi peel upregulates sirt1 and improves lipid /glucose metabolism in HFD-fed mice."},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Haruna Aihara"},{"name":"Wenting Xu"},{"name":"Meina Jin"},{"name":"Yosuke Tomida"},{"name":"Tomomi Yamaoka"},{"name":"Naonobu Tanaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"Haruna Aihara"},{"name":"Wenting Xu"},{"name":"Meina Jin"},{"name":"Yosuke Tomida"},{"name":"Tomomi Yamaoka"},{"name":"Naonobu Tanaka"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"第60回日本糖尿病学会","ja":"第60回日本糖尿病学会"},"publication_date":"2017-05-18","languages":["eng"],"location":{"en":"Nagoya","ja":"Nagoya"},"is_international_presentation":false},"priority":"input_data"} line:260, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327141","label":"url"}],"presentation_title":{"en":"有害事象自発報告データベースを基にしたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究","ja":"有害事象自発報告データベースを基にしたベバシズマブの抗腫瘍効果を減弱させる薬剤の探索研究"},"presenters":{"en":[{"name":"Mitsui Marin"},{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Urushizaki Shiori"},{"name":"桐野 靖"},{"name":"Saike Kazuhito"},{"name":"Moriguchi Hiroshi"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"三井 茉綸"},{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"漆崎 汐里"},{"name":"桐野 靖"},{"name":"斉家 和仁"},{"name":"森口 浩史"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会 第137年会","ja":"日本薬学会 第137年会"},"publication_date":"2017-03-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:261, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327140","label":"url"}],"presentation_title":{"en":"FXa 阻害剤の片側尿管結紮モデルマウスにおける腎間質線維化抑制作用","ja":"FXa 阻害剤の片側尿管結紮モデルマウスにおける腎間質線維化抑制作用"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会 第137年会","ja":"日本薬学会 第137年会"},"publication_date":"2017-03-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:262, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327139","label":"url"}],"presentation_title":{"en":"アンジオテンシンII 誘発性血管リモデリングに対するキサンチンオキシダーゼ阻害剤の影響","ja":"アンジオテンシンII 誘発性血管リモデリングに対するキサンチンオキシダーゼ阻害剤の影響"},"presenters":{"en":[{"name":"Ikutoh Raiki"},{"name":"Imanishi Masaki"},{"name":"Tanaka Kyohei"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"生藤 来希"},{"name":"今西 正樹"},{"name":"田中 恭平"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会 第137年会","ja":"日本薬学会 第137年会"},"publication_date":"2017-03-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:263, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327138","label":"url"}],"presentation_title":{"en":"Excess iron on the risk of tissue injury","ja":"Excess iron on the risk of tissue injury"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"第90回日本薬理学会年会","ja":"第90回日本薬理学会年会"},"publication_date":"2017-03-17","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:264, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376315"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325798","label":"url"}],"presentation_title":{"en":"Excess iron action on risk of tissue injury","ja":"Excess iron action on risk of tissue injury"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"第90回日本薬理学会年会 年会企画ナノシンポジウム 「機能性食品における薬理学」","ja":"第90回日本薬理学会年会 年会企画ナノシンポジウム 「機能性食品における薬理学」"},"publication_date":"2017-03-17","invited":true,"languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:265, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327137","label":"url"}],"presentation_title":{"en":"Factor Xa inhibitor attenuates renal fibrosis in mice with unilateral ureteral obstruction","ja":"Xa因子阻害薬は一側尿管結紮誘導性腎線維化を抑制する"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第90回日本薬理学会年会","ja":"第90回日本薬理学会年会"},"publication_date":"2017-03-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:266, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327136","label":"url"}],"presentation_title":{"en":"Febuxostat suppresses angiotensin II-induced aortic fibrosis","ja":"フェブキソスタットはアンジオテンシンII誘発性大動脈線維化を抑制する"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tanaka Kyohei"},{"name":"Ikuto Raiki"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"田中 恭平"},{"name":"生藤 来希"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第90回日本薬理学会年会","ja":"第90回日本薬理学会年会"},"publication_date":"2017-03-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:267, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=329997","label":"url"}],"presentation_title":{"en":"フェブキソスタットはアンジオテンシンII誘発性大動脈繊維化を抑制する","ja":"フェブキソスタットはアンジオテンシンII誘発性大動脈繊維化を抑制する"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"田中 恭平"},{"name":"生藤 来希"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"田中 恭平"},{"name":"生藤 来希"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第90回日本薬理学会年会(長崎)","ja":"第90回日本薬理学会年会(長崎)"},"publication_date":"2017-03-15","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:268, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327135","label":"url"}],"presentation_title":{"en":"The effect of quercetin on the aortic dissection onset via its endothelial protective effect in mice","ja":"ケルセチンの内皮保護作用を介したマウス大動脈解離発症に対する効果"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Hosooka Mayuko"},{"name":"Saito Naoko"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"細岡 真由子"},{"name":"齊藤 尚子"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"event":{"en":"第90回日本薬理学会年会","ja":"第90回日本薬理学会年会"},"publication_date":"2017-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:269, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327134","label":"url"}],"presentation_title":{"en":"Significance of central regulation in physical exercise-induced metabolic alterations in skeletal muscles","ja":"身体運動時に生じる骨格筋代謝状態の変化における,中枢性調節機構の意義"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Tomokawa Goki"},{"name":"Matsuda Yuki"},{"name":"Yamane Moe"},{"name":"Hattori Mana"},{"name":"Oonishi Reina"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"友川 剛己"},{"name":"松田 裕樹"},{"name":"山根 萌"},{"name":"服部 真奈"},{"name":"大西 怜奈"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"The 90th Annual Meeting of The Japanese Pharmacology Society","ja":"第90回日本薬理学会年会"},"publication_date":"2017-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:270, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333078","label":"url"}],"presentation_title":{"en":"鉄ストレスと代謝性疾患-鉄ストレスによる疾患と,鉄ストレスによる治療","ja":"鉄ストレスと代謝性疾患-鉄ストレスによる疾患と,鉄ストレスによる治療"},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Miyamoto Licht"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"池田 康将"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"宮本 理人"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第137年会","ja":"日本薬学会第137年会"},"publication_date":"2017-03","languages":["jpn"],"location":{"en":"Sendai","ja":"仙台"},"is_international_presentation":false},"priority":"input_data"} line:271, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327162","label":"url"}],"presentation_title":{"en":"有害事象自発報告データベースを切り口としたベバシズマブと相互作用を起こす薬剤の探索研究","ja":"有害事象自発報告データベースを切り口としたベバシズマブと相互作用を起こす薬剤の探索研究"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Izawa-Ishizawa Yuki"},{"name":"桐野 靖"},{"name":"三井 茉綸"},{"name":"漆崎 汐里"},{"name":"斉家 和仁"},{"name":"森口 浩史"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"石澤 有紀"},{"name":"桐野 靖"},{"name":"三井 茉綸"},{"name":"漆崎 汐里"},{"name":"斉家 和仁"},{"name":"森口 浩史"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第46回日本心脈管作動物質学会年会","ja":"第46回日本心脈管作動物質学会年会"},"publication_date":"2017-02-10","languages":["jpn"],"location":{"en":"Naha","ja":"那覇"},"is_international_presentation":false},"priority":"input_data"} line:272, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327160","label":"url"}],"presentation_title":{"en":"Angiotensin II誘発性血管リモデリングに対するfebuxostatの効果","ja":"Angiotensin II誘発性血管リモデリングに対するfebuxostatの効果"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"田中 恭平"},{"name":"生藤 来希"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"今西 正樹"},{"name":"田中 恭平"},{"name":"生藤 来希"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第46回日本心脈管作動物質学会","ja":"第46回日本心脈管作動物質学会"},"publication_date":"2017-02-10","languages":["jpn"],"location":{"en":"Naha","ja":"那覇"},"is_international_presentation":false},"priority":"input_data"} line:273, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327158","label":"url"}],"presentation_title":{"en":"身体運動時に生じる骨格筋代謝状態の変化における,中枢を介した調節機構の意義","ja":"身体運動時に生じる骨格筋代謝状態の変化における,中枢を介した調節機構の意義"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"友川 剛己"},{"name":"松田 裕樹"},{"name":"山根 萌"},{"name":"服部 真奈"},{"name":"大西 伶奈"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"友川 剛己"},{"name":"松田 裕樹"},{"name":"山根 萌"},{"name":"服部 真奈"},{"name":"大西 伶奈"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"},{"name":"土屋 浩一郎"}]},"event":{"en":"第46回日本心脈管作動物質学会","ja":"第46回日本心脈管作動物質学会"},"publication_date":"2017-02-10","languages":["jpn"],"location":{"en":"Naha","ja":"那覇"},"is_international_presentation":false},"priority":"input_data"} line:274, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327157","label":"url"}],"presentation_title":{"en":"慢性腎不全における尿毒素蓄積が生体内鉄代謝に与える影響の検討","ja":"慢性腎不全における尿毒素蓄積が生体内鉄代謝に与える影響の検討"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Watanabe Hiroaki"},{"name":"Horinouchi Yuya"},{"name":"Satoh Akiho"},{"name":"Oshima Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"堀ノ内 裕也"},{"name":"佐藤 明穂"},{"name":"大島 啓亮"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第46回日本心脈管作動物質学会","ja":"第46回日本心脈管作動物質学会"},"publication_date":"2017-02-10","languages":["jpn"],"location":{"en":"Naha","ja":"那覇"},"is_international_presentation":false},"priority":"input_data"} line:275, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=325797","label":"url"}],"presentation_title":{"en":"ケルセチンによるマウス大動脈解離発症予防効果の検討","ja":"ケルセチンによるマウス大動脈解離発症予防効果の検討"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"細岡 真由子"},{"name":"斎藤 尚子"},{"name":"鍵本 優有"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"石澤 有紀"},{"name":"細岡 真由子"},{"name":"斎藤 尚子"},{"name":"鍵本 優有"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第46回日本心脈管作動物質学会年会","ja":"第46回日本心脈管作動物質学会年会"},"publication_date":"2017-02-10","languages":["jpn"],"location":{"en":"Naha","ja":"那覇"},"is_international_presentation":false},"priority":"input_data"} line:276, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=333077","label":"url"}],"presentation_title":{"en":"水泳運動負荷時に生じる骨格筋AMPK活性化の新たなメカニズム,第46回日本心脈管作動物質学会年会","ja":"水泳運動負荷時に生じる骨格筋AMPK活性化の新たなメカニズム,第46回日本心脈管作動物質学会年会"},"presenters":{"en":[{"name":"友川 剛己"},{"name":"Miyamoto Licht"},{"name":"松田 裕樹"},{"name":"山根 萌"},{"name":"服部 真奈"},{"name":"大西 怜奈"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"友川 剛己"},{"name":"宮本 理人"},{"name":"松田 裕樹"},{"name":"山根 萌"},{"name":"服部 真奈"},{"name":"大西 怜奈"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"publication_date":"2017-02","languages":["jpn"],"location":{"en":"Okinawa","ja":"沖縄"},"is_international_presentation":false},"priority":"input_data"} line:277, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=322285","label":"url"}],"presentation_title":{"en":"Artesunateによる細胞傷害発現機序の解明1","ja":"Artesunateによる細胞傷害発現機序の解明1"},"presenters":{"en":[{"name":"Kangawa Yumi"},{"name":"Fukue Chiharu"},{"name":"Tsuda Katsunori"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Hamano Shuichi"}],"ja":[{"name":"寒川 裕未"},{"name":"福榮 千花"},{"name":"津田 勝範"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"濱野 修一"}]},"event":{"en":"第40回 徳島県医学検査学会","ja":"第40回 徳島県医学検査学会"},"publication_date":"2016-12-11","languages":["jpn"],"location":{"en":"徳島市","ja":"徳島市"},"is_international_presentation":false},"priority":"input_data"} line:278, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=322284","label":"url"}],"presentation_title":{"en":"Artesunateによる細胞傷害発現機序の解明2","ja":"Artesunateによる細胞傷害発現機序の解明2"},"presenters":{"en":[{"name":"Fukue Chiharu"},{"name":"Kangawa Yumi"},{"name":"Tsuda Katsunori"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Hamano Shuichi"}],"ja":[{"name":"福榮 千花"},{"name":"寒川 裕未"},{"name":"津田 勝範"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"濱野 修一"}]},"event":{"en":"第40回 徳島県医学検査学会","ja":"第40回 徳島県医学検査学会"},"publication_date":"2016-12-11","languages":["jpn"],"location":{"en":"徳島市","ja":"徳島市"},"is_international_presentation":false},"priority":"input_data"} line:279, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327153","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンは虚血性皮弁モデルにおいて皮弁壊死を抑制する","ja":"ニトロソニフェジピンは虚血性皮弁モデルにおいて皮弁壊死を抑制する"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Fukunaga Yutaka"},{"name":"西良 恵理子"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Zamami Yoshito"},{"name":"Takechi Kenshi"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Hashimoto Ichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"福永 豊"},{"name":"西良 恵理子"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"座間味 義人"},{"name":"武智 研志"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"橋本 一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第26回日本循環薬理学会","ja":"第26回日本循環薬理学会"},"publication_date":"2016-12-02","languages":["jpn"],"location":{"en":"Matsumoto","ja":"松本"},"is_international_presentation":false},"priority":"input_data"} line:280, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327148","label":"url"}],"presentation_title":{"en":"脳内グリコーゲンによる代謝調節効果の検討","ja":"脳内グリコーゲンによる代謝調節効果の検討"},"presenters":{"en":[{"name":"高橋 梨恵"},{"name":"Miyamoto Licht"},{"name":"友川 剛己"},{"name":"宮武 由実子"},{"name":"Sakaue Hiroshi"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"高橋 梨恵"},{"name":"宮本 理人"},{"name":"友川 剛己"},{"name":"宮武 由実子"},{"name":"阪上 浩"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第130回日本薬理学会近畿部会","ja":"第130回日本薬理学会近畿部会"},"publication_date":"2016-11-19","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:281, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327147","label":"url"}],"presentation_title":{"en":"スダチ果皮芳香成分が糖脂質代謝に与える影響","ja":"スダチ果皮芳香成分が糖脂質代謝に与える影響"},"presenters":{"en":[{"name":"福田 恵介"},{"name":"Miyamoto Licht"},{"name":"高橋 梨恵"},{"name":"Tamaki Toshiaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"福田 恵介"},{"name":"宮本 理人"},{"name":"高橋 梨恵"},{"name":"玉置 俊晃"},{"name":"池田 康将"},{"name":"土屋 浩一郎"}]},"event":{"en":"第130回日本薬理学会近畿部会","ja":"第130回日本薬理学会近畿部会"},"publication_date":"2016-11-19","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:282, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327146","label":"url"}],"presentation_title":{"en":"Quercetin による血管内皮細胞保護効果の検討","ja":"Quercetin による血管内皮細胞保護効果の検討"},"presenters":{"en":[{"name":"細岡 真由子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"斎藤 尚子"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Miyamoto Licht"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"細岡 真由子"},{"name":"石澤 有紀"},{"name":"斎藤 尚子"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"宮本 理人"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第130回日本薬理学会近畿部会","ja":"第130回日本薬理学会近畿部会"},"publication_date":"2016-11-19","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:283, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326753","label":"url"}],"presentation_title":{"en":"鉄欠乏が骨格筋に与える作用の検討","ja":"鉄欠乏が骨格筋に与える作用の検討"},"presenters":{"en":[{"name":"Satoh Akiho"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Horinouchi Yuya"},{"name":"Imao Mizuki"},{"name":"Watanabe Hiroaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"佐藤 明穂"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"今尾 瑞季"},{"name":"渡邊 大晃"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第55回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第55回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2016-11-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:284, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326751","label":"url"}],"presentation_title":{"en":"虚血性皮弁壊死モデルにおける抗酸化薬ニトロソニフェジピンの壊死抑制効果","ja":"虚血性皮弁壊死モデルにおける抗酸化薬ニトロソニフェジピンの壊死抑制効果"},"presenters":{"en":[{"name":"Fukunaga Yutaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Hashimoto Ichiro"}],"ja":[{"name":"福永 豊"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"橋本 一郎"}]},"event":{"en":"第25回日本形成外科学会基礎学術集会","ja":"第25回日本形成外科学会基礎学術集会"},"publication_date":"2016-09-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:285, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=330050","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニングを切り口としたベバシズマブ誘発高血圧に対する予防薬の探索研究","ja":"ドラッグリポジショニングを切り口としたベバシズマブ誘発高血圧に対する予防薬の探索研究"},"presenters":{"en":[{"name":"三井 茉綸"},{"name":"Zamami Yoshito"},{"name":"漆崎 汐里"},{"name":"斉家 和仁"},{"name":"森口 浩史"},{"name":"Takechi Kenshi"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"Miyamoto Licht"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Fujino Hiromichi"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"三井 茉綸"},{"name":"座間味 義人"},{"name":"漆崎 汐里"},{"name":"斉家 和仁"},{"name":"森口 浩史"},{"name":"武智 研志"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"宮本 理人"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"藤野 裕道"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第27回霧島神経薬理フォーラム(福岡)","ja":"第27回霧島神経薬理フォーラム(福岡)"},"publication_date":"2016-08-19","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:286, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326749","label":"url"}],"presentation_title":{"en":"速効型インスリン分泌促進薬とSGLT2阻害薬の併用による薬効の検討","ja":"速効型インスリン分泌促進薬とSGLT2阻害薬の併用による薬効の検討"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"秦野 彩"},{"name":"竹之熊 和也"},{"name":"土橋 有希"},{"name":"矢野 友章"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"秦野 彩"},{"name":"竹之熊 和也"},{"name":"土橋 有希"},{"name":"矢野 友章"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第129回日本薬理学会近畿部会","ja":"第129回日本薬理学会近畿部会"},"publication_date":"2016-06-24","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:287, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=316852","label":"url"}],"presentation_title":{"en":"ケルセチン代謝産物Q3GAの血管内皮膚細胞に対する短期及び長期効果の検討","ja":"ケルセチン代謝産物Q3GAの血管内皮膚細胞に対する短期及び長期効果の検討"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"細岡 真由子"},{"name":"斎藤 尚子"},{"name":"Horinouchi Yuya"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"細岡 真由子"},{"name":"斎藤 尚子"},{"name":"堀ノ内 裕也"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第129回日薬理学会学会近畿部会( 広島)","ja":"第129回日薬理学会学会近畿部会( 広島)"},"publication_date":"2016-06-24","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:288, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=316851","label":"url"}],"presentation_title":{"en":"骨格筋分化における鉄の役割","ja":"骨格筋分化における鉄の役割"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"佐藤 明穂"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"佐藤 明穂"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第129回日薬理学会学会近畿部会 (広島)","ja":"第129回日薬理学会学会近畿部会 (広島)"},"publication_date":"2016-06-24","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:289, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=320670","label":"url"}],"presentation_title":{"en":"鉄は低酸素誘導因子を抑制してエリスロポエチン発現を低下させる","ja":"鉄は低酸素誘導因子を抑制してエリスロポエチン発現を低下させる"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Oshima Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"大島 啓亮"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第59回日本腎臓学会学術総会","ja":"第59回日本腎臓学会学術総会"},"publication_date":"2016-06-19","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:290, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311519","label":"url"}],"presentation_title":{"en":"スダチ果皮における抗メタボリックシンドローム作用を有する物質の同定","ja":"スダチ果皮における抗メタボリックシンドローム作用を有する物質の同定"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"粟飯原 遥菜"},{"name":"許 文婷"},{"name":"靳 美娜"},{"name":"冨田 洋輔"},{"name":"山岡 朋美"},{"name":"Tanaka Naonobu"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"粟飯原 遥菜"},{"name":"許 文婷"},{"name":"靳 美娜"},{"name":"冨田 洋輔"},{"name":"山岡 朋美"},{"name":"田中 直伸"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本薬学会第136年会(横浜)","ja":"日本薬学会第136年会(横浜)"},"publication_date":"2016-03-27","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:291, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311517","label":"url"}],"presentation_title":{"en":"ケルセチン生体内代謝産物 quercetin -3-O-β-Dglucuronideによる血管内皮細胞保護効果","ja":"ケルセチン生体内代謝産物 quercetin -3-O-β-Dglucuronideによる血管内皮細胞保護効果"},"presenters":{"en":[{"name":"細岡 真由子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"斎藤 尚子"},{"name":"Miyamoto Licht"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"細岡 真由子"},{"name":"石澤 有紀"},{"name":"斎藤 尚子"},{"name":"宮本 理人"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本薬学会第136年会(横浜)","ja":"日本薬学会第136年会(横浜)"},"publication_date":"2016-03-27","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:292, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311516","label":"url"}],"presentation_title":{"en":"無機リン刺激による血管平滑筋細胞石灰化におけるrho-kinase 及び cyclophilinA の関与","ja":"無機リン刺激による血管平滑筋細胞石灰化におけるrho-kinase 及び cyclophilinA の関与"},"presenters":{"en":[{"name":"鍵本 優有"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"鍵本 優有"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会第136年会(横浜)","ja":"日本薬学会第136年会(横浜)"},"publication_date":"2016-03-27","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:293, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311515","label":"url"}],"presentation_title":{"en":"慢性腎臓病におけるヘプシジン制御メカニズムの検討","ja":"慢性腎臓病におけるヘプシジン制御メカニズムの検討"},"presenters":{"en":[{"name":"Watanabe Hiroaki"},{"name":"Ikeda Yasumasa"},{"name":"Hamano Hirofumi"},{"name":"Satoh Akiho"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"渡邉 大晃"},{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"佐藤 明穂"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"日本薬学会第136年会(横浜)","ja":"日本薬学会第136年会(横浜)"},"publication_date":"2016-03-27","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:294, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311514","label":"url"}],"presentation_title":{"en":"鉄過剰による骨格筋分化抑制作用の解明","ja":"鉄過剰による骨格筋分化抑制作用の解明"},"presenters":{"en":[{"name":"佐藤 明穂"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"濱野 裕章"},{"name":"今尾 瑞季"},{"name":"渡邉 大晃"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"},{"name":"Miyamoto Licht"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"佐藤 明穂"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"濱野 裕章"},{"name":"今尾 瑞季"},{"name":"渡邉 大晃"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"},{"name":"宮本 理人"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本薬学会第136年会(横浜)","ja":"日本薬学会第136年会(横浜)"},"publication_date":"2016-03-27","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:295, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=310545","label":"url"}],"presentation_title":{"en":"Iron Supplementation Suppressed Erythropoietin Expression through HIF-dependent Pathway","ja":"Iron Supplementation Suppressed Erythropoietin Expression through HIF-dependent Pathway"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Oshima Keisuke"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"大島 啓亮"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"The 80th Annual Scientific Meeting of the Japanese Circulation Society","ja":"The 80th Annual Scientific Meeting of the Japanese Circulation Society"},"publication_date":"2016-03-19","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:296, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311502","label":"url"}],"presentation_title":{"en":"電位依存性カリウムチャネルKv2.2は腎虚血再灌流障害の軽減に関与する","ja":"電位依存性カリウムチャネルKv2.2は腎虚血再灌流障害の軽減に関与する"},"presenters":{"en":[{"name":"太田 和馬"},{"name":"Kihira Yoshitaka"},{"name":"岸渕 麗奈"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"太田 和馬"},{"name":"木平 孝高"},{"name":"岸渕 麗奈"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-11","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:297, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311498","label":"url"}],"presentation_title":{"en":"HIF-1aはアポトーシス制御因子Bcl-2及びCHAC1の発現制御を介して腎虚血再灌流障害からの回復に関与する","ja":"HIF-1aはアポトーシス制御因子Bcl-2及びCHAC1の発現制御を介して腎虚血再灌流障害からの回復に関与する"},"presenters":{"en":[{"name":"岸渕 麗奈"},{"name":"Kihira Yoshitaka"},{"name":"Yamaguchi Kunihisa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"岸渕 麗奈"},{"name":"木平 孝高"},{"name":"山口 邦久"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-11","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:298, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311496","label":"url"}],"presentation_title":{"en":"ケルセチン代謝物Q3GAによる血管内皮細胞保護効果の検討","ja":"ケルセチン代謝物Q3GAによる血管内皮細胞保護効果の検討"},"presenters":{"en":[{"name":"斎藤 尚子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"細岡 真由子"},{"name":"Kihira Yoshitaka"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"斎藤 尚子"},{"name":"石澤 有紀"},{"name":"細岡 真由子"},{"name":"木平 孝高"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-11","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:299, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311494","label":"url"}],"presentation_title":{"en":"神経突起伸長および脳卒中後神経症状に対するニトロソニフェジピンの効果","ja":"神経突起伸長および脳卒中後神経症状に対するニトロソニフェジピンの効果"},"presenters":{"en":[{"name":"青木 友里"},{"name":"Izawa-Ishizawa Yuki"},{"name":"高田 真衣"},{"name":"田渕 正樹"},{"name":"Imanishi Masaki"},{"name":"Zamami Yoshito"},{"name":"福永 豊"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"青木 友里"},{"name":"石澤 有紀"},{"name":"高田 真衣"},{"name":"田渕 正樹"},{"name":"今西 正樹"},{"name":"座間味 義人"},{"name":"福永 豊"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-10","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:300, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311492","label":"url"}],"presentation_title":{"en":"鉄のエリスロポエチン発現への影響の検討","ja":"鉄のエリスロポエチン発現への影響の検討"},"presenters":{"en":[{"name":"大島 啓亮"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"大島 啓亮"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-10","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:301, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311488","label":"url"}],"presentation_title":{"en":"鉄欠乏に伴う骨格筋萎縮メカニズム","ja":"鉄欠乏に伴う骨格筋萎縮メカニズム"},"presenters":{"en":[{"name":"佐藤 明穂"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"濱野 裕章"},{"name":"今尾 瑞季"},{"name":"渡邉 大晃"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"佐藤 明穂"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"濱野 裕章"},{"name":"今尾 瑞季"},{"name":"渡邉 大晃"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-10","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:302, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=319269","label":"url"}],"presentation_title":{"en":"Identification of an active compound on lipid metabolism from Sudachi peel","ja":"Identification of an active compound on lipid metabolism from Sudachi peel"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"Aihara Haruna"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"Tomida Yosuke"},{"name":"Yamaoka Tomomi"},{"name":"Tanaka Naonobu"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"Aihara Haruna"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"Tomida Yosuke"},{"name":"Yamaoka Tomomi"},{"name":"田中 直伸"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"薬理学会(パシフィコ)","ja":"薬理学会(パシフィコ)"},"publication_date":"2016-03-09","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:303, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311487","label":"url"}],"presentation_title":{"en":"脂質低下作用を有するスダチ果皮由来化合物の薬理作用","ja":"脂質低下作用を有するスダチ果皮由来化合物の薬理作用"},"presenters":{"en":[{"name":"Miyamoto Licht"},{"name":"粟飯原 遥菜"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"冨田 洋輔"},{"name":"山岡 朋美"},{"name":"Tanaka Naonobu"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Kashiwada Yoshiki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"宮本 理人"},{"name":"粟飯原 遥菜"},{"name":"Xu Wenting"},{"name":"Jin Meina"},{"name":"冨田 洋輔"},{"name":"山岡 朋美"},{"name":"田中 直伸"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"柏田 良樹"},{"name":"土屋 浩一郎"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-09","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:304, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311483","label":"url"}],"presentation_title":{"en":"尿毒素は慢性腎不全におけるヘプシジン発現に関与する","ja":"尿毒素は慢性腎不全におけるヘプシジン発現に関与する"},"presenters":{"en":[{"name":"濱野 裕章"},{"name":"Ikeda Yasumasa"},{"name":"渡邉 大晃"},{"name":"佐藤 明穂"},{"name":"大島 啓亮"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"渡邉 大晃"},{"name":"佐藤 明穂"},{"name":"大島 啓亮"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-09","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:305, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311472","label":"url"}],"presentation_title":{"en":"Development of endothelial dysfunction-induced aortic dissection model and search for a preventive strategy","ja":"Development of endothelial dysfunction-induced aortic dissection model and search for a preventive strategy"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Zamami Yoshito"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"座間味 義人"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第89回 日本薬理学会年会(神奈川)","ja":"第89回 日本薬理学会年会(神奈川)"},"publication_date":"2016-03-09","invited":true,"languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:306, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311463","label":"url"}],"presentation_title":{"en":"ニフェジピン光分解産物による血管リモデリング抑制効果","ja":"ニフェジピン光分解産物による血管リモデリング抑制効果"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"小原 佑介"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"小原 佑介"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第252回 徳島医学会学術集会(平成27年度冬期)","ja":"第252回 徳島医学会学術集会(平成27年度冬期)"},"publication_date":"2016-02-14","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:307, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=310544","label":"url"}],"presentation_title":{"en":"鉄のエリスロポエチン発現への影響の検討","ja":"鉄のエリスロポエチン発現への影響の検討"},"presenters":{"en":[{"name":"Oshima Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"大島 啓亮"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第45回日本心脈管作動物質学会","ja":"第45回日本心脈管作動物質学会"},"publication_date":"2016-02-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:308, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311450","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンによる抗大動脈瘤機序の検討","ja":"ニトロソニフェジピンによる抗大動脈瘤機序の検討"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"小原 佑介"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"小原 佑介"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第45回日本心脈管作動物質学会","ja":"第45回日本心脈管作動物質学会"},"publication_date":"2016-02-05","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:309, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311442","label":"url"}],"presentation_title":{"en":"高リン刺激は血管平滑筋細胞においてrho-kinase-cyclophilin A経路を活性化させる","ja":"高リン刺激は血管平滑筋細胞においてrho-kinase-cyclophilin A経路を活性化させる"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"鍵本 優有"},{"name":"斎藤 尚子"},{"name":"高田 真衣"},{"name":"Kihira Yoshitaka"},{"name":"Imanishi Masaki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"鍵本 優有"},{"name":"斎藤 尚子"},{"name":"高田 真衣"},{"name":"木平 孝高"},{"name":"今西 正樹"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第45回日本心脈管作動物質学会","ja":"第45回日本心脈管作動物質学会"},"publication_date":"2016-02-05","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:310, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=302612","label":"url"}],"presentation_title":{"en":"臓器障害における生体内鉄代謝の意義と鉄除去による病態改善効果","ja":"臓器障害における生体内鉄代謝の意義と鉄除去による病態改善効果"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"心血管代謝週間(CVMW)(第19回日本心血管内分泌代謝学会学術総会) シンポジウム","ja":"心血管代謝週間(CVMW)(第19回日本心血管内分泌代謝学会学術総会) シンポジウム"},"publication_date":"2015-12-11","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:311, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311440","label":"url"}],"presentation_title":{"en":"慢性腎臓病におけるヘプシジン制御メカニズムの検討","ja":"慢性腎臓病におけるヘプシジン制御メカニズムの検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"濱野 裕章"},{"name":"渡邉 大晃"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"濱野 裕章"},{"name":"渡邉 大晃"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第25回日本循環薬理学会","ja":"第25回日本循環薬理学会"},"publication_date":"2015-12-04","languages":["jpn"],"location":{"en":"Nara","ja":"奈良"},"is_international_presentation":false},"priority":"input_data"} line:312, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311439","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの 生命予後を改善する","ja":"ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの 生命予後を改善する"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"高田 真衣"},{"name":"田渕 正樹"},{"name":"Imanishi Masaki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"高田 真衣"},{"name":"田渕 正樹"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第25回日本循環薬理学会","ja":"第25回日本循環薬理学会"},"publication_date":"2015-12-04","languages":["jpn"],"location":{"en":"Nara","ja":"奈良"},"is_international_presentation":false},"priority":"input_data"} line:313, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311438","label":"url"}],"presentation_title":{"en":"大動脈解離発症における内皮障害の関与","ja":"大動脈解離発症における内皮障害の関与"},"presenters":{"en":[{"name":"斎藤 尚子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"戸谷 紘基"},{"name":"Imanishi Masaki"},{"name":"鍵本 優有"},{"name":"細岡 真由子"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"斎藤 尚子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"戸谷 紘基"},{"name":"今西 正樹"},{"name":"鍵本 優有"},{"name":"細岡 真由子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第25回日本循環薬理学会","ja":"第25回日本循環薬理学会"},"publication_date":"2015-12-04","languages":["jpn"],"location":{"en":"Nara","ja":"奈良"},"is_international_presentation":false},"priority":"input_data"} line:314, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311436","label":"url"}],"presentation_title":{"en":"慢性腎不全における尿毒素によるヘプシジン制御機構","ja":"慢性腎不全における尿毒素によるヘプシジン制御機構"},"presenters":{"en":[{"name":"Hamano Hirofumi"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Satoh Akiho"},{"name":"Watanabe Hiroaki"},{"name":"Oshima Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"濱野 裕章"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"佐藤 明穂"},{"name":"渡邉 大晃"},{"name":"大島 啓亮"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第128回日本薬理学会近畿部会","ja":"第128回日本薬理学会近畿部会"},"publication_date":"2015-11-20","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:315, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311364","label":"url"}],"presentation_title":{"en":"鉄蓄積によって引き起こされる骨格筋萎縮のメカニズム","ja":"鉄蓄積によって引き起こされる骨格筋萎縮のメカニズム"},"presenters":{"en":[{"name":"今尾 瑞季"},{"name":"Ikeda Yasumasa"},{"name":"佐藤 明穂"},{"name":"濱野 裕章"},{"name":"Horinouchi Yuya"},{"name":"Miyamoto Licht"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"今尾 瑞季"},{"name":"池田 康将"},{"name":"佐藤 明穂"},{"name":"濱野 裕章"},{"name":"堀ノ内 裕也"},{"name":"宮本 理人"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2015-11-01","languages":["jpn"],"location":{"en":"Kochi","ja":"高知"},"is_international_presentation":false},"priority":"input_data"} line:316, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311360","label":"url"}],"presentation_title":{"en":"悪性脳卒中易発性高血圧自然発症ラットの神経症状に対するニトロソニフェジピンの効果","ja":"悪性脳卒中易発性高血圧自然発症ラットの神経症状に対するニトロソニフェジピンの効果"},"presenters":{"en":[{"name":"高田 真衣"},{"name":"Ishizawa Keisuke"},{"name":"田渕 正樹"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"高田 真衣"},{"name":"石澤 啓介"},{"name":"田渕 正樹"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2015-11-01","languages":["jpn"],"location":{"en":"Kochi","ja":"高知"},"is_international_presentation":false},"priority":"input_data"} line:317, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=311356","label":"url"}],"presentation_title":{"en":"大動脈解離発症における内皮障害の関与の検討","ja":"大動脈解離発症における内皮障害の関与の検討"},"presenters":{"en":[{"name":"戸谷 紘基"},{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"細岡 真由子"},{"name":"鍵本 優有"},{"name":"斎藤 尚子"},{"name":"Miyamoto Licht"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"戸谷 紘基"},{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"細岡 真由子"},{"name":"鍵本 優有"},{"name":"斎藤 尚子"},{"name":"宮本 理人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第54回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2015-11-01","languages":["jpn"],"location":{"en":"Kochi","ja":"高知"},"is_international_presentation":false},"priority":"input_data"} line:318, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=302605","label":"url"}],"presentation_title":{"en":"鉄欠乏は骨格筋量減少の原因となる","ja":"鉄欠乏は骨格筋量減少の原因となる"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"佐藤 明穂"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"佐藤 明穂"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第39回日本鉄バイオサイエンス学会学術集会","ja":"第39回日本鉄バイオサイエンス学会学術集会"},"publication_date":"2015-08-30","languages":["jpn"],"location":{"en":"Okayama","ja":"岡山"},"is_international_presentation":false},"priority":"input_data"} line:319, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=303118","label":"url"}],"presentation_title":{"en":"YC1 increased adiponectin expression in 3T3-L1 adipocytes","ja":"YC1 increased adiponectin expression in 3T3-L1 adipocytes"},"presenters":{"en":[{"name":"Burentogtokh Ariunzaya"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Burentogtokh Ariunzaya"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム2015","ja":"次世代を担う創薬・医療薬理シンポジウム2015"},"publication_date":"2015-08-29","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:320, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=301261","label":"url"}],"presentation_title":{"en":"血管石灰化シグナルにおけるRhoキナーゼおよびサイクロフィリンAの関与","ja":"血管石灰化シグナルにおけるRhoキナーゼおよびサイクロフィリンAの関与"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"大越 瑞穂"},{"name":"土肥 紗希子"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"大越 瑞穂"},{"name":"土肥 紗希子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"}]},"event":{"en":"第47回日本動脈硬化学会総会・学術集会","ja":"第47回日本動脈硬化学会総会・学術集会"},"publication_date":"2015-07-10","languages":["jpn"],"location":{"en":"Sendai","ja":"仙台"},"is_international_presentation":false},"priority":"input_data"} line:321, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=299388","label":"url"}],"presentation_title":{"en":"心血管病におけるアンドロゲン-AR系の役割","ja":"心血管病におけるアンドロゲン-AR系の役割"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"松本 俊夫"}]},"event":{"en":"第33回 内分泌代謝学サマーセミナー","ja":"第33回 内分泌代謝学サマーセミナー"},"publication_date":"2015-07-09","languages":["jpn"],"location":{"en":"Fukuoka","ja":"福岡"},"is_international_presentation":false},"priority":"input_data"} line:322, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=294509","label":"url"}],"presentation_title":{"en":"心血管疾患における男性ホルモンの意義","ja":"心血管疾患における男性ホルモンの意義"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Akaike Masashi"},{"name":"Tamaki Toshiaki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"赤池 雅史"},{"name":"玉置 俊晃"},{"name":"松本 俊夫"}]},"event":{"en":"第15回日本抗加齢医学会総会 シンポジウム「知って得するテストステロンアップデート」","ja":"第15回日本抗加齢医学会総会 シンポジウム「知って得するテストステロンアップデート」"},"publication_date":"2015-05-29","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:323, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=301272","label":"url"}],"presentation_title":{"en":"Bilirubin Promotes Ischemic-Induced Revascularization through Akt-eNOS Pathway","ja":"Bilirubin Promotes Ischemic-Induced Revascularization through Akt-eNOS Pathway"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Yusuke Kanai"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Yusuke Kanai"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第79回 日本循環器学会学術集会","ja":"第79回 日本循環器学会学術集会"},"publication_date":"2015-04-24","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:324, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=292230","label":"url"}],"presentation_title":{"en":"腎虚血再灌流障害において低酸素誘導因子が制御する因子の探索","ja":"腎虚血再灌流障害において低酸素誘導因子が制御する因子の探索"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"岸渕 麗奈"},{"name":"Yamaguchi Kunihisa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"岸渕 麗奈"},{"name":"山口 邦久"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第135年会(神戸)","ja":"日本薬学会第135年会(神戸)"},"publication_date":"2015-03-28","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:325, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=293233","label":"url"}],"presentation_title":{"en":"悪性脳卒中易発性高血圧自然発症ラットに対するニトロソニフェジピンの効果","ja":"悪性脳卒中易発性高血圧自然発症ラットに対するニトロソニフェジピンの効果"},"presenters":{"en":[{"name":"Takata Mai"},{"name":"Ishizawa Keisuke"},{"name":"田渕 正樹"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"高田 真衣"},{"name":"石澤 啓介"},{"name":"田渕 正樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"日本薬学会第135年会(神戸)","ja":"日本薬学会第135年会(神戸)"},"publication_date":"2015-03-26","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:326, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=293231","label":"url"}],"presentation_title":{"en":"ビリルビンは虚血後血管新生を促進する","ja":"ビリルビンは虚血後血管新生を促進する"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第88回 日本薬理学会年会(愛知)","ja":"第88回 日本薬理学会年会(愛知)"},"publication_date":"2015-03-20","languages":["jpn"],"location":{"en":"Nagoya","ja":"名古屋"},"is_international_presentation":false},"priority":"input_data"} line:327, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=293225","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの生存期間を延長させる","ja":"ニトロソニフェジピンは悪性脳卒中易発性高血圧自然発症ラットの生存期間を延長させる"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"田渕 正樹"},{"name":"Takata Mai"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"田渕 正樹"},{"name":"高田 真衣"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第88回 日本薬理学会年会(愛知)","ja":"第88回 日本薬理学会年会(愛知)"},"publication_date":"2015-03-20","languages":["jpn"],"location":{"en":"Nagoya","ja":"名古屋"},"is_international_presentation":false},"priority":"input_data"} line:328, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=293224","label":"url"}],"presentation_title":{"en":"大動脈解離発症における血管内皮機能障害の関与","ja":"大動脈解離発症における血管内皮機能障害の関与"},"presenters":{"en":[{"name":"Toya Hiroki"},{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kohara Yusuke"},{"name":"Nagao Tomoko"},{"name":"今西 正樹"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"戸谷 紘基"},{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"小原 佑介"},{"name":"長尾 朋子"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第88回 日本薬理学会年会(愛知)","ja":"第88回 日本薬理学会年会(愛知)"},"publication_date":"2015-03-19","languages":["jpn"],"location":{"en":"Nagoya","ja":"名古屋"},"is_international_presentation":false},"priority":"input_data"} line:329, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=292236","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible factor-1 participates in induction of apoptosis in renal reperfusion injury","ja":"低酸素誘導因子-1αは腎虚血再灌流障害においてアボトーシスの誘導に関与する"},"presenters":{"en":[{"name":"岸渕 麗奈"},{"name":"Kihira Yoshitaka"},{"name":"Yamaguchi Kunihisa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"岸渕 麗奈"},{"name":"木平 孝高"},{"name":"山口 邦久"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第88回 日本薬理学会年会(愛知)","ja":"第88回 日本薬理学会年会(愛知)"},"publication_date":"2015-03-19","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:330, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=293223","label":"url"}],"presentation_title":{"en":"血管平滑筋細胞において無機リンによる石灰化シグナルにはRho-kinaseおよびcyclophilin Aが関与する","ja":"血管平滑筋細胞において無機リンによる石灰化シグナルにはRho-kinaseおよびcyclophilin Aが関与する"},"presenters":{"en":[{"name":"Ogoshi Mizuho"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Doi Sakiko"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"大越 瑞穂"},{"name":"石澤 有紀"},{"name":"土肥 紗希子"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第88回 日本薬理学会年会(愛知)","ja":"第88回 日本薬理学会年会(愛知)"},"publication_date":"2015-03-18","languages":["eng"],"location":{"en":"Nagoya","ja":"Nagoya"},"is_international_presentation":false},"priority":"input_data"} line:331, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=292239","label":"url"}],"presentation_title":{"en":"Hypoxia decreases glucagon-like peptide-1 secretion from glutag cell lines","ja":"Hypoxia decreases glucagon-like peptide-1 secretion from glutag cell lines"},"presenters":{"en":[{"name":"Ariunzaya Burentogtokh"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"Ariunzaya Burentogtokh"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第88回 日本薬理学会年会(愛知)","ja":"第88回 日本薬理学会年会(愛知)"},"publication_date":"2015-03-18","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:332, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287097","label":"url"}],"presentation_title":{"en":"ビリルビンの血管新生促進作用の検討","ja":"ビリルビンの血管新生促進作用の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"金井 佑亮"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"金井 佑亮"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第44回 日本心脈管作動物質学会","ja":"第44回 日本心脈管作動物質学会"},"publication_date":"2015-02-06","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:333, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287099","label":"url"}],"presentation_title":{"en":"ビリルビンは血管内皮細胞を活性化させて,虚血後血管新生を促進する","ja":"ビリルビンは血管内皮細胞を活性化させて,虚血後血管新生を促進する"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"金井 佑亮"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"金井 佑亮"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第24回 循環薬理学会","ja":"第24回 循環薬理学会"},"publication_date":"2014-12-05","languages":["jpn"],"location":{"en":"Yamagata","ja":"山形"},"is_international_presentation":false},"priority":"input_data"} line:334, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287098","label":"url"}],"presentation_title":{"en":"新規薬剤誘発性大動脈解離モデルを用いたスタチンの効果の検討","ja":"新規薬剤誘発性大動脈解離モデルを用いたスタチンの効果の検討"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"長尾 朋子"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"細岡 真由子"},{"name":"高田 真衣"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"長尾 朋子"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"細岡 真由子"},{"name":"高田 真衣"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第24回 循環薬理学会","ja":"第24回 循環薬理学会"},"publication_date":"2014-12-05","languages":["jpn"],"location":{"en":"Yamagata","ja":"山形"},"is_international_presentation":false},"priority":"input_data"} line:335, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=288203","label":"url"}],"presentation_title":{"en":"低酸素誘導因子の機能不全は腎虚血再灌流障害からの回復を阻害する","ja":"低酸素誘導因子の機能不全は腎虚血再灌流障害からの回復を阻害する"},"presenters":{"en":[{"name":"岸渕 麗奈"},{"name":"Kihira Yoshitaka"},{"name":"Yamaguchi Kunihisa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"岸渕 麗奈"},{"name":"木平 孝高"},{"name":"山口 邦久"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第36回 生体膜と薬物の相互作用シンポジウム","ja":"第36回 生体膜と薬物の相互作用シンポジウム"},"publication_date":"2014-11-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:336, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=288202","label":"url"}],"presentation_title":{"en":"高脂肪食誘発肥満に対する脂肪特異的低酸素誘導因子欠損の影響","ja":"高脂肪食誘発肥満に対する脂肪特異的低酸素誘導因子欠損の影響"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第36回 生体膜と薬物の相互作用シンポジウム","ja":"第36回 生体膜と薬物の相互作用シンポジウム"},"publication_date":"2014-11-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:337, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397015","label":"url"}],"presentation_title":{"en":"HMG-CoA 還元酵素阻害薬の大動脈解離に対する効果","ja":"HMG-CoA 還元酵素阻害薬の大動脈解離に対する効果"},"presenters":{"en":[{"name":"長尾 朋子"},{"name":"Ishizawa Keisuke"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"長尾 朋子"},{"name":"石澤 啓介"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2014-11-08","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:338, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287121","label":"url"}],"presentation_title":{"en":"HMG-CoA 還元酵素阻害薬の大動脈解離に対する効果","ja":"HMG-CoA 還元酵素阻害薬の大動脈解離に対する効果"},"presenters":{"en":[{"name":"長尾 朋子"},{"name":"Ishizawa Keisuke"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"今西 正樹"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"長尾 朋子"},{"name":"石澤 啓介"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2014-11-08","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:339, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287120","label":"url"}],"presentation_title":{"en":"大動脈瘤形成に対する新規抗酸化薬の効果","ja":"大動脈瘤形成に対する新規抗酸化薬の効果"},"presenters":{"en":[{"name":"小原 佑介"},{"name":"Ishizawa Keisuke"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"今西 正樹"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"小原 佑介"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第53回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2014-11-08","languages":["jpn"],"location":{"en":"Hiroshima","ja":"広島"},"is_international_presentation":false},"priority":"input_data"} line:340, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287094","label":"url"}],"presentation_title":{"en":"低酸素誘導因子の腎虚血再灌流障害に対する役割","ja":"低酸素誘導因子の腎虚血再灌流障害に対する役割"},"presenters":{"en":[{"name":"岸渕 麗奈"},{"name":"Kihira Yoshitaka"},{"name":"Yamaguchi Kunihisa"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"岸渕 麗奈"},{"name":"木平 孝高"},{"name":"山口 邦久"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第126回日本薬理学会近畿部会","ja":"第126回日本薬理学会近畿部会"},"publication_date":"2014-10-24","languages":["jpn"],"location":{"en":"Wakayama","ja":"和歌山"},"is_international_presentation":false},"priority":"input_data"} line:341, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287093","label":"url"}],"presentation_title":{"en":"大動脈解離に対するピタバスタチンの効果","ja":"大動脈解離に対するピタバスタチンの効果"},"presenters":{"en":[{"name":"長尾 朋子"},{"name":"Ishizawa Keisuke"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"今西 正樹"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"長尾 朋子"},{"name":"石澤 啓介"},{"name":"戸谷 紘基"},{"name":"小原 佑介"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第126回日本薬理学会近畿部会","ja":"第126回日本薬理学会近畿部会"},"publication_date":"2014-10-24","languages":["jpn"],"location":{"en":"Wakayama","ja":"和歌山"},"is_international_presentation":false},"priority":"input_data"} line:342, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287103","label":"url"}],"presentation_title":{"en":"鉄による骨格筋萎縮メカニズムの検討","ja":"鉄による骨格筋萎縮メカニズムの検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"今尾 瑞季"},{"name":"佐藤 明穂"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"今尾 瑞季"},{"name":"佐藤 明穂"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本鉄バイオサイエンス学会 第38回学術集会","ja":"日本鉄バイオサイエンス学会 第38回学術集会"},"publication_date":"2014-09-07","languages":["jpn"],"location":{"en":"Sendai","ja":"仙台"},"is_international_presentation":false},"priority":"input_data"} line:343, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287117","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンは大動脈瘤の形成を抑制する","ja":"ニトロソニフェジピンは大動脈瘤の形成を抑制する"},"presenters":{"en":[{"name":"小原 佑介"},{"name":"Ishizawa Keisuke"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"小原 佑介"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"細岡 真由子"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム 2014","ja":"次世代を担う創薬・医療薬理シンポジウム 2014"},"publication_date":"2014-08-30","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:344, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=287116","label":"url"}],"presentation_title":{"en":"血管内皮障害を介する新規大動脈解離モデルの作製","ja":"血管内皮障害を介する新規大動脈解離モデルの作製"},"presenters":{"en":[{"name":"戸谷 紘基"},{"name":"Ishizawa Keisuke"},{"name":"小原 佑介"},{"name":"長尾 朋子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"戸谷 紘基"},{"name":"石澤 啓介"},{"name":"小原 佑介"},{"name":"長尾 朋子"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム 2014","ja":"次世代を担う創薬・医療薬理シンポジウム 2014"},"publication_date":"2014-08-30","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:345, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=305561","label":"url"}],"presentation_title":{"en":"食事による血中NOレベル変動の検討","ja":"食事による血中NOレベル変動の検討"},"presenters":{"en":[{"name":"矢野 友章"},{"name":"Miyamoto Licht"},{"name":"竹之熊 和也"},{"name":"福田 恵介"},{"name":"津田 勝範"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"矢野 友章"},{"name":"宮本 理人"},{"name":"竹之熊 和也"},{"name":"福田 恵介"},{"name":"津田 勝範"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第249回徳島医学会","ja":"第249回徳島医学会"},"publication_date":"2014-07-27","languages":["jpn"],"location":{"en":"徳島","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:346, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=297620","label":"url"}],"presentation_title":{"en":"動脈硬化および虚血に対するeNOS非依存的なピタバスタチンの臓器保護効果の検討","ja":"動脈硬化および虚血に対するeNOS非依存的なピタバスタチンの臓器保護効果の検討"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"上元 良子"},{"name":"石川 カズ江"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"上元 良子"},{"name":"石川 カズ江"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第46回日本動脈硬化学会総会・学術集会","ja":"第46回日本動脈硬化学会総会・学術集会"},"publication_date":"2014-07-11","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:347, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=283620","label":"url"}],"presentation_title":{"en":"薬剤誘導性大動脈瘤モデルに対するニトロソニフェジピンの効果","ja":"薬剤誘導性大動脈瘤モデルに対するニトロソニフェジピンの効果"},"presenters":{"en":[{"name":"小原 佑介"},{"name":"Ishizawa Keisuke"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"小原 佑介"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"戸谷 紘基"},{"name":"長尾 朋子"},{"name":"壱岐 豊"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第125回日本薬理学会近畿部会","ja":"第125回日本薬理学会近畿部会"},"publication_date":"2014-06-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:348, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=279277","label":"url"}],"presentation_title":{"en":"アンジオテンシンIIは鉄吸収制御と生体内鉄分布変化に関与する","ja":"アンジオテンシンIIは鉄吸収制御と生体内鉄分布変化に関与する"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Miyamoto Licht"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"宮本 理人"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第125回日本薬理学会近畿部会","ja":"第125回日本薬理学会近畿部会"},"publication_date":"2014-06-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:349, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=283871","label":"url"}],"presentation_title":{"en":"血管リモデリングにおける低酸素誘導因子HIF-1αの役割","ja":"血管リモデリングにおける低酸素誘導因子HIF-1αの役割"},"presenters":{"en":[{"name":"今西 正樹"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第134年会","ja":"日本薬学会第134年会"},"publication_date":"2014-03-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:350, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=277010","label":"url"}],"presentation_title":{"en":"腸管L細胞のグルカゴン様ペプチド-1分泌に対する低酸素の影響","ja":"腸管L細胞のグルカゴン様ペプチド-1分泌に対する低酸素の影響"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"BURENTOGTOKH Ariunzaya"},{"name":"Itoh Mari"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"Ariunzaya Burentogtokh"},{"name":"伊藤 麻里"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第134年会","ja":"日本薬学会第134年会"},"publication_date":"2014-03-27","languages":["jpn"],"location":{"en":"熊本","ja":"熊本"},"is_international_presentation":false},"priority":"input_data"} line:351, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=283631","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine ameliorates the progression of renal disease associated with endothelial dysfunction independently of eNOS","ja":"ニトロソニフェジピンはeNOS非依存的に内皮障害を伴う腎障害の進展を抑制する"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Yamano Noriko"},{"name":"布 あさ美"},{"name":"今西 正樹"},{"name":"櫻田 巧"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"山野 範子"},{"name":"布 あさ美"},{"name":"今西 正樹"},{"name":"櫻田 巧"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第87回日本薬理学会年会","ja":"第87回日本薬理学会年会"},"publication_date":"2014-03-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:352, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=279396","label":"url"}],"presentation_title":{"en":"The mechanism of sj=keletal muscle atroph induced by iron","ja":"鉄によって引き起こされる骨格筋萎縮のメカニズム"},"presenters":{"en":[{"name":"Imao Mizuki"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今尾 瑞季"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第87回日本薬理学会年会","ja":"第87回日本薬理学会年会"},"publication_date":"2014-03-20","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:353, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=279389","label":"url"}],"presentation_title":{"en":"The effects of iron reduction on obesity, diabetes and diabetic complications","ja":"鉄除去・鉄制限による肥満・糖尿病とその合併症の改善効果"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"第87回日本薬理学会年会","ja":"第87回日本薬理学会年会"},"publication_date":"2014-03-20","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:354, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=275179","label":"url"}],"presentation_title":{"en":"アンジオテンシンIIは十二指腸鉄輸送体発現とマクロファージ鉄量を増加させる","ja":"アンジオテンシンIIは十二指腸鉄輸送体発現とマクロファージ鉄量を増加させる"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第43回日本心脈管作動物質学会","ja":"第43回日本心脈管作動物質学会"},"publication_date":"2014-02-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:355, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274318","label":"url"}],"presentation_title":{"en":"薬剤誘導性大動脈瘤モデルにおける平滑筋由来hypoxia-inducible factor-1αの役割","ja":"薬剤誘導性大動脈瘤モデルにおける平滑筋由来hypoxia-inducible factor-1αの役割"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Kurobe Hirotsugu"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"黒部 裕嗣"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第23回日本循環薬理学会","ja":"第23回日本循環薬理学会"},"publication_date":"2013-12-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:356, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=286864","label":"url"}],"presentation_title":{"en":"血管内皮細胞特異的HIF-2α強制発現マウスを用いた虚血皮弁モデルの作製と検討","ja":"血管内皮細胞特異的HIF-2α強制発現マウスを用いた虚血皮弁モデルの作製と検討"},"presenters":{"en":[{"name":"Morimoto Atsushi"},{"name":"Tomita Shuhei"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Hashimoto Ichiro"},{"name":"高久 暢"},{"name":"Nakanishi Hideki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"森本 篤志"},{"name":"冨田 修平"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"橋本 一郎"},{"name":"高久 暢"},{"name":"中西 秀樹"},{"name":"玉置 俊晃"}]},"event":{"en":"第22回 日本形成外科学会基礎学術集会","ja":"第22回 日本形成外科学会基礎学術集会"},"publication_date":"2013-11-07","languages":["jpn"],"location":{"en":"Niigata","ja":"新潟"},"is_international_presentation":false},"priority":"input_data"} line:357, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273306","label":"url"}],"presentation_title":{"en":"肥満に伴う脂肪組織炎症に対する低酸素誘導因子の役割","ja":"肥満に伴う脂肪組織炎症に対する低酸素誘導因子の役割"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第124回日本薬理学会近畿部会","ja":"第124回日本薬理学会近畿部会"},"publication_date":"2013-11-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:358, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273305","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンは血管内皮機能を改善することで糖尿病性腎症の進展を抑制する","ja":"ニトロソニフェジピンは血管内皮機能を改善することで糖尿病性腎症の進展を抑制する"},"presenters":{"en":[{"name":"布 あさ美"},{"name":"Ishizawa Keisuke"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"櫻田 巧"},{"name":"Imanishi Masaki"},{"name":"Miyamoto Licht"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"布 あさ美"},{"name":"石澤 啓介"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"宮本 理人"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2013-10-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:359, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273303","label":"url"}],"presentation_title":{"en":"平滑筋由来HIF-1 αがアンジオテンシンII 誘発血管リモデリングに関与するメカニズム","ja":"平滑筋由来HIF-1 αがアンジオテンシンII 誘発血管リモデリングに関与するメカニズム"},"presenters":{"en":[{"name":"Suzuki Yuta"},{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"鈴木 雄太"},{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2013-10-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:360, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273302","label":"url"}],"presentation_title":{"en":"血管傷害モデルに伴う血管リモデリングにおける骨髄由来細胞のHIF1 αの役割","ja":"血管傷害モデルに伴う血管リモデリングにおける骨髄由来細胞のHIF1 αの役割"},"presenters":{"en":[{"name":"Murakami Masaki"},{"name":"Maeda Yusaku"},{"name":"Tomita Shuhei"},{"name":"Imanishi Masaki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"村上 正樹"},{"name":"前田 悠作"},{"name":"冨田 修平"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2013-10-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:361, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273301","label":"url"}],"presentation_title":{"en":"脂肪細胞の低酸素誘導因子欠損による耐糖能改善メカニズムの解析","ja":"脂肪細胞の低酸素誘導因子欠損による耐糖能改善メカニズムの解析"},"presenters":{"en":[{"name":"Miyake Mariko"},{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"三宅 真理子"},{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第52回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2013-10-27","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:362, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274341","label":"url"}],"presentation_title":{"en":"フェリチンの炎症惹起作用","ja":"フェリチンの炎症惹起作用"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Imao Mizuki"},{"name":"Horinouchi Yuya"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"今尾 瑞季"},{"name":"堀ノ内 裕也"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第37回日本鉄バイオサイエンス学会","ja":"第37回日本鉄バイオサイエンス学会"},"publication_date":"2013-09-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:363, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273299","label":"url"}],"presentation_title":{"en":"血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する","ja":"血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する"},"presenters":{"en":[{"name":"Murakami Masaki"},{"name":"Tomita Shuhei"},{"name":"Maeda Yusaku"},{"name":"Imanishi Masaki"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"村上 正樹"},{"name":"冨田 修平"},{"name":"前田 悠作"},{"name":"今西 正樹"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム2013","ja":"次世代を担う創薬・医療薬理シンポジウム2013"},"publication_date":"2013-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:364, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273297","label":"url"}],"presentation_title":{"en":"糖尿病性腎症における腎内局所アンジオテンシノーゲンに対するニトロソニフェジピンの効果","ja":"糖尿病性腎症における腎内局所アンジオテンシノーゲンに対するニトロソニフェジピンの効果"},"presenters":{"en":[{"name":"Yamano Noriko"},{"name":"Ishizawa Keisuke"},{"name":"小堀 浩幸"},{"name":"Urushihara Maki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山野 範子"},{"name":"石澤 啓介"},{"name":"小堀 浩幸"},{"name":"漆原 真樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第123回日本薬理学会近畿部会","ja":"第123回日本薬理学会近畿部会"},"publication_date":"2013-07-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:365, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376316"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273296","label":"url"}],"presentation_title":{"en":"血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に関与するメカニズムの解析","ja":"血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に関与するメカニズムの解析"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第34回日本炎症・再生医学会","ja":"第34回日本炎症・再生医学会"},"publication_date":"2013-07-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:366, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=274313","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンは血管内皮保護作用を示して糖尿病性腎症進展を抑制する","ja":"ニトロソニフェジピンは血管内皮保護作用を示して糖尿病性腎症進展を抑制する"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"櫻田 巧"},{"name":"Imanishi Masaki"},{"name":"Nuno Asami"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"布 あさ美"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第56回日本腎臓学会学術総会","ja":"第56回日本腎臓学会学術総会"},"publication_date":"2013-05-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:367, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266781","label":"url"}],"presentation_title":{"en":"アンドロゲン受容体は性差非依存的にVEGF受容体を介して虚血反応性血管新生を促進する","ja":"アンドロゲン受容体は性差非依存的にVEGF受容体を介して虚血反応性血管新生を促進する"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Sakari Matomo"},{"name":"Matsumoto Takahiro"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"盛 真友"},{"name":"松本 高広"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第86回日本内分泌学会学術総会","ja":"第86回日本内分泌学会学術総会"},"publication_date":"2013-04-26","languages":["jpn"],"location":{"en":"Sendai","ja":"仙台"},"is_international_presentation":false},"priority":"input_data"} line:368, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260860","label":"url"}],"presentation_title":{"en":"酸化ストレスに起因する心腎血管障害の克服を目指す新規治療薬開発","ja":"酸化ストレスに起因する心腎血管障害の克服を目指す新規治療薬開発"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"石澤 有紀"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第133年会","ja":"日本薬学会第133年会"},"publication_date":"2013-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:369, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260859","label":"url"}],"presentation_title":{"en":"糖尿病に対する鉄の関与とキレート療法","ja":"糖尿病に対する鉄の関与とキレート療法"},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Yamano Noriko"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"山野 範子"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第133年会","ja":"日本薬学会第133年会"},"publication_date":"2013-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:370, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260856","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible factor-1a; in vascular smooth muscle cells contributes to AT1 receptor expression in angiotensin II-induced vascular remodeling in mice","ja":"Hypoxia-inducible factor-1a; in vascular smooth muscle cells contributes to AT1 receptor expression in angiotensin II-induced vascular remodeling in mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:371, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260853","label":"url"}],"presentation_title":{"en":"Secretion of glucagon-like peptide-1 from Intestinal L cell in hypoxia","ja":"Secretion of glucagon-like peptide-1 from Intestinal L cell in hypoxia"},"presenters":{"en":[{"name":"Itoh Mari"},{"name":"Kihira Yoshitaka"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"伊藤 麻里"},{"name":"木平 孝高"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:372, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260852","label":"url"}],"presentation_title":{"en":"The influence of angiotensin II on duodenal iron absorption","ja":"The influence of angiotensin II on duodenal iron absorption"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"Sakurada Takumi"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"櫻田 巧"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:373, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260848","label":"url"}],"presentation_title":{"en":"Bovine lactoferrin stimulated angiogenesis in response to ischemic hindlimb","ja":"Bovine lactoferrin stimulated angiogenesis in response to ischemic hindlimb"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-23","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:374, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260846","label":"url"}],"presentation_title":{"en":"Y-27632, a rho-kinase inhibitor, inhibits inorganic phosphate-induced ERK1/2 phosphorylation and ALP activity in vascular smooth muscle cells","ja":"Y-27632, a rho-kinase inhibitor, inhibits inorganic phosphate-induced ERK1/2 phosphorylation and ALP activity in vascular smooth muscle cells"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Doi Sakiko"},{"name":"Imanishi Masaki"},{"name":"Sakurada Takumi"},{"name":"Yamano Noriko"},{"name":"Kohara Yusuke"},{"name":"Nagao Tomoko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"土肥 紗希子"},{"name":"今西 正樹"},{"name":"櫻田 巧"},{"name":"山野 範子"},{"name":"小原 祐介"},{"name":"長尾 朋子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:375, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260844","label":"url"}],"presentation_title":{"en":"The Effects of Iron chelatoion against Renal Fibrosis in Unilateral Ureteral Obstruction Mice Model","ja":"The Effects of Iron chelatoion against Renal Fibrosis in Unilateral Ureteral Obstruction Mice Model"},"presenters":{"en":[{"name":"Ohzono Iori"},{"name":"Ikeda Yasumasa"},{"name":"Tajima Souichirou"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"大園 伊織"},{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:376, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260842","label":"url"}],"presentation_title":{"en":"Adipocyte-specific hypoxia-inducible factor-1alpha knockout stimulated GLP-1 and insulin secretions in mice","ja":"Adipocyte-specific hypoxia-inducible factor-1alpha knockout stimulated GLP-1 and insulin secretions in mice"},"presenters":{"en":[{"name":"Hoshina Yoji"},{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Miyake Mariko"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"保科 耀司"},{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"三宅 真理子"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:377, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260840","label":"url"}],"presentation_title":{"en":"Effects of nitrosonifedipine on the diabetic nephropathy with the endothelial dysfunction","ja":"Effects of nitrosonifedipine on the diabetic nephropathy with the endothelial dysfunction"},"presenters":{"en":[{"name":"Yamano Noriko"},{"name":"Ishizawa Keisuke"},{"name":"Fujii Shoko"},{"name":"Nuno Asami"},{"name":"Imanishi Masaki"},{"name":"Sakurada Takumi"},{"name":"Suzuki Yuta"},{"name":"Endo Furi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山野 範子"},{"name":"石澤 啓介"},{"name":"藤井 聖子"},{"name":"布 あさ美"},{"name":"今西 正樹"},{"name":"櫻田 巧"},{"name":"鈴木 雄太"},{"name":"遠藤 ふうり"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第86回日本薬理学会年会","ja":"第86回日本薬理学会年会"},"publication_date":"2013-03-21","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:378, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260814","label":"url"}],"presentation_title":{"en":"Low Iron Diet Limits Development of Diabetic Nephropathy In db/db Mice","ja":"Low Iron Diet Limits Development of Diabetic Nephropathy In db/db Mice"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第77回日本循環器学会学術集会","ja":"第77回日本循環器学会学術集会"},"publication_date":"2013-03-16","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:379, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260812","label":"url"}],"presentation_title":{"en":"ニトロソニフェジピンは血管内皮細胞障害を伴う糖尿病性腎症の進展を抑制する","ja":"ニトロソニフェジピンは血管内皮細胞障害を伴う糖尿病性腎症の進展を抑制する"},"presenters":{"en":[{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Yamano Noriko"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Fujii Shoko"},{"name":"Nuno Asami"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"山野 範子"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"藤井 聖子"},{"name":"布 あさ美"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第42回日本心脈管作動物質学会","ja":"第42回日本心脈管作動物質学会"},"publication_date":"2013-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:380, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260811","label":"url"}],"presentation_title":{"en":"鉄制限食によってdb/dbマウスの糖尿病性腎症進展は抑制される","ja":"鉄制限食によってdb/dbマウスの糖尿病性腎症進展は抑制される"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第42回日本心脈管作動物質学会","ja":"第42回日本心脈管作動物質学会"},"publication_date":"2013-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:381, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260810","label":"url"}],"presentation_title":{"en":"無機リン刺激による血管平滑筋細胞石灰化におけるRho-kinaseの関与","ja":"無機リン刺激による血管平滑筋細胞石灰化におけるRho-kinaseの関与"},"presenters":{"en":[{"name":"Doi Sakiko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Kohara Yusuke"},{"name":"Nagao Tomoko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土肥 紗希子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"小原 祐介"},{"name":"長尾 朋子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第42回日本心脈管作動物質学会","ja":"第42回日本心脈管作動物質学会"},"publication_date":"2013-02-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:382, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=260809","label":"url"}],"presentation_title":{"en":"脂肪細胞特異的低酸素誘導因子欠損マウスに観察される耐糖能の改善にはglucagon-like peptide-1が関与する","ja":"脂肪細胞特異的低酸素誘導因子欠損マウスに観察される耐糖能の改善にはglucagon-like peptide-1が関与する"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Miyake Mariko"},{"name":"Hoshina Yoji"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"三宅 真理子"},{"name":"保科 耀司"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第42回日本心脈管作動物質学会","ja":"第42回日本心脈管作動物質学会"},"publication_date":"2013-02-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:383, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259227","label":"url"}],"presentation_title":{"en":"Angiotensin II慢性投与はhypoxia-inducible factor-1αを介して血管リモデリングを惹起する","ja":"Angiotensin II慢性投与はhypoxia-inducible factor-1αを介して血管リモデリングを惹起する"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Suzuki Yuta"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"鈴木 雄太"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第33回日本臨床薬理学会学術総会","ja":"第33回日本臨床薬理学会学術総会"},"publication_date":"2012-12-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:384, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376317"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259226","label":"url"}],"presentation_title":{"en":"血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に寄与するメカニズムの解析","ja":"血管平滑筋細胞のhypoxia-inducible factor-1αがangiotensinⅡ誘発血管リモデリング形成に寄与するメカニズムの解析"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第22回日本循環薬理学会","ja":"第22回日本循環薬理学会"},"publication_date":"2012-11-30","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:385, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376318"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259225","label":"url"}],"presentation_title":{"en":"鉄吸収機構におけるAngiotensinⅡの効果の検討","ja":"鉄吸収機構におけるAngiotensinⅡの効果の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第122回日本薬理学会近畿部会","ja":"第122回日本薬理学会近畿部会"},"publication_date":"2012-11-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:386, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259223","label":"url"}],"presentation_title":{"en":"Nifedipine 光分解産物であるnitrosonifedipine は糖尿病性腎症進展を抑制する","ja":"Nifedipine 光分解産物であるnitrosonifedipine は糖尿病性腎症進展を抑制する"},"presenters":{"en":[{"name":"Fujii Shoko"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Nuno Asami"},{"name":"Suzuki Yuta"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"藤井 聖子"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"布 あさ美"},{"name":"鈴木 雄太"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第51回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第51回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2012-11-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:387, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376319"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=257873","label":"url"}],"presentation_title":{"en":"血管平滑筋細胞におけるHIF-1αのangiotensinⅡ誘発血管リモデリング形成およびAT1受容体発現への関与;平滑筋特異的HIF-1α遺伝子欠損マウスを用いた検討 The Role of HIF-1α in angiotensin Ⅱ-induced Vascular Remodeling and AT1 Receptor Expression in Vascular Smooth Muscle Cells","ja":"血管平滑筋細胞におけるHIF-1αのangiotensinⅡ誘発血管リモデリング形成およびAT1受容体発現への関与;平滑筋特異的HIF-1α遺伝子欠損マウスを用いた検討 The Role of HIF-1α in angiotensin Ⅱ-induced Vascular Remodeling and AT1 Receptor Expression in Vascular Smooth Muscle Cells"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第35回日本高血圧学会総会","ja":"第35回日本高血圧学会総会"},"publication_date":"2012-09-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:388, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=256367","label":"url"}],"presentation_title":{"en":"糖尿病性腎症進展に対するニトロソニフェジピンの抑制作用","ja":"糖尿病性腎症進展に対するニトロソニフェジピンの抑制作用"},"presenters":{"en":[{"name":"Nuno Asami"},{"name":"Ishizawa Keisuke"},{"name":"Fujii Shoko"},{"name":"櫻田 巧"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Suzuki Yuta"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"布 あさ美"},{"name":"石澤 啓介"},{"name":"藤井 聖子"},{"name":"櫻田 巧"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"鈴木 雄太"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム2012","ja":"次世代を担う創薬・医療薬理シンポジウム2012"},"publication_date":"2012-09-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:389, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376320"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=256358","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発血管リモデリングにおける血管平滑筋細胞内HIFシグナルの解析","ja":"AngiotensinⅡ誘発血管リモデリングにおける血管平滑筋細胞内HIFシグナルの解析"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム2012","ja":"次世代を担う創薬・医療薬理シンポジウム2012"},"publication_date":"2012-09-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:390, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376321"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=256317","label":"url"}],"presentation_title":{"en":"十二指腸からの鉄吸収に対するAngiotensinⅡの影響","ja":"十二指腸からの鉄吸収に対するAngiotensinⅡの影響"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"櫻田 巧"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"櫻田 巧"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第36回日本鉄バイオサイエンス学会学術集会","ja":"第36回日本鉄バイオサイエンス学会学術集会"},"publication_date":"2012-09-01","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:391, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=257875","label":"url"}],"presentation_title":{"en":"血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する","ja":"血管傷害モデルに伴う血管リモデリング形成過程には,傷害部位に動員される骨髄由来細胞のHIFが関与する"},"presenters":{"en":[{"name":"Maeda Yusaku"},{"name":"Tomita Shuhei"},{"name":"Murakami Masaki"},{"name":"Imanishi Masaki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"前田 悠作"},{"name":"冨田 修平"},{"name":"村上 正樹"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第121回日本薬理学会近畿部会","ja":"第121回日本薬理学会近畿部会"},"publication_date":"2012-06-29","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:392, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=257874","label":"url"}],"presentation_title":{"en":"平滑筋特異的hypoxia-inducible factor-1α欠損がangiotensin II誘発血管リモデリング形成に及ぼす影響","ja":"平滑筋特異的hypoxia-inducible factor-1α欠損がangiotensin II誘発血管リモデリング形成に及ぼす影響"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Tomita Shuhei"},{"name":"Ishizawa Keisuke"},{"name":"Suzuki Yuta"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"冨田 修平"},{"name":"石澤 啓介"},{"name":"鈴木 雄太"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第121回日本薬理学会近畿部会","ja":"第121回日本薬理学会近畿部会"},"publication_date":"2012-06-29","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:393, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=248251","label":"url"}],"presentation_title":{"en":"肥満進展における鉄と酸化ストレス","ja":"肥満進展における鉄と酸化ストレス"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第65回日本酸化ストレス学会学術集会 シンポジウム「金属と酸化ストレスの関係を探る:基礎から臨床研究へ」","ja":"第65回日本酸化ストレス学会学術集会 シンポジウム「金属と酸化ストレスの関係を探る:基礎から臨床研究へ」"},"publication_date":"2012-06-08","invited":true,"languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:394, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259214","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine はangiotensin II 誘発のマウス血管リモデリングを改善する","ja":"Nitrosonifedipine はangiotensin II 誘発のマウス血管リモデリングを改善する"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Fujii Shoko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Miyamoto Licht"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"藤井 聖子"},{"name":"石澤 有紀"},{"name":"宮本 理人"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第65回日本酸化ストレス学会学術集会","ja":"第65回日本酸化ストレス学会学術集会"},"publication_date":"2012-06-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:395, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259212","label":"url"}],"presentation_title":{"en":"糖尿病モデルマウスにおいてニトロソニフェジピンは腎症の進展を抑制する","ja":"糖尿病モデルマウスにおいてニトロソニフェジピンは腎症の進展を抑制する"},"presenters":{"en":[{"name":"Fujii Shoko"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Imanishi Masaki"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"藤井 聖子"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第55回日本腎臓学会学術総会","ja":"第55回日本腎臓学会学術総会"},"publication_date":"2012-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:396, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266998","label":"url"}],"presentation_title":{"en":"エイコサペントエン酸は酸化ストレス抑制を介して心臓リモデリングを抑制する","ja":"エイコサペントエン酸は酸化ストレス抑制を介して心臓リモデリングを抑制する"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"日本高血圧学会 第1回臨床高血圧フォーラム","ja":"日本高血圧学会 第1回臨床高血圧フォーラム"},"publication_date":"2012-05-12","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:397, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246545","label":"url"}],"presentation_title":{"en":"脂肪細胞における低酸素誘導因子1a欠損は高脂肪食負荷による耐糖能異常の発現を抑制する","ja":"脂肪細胞における低酸素誘導因子1a欠損は高脂肪食負荷による耐糖能異常の発現を抑制する"},"presenters":{"en":[{"name":"Miyake Mariko"},{"name":"Kihira Yoshitaka"},{"name":"Hirata Manami"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"三宅 真理子"},{"name":"木平 孝高"},{"name":"平田 愛美"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"日本薬学会第132年会","ja":"日本薬学会第132年会"},"publication_date":"2012-03-30","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:398, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246543","label":"url"}],"presentation_title":{"en":"2型糖尿病性腎症に対するニトロソニフェジピンの効果","ja":"2型糖尿病性腎症に対するニトロソニフェジピンの効果"},"presenters":{"en":[{"name":"Nuno Asami"},{"name":"Ishizawa Keisuke"},{"name":"藤井 聖子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Sakurada Takumi"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"布 あさ美"},{"name":"石澤 啓介"},{"name":"藤井 聖子"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"櫻田 巧"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第132年会","ja":"日本薬学会第132年会"},"publication_date":"2012-03-29","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:399, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246542","label":"url"}],"presentation_title":{"en":"Bovine Lactoferin Promotes Angiogenesis Via Akt-eNOS Dependent Pathway in Vascular Endothelial Cells","ja":"Bovine Lactoferin Promotes Angiogenesis Via Akt-eNOS Dependent Pathway in Vascular Endothelial Cells"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第76回日本循環器学会学術集会","ja":"第76回日本循環器学会学術集会"},"publication_date":"2012-03-18","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:400, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246540","label":"url"}],"presentation_title":{"en":"Protective effect of dietary iron restriction on diabetic nephropathy","ja":"Protective effect of dietary iron restriction on diabetic nephropathy"},"presenters":{"en":[{"name":"Enomoto Hideaki"},{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"榎本 英明"},{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第85回日本薬理学会年会","ja":"第85回日本薬理学会年会"},"publication_date":"2012-03-16","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:401, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246539","label":"url"}],"presentation_title":{"en":"Accumulated iron storage in high fat diet-induced obese and diabetic mice","ja":"Accumulated iron storage in high fat diet-induced obese and diabetic mice"},"presenters":{"en":[{"name":"Yamano Noriko"},{"name":"Ikeda Yasumasa"},{"name":"Sakama Minoru"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山野 範子"},{"name":"池田 康将"},{"name":"阪間 稔"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第85回日本薬理学会年会","ja":"第85回日本薬理学会年会"},"publication_date":"2012-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:402, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246538","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine prevents the progression of diabetic nephropathy in type 2 diabetic mice","ja":"Nitrosonifedipine prevents the progression of diabetic nephropathy in type 2 diabetic mice"},"presenters":{"en":[{"name":"Fujii Shoko"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Nuno Asami"},{"name":"Suzuki Yuta"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"藤井 聖子"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"布 あさ美"},{"name":"鈴木 雄太"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第85回日本薬理学会年会","ja":"第85回日本薬理学会年会"},"publication_date":"2012-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:403, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246537","label":"url"}],"presentation_title":{"en":"Preoperative stabilization of HIF-1 by systemic introduction of dimethyloxalylglycine (DMOG), improves skin flap survival","ja":"Preoperative stabilization of HIF-1 by systemic introduction of dimethyloxalylglycine (DMOG), improves skin flap survival"},"presenters":{"en":[{"name":"Tomita Shuhei"},{"name":"Takaku Mitsuru"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"冨田 修平"},{"name":"高久 暢"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第85回日本薬理学会年会","ja":"第85回日本薬理学会年会"},"publication_date":"2012-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:404, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246536","label":"url"}],"presentation_title":{"en":"The inhibitory effects of smooth muscle cell-specific hypoxia-inducible factor-1a deficiency on angiotensin 2-induced vascular remodeling in mice","ja":"The inhibitory effects of smooth muscle cell-specific hypoxia-inducible factor-1a deficiency on angiotensin 2-induced vascular remodeling in mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第85回日本薬理学会年会","ja":"第85回日本薬理学会年会"},"publication_date":"2012-03-14","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:405, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=246534","label":"url"}],"presentation_title":{"en":"High fat diet-induced inflammation in adipose tissues is reduced in adipocyte-specific hypoxia-inducible factor-1a knockout mice","ja":"High fat diet-induced inflammation in adipose tissues is reduced in adipocyte-specific hypoxia-inducible factor-1a knockout mice"},"presenters":{"en":[{"name":"Hirata Manami"},{"name":"Kihira Yoshitaka"},{"name":"Miyake Mariko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"平田 愛美"},{"name":"木平 孝高"},{"name":"三宅 真理子"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第85回日本薬理学会年会","ja":"第85回日本薬理学会年会"},"publication_date":"2012-03-14","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:406, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=244269","label":"url"}],"presentation_title":{"en":"Nitrosonifedipineは2型糖尿病モデルマウスにおける腎症進展を抑制する","ja":"Nitrosonifedipineは2型糖尿病モデルマウスにおける腎症進展を抑制する"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Fujii Shoko"},{"name":"Nuno Asami"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Imanishi Masaki"},{"name":"Sakurada Takumi"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"藤井 聖子"},{"name":"布 あさ美"},{"name":"石澤 有紀"},{"name":"今西 正樹"},{"name":"櫻田 巧"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第41回心脈管作動物質学会","ja":"第41回心脈管作動物質学会"},"publication_date":"2012-02-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:407, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=244267","label":"url"}],"presentation_title":{"en":"肥満に伴う耐糖能異常の発現に対する脂肪細胞の低酸素誘導因子の役割","ja":"肥満に伴う耐糖能異常の発現に対する脂肪細胞の低酸素誘導因子の役割"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Miyake Mariko"},{"name":"Hirata Manami"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"木平 孝高"},{"name":"三宅 真理子"},{"name":"平田 愛美"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第41回心脈管作動物質学会","ja":"第41回心脈管作動物質学会"},"publication_date":"2012-02-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:408, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=244266","label":"url"}],"presentation_title":{"en":"The alternation of iron metabolism in high fat diet-induced obese and diabetic mice","ja":"The alternation of iron metabolism in high fat diet-induced obese and diabetic mice"},"presenters":{"en":[{"name":"Yamano Noriko"},{"name":"Ikeda Yasumasa"},{"name":"Sakama Minoru"},{"name":"Tajima Soichiro"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山野 範子"},{"name":"池田 康将"},{"name":"阪間 稔"},{"name":"Tajima Soichiro"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第34回日本分子生物学会年会","ja":"第34回日本分子生物学会年会"},"publication_date":"2011-12-14","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:409, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=259207","label":"url"}],"presentation_title":{"en":"糖尿病腎症進展における鉄除去の効果","ja":"糖尿病腎症進展における鉄除去の効果"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Enomoto Hideaki"},{"name":"田島 壮一郎"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"榎本 英明"},{"name":"田島 壮一郎"},{"name":"石澤 有紀"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"腎と高血圧update","ja":"腎と高血圧update"},"publication_date":"2011-12-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:410, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=244265","label":"url"}],"presentation_title":{"en":"PHD阻害剤の虚血皮弁生存拡大に対する効果","ja":"PHD阻害剤の虚血皮弁生存拡大に対する効果"},"presenters":{"en":[{"name":"Takaku Mitsuru"},{"name":"Tomita Shuhei"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Nakanishi Hideki"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"高久 暢"},{"name":"冨田 修平"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"中西 秀樹"},{"name":"玉置 俊晃"}]},"event":{"en":"第21回日本循環薬理学会","ja":"第21回日本循環薬理学会"},"publication_date":"2011-12-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:411, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376322"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242466","label":"url"}],"presentation_title":{"en":"血管平滑筋細胞のhypoxia-inducible factor-1αはangiotensinⅡ誘発血管リモデリングの形成に関与する","ja":"血管平滑筋細胞のhypoxia-inducible factor-1αはangiotensinⅡ誘発血管リモデリングの形成に関与する"},"presenters":{"en":[{"name":"Taniguchi Jumpei"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tsuchiya Koichiro"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"谷口 順平"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"川添 和義"},{"name":"土屋 浩一郎"},{"name":"水口 和生"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第50回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第50回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2011-11-12","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:412, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397024","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発性血管リモデリングは平滑筋特異的HIF-1α遺伝子欠損により抑制される","ja":"AngiotensinⅡ誘発性血管リモデリングは平滑筋特異的HIF-1α遺伝子欠損により抑制される"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第34回日本高血圧学会総会","ja":"第34回日本高血圧学会総会"},"publication_date":"2011-10-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:413, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376323"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242117","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発性血管リモデリングは平滑筋特異的HIF-1α遺伝子欠損により抑制される","ja":"AngiotensinⅡ誘発性血管リモデリングは平滑筋特異的HIF-1α遺伝子欠損により抑制される"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第34回日本高血圧学会総会","ja":"第34回日本高血圧学会総会"},"publication_date":"2011-10-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:414, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=252466","label":"url"}],"presentation_title":{"en":"エイコサペントエン酸の酸化ストレス抑制を介したアンジオテンシンII刺激による心血管リモデリング抑制効果の検討","ja":"エイコサペントエン酸の酸化ストレス抑制を介したアンジオテンシンII刺激による心血管リモデリング抑制効果の検討"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第34回 日本高血圧学会総会","ja":"第34回 日本高血圧学会総会"},"publication_date":"2011-10-21","languages":["jpn"],"location":{"en":"栃木","ja":"栃木"},"is_international_presentation":false},"priority":"input_data"} line:415, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=241573","label":"url"}],"presentation_title":{"en":"肥満の脂肪組織における鉄の役割","ja":"肥満の脂肪組織における鉄の役割"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Yamano Noriko"},{"name":"Horinouchi Yuya"},{"name":"Sakurada Takumi"},{"name":"Kihira Yoshitaka"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"山野 範子"},{"name":"堀ノ内 裕也"},{"name":"櫻田 巧"},{"name":"木平 孝高"},{"name":"石澤 有紀"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第35回日本鉄バイオサイエンス学会学術集会","ja":"第35回日本鉄バイオサイエンス学会学術集会"},"publication_date":"2011-09-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:416, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300021","label":"url"}],"presentation_title":{"en":"心血管臓器におけるアンドロゲン作用の意義","ja":"心血管臓器におけるアンドロゲン作用の意義"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"松本 俊夫"}]},"event":{"en":"第11回日本内分泌学会四国支部学術集会 高知","ja":"第11回日本内分泌学会四国支部学術集会 高知"},"publication_date":"2011-09-10","languages":["jpn"],"location":{"en":"Kochi","ja":"高知"},"is_international_presentation":false},"priority":"input_data"} line:417, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=299997","label":"url"}],"presentation_title":{"en":"Eicosapentaenoic acid-to-arachidonic acid ratio is inversely associated with albuminuria in individuals with cardiovascular risk factors","ja":"Eicosapentaenoic acid-to-arachidonic acid ratio is inversely associated with albuminuria in individuals with cardiovascular risk factors"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"久岡 白陽花"},{"name":"平田 陽一郎"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"久岡 白陽花"},{"name":"平田 陽一郎"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第75回日本循環器学会総会・学術集会 パシフィコ横浜","ja":"第75回日本循環器学会総会・学術集会 パシフィコ横浜"},"publication_date":"2011-08-03","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:418, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=299991","label":"url"}],"presentation_title":{"en":"Eicosapentaenoic acid protects against angiotensin II-induced cardiovascular remodeling via attenuation of oxidative stress.","ja":"Eicosapentaenoic acid protects against angiotensin II-induced cardiovascular remodeling via attenuation of oxidative stress."},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第75回 日本循環器学会総会・学術集会 パシフィコ横浜","ja":"第75回 日本循環器学会総会・学術集会 パシフィコ横浜"},"publication_date":"2011-08-03","languages":["jpn"],"location":{"en":"Yokohama","ja":"横浜"},"is_international_presentation":false},"priority":"input_data"} line:419, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231985","label":"url"}],"presentation_title":{"en":"Hypoxia-inducible factor-1a in vascular smooth muscle cells contributes to the development of angiotensin -induced vascular remodeling","ja":"Hypoxia-inducible factor-1a in vascular smooth muscle cells contributes to the development of angiotensin -induced vascular remodeling"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第43回日本動脈硬化学会 総会・学術集会","ja":"第43回日本動脈硬化学会 総会・学術集会"},"publication_date":"2011-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:420, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=236356","label":"url"}],"presentation_title":{"en":"動脈硬化におけるhypoxia-inducible factor-1αの新規治療標的分子としての可能性","ja":"動脈硬化におけるhypoxia-inducible factor-1αの新規治療標的分子としての可能性"},"presenters":{"en":[{"name":"Taniguchi Jumpei"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"久次米 敏秀"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tsuchiya Koichiro"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"谷口 順平"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"久次米 敏秀"},{"name":"川添 和義"},{"name":"土屋 浩一郎"},{"name":"水口 和生"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"医療薬学フォーラム2011/第19回クリニカルファーマシーシンポジウム","ja":"医療薬学フォーラム2011/第19回クリニカルファーマシーシンポジウム"},"publication_date":"2011-07-09","languages":["jpn"],"location":{"en":"Asahikawa","ja":"旭川"},"is_international_presentation":false},"priority":"input_data"} line:421, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376324"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=231193","label":"url"}],"presentation_title":{"en":"AngiotensisⅡ誘発血管リモデリングは血管平滑筋細胞のhypoxia-inducible factor-1αを介して形成される","ja":"AngiotensisⅡ誘発血管リモデリングは血管平滑筋細胞のhypoxia-inducible factor-1αを介して形成される"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Yamano Noriko"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"山野 範子"},{"name":"石澤 有紀"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第119回日本薬理学会近畿部会","ja":"第119回日本薬理学会近畿部会"},"publication_date":"2011-07-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:422, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376325"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230828","label":"url"}],"presentation_title":{"en":"ヒト腎糸球体血管内皮細胞において細胞内遊離鉄はangiotensin ⅡによるICAM-1の発現を増強する","ja":"ヒト腎糸球体血管内皮細胞において細胞内遊離鉄はangiotensin ⅡによるICAM-1の発現を増強する"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第54回日本腎臓学会学術集会","ja":"第54回日本腎臓学会学術集会"},"publication_date":"2011-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:423, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230833","label":"url"}],"presentation_title":{"en":"鉄除去薬による糖尿病の病態改善効果の検討","ja":"鉄除去薬による糖尿病の病態改善効果の検討"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第84回日本内分泌学会学術集会","ja":"第84回日本内分泌学会学術集会"},"publication_date":"2011-04","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:424, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376326"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=252156","label":"url"}],"presentation_title":{"en":"フェノフィブラートはアンジオテンシンⅡ負荷による高血圧と心筋リモデリングを抑制する","ja":"フェノフィブラートはアンジオテンシンⅡ負荷による高血圧と心筋リモデリングを抑制する"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第84回 日本内分泌学会学術総会","ja":"第84回 日本内分泌学会学術総会"},"publication_date":"2011-04-22","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:425, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230750","label":"url"}],"presentation_title":{"en":"心血管リモデリングにおける男性ホルモンの作用","ja":"心血管リモデリングにおける男性ホルモンの作用"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"佐藤 隆史"},{"name":"Akaike Masashi"},{"name":"Tamaki Toshiaki"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"佐藤 隆史"},{"name":"赤池 雅史"},{"name":"玉置 俊晃"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第84回日本内分泌学会学術集会 シンポジウム「心血管病を内分泌・代謝面から考察する」","ja":"第84回日本内分泌学会学術集会 シンポジウム「心血管病を内分泌・代謝面から考察する」"},"publication_date":"2011-04-22","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:426, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=252157","label":"url"}],"presentation_title":{"en":"グルココルチコイド誘発性血管内皮細胞障害に対するアルドステロン受容体拮抗薬の効果","ja":"グルココルチコイド誘発性血管内皮細胞障害に対するアルドステロン受容体拮抗薬の効果"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"石川 カズ江"},{"name":"Yoshida Sumiko"},{"name":"Ueda Yuka"},{"name":"Iwase Takashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"石川 カズ江"},{"name":"吉田 守美子"},{"name":"上田 由佳"},{"name":"岩瀬 俊"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第84回 日本内分泌学会学術総会","ja":"第84回 日本内分泌学会学術総会"},"publication_date":"2011-04-21","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:427, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376327"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=252155","label":"url"}],"presentation_title":{"en":"エイコサペントエン酸は酸化ストレス抑制を介してアンジオテンシンⅡ刺激による心血管リモデリングを抑制する","ja":"エイコサペントエン酸は酸化ストレス抑制を介してアンジオテンシンⅡ刺激による心血管リモデリングを抑制する"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第84回 日本内分泌学会学術総会","ja":"第84回 日本内分泌学会学術総会"},"publication_date":"2011-04-21","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:428, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=252154","label":"url"}],"presentation_title":{"en":"虚血ストレスによる骨格筋アポトーシスおよび血管新生におけるアンドロゲン受容体の意義","ja":"虚血ストレスによる骨格筋アポトーシスおよび血管新生におけるアンドロゲン受容体の意義"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第84回 日本内分泌学会学術総会","ja":"第84回 日本内分泌学会学術総会"},"publication_date":"2011-04-21","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:429, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230875","label":"url"}],"presentation_title":{"en":"Iron elimination ameliorated glucose tolerance through suppression of oxidative stress and inflammation on fat in diabetic mice","ja":"Iron elimination ameliorated glucose tolerance through suppression of oxidative stress and inflammation on fat in diabetic mice"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"Tajima Soichiro"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第75回日本循環器学会総会・学術集会","ja":"第75回日本循環器学会総会・学術集会"},"publication_date":"2011-03","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:430, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230874","label":"url"}],"presentation_title":{"en":"Heparin cofactor II enhances vascular endothelial cells function and angiogenesis","ja":"Heparin cofactor II enhances vascular endothelial cells function and angiogenesis"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Yoshida Sumiko"},{"name":"Iwase Takashi"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"吉田 守美子"},{"name":"岩瀬 俊"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"佐田 政隆"},{"name":"松本 俊夫"},{"name":"玉置 俊晃"}]},"event":{"en":"第75回日本循環器学会総会・学術集会","ja":"第75回日本循環器学会総会・学術集会"},"publication_date":"2011-03","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:431, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230848","label":"url"}],"presentation_title":{"en":"The alternation of iron transport-related genes in high fat diet-induced obese and diabetic mice","ja":"The alternation of iron transport-related genes in high fat diet-induced obese and diabetic mice"},"presenters":{"en":[{"name":"Yamano Noriko"},{"name":"Ikeda Yasumasa"},{"name":"Sakama Minoru"},{"name":"Tajima Soichiro"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山野 範子"},{"name":"池田 康将"},{"name":"阪間 稔"},{"name":"田島 壮一郎"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第84回日本薬理学会年会","ja":"第84回日本薬理学会年会"},"publication_date":"2011-03","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:432, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230847","label":"url"}],"presentation_title":{"en":"bFGF and insulin differentially regulate hypoxia-inducible factor-1 alpha in adipocytes","ja":"bFGF and insulin differentially regulate hypoxia-inducible factor-1 alpha in adipocytes"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第84回日本薬理学会年会","ja":"第84回日本薬理学会年会"},"publication_date":"2011-03","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:433, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230846","label":"url"}],"presentation_title":{"en":"Role of HIF-1b in endothelial cells in monocrotaline-induced pulmonary hypertension","ja":"Role of HIF-1b in endothelial cells in monocrotaline-induced pulmonary hypertension"},"presenters":{"en":[{"name":"Fukuhara Yayoi"},{"name":"Tomita Shuhei"},{"name":"Urata Masahisa"},{"name":"Kihira Yoshitaka"},{"name":"Takaku Mitsuru"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"福原 弥生"},{"name":"冨田 修平"},{"name":"浦田 将久"},{"name":"木平 孝高"},{"name":"高久 暢"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第84回日本薬理学会年会","ja":"第84回日本薬理学会年会"},"publication_date":"2011-03","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:434, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230844","label":"url"}],"presentation_title":{"en":"Deferoxamine, an iron chelator, promotes revascularization via endothelial cells activation","ja":"Deferoxamine, an iron chelator, promotes revascularization via endothelial cells activation"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tajima Soichiro"},{"name":"Yoshida Sumiko"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"吉田 守美子"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第84回日本薬理学会年会","ja":"第84回日本薬理学会年会"},"publication_date":"2011-03","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:435, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230843","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine, a photodegrative metabolite of nifedipine, improves angiotensin -induced vascular remodeling","ja":"Nitrosonifedipine, a photodegrative metabolite of nifedipine, improves angiotensin -induced vascular remodeling"},"presenters":{"en":[{"name":"Sakurada Takumi"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Tominaga Erika"},{"name":"Taniguchi Junpei"},{"name":"Fujii Shoko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"櫻田 巧"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"富永 えりか"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第84回日本薬理学会年会","ja":"第84回日本薬理学会年会"},"publication_date":"2011-03","languages":["eng"],"location":{"en":"Yokohama","ja":"Yokohama"},"is_international_presentation":false},"priority":"input_data"} line:436, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230842","label":"url"}],"presentation_title":{"en":"Angiotensin -induced vascular remodeling is surpressed in smooth muscle cell-specific hypoxia-inducible factor-1a deficient mice","ja":"Angiotensin -induced vascular remodeling is surpressed in smooth muscle cell-specific hypoxia-inducible factor-1a deficient mice"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第84回日本薬理学会年会","ja":"第84回日本薬理学会年会"},"publication_date":"2011-03","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:437, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230841","label":"url"}],"presentation_title":{"en":"Nitrosonifedipineによる血管リモデリング抑制効果の検討","ja":"Nitrosonifedipineによる血管リモデリング抑制効果の検討"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Sakurada Takumi"},{"name":"富永 えりか"},{"name":"Horinouchi Yuya"},{"name":"Taniguchi Jumpei"},{"name":"Fujii Shoko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"富永 えりか"},{"name":"堀ノ内 裕也"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"日本薬学会第131回年会","ja":"日本薬学会第131回年会"},"publication_date":"2011-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:438, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=314762","label":"url"}],"presentation_title":{"en":"Nitrosonifedipine の細胞保護効果に関する検討","ja":"Nitrosonifedipine の細胞保護効果に関する検討"},"presenters":{"en":[{"name":"Horinouchi Yuya"},{"name":"Tsuchiya Koichiro"},{"name":"田島 壮一郎"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tamaki Toshiaki"},{"name":"Minakuchi Kazuo"}],"ja":[{"name":"堀ノ内 裕也"},{"name":"土屋 浩一郎"},{"name":"田島 壮一郎"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"川添 和義"},{"name":"玉置 俊晃"},{"name":"水口 和生"}]},"event":{"en":"日本薬学会第131年会","ja":"日本薬学会第131年会"},"publication_date":"2011-03-28","languages":["jpn"],"location":{"en":"Shizuoka","ja":"静岡"},"is_international_presentation":false},"priority":"input_data"} line:439, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397016","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発血管リモデリングにおけるhypoxia-inducible factor-1αの役割","ja":"AngiotensinⅡ誘発血管リモデリングにおけるhypoxia-inducible factor-1αの役割"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:440, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=314755","label":"url"}],"presentation_title":{"en":"鉄除去は脂肪肥大を抑制して糖尿病を改善する","ja":"鉄除去は脂肪肥大を抑制して糖尿病を改善する"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Yamano Noriko"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"山野 範子"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:441, {"insert":{"user_id":"B000241782","type":"presentations","id":"30496241"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=314752","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発血管リモデリングに対するニトロソニフェジピンの抑制作用","ja":"AngiotensinⅡ誘発血管リモデリングに対するニトロソニフェジピンの抑制作用"},"presenters":{"en":[{"name":"Sakurada Takumi"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"富永 えりか"},{"name":"Taniguchi Jumpei"},{"name":"Fujii Shoko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"櫻田 巧"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"富永 えりか"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:442, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230872","label":"url"}],"presentation_title":{"en":"マウス下肢虚血モデルにおいて鉄キレート剤Deferoxamineは酸化ストレスとアポトーシスを抑制する","ja":"マウス下肢虚血モデルにおいて鉄キレート剤Deferoxamineは酸化ストレスとアポトーシスを抑制する"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Yoshida Sumiko"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"吉田 守美子"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:443, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230869","label":"url"}],"presentation_title":{"en":"高脂肪食負荷肥満マウスにおける鉄吸収動態の検討","ja":"高脂肪食負荷肥満マウスにおける鉄吸収動態の検討"},"presenters":{"en":[{"name":"Yamano Noriko"},{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"山野 範子"},{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:444, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230867","label":"url"}],"presentation_title":{"en":"鉄除去は脂肪肥大を抑制して糖尿病を改善する","ja":"鉄除去は脂肪肥大を抑制して糖尿病を改善する"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Yamano Noriko"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"山野 範子"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:445, {"insert":{"user_id":"B000241782","type":"presentations","id":"30496242"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230753","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発血管リモデリングに対するニトロソニフェジピンの抑制作用","ja":"AngiotensinⅡ誘発血管リモデリングに対するニトロソニフェジピンの抑制作用"},"presenters":{"en":[{"name":"Sakurada Takumi"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Horinouchi Yuya"},{"name":"富永 えりか"},{"name":"Taniguchi Jumpei"},{"name":"Fujii Shoko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"櫻田 巧"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"堀ノ内 裕也"},{"name":"富永 えりか"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:446, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376330"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230752","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発血管リモデリングにおけるhypoxia-inducible factor-1αの役割","ja":"AngiotensinⅡ誘発血管リモデリングにおけるhypoxia-inducible factor-1αの役割"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"},{"name":"Tomita Shuhei"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"},{"name":"冨田 修平"}]},"event":{"en":"第40回日本心脈管作動物質学会","ja":"第40回日本心脈管作動物質学会"},"publication_date":"2011-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:447, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=234062","label":"url"}],"presentation_title":{"en":"アンドロゲン受容体は虚血後骨格筋細胞のアポトーシスと血管新生を制御する","ja":"アンドロゲン受容体は虚血後骨格筋細胞のアポトーシスと血管新生を制御する"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第18回日本血管生物医学会学術集会","ja":"第18回日本血管生物医学会学術集会"},"publication_date":"2010-12-01","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:448, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230975","label":"url"}],"presentation_title":{"en":"Deferoxamine, an iron chelator, enhances angiogenesis through Akt-eNOS-dependent pathway in endothelial cells","ja":"Deferoxamine, an iron chelator, enhances angiogenesis through Akt-eNOS-dependent pathway in endothelial cells"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"田島 壮一郎"},{"name":"Yoshida Sumiko"},{"name":"Yamano Noriko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Aihara Ken-ichi"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"田島 壮一郎"},{"name":"吉田 守美子"},{"name":"山野 範子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"粟飯原 賢一"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第18回日本血管生物医学会学術集会","ja":"第18回日本血管生物医学会学術集会"},"publication_date":"2010-12","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:449, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230751","label":"url"}],"presentation_title":{"en":"HIF-2/ARNT control hair differentiation by up-regulating p21Waf1/Cip1","ja":"HIF-2/ARNT control hair differentiation by up-regulating p21Waf1/Cip1"},"presenters":{"en":[{"name":"Imamura Yuuko"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今村 優子"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第33回日本分子生物学会年会","ja":"第33回日本分子生物学会年会"},"publication_date":"2010-12","languages":["eng"],"location":{"en":"Hyogo Prefecture","ja":"Hyogo Prefecture"},"is_international_presentation":false},"priority":"input_data"} line:450, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219731","label":"url"}],"presentation_title":{"en":"脂肪細胞における塩基性繊維芽細胞増殖因子による低酸素誘導因子誘導とそれを介した糖輸送担体発現誘導","ja":"脂肪細胞における塩基性繊維芽細胞増殖因子による低酸素誘導因子誘導とそれを介した糖輸送担体発現誘導"},"presenters":{"en":[{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第118回日本薬理学会近畿部会","ja":"第118回日本薬理学会近畿部会"},"publication_date":"2010-11-19","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:451, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=230976","label":"url"}],"presentation_title":{"en":"鉄キレート剤 deferoxamine は内皮細胞活性化により血管新生を促進する","ja":"鉄キレート剤 deferoxamine は内皮細胞活性化により血管新生を促進する"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Tomita Shuhei"},{"name":"Yamano Noriko"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"冨田 修平"},{"name":"山野 範子"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第20回日本循環薬理学会","ja":"第20回日本循環薬理学会"},"publication_date":"2010-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:452, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232757","label":"url"}],"presentation_title":{"en":"亜硝酸塩由来血中NO動態に与える経口鉄の影響","ja":"亜硝酸塩由来血中NO動態に与える経口鉄の影響"},"presenters":{"en":[{"name":"Tsuchiya Koichiro"},{"name":"Ishizawa Keisuke"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"土屋 浩一郎"},{"name":"石澤 啓介"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第22回腎とフリーラジカル研究会","ja":"第22回腎とフリーラジカル研究会"},"publication_date":"2010-10-16","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:453, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232718","label":"url"}],"presentation_title":{"en":"Angiotensin II による血管平滑筋細胞の遊走および増殖に対するnifedipine代謝物の抑制作用とそのメカニズム","ja":"Angiotensin II による血管平滑筋細胞の遊走および増殖に対するnifedipine代謝物の抑制作用とそのメカニズム"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"富永 えりか"},{"name":"櫻田 巧"},{"name":"Horinouchi Yuya"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"富永 えりか"},{"name":"櫻田 巧"},{"name":"堀ノ内 裕也"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第33回日本高血圧学会","ja":"第33回日本高血圧学会"},"publication_date":"2010-10-15","languages":["jpn"],"location":{"en":"Fukuoka","ja":"福岡"},"is_international_presentation":false},"priority":"input_data"} line:454, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267010","label":"url"}],"presentation_title":{"en":"ピタバスタチンによる血管内皮細胞での一酸化窒素合成酵素の発現亢進作用とその機序の検討","ja":"ピタバスタチンによる血管内皮細胞での一酸化窒素合成酵素の発現亢進作用とその機序の検討"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"石川 カズ江"},{"name":"Ikeda Yasumasa"},{"name":"Yoshida Sumiko"},{"name":"Ueda Yuka"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"赤池 雅史"},{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"石川 カズ江"},{"name":"池田 康将"},{"name":"吉田 守美子"},{"name":"上田 由佳"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"event":{"en":"第33回日本高血圧学会総会","ja":"第33回日本高血圧学会総会"},"publication_date":"2010-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:455, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=237968","label":"url"}],"presentation_title":{"en":"2型糖尿病モデルマウスに対する鉄キレート剤による糖尿病改善効果の検討","ja":"2型糖尿病モデルマウスに対する鉄キレート剤による糖尿病改善効果の検討"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Yamano Noriko"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"山野 範子"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第34回日本鉄バイオサイエンス学会学術集会","ja":"第34回日本鉄バイオサイエンス学会学術集会"},"publication_date":"2010-09-11","languages":["jpn"],"location":{"en":"東京国際フォーラム","ja":"東京国際フォーラム"},"is_international_presentation":false},"priority":"input_data"} line:456, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376331"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=237958","label":"url"}],"presentation_title":{"en":"AngiotensinⅡ誘発血管リモデリングに対するnitrosonifedipineの抑制効果","ja":"AngiotensinⅡ誘発血管リモデリングに対するnitrosonifedipineの抑制効果"},"presenters":{"en":[{"name":"藤井 聖子"},{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"富永 えりか"},{"name":"桜田 巧"},{"name":"谷口 順平"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"藤井 聖子"},{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"富永 えりか"},{"name":"桜田 巧"},{"name":"谷口 順平"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"次世代を担う創薬・医療薬理シンポジウム2010","ja":"次世代を担う創薬・医療薬理シンポジウム2010"},"publication_date":"2010-09-11","languages":["jpn"],"location":{"en":"京都大学薬学部","ja":"京都大学薬学部"},"is_international_presentation":false},"priority":"input_data"} line:457, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232752","label":"url"}],"presentation_title":{"en":"動脈硬化に伴う血管リモデリングに対してT細胞のHIF-1 は抑制的に機能する.","ja":"動脈硬化に伴う血管リモデリングに対してT細胞のHIF-1 は抑制的に機能する."},"presenters":{"en":[{"name":"Tomita Shuhei"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"冨田 修平"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第31回日本炎症再生医学会","ja":"第31回日本炎症再生医学会"},"publication_date":"2010-08-05","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:458, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300251","label":"url"}],"presentation_title":{"en":"A role of androgen receptor in ischemia-induced tissue damage and angiogenesis in male","ja":"A role of androgen receptor in ischemia-induced tissue damage and angiogenesis in male"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第42回日本動脈硬化学会総会・学術集会 長良川国際会議場","ja":"第42回日本動脈硬化学会総会・学術集会 長良川国際会議場"},"publication_date":"2010-07-15","languages":["jpn"],"location":{"en":"Gifu","ja":"岐阜"},"is_international_presentation":false},"priority":"input_data"} line:459, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232717","label":"url"}],"presentation_title":{"en":"Nifedipine代謝物によるangiotensin II 誘発血管平滑筋細胞遊走及び増殖に対する抑制作用","ja":"Nifedipine代謝物によるangiotensin II 誘発血管平滑筋細胞遊走及び増殖に対する抑制作用"},"presenters":{"en":[{"name":"Imanishi Masaki"},{"name":"Ishizawa Keisuke"},{"name":"富永 えりか"},{"name":"Horinouchi Yuya"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"今西 正樹"},{"name":"石澤 啓介"},{"name":"富永 えりか"},{"name":"堀ノ内 裕也"},{"name":"谷口 順平"},{"name":"藤井 聖子"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第117回日本薬理学会近畿部会","ja":"第117回日本薬理学会近畿部会"},"publication_date":"2010-07-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:460, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=233597","label":"url"}],"presentation_title":{"en":"A role of androgen receptor in iscchemia-induced tissue damage and angiogenesis in male.","ja":"A role of androgen receptor in iscchemia-induced tissue damage and angiogenesis in male."},"presenters":{"en":[{"name":"Sumiko, Y."},{"name":"Aihara Ken-ichi"},{"name":"Ise, T."},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"Sumiko, Y."},{"name":"粟飯原 賢一"},{"name":"Ise, T."},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第42回日本動脈硬化学会総会・学術集会","ja":"第42回日本動脈硬化学会総会・学術集会"},"publication_date":"2010-07","languages":["eng"],"location":{"en":"Gifu","ja":"Gifu"},"is_international_presentation":false},"priority":"input_data"} line:461, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300239","label":"url"}],"presentation_title":{"en":"アンドロゲンーアンドロゲン受容体系は下肢虚血における組織傷害防御と血管新生に必須である","ja":"アンドロゲンーアンドロゲン受容体系は下肢虚血における組織傷害防御と血管新生に必須である"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"2010 年度(第 52 回)日本老年医学会学術集会 神戸国際会議場・神戸商工会議所・神戸ポートピアホテル","ja":"2010 年度(第 52 回)日本老年医学会学術集会 神戸国際会議場・神戸商工会議所・神戸ポートピアホテル"},"publication_date":"2010-06-24","languages":["jpn"],"location":{"en":"Kobe","ja":"神戸"},"is_international_presentation":false},"priority":"input_data"} line:462, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376332"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=237952","label":"url"}],"presentation_title":{"en":"Nifedipine代謝物はangiotensinⅡによる血管平滑筋細胞遊走および増殖を抑制する","ja":"Nifedipine代謝物はangiotensinⅡによる血管平滑筋細胞遊走および増殖を抑制する"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Imanishi Masaki"},{"name":"Tminaga Erika"},{"name":"Horinouchi Yuya"},{"name":"Sakurada Takumi"},{"name":"Taniguchi Zyunpei"},{"name":"Fujii Seiko"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"石澤 啓介"},{"name":"今西 正樹"},{"name":"Tminaga Erika"},{"name":"堀ノ内 裕也"},{"name":"Sakurada Takumi"},{"name":"Taniguchi Zyunpei"},{"name":"Fujii Seiko"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"第63回日本酸化ストレス学会","ja":"第63回日本酸化ストレス学会"},"publication_date":"2010-06-24","languages":["jpn"],"location":{"en":"神奈川県民ホール","ja":"神奈川県民ホール"},"is_international_presentation":false},"priority":"input_data"} line:463, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=219850","label":"url"}],"presentation_title":{"en":"The effect of SUDACHI peel, a specialty of Tokushima, as anti-metabolic syndrome","ja":"徳島県名産スダチ果皮の抗生活習慣病作用"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"田島 壮一郎"},{"name":"Horinouchi Yuya"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Takaishi Yoshihisa"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"田島 壮一郎"},{"name":"堀ノ内 裕也"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"高石 喜久"},{"name":"玉置 俊晃"}]},"event":{"en":"第83回日本薬理学会年会 シンポジウム「 肥満の栄養ゲノミクスと薬理ゲノミクス」","ja":"第83回日本薬理学会年会 シンポジウム「 肥満の栄養ゲノミクスと薬理ゲノミクス」"},"publication_date":"2010-03-22","invited":true,"languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:464, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232713","label":"url"}],"presentation_title":{"en":"ケルセチンの生体内代謝と動脈硬化予防効果","ja":"ケルセチンの生体内代謝と動脈硬化予防効果"},"presenters":{"en":[{"name":"Ishizawa Keisuke"},{"name":"Yoshizumi Masanori"},{"name":"Naruantungalag Dortsuren"},{"name":"今村 優子"},{"name":"Ikeda Yasumasa"},{"name":"Terao Junji"},{"name":"Tsuchiya Koichiro"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"石澤 啓介"},{"name":"吉栖 正典"},{"name":"Naruantungalag Dortsuren"},{"name":"今村 優子"},{"name":"池田 康将"},{"name":"寺尾 純二"},{"name":"土屋 浩一郎"},{"name":"玉置 俊晃"}]},"event":{"en":"第83回 日本薬理学会年会シンポジウム「健康食品の薬理学」","ja":"第83回 日本薬理学会年会シンポジウム「健康食品の薬理学」"},"publication_date":"2010-03-16","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:465, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232667","label":"url"}],"presentation_title":{"en":"KK-Ay マウスにおける鉄キレート剤Deferoxamineによる糖尿病病態改善効果の検討","ja":"KK-Ay マウスにおける鉄キレート剤Deferoxamineによる糖尿病病態改善効果の検討"},"presenters":{"en":[{"name":"田島 壮一郎"},{"name":"Ikeda Yasumasa"},{"name":"Tsuchiya Koichiro"},{"name":"Horinouchi Yuya"},{"name":"櫻田 巧"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Kawazoe Kazuyoshi"},{"name":"Tomita Shuhei"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"田島 壮一郎"},{"name":"池田 康将"},{"name":"土屋 浩一郎"},{"name":"堀ノ内 裕也"},{"name":"櫻田 巧"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"川添 和義"},{"name":"冨田 修平"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第83回 日本薬理学会","ja":"第83回 日本薬理学会"},"publication_date":"2010-03-16","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:466, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300241","label":"url"}],"presentation_title":{"en":"Accelerated cellular apoptosis and impaired angiogenesis after hindlimb ischemia in male mice lacking androgen receptor","ja":"Accelerated cellular apoptosis and impaired angiogenesis after hindlimb ischemia in male mice lacking androgen receptor"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第74回 日本循環器学会総会・学術集会 国立京都国際会館","ja":"第74回 日本循環器学会総会・学術集会 国立京都国際会館"},"publication_date":"2010-03-05","languages":["jpn"],"location":{"en":"Kyoto","ja":"京都"},"is_international_presentation":false},"priority":"input_data"} line:467, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232619","label":"url"}],"presentation_title":{"en":"T細胞のHIF-1aは,動脈硬化に伴う血管リモデリングを抑制的に制御する","ja":"T細胞のHIF-1aは,動脈硬化に伴う血管リモデリングを抑制的に制御する"},"presenters":{"en":[{"name":"Fukuhara Yayoi"},{"name":"Tomita Shuhei"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tsuchiya Koichiro"},{"name":"Yoshizumi Masanori"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"福原 弥生"},{"name":"冨田 修平"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"土屋 浩一郎"},{"name":"吉栖 正典"},{"name":"玉置 俊晃"}]},"event":{"en":"第39回日本心脈管作動物質学会","ja":"第39回日本心脈管作動物質学会"},"publication_date":"2010-02-05","languages":["jpn"],"location":{"en":"愛知県","ja":"愛知県"},"is_international_presentation":false},"priority":"input_data"} line:468, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=232616","label":"url"}],"presentation_title":{"en":"鉄キレート剤 Deferoxamine の血管新生左葉―マウス下肢虚血モデルにおける検討―","ja":"鉄キレート剤 Deferoxamine の血管新生左葉―マウス下肢虚血モデルにおける検討―"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Kihira Yoshitaka"},{"name":"Ishizawa Keisuke"},{"name":"Tomita Shuhei"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 康将"},{"name":"木平 孝高"},{"name":"石澤 啓介"},{"name":"冨田 修平"},{"name":"玉置 俊晃"}]},"event":{"en":"第39回日本心脈管作動物質学会","ja":"第39回日本心脈管作動物質学会"},"publication_date":"2010-02-05","languages":["jpn"],"location":{"en":"愛知県","ja":"愛知県"},"is_international_presentation":false},"priority":"input_data"} line:469, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=242152","label":"url"}],"presentation_title":{"en":"Angiotensin IIによる血管平滑筋細胞遊走に対するnifedipine代謝物の影響","ja":"Angiotensin IIによる血管平滑筋細胞遊走に対するnifedipine代謝物の影響"},"presenters":{"en":[{"name":"富永 えりか"},{"name":"Ishizawa Keisuke"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"谷口 順平"},{"name":"Kawazoe Kazuyoshi"},{"name":"Kihira Yoshitaka"},{"name":"Ikeda Yasumasa"},{"name":"Tomita Shuhei"},{"name":"Tsuchiya Koichiro"},{"name":"Minakuchi Kazuo"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"富永 えりか"},{"name":"石澤 啓介"},{"name":"櫻田 巧"},{"name":"今西 正樹"},{"name":"谷口 順平"},{"name":"川添 和義"},{"name":"木平 孝高"},{"name":"池田 康将"},{"name":"冨田 修平"},{"name":"土屋 浩一郎"},{"name":"水口 和生"},{"name":"玉置 俊晃"}]},"event":{"en":"第30回日本臨床薬理学会年会","ja":"第30回日本臨床薬理学会年会"},"publication_date":"2009-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:470, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267013","label":"url"}],"presentation_title":{"en":"ミネラルコルチコイド受容体を介したグルココルチコイド過剰による血管内皮細胞障害作用","ja":"ミネラルコルチコイド受容体を介したグルココルチコイド過剰による血管内皮細胞障害作用"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"石川 カズ江"},{"name":"Yoshida Sumiko"},{"name":"Ueda Yuka"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"石川 カズ江"},{"name":"吉田 守美子"},{"name":"上田 由佳"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"event":{"en":"第32回日本高血圧学会総会","ja":"第32回日本高血圧学会総会"},"publication_date":"2009-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:471, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267038","label":"url"}],"presentation_title":{"en":"グルココルチコイド誘発性血管内皮細胞障害におけるミネラルコルチコイド受容体の関与","ja":"グルココルチコイド誘発性血管内皮細胞障害におけるミネラルコルチコイド受容体の関与"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"石川 カズ江"},{"name":"住友 由佳"},{"name":"Yoshida Sumiko"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"石川 カズ江"},{"name":"住友 由佳"},{"name":"吉田 守美子"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"event":{"en":"第82回日本内分泌学会学術総会","ja":"第82回日本内分泌学会学術総会"},"publication_date":"2009-04-23","languages":["jpn"],"location":{"en":"Maebashi","ja":"前橋"},"is_international_presentation":false},"priority":"input_data"} line:472, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300315","label":"url"}],"presentation_title":{"en":"Glucocorticoid Excess Causes Vascular Endothelial Cell Dysfunction through Activation of Mineral Corticoid Receptor","ja":"Glucocorticoid Excess Causes Vascular Endothelial Cell Dysfunction through Activation of Mineral Corticoid Receptor"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"石川 カズ江"},{"name":"Yoshida Sumiko"},{"name":"住友 由佳"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"石川 カズ江"},{"name":"吉田 守美子"},{"name":"住友 由佳"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"event":{"en":"第73回日本循環器学会総会・学術集会","ja":"第73回日本循環器学会総会・学術集会"},"publication_date":"2009-03-20","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:473, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300466","label":"url"}],"presentation_title":{"en":"ピタバスタチンはERK5-KLF2経路の活性化を介して血管内皮細胞での一酸化窒素合成酵素の発現を亢進する","ja":"ピタバスタチンはERK5-KLF2経路の活性化を介して血管内皮細胞での一酸化窒素合成酵素の発現を亢進する"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"石川 カズ江"},{"name":"Ikeda Yasumasa"},{"name":"Yoshida Sumiko"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"阿部 純一"},{"name":"Matsumoto Toshio"},{"name":"Sata Masataka"}],"ja":[{"name":"赤池 雅史"},{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"石川 カズ江"},{"name":"池田 康将"},{"name":"吉田 守美子"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"阿部 純一"},{"name":"松本 俊夫"},{"name":"佐田 政隆"}]},"event":{"en":"第31回日本高血圧学会総会","ja":"第31回日本高血圧学会総会"},"publication_date":"2008-10-09","languages":["jpn"],"location":{"en":"Sapporo","ja":"札幌"},"is_international_presentation":false},"priority":"input_data"} line:474, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267084","label":"url"}],"presentation_title":{"en":"ピタバスタチンはRac-1を介した酸化ストレス制御によりeNOS非依存的にアンジオテンシンIIによる心房リモデリングを抑制する","ja":"ピタバスタチンはRac-1を介した酸化ストレス制御によりeNOS非依存的にアンジオテンシンIIによる心房リモデリングを抑制する"},"presenters":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Ise Takayuki"},{"name":"Yoshida Sumiko"},{"name":"住友 由佳"},{"name":"Ikeda Yasumasa"},{"name":"岩瀬 俊"},{"name":"Soeki Takeshi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"伊勢 孝之"},{"name":"吉田 守美子"},{"name":"住友 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"添木 武"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第40回日本動脈硬化学会総会","ja":"第40回日本動脈硬化学会総会"},"publication_date":"2008-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:475, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300425","label":"url"}],"presentation_title":{"en":"HMG-CoA Reductase Inhibitor Pitavastatin Increases the Expression of Endothelial NOS through Activation of ERK5-KLF2 Pathway in Vascular Endothelial Cells","ja":"HMG-CoA Reductase Inhibitor Pitavastatin Increases the Expression of Endothelial NOS through Activation of ERK5-KLF2 Pathway in Vascular Endothelial Cells"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"石川 カズ江"},{"name":"Ise Takayuki"},{"name":"Yoshida Sumiko"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Jun-ichi Abe"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"赤池 雅史"},{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"石川 カズ江"},{"name":"伊勢 孝之"},{"name":"吉田 守美子"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"Jun-ichi Abe"},{"name":"松本 俊夫"}]},"event":{"en":"第72回日本循環器学会学術集会","ja":"第72回日本循環器学会学術集会"},"publication_date":"2008-03-28","languages":["jpn"],"location":{"en":"Fukuoka","ja":"福岡"},"is_international_presentation":false},"priority":"input_data"} line:476, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267093","label":"url"}],"presentation_title":{"en":"Pitavastatinはangiotensin IIによる心腎障害をeNOS非依存性にrac1抑制による酸化ストレス抑制を介して改善する","ja":"Pitavastatinはangiotensin IIによる心腎障害をeNOS非依存性にrac1抑制による酸化ストレス抑制を介して改善する"},"presenters":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Ise Takayuki"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"伊勢 孝之"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第30回日本高血圧学会総会","ja":"第30回日本高血圧学会総会"},"publication_date":"2007-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:477, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267092","label":"url"}],"presentation_title":{"en":"グルココルチコイド誘発性高血圧に対するピタバスタチンの効果とその機序の検討","ja":"グルココルチコイド誘発性高血圧に対するピタバスタチンの効果とその機序の検討"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"石川 カズ江"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"八木 秀介"},{"name":"池田 康将"},{"name":"石川 カズ江"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"}]},"event":{"en":"第30回日本高血圧学会総会プログラム","ja":"第30回日本高血圧学会総会プログラム"},"publication_date":"2007-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:478, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267091","label":"url"}],"presentation_title":{"en":"血管リモデリング制御因子としての活性化ビタミンD","ja":"血管リモデリング制御因子としての活性化ビタミンD"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Ise Takayuki"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"伊勢 孝之"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第30回日本高血圧学会総会","ja":"第30回日本高血圧学会総会"},"publication_date":"2007-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:479, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267096","label":"url"}],"presentation_title":{"en":"活性化ビタミンDは臨床的動脈硬化抑制因子である","ja":"活性化ビタミンDは臨床的動脈硬化抑制因子である"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第39回日本動脈硬化学会総会・学術集会","ja":"第39回日本動脈硬化学会総会・学術集会"},"publication_date":"2007-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:480, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267097","label":"url"}],"presentation_title":{"en":"活性化ビタミンDの抗動脈硬化作用に関する臨床的検討","ja":"活性化ビタミンDの抗動脈硬化作用に関する臨床的検討"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Kondo Takeshi"},{"name":"重清 友理"},{"name":"Kinouchi Mizuho"},{"name":"Endo Itsuro"},{"name":"Fujinaka Yuichi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"近藤 剛史"},{"name":"重清 友理"},{"name":"木内 美瑞穂"},{"name":"遠藤 逸朗"},{"name":"藤中 雄一"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第80回日本内分泌学会学術総会","ja":"第80回日本内分泌学会学術総会"},"publication_date":"2007-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:481, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267160","label":"url"}],"presentation_title":{"en":"エリスロポイエチンを用いた新たな血管新生療法の試み","ja":"エリスロポイエチンを用いた新たな血管新生療法の試み"},"presenters":{"en":[{"name":"Iwase Takashi"},{"name":"住友 由佳"},{"name":"Yagi Shusuke"},{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Ozaki Shuji"},{"name":"Akaike Masashi"},{"name":"Abe Masahiro"},{"name":"Matsumoto Toshio"},{"name":"Kitagawa Tetsuya"}],"ja":[{"name":"岩瀬 俊"},{"name":"住友 由佳"},{"name":"八木 秀介"},{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"尾崎 修治"},{"name":"赤池 雅史"},{"name":"安倍 正博"},{"name":"松本 俊夫"},{"name":"北川 哲也"}]},"event":{"en":"第104回日本内科学会総会・講演会","ja":"第104回日本内科学会総会・講演会"},"publication_date":"2007-04","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:482, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267159","label":"url"}],"presentation_title":{"en":"活性化ビタミンDによる血管リモデリング制御作用","ja":"活性化ビタミンDによる血管リモデリング制御作用"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第104回日本内科学会総会・講演会","ja":"第104回日本内科学会総会・講演会"},"publication_date":"2007-04","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:483, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267157","label":"url"}],"presentation_title":{"en":"PitavastatinはAngiotensin IIによる心血管リモデリングと腎障害をeNOS非依存性に抑制する","ja":"PitavastatinはAngiotensin IIによる心血管リモデリングと腎障害をeNOS非依存性に抑制する"},"presenters":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第36回日本心脈管作動物質学会","ja":"第36回日本心脈管作動物質学会"},"publication_date":"2007-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:484, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267156","label":"url"}],"presentation_title":{"en":"アンドロゲン-アンドロゲン受容体システムによる血管リモデリング制御機構の解析","ja":"アンドロゲン-アンドロゲン受容体システムによる血管リモデリング制御機構の解析"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"住友 由佳"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Azuma Hiroyuki"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"住友 由佳"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"東 博之"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第36回日本心脈管作動物質学会","ja":"第36回日本心脈管作動物質学会"},"publication_date":"2007-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:485, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267154","label":"url"}],"presentation_title":{"en":"ピタバスタチンは血管内皮機能の改善を介してグルココルチコイド過剰による高血圧を予防する","ja":"ピタバスタチンは血管内皮機能の改善を介してグルココルチコイド過剰による高血圧を予防する"},"presenters":{"en":[{"name":"Akaike Masashi"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"石川 カズ江"},{"name":"Yagi Shusuke"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"赤池 雅史"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"石川 カズ江"},{"name":"八木 秀介"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"}]},"event":{"en":"第36回日本心脈管作動物質学会","ja":"第36回日本心脈管作動物質学会"},"publication_date":"2007-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:486, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267151","label":"url"}],"presentation_title":{"en":"ApoE欠損マウスにおける血漿ヘパリンコファクターII活性の低下は酸化ストレスを増大させ粥状動脈硬化を促進させる","ja":"ApoE欠損マウスにおける血漿ヘパリンコファクターII活性の低下は酸化ストレスを増大させ粥状動脈硬化を促進させる"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"住友 由佳"},{"name":"Iwase Takashi"},{"name":"Azuma Hiroyuki"},{"name":"加藤 茂明"},{"name":"Akaike Masashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"住友 由佳"},{"name":"岩瀬 俊"},{"name":"東 博之"},{"name":"加藤 茂明"},{"name":"赤池 雅史"},{"name":"松本 俊夫"}]},"event":{"en":"第36回日本心脈管作動物質学会","ja":"第36回日本心脈管作動物質学会"},"publication_date":"2007-02-09","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:487, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267206","label":"url"}],"presentation_title":{"en":"Thrombin inactivation by synthetic thrombin antagonist argatroban ameliorates insulin resistance in type 2 diabetic db/db mice","ja":"Thrombin inactivation by synthetic thrombin antagonist argatroban ameliorates insulin resistance in type 2 diabetic db/db mice"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Masatomo Mihara"},{"name":"Hiroyuki Azuma"},{"name":"Akaike Masashi"},{"name":"Matsushita Takaya"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"Shunji Hashizume"},{"name":"Mitsunori Fujimura"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"Masatomo Mihara"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"松下 隆哉"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"橋詰 俊二"},{"name":"藤村 光則"},{"name":"松本 俊夫"}]},"event":{"en":"The 70th Anniversary Annual Scientific Meetings of the Japanese Circulation Society","ja":"The 70th Anniversary Annual Scientific Meetings of the Japanese Circulation Society"},"publication_date":"2006-03","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:488, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266964","label":"url"}],"presentation_title":{"en":"ヘパリンコファクターIIは末梢動脈閉塞症に対する独立した防御因子である","ja":"ヘパリンコファクターIIは末梢動脈閉塞症に対する独立した防御因子である"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Kurobe Hirotsugu"},{"name":"藤村 光則"},{"name":"Yagi Shusuke"},{"name":"橋詰 俊二"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Kitagawa Tetsuya"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"黒部 裕嗣"},{"name":"藤村 光則"},{"name":"八木 秀介"},{"name":"橋詰 俊二"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"北川 哲也"},{"name":"松本 俊夫"}]},"event":{"en":"第28回日本血栓止血学会学術集会","ja":"第28回日本血栓止血学会学術集会"},"publication_date":"2005-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:489, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267205","label":"url"}],"presentation_title":{"en":"新規血管リモデリング抑制因子 ヘパリンコファクターIIの臨床 および分子生物学的解析","ja":"新規血管リモデリング抑制因子 ヘパリンコファクターIIの臨床 および分子生物学的解析"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Kurobe Hirotsugu"},{"name":"Sata Masataka"},{"name":"Ikeda Yasumasa"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"Iwase Takashi"},{"name":"Yagi Shusuke"},{"name":"大水 章正"},{"name":"塚田 稔"},{"name":"Kitagawa Tetsuya"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"黒部 裕嗣"},{"name":"佐田 政隆"},{"name":"池田 康将"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"岩瀬 俊"},{"name":"八木 秀介"},{"name":"大水 章正"},{"name":"塚田 稔"},{"name":"北川 哲也"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第13回日本血管生物医学会","ja":"第13回日本血管生物医学会"},"publication_date":"2005-10","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:490, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267165","label":"url"}],"presentation_title":{"en":"Pitavastatinは,Angiotensin IIによるマウス冠動脈リモデリングを抑制する","ja":"Pitavastatinは,Angiotensin IIによるマウス冠動脈リモデリングを抑制する"},"presenters":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"藤村 光則"},{"name":"Ikeda Yasumasa"},{"name":"橋詰 俊二"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"藤村 光則"},{"name":"池田 康将"},{"name":"橋詰 俊二"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第37回日本動脈硬化学会総会","ja":"第37回日本動脈硬化学会総会"},"publication_date":"2005-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:491, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267164","label":"url"}],"presentation_title":{"en":"新規血管リモデリング抑制因子ヘパリンコファクターIIの分子生物学的解析","ja":"新規血管リモデリング抑制因子ヘパリンコファクターIIの分子生物学的解析"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"大水 正章"},{"name":"塚田 稔"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"大水 正章"},{"name":"塚田 稔"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第37回日本動脈硬化学会総会","ja":"第37回日本動脈硬化学会総会"},"publication_date":"2005-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:492, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267163","label":"url"}],"presentation_title":{"en":"トロンビン作用の阻害は2型糖尿病モデルdb/dbマウスのインスリン抵抗性を改善する","ja":"トロンビン作用の阻害は2型糖尿病モデルdb/dbマウスのインスリン抵抗性を改善する"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"三原 正朋"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"Matsushita Takaya"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"三原 正朋"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"松下 隆哉"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第78回日本内分泌学会総会学術集会","ja":"第78回日本内分泌学会総会学術集会"},"publication_date":"2005-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:493, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267162","label":"url"}],"presentation_title":{"en":"アンドロゲン-アンドロゲン受容体システムはドキソルビシンによる心筋酸化ストレスに対して防御的に作用する","ja":"アンドロゲン-アンドロゲン受容体システムはドキソルビシンによる心筋酸化ストレスに対して防御的に作用する"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Yagi Shusuke"},{"name":"Iwase Takashi"},{"name":"橋詰 俊二"},{"name":"藤村 光則"},{"name":"Azuma Hiroyuki"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"八木 秀介"},{"name":"岩瀬 俊"},{"name":"橋詰 俊二"},{"name":"藤村 光則"},{"name":"東 博之"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第78回日本内分泌学会総会学術集会","ja":"第78回日本内分泌学会総会学術集会"},"publication_date":"2005-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:494, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267161","label":"url"}],"presentation_title":{"en":"Pitavastatinは,Angiotensin IIによるマウス冠動脈および心筋リモデリングを抑制する","ja":"Pitavastatinは,Angiotensin IIによるマウス冠動脈および心筋リモデリングを抑制する"},"presenters":{"en":[{"name":"Yagi Shusuke"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"橋詰 俊二"},{"name":"藤村 光則"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"八木 秀介"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"橋詰 俊二"},{"name":"藤村 光則"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第78回日本内分泌学会総会学術集会","ja":"第78回日本内分泌学会総会学術集会"},"publication_date":"2005-07","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:495, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266966","label":"url"}],"presentation_title":{"en":"Heparin cofactor II is required for fetal development and attenuates cuff-injured vascular remodeling in mice","ja":"Heparin cofactor II is required for fetal development and attenuates cuff-injured vascular remodeling in mice"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"MItsunori Fujimura"},{"name":"Shunji Hashizume"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Hirotaka Kawano"},{"name":"Takashi Yamada"},{"name":"Tohru Fukuda"},{"name":"Keisuke Sekine"},{"name":"Takashi Sato"},{"name":"Yuko Nakamichi"},{"name":"Yoko Yamamoto"},{"name":"Kimihiro Yoshimura"},{"name":"Tomoyuki Watanabe"},{"name":"Takashi Nakamura"},{"name":"Akira Ohmizu"},{"name":"Tsukada Minoru"},{"name":"Shigeaki Kato"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"河野 博隆"},{"name":"山田 高嗣"},{"name":"福田 亨"},{"name":"関根 圭介"},{"name":"佐藤 隆史"},{"name":"中道 裕子"},{"name":"山本 陽子"},{"name":"吉村 公宏"},{"name":"渡邊 智之"},{"name":"中村 貴"},{"name":"Akira Ohmizu"},{"name":"Tsukada Minoru"},{"name":"Shigeaki Kato"},{"name":"松本 俊夫"}]},"event":{"en":"The 37th Japan Atherosclerosis Society Annual Meeting","ja":"The 37th Japan Atherosclerosis Society Annual Meeting"},"publication_date":"2005-07","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:496, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267197","label":"url"}],"presentation_title":{"en":"ヘパリンコファクターIIは末梢動脈閉塞性病変進展に対する新規抑制因子である","ja":"ヘパリンコファクターIIは末梢動脈閉塞性病変進展に対する新規抑制因子である"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Kurobe Hirotsugu"},{"name":"藤村 光則"},{"name":"Yagi Shusuke"},{"name":"橋詰 俊二"},{"name":"Ikeda Yasumasa"},{"name":"Kitagawa Tetsuya"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"黒部 裕嗣"},{"name":"藤村 光則"},{"name":"八木 秀介"},{"name":"橋詰 俊二"},{"name":"池田 康将"},{"name":"北川 哲也"},{"name":"松本 俊夫"}]},"event":{"en":"第102回日本内科学会総会・講演会","ja":"第102回日本内科学会総会・講演会"},"publication_date":"2005-04","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:497, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266755","label":"url"}],"presentation_title":{"en":"Angiotensin II Antagonist Valsartan Ameliorates Nitric Oxide Bioavailability and Arterial Stiffness Accompanied with The Reduction of Blood Pressure and Pulse Pressure in Elderly Hypertensives","ja":"Angiotensin II Antagonist Valsartan Ameliorates Nitric Oxide Bioavailability and Arterial Stiffness Accompanied with The Reduction of Blood Pressure and Pulse Pressure in Elderly Hypertensives"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Midori Kato"},{"name":"Mitsunori Fujimura"},{"name":"Shunji Hashizume"},{"name":"Yagi Shusuke"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"Midori Kato"},{"name":"Mitsunori Fujimura"},{"name":"Shunji Hashizume"},{"name":"八木 秀介"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第69回日本循環器学会総会・学術集会","ja":"第69回日本循環器学会総会・学術集会"},"publication_date":"2005-03","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:498, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266432","label":"url"}],"presentation_title":{"en":"Arterial Cuff Injury Causes Enhanced Neointimal Formation and Increased Adventitial Area in Heterozygous Heparin Cofactor II Deficient Mice","ja":"Arterial Cuff Injury Causes Enhanced Neointimal Formation and Increased Adventitial Area in Heterozygous Heparin Cofactor II Deficient Mice"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"松本 俊夫"}]},"event":{"en":"第69回日本循環器学会総会・学術集会","ja":"第69回日本循環器学会総会・学術集会"},"publication_date":"2005-03","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:499, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267198","label":"url"}],"presentation_title":{"en":"アンドロゲン-アンドロゲン受容体系は生体の心筋防御機構である","ja":"アンドロゲン-アンドロゲン受容体系は生体の心筋防御機構である"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"藤村 光則"},{"name":"Yagi Shusuke"},{"name":"橋詰 俊二"},{"name":"Azuma Hiroyuki"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"藤村 光則"},{"name":"八木 秀介"},{"name":"橋詰 俊二"},{"name":"東 博之"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第42回日本臨床分子医学会学術総会","ja":"第42回日本臨床分子医学会学術総会"},"publication_date":"2005","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:500, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266962","label":"url"}],"presentation_title":{"en":"ヘパリンコファクターII欠乏マウスにおける 血管リモデリング異常の解析","ja":"ヘパリンコファクターII欠乏マウスにおける 血管リモデリング異常の解析"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"Yagi Shusuke"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"藤村 光則"},{"name":"橋詰 俊二"},{"name":"八木 秀介"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第27回日本血栓止血学会学術集会","ja":"第27回日本血栓止血学会学術集会"},"publication_date":"2004-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:501, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267192","label":"url"}],"presentation_title":{"en":"ビタミンD-ビタミンD受容体システムによる血液凝固調節作用の解析","ja":"ビタミンD-ビタミンD受容体システムによる血液凝固調節作用の解析"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"Ikeda Yasumasa"},{"name":"周藤 俊樹"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"池田 康将"},{"name":"周藤 俊樹"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第77回日本内分泌学会学術総会","ja":"第77回日本内分泌学会学術総会"},"publication_date":"2004-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:502, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267191","label":"url"}],"presentation_title":{"en":"アンドロゲン-アンドロゲン受容体システムは生体における心筋肥大及び心筋線維化の調節因子である","ja":"アンドロゲン-アンドロゲン受容体システムは生体における心筋肥大及び心筋線維化の調節因子である"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"森岡 将臣"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"山口 普史"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"Azuma Hiroyuki"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"池田 康将"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"森岡 将臣"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"山口 普史"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"東 博之"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第77回日本内分泌学会学術総会","ja":"第77回日本内分泌学会学術総会"},"publication_date":"2004-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:503, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1573387451866119936/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266960","label":"url"}],"presentation_title":{"en":"拡張型心筋症様病態を呈したCushing病の一例","ja":"拡張型心筋症様病態を呈したCushing病の一例"},"presenters":{"en":[{"name":"山口 普史"},{"name":"七條 加奈"},{"name":"Matsushita Takaya"},{"name":"Ikeda Yasumasa"},{"name":"森岡 将臣"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"Aihara Ken-ichi"},{"name":"Inoue Daisuke"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"山口 普史"},{"name":"七條 加奈"},{"name":"松下 隆哉"},{"name":"池田 康将"},{"name":"森岡 将臣"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"粟飯原 賢一"},{"name":"井上 大輔"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"Circulation journal : official journal of the Japanese Circulation Society","ja":"第83回日本循環器学会中国・四国合同地方会"},"publication_date":"2004-04-20","languages":["jpn"],"promoter":{"en":"The Japanese Circulation Society","ja":"社団法人 日本循環器学会"},"is_international_presentation":false},"priority":"input_data"} line:504, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://cir.nii.ac.jp/crid/1571135652052441728/","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266957","label":"url"}],"presentation_title":{"en":"Torsade de pointesを合併した汎下垂体機能低下症の一例","ja":"Torsade de pointesを合併した汎下垂体機能低下症の一例"},"presenters":{"en":[{"name":"Ikeda Yasumasa"},{"name":"山口 普史"},{"name":"七條 加奈"},{"name":"森岡 将臣"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"吉田 智則"},{"name":"藤村 光則"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"},{"name":"木村 建彦"},{"name":"西内 健"}],"ja":[{"name":"池田 康将"},{"name":"山口 普史"},{"name":"七條 加奈"},{"name":"森岡 将臣"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"吉田 智則"},{"name":"藤村 光則"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"松本 俊夫"},{"name":"木村 建彦"},{"name":"西内 健"}]},"event":{"en":"Circulation journal : official journal of the Japanese Circulation Society","ja":"第83回日本循環器学会中国・四国合同地方会"},"publication_date":"2004-04-20","languages":["jpn"],"promoter":{"en":"Japanese Circulation Society","ja":"社団法人日本循環器学会"},"is_international_presentation":false},"priority":"input_data"} line:505, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267196","label":"url"}],"presentation_title":{"en":"核内受容体PPARαの活性化は巨核球/血小板内PDGF-BBの産生を抑制する","ja":"核内受容体PPARαの活性化は巨核球/血小板内PDGF-BBの産生を抑制する"},"presenters":{"en":[{"name":"橋詰 俊二"},{"name":"Ikeda Yasumasa"},{"name":"加藤 みどり"},{"name":"山口 普史"},{"name":"吉田 智則"},{"name":"藤村 光則"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"橋詰 俊二"},{"name":"池田 康将"},{"name":"加藤 みどり"},{"name":"山口 普史"},{"name":"吉田 智則"},{"name":"藤村 光則"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第36回日本動脈硬化学会総会","ja":"第36回日本動脈硬化学会総会"},"publication_date":"2004","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:506, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267194","label":"url"}],"presentation_title":{"en":"ヘパリンコファクターIIの動脈硬化抑制作用に関する臨床的検討","ja":"ヘパリンコファクターIIの動脈硬化抑制作用に関する臨床的検討"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"高森 信行"},{"name":"Kanagawa Yasuhiko"},{"name":"藤村 光則"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"Ikeda Yasumasa"},{"name":"田村 克也"},{"name":"近藤 彰"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"高森 信行"},{"name":"金川 泰彦"},{"name":"藤村 光則"},{"name":"加藤 みどり"},{"name":"橋詰 俊二"},{"name":"池田 康将"},{"name":"田村 克也"},{"name":"近藤 彰"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第41回日本臨床分子医学会学術総会","ja":"第41回日本臨床分子医学会学術総会"},"publication_date":"2004","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:507, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267187","label":"url"}],"presentation_title":{"en":"遺伝性出血性末梢血管拡張症9家系における臨床病型と遺伝子変異に関する解析","ja":"遺伝性出血性末梢血管拡張症9家系における臨床病型と遺伝子変異に関する解析"},"presenters":{"en":[{"name":"山口 普史"},{"name":"Ikeda Yasumasa"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"吉田 智則"},{"name":"藤村 光則"},{"name":"Aihara Ken-ichi"},{"name":"Akaike Masashi"},{"name":"Azuma Hiroyuki"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"山口 普史"},{"name":"池田 康将"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"吉田 智則"},{"name":"藤村 光則"},{"name":"粟飯原 賢一"},{"name":"赤池 雅史"},{"name":"東 博之"},{"name":"松本 俊夫"}]},"event":{"en":"第25回日本血栓止血学会学術集会","ja":"第25回日本血栓止血学会学術集会"},"publication_date":"2003-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:508, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267186","label":"url"}],"presentation_title":{"en":"ヘパリンコファクターIIは高齢者における新規動脈硬化抑制因子である","ja":"ヘパリンコファクターIIは高齢者における新規動脈硬化抑制因子である"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"高森 信行"},{"name":"Kanagawa Yasuhiko"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"山口 普史"},{"name":"Ikeda Yasumasa"},{"name":"加藤 修司"},{"name":"荒瀬 友子"},{"name":"近藤 彰"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"高森 信行"},{"name":"金川 泰彦"},{"name":"藤村 光則"},{"name":"吉田 智則"},{"name":"橋詰 俊二"},{"name":"加藤 みどり"},{"name":"山口 普史"},{"name":"池田 康将"},{"name":"加藤 修司"},{"name":"荒瀬 友子"},{"name":"近藤 彰"},{"name":"松本 俊夫"}]},"event":{"en":"第25回日本血栓止血学会学術集会","ja":"第25回日本血栓止血学会学術集会"},"publication_date":"2003-11","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:509, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267309","label":"url"}],"presentation_title":{"en":"Vitamin D/Vitamin D Receptor System Regulates Antithrombogenicity in vivo","ja":"Vitamin D/Vitamin D Receptor System Regulates Antithrombogenicity in vivo"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Mitsunori Fujimura"},{"name":"Toshiki Sudo"},{"name":"Hideki Hayashi"},{"name":"Yoshihisa Yamada"},{"name":"Tomonori Yoshida"},{"name":"Hiroshi Yamaguchi"},{"name":"Shunji Hashizume"},{"name":"Midori Kato"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"Mitsunori Fujimura"},{"name":"Toshiki Sudo"},{"name":"Hideki Hayashi"},{"name":"Yoshihisa Yamada"},{"name":"Tomonori Yoshida"},{"name":"Hiroshi Yamaguchi"},{"name":"Shunji Hashizume"},{"name":"Midori Kato"},{"name":"松本 俊夫"}]},"event":{"en":"第68回日本循環器学会総会学術集会","ja":"第68回日本循環器学会総会学術集会"},"publication_date":"2003-03","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:510, {"insert":{"user_id":"B000241782","type":"presentations","id":"41349373"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=393894","label":"url"}],"presentation_title":{"en":"生命金属元素鉄と代謝疾患","ja":"生命金属元素鉄と代謝疾患"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"2022年度 肥満・糖尿病クラスター・ミニリトリート","ja":"2022年度 肥満・糖尿病クラスター・ミニリトリート"},"publication_date":"2023-02-03","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:511, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376333"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=363199","label":"url"}],"presentation_title":{"en":"鉄代謝と糖尿病","ja":"鉄代謝と糖尿病"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"徳島大学糖尿病臨床・研究開発センター 設立 10 周年記念シンポジウム","ja":"徳島大学糖尿病臨床・研究開発センター 設立 10 周年記念シンポジウム"},"publication_date":"2020-02-21","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:512, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376334"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=351147","label":"url"}],"presentation_title":{"en":"The role of iron in obesity and diabetes","ja":"The role of iron in obesity and diabetes"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"Joint Symposium (Hannover Medical School- Institute of Advanced Medical Sciences in Tokushima University)","ja":"Joint Symposium (Hannover Medical School- Institute of Advanced Medical Sciences in Tokushima University)"},"publication_date":"2019-05-14","languages":["eng"],"is_international_presentation":false},"priority":"input_data"} line:513, {"insert":{"user_id":"B000241782","type":"presentations","id":"30376335"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=348478","label":"url"}],"presentation_title":{"en":"健康と微量栄養素 ー鉄の役割についてー","ja":"健康と微量栄養素 ー鉄の役割についてー"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"市民公開講座「食と薬から健康長寿を考える」","ja":"市民公開講座「食と薬から健康長寿を考える」"},"publication_date":"2018-12-09","languages":["jpn"],"promoter":{"en":"文部科学省 概算特別要求「細胞内分子記憶機能解明による食育イノベーション推進研究」(H26-H30)","ja":"文部科学省 概算特別要求「細胞内分子記憶機能解明による食育イノベーション推進研究」(H26-H30)"},"is_international_presentation":false},"priority":"input_data"} line:514, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=327150","label":"url"}],"presentation_title":{"en":"ケルセチンによる血管保護効果の検討","ja":"ケルセチンによる血管保護効果の検討"},"presenters":{"en":[{"name":"池田 裕美子"},{"name":"斎藤 尚子"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Horinouchi Yuya"},{"name":"Ikeda Yasumasa"},{"name":"Ishizawa Keisuke"},{"name":"Tamaki Toshiaki"}],"ja":[{"name":"池田 裕美子"},{"name":"斎藤 尚子"},{"name":"石澤 有紀"},{"name":"堀ノ内 裕也"},{"name":"池田 康将"},{"name":"石澤 啓介"},{"name":"玉置 俊晃"}]},"event":{"en":"西日本医学生学術フォーラム(第5回医学研究学生フォーラム)","ja":"西日本医学生学術フォーラム(第5回医学研究学生フォーラム)"},"publication_date":"2016-12-10","location":{"en":"Okayama","ja":"岡山"},"is_international_presentation":false},"priority":"input_data"} line:515, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=320267","label":"url"}],"presentation_title":{"en":"慢性腎不全における鉄代謝変化と腎性貧血との関連","ja":"慢性腎不全における鉄代謝変化と腎性貧血との関連"},"presenters":{"en":[{"name":"Ikeda Yasumasa"}],"ja":[{"name":"池田 康将"}]},"event":{"en":"第9回慢性腎臓病(CKD)病態研究会","ja":"第9回慢性腎臓病(CKD)病態研究会"},"publication_date":"2016-09-10","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:516, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=326750","label":"url"}],"presentation_title":{"en":"ドラッグリポジショニング手法を用いた新規循環器治療薬の探索研究","ja":"ドラッグリポジショニング手法を用いた新規循環器治療薬の探索研究"},"presenters":{"en":[{"name":"Zamami Yoshito"},{"name":"Imanishi Masaki"},{"name":"Takechi Kenshi"},{"name":"Horinouchi Yuya"},{"name":"Miyamoto Licht"},{"name":"Izawa-Ishizawa Yuki"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Ishizawa Keisuke"}],"ja":[{"name":"座間味 義人"},{"name":"今西 正樹"},{"name":"武智 研志"},{"name":"堀ノ内 裕也"},{"name":"宮本 理人"},{"name":"石澤 有紀"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"石澤 啓介"}]},"event":{"en":"第23回大阪市大フォーラム","ja":"第23回大阪市大フォーラム"},"publication_date":"2016-08-04","languages":["jpn"],"location":{"en":"Osaka","ja":"大阪"},"is_international_presentation":false},"priority":"input_data"} line:517, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=299392","label":"url"}],"presentation_title":{"en":"-","ja":"雄性生体の動脈硬化形成におけるマクロファージ・アンドロゲン受容体の意義"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"上元 良子"},{"name":"石川 カズ江"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"上元 良子"},{"name":"石川 カズ江"}]},"event":{"en":"第6回 テストステロン研究会","ja":"第6回 テストステロン研究会"},"publication_date":"2015-09-04","languages":["jpn"],"location":{"en":"埼玉県","ja":"埼玉県"},"is_international_presentation":false},"priority":"input_data"} line:518, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=319073","label":"url"}],"presentation_title":{"en":"鉄過剰ストレスに対するニトロソニフェジピン(NO-NIF)の抗酸化メカニズム検討","ja":"鉄過剰ストレスに対するニトロソニフェジピン(NO-NIF)の抗酸化メカニズム検討"},"presenters":{"en":[{"name":"津田 勝範"},{"name":"Miyamoto Licht"},{"name":"森本 悠里"},{"name":"Hamano Shuichi"},{"name":"Ishizawa Keisuke"},{"name":"木平 考高"},{"name":"Ikeda Yasumasa"},{"name":"Tamaki Toshiaki"},{"name":"Tsuchiya Koichiro"}],"ja":[{"name":"津田 勝範"},{"name":"宮本 理人"},{"name":"森本 悠里"},{"name":"濱野 修一"},{"name":"石澤 啓介"},{"name":"木平 考高"},{"name":"池田 康将"},{"name":"玉置 俊晃"},{"name":"土屋 浩一郎"}]},"event":{"en":"徳島医学会","ja":"徳島医学会"},"publication_date":"2015-08-02","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:519, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=273454","label":"url"}],"presentation_title":{"en":"心血管ストレス制御におけるアンドロゲン受容体機能の性差","ja":"心血管ストレス制御におけるアンドロゲン受容体機能の性差"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"上元 良子"},{"name":"石川 カズ江"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"上元 良子"},{"name":"石川 カズ江"},{"name":"松本 俊夫"}]},"event":{"en":"第4回テストステロン研究会","ja":"第4回テストステロン研究会"},"publication_date":"2013-11-09","languages":["jpn"],"location":{"en":"Karuizawa","ja":"軽井沢"},"is_international_presentation":false},"priority":"input_data"} line:520, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=266807","label":"url"}],"presentation_title":{"en":"虚血耐性における性差非依存性のアンドロゲン受容体作用","ja":"虚血耐性における性差非依存性のアンドロゲン受容体作用"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第5回核内受容体・ホルモン研究会","ja":"第5回核内受容体・ホルモン研究会"},"publication_date":"2013-03-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:521, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=269445","label":"url"}],"presentation_title":{"en":"アンドロゲン受容体は,虚血ストレスに対する骨格筋アポトーシス防御および血管新生に必須である","ja":"アンドロゲン受容体は,虚血ストレスに対する骨格筋アポトーシス防御および血管新生に必須である"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第4回核内受容体研究会","ja":"第4回核内受容体研究会"},"publication_date":"2012-04-06","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:522, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=300236","label":"url"}],"presentation_title":{"en":"アンドロゲン受容体は,虚血ストレスに対する骨格筋アポトーシス防御および血管新生に必須である","ja":"アンドロゲン受容体は,虚血ストレスに対する骨格筋アポトーシス防御および血管新生に必須である"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第3回 核内受容体研究会 帝人ファーマ株式会社","ja":"第3回 核内受容体研究会 帝人ファーマ株式会社"},"publication_date":"2011-03-11","languages":["jpn"],"location":{"en":"Tokyo","ja":"東京"},"is_international_presentation":false},"priority":"input_data"} line:523, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=301820","label":"url"}],"presentation_title":{"en":"エイコサペンタエン酸の心血管リモデリング抑制効果の検討","ja":"エイコサペンタエン酸の心血管リモデリング抑制効果の検討"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第3回Tokushima Young Investigators Conference","ja":"第3回Tokushima Young Investigators Conference"},"publication_date":"2011-03-10","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:524, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=301816","label":"url"}],"presentation_title":{"en":"EPAによる心血管リモデリング抑制効果の検討","ja":"EPAによる心血管リモデリング抑制効果の検討"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第30回心血管セミナー","ja":"第30回心血管セミナー"},"publication_date":"2011-01-22","languages":["jpn"],"location":{"en":"Takamatsu","ja":"高松"},"is_international_presentation":false},"priority":"input_data"} line:525, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=301855","label":"url"}],"presentation_title":{"en":"虚血および血管新生におけるアンドロゲン作用の検討","ja":"虚血および血管新生におけるアンドロゲン作用の検討"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"興和学術講演会","ja":"興和学術講演会"},"publication_date":"2010-05-17","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:526, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267294","label":"url"}],"presentation_title":{"en":"心血管ストレスに対するandrogen-androgen 受容体系の役割","ja":"心血管ストレスに対するandrogen-androgen 受容体系の役割"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Yoshida Sumiko"},{"name":"Ikeda Yasumasa"},{"name":"Akaike Masashi"},{"name":"加藤 茂明"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"吉田 守美子"},{"name":"池田 康将"},{"name":"赤池 雅史"},{"name":"加藤 茂明"},{"name":"松本 俊夫"}]},"event":{"en":"第2回核内受容体研究会","ja":"第2回核内受容体研究会"},"publication_date":"2010-03-12","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} line:527, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=301907","label":"url"}],"presentation_title":{"en":"下肢虚血モデルを用いたアンドロゲン受容体による虚血臓器保護効果の検討","ja":"下肢虚血モデルを用いたアンドロゲン受容体による虚血臓器保護効果の検討"},"presenters":{"en":[{"name":"Yoshida Sumiko"},{"name":"Aihara Ken-ichi"},{"name":"Ueda Yuka"},{"name":"Ikeda Yasumasa"},{"name":"倉橋 清衛"},{"name":"Kinouchi Mizuho"},{"name":"Endo Itsuro"},{"name":"Fujinaka Yuichi"},{"name":"Iwase Takashi"},{"name":"Akaike Masashi"},{"name":"Sata Masataka"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"吉田 守美子"},{"name":"粟飯原 賢一"},{"name":"上田 由佳"},{"name":"池田 康将"},{"name":"倉橋 清衛"},{"name":"木内 美瑞穂"},{"name":"遠藤 逸朗"},{"name":"藤中 雄一"},{"name":"岩瀬 俊"},{"name":"赤池 雅史"},{"name":"佐田 政隆"},{"name":"松本 俊夫"}]},"event":{"en":"第15回徳島内分泌研究会","ja":"第15回徳島内分泌研究会"},"publication_date":"2009-11-13","languages":["jpn"],"location":{"en":"Tokushima","ja":"徳島"},"is_international_presentation":false},"priority":"input_data"} line:528, {"insert":{"user_id":"B000241782","type":"presentations"},"similar_merge":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=267296","label":"url"}],"presentation_title":{"en":"新規血管リモデリング抑制因子 ヘパリンコファクターIIの 分子生物学的解析","ja":"新規血管リモデリング抑制因子 ヘパリンコファクターIIの 分子生物学的解析"},"presenters":{"en":[{"name":"Aihara Ken-ichi"},{"name":"Azuma Hiroyuki"},{"name":"Akaike Masashi"},{"name":"Ikeda Yasumasa"},{"name":"Yagi Shusuke"},{"name":"住友 由佳"},{"name":"Yoshida Sumiko"},{"name":"Ise Takayuki"},{"name":"Iwase Takashi"},{"name":"Matsumoto Toshio"}],"ja":[{"name":"粟飯原 賢一"},{"name":"東 博之"},{"name":"赤池 雅史"},{"name":"池田 康将"},{"name":"八木 秀介"},{"name":"住友 由佳"},{"name":"吉田 守美子"},{"name":"伊勢 孝之"},{"name":"岩瀬 俊"},{"name":"松本 俊夫"}]},"event":{"en":"第9回四国循環器研究会","ja":"第9回四国循環器研究会"},"publication_date":"2007-09-15","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"} ==== end registerFile(/WWW/pub2/data/ERD/person/219499/researchmap/presentations.jsonl, QsEv-I4B7kacV6CWXvWR) ==== ====== BulkResult(B000241782, IcEv-I4B7kacV6CWWPVe) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:05Z","end_datetime":"2024-04-19T21:14:05Z","estimated_end_datetime":"2024-04-19T21:14:06Z","total_items":97} --- success {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:05Z","end_datetime":"2024-04-19T21:14:05Z","estimated_end_datetime":"2024-04-19T21:14:06Z","total_items":97} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"45827841","link":"https://api.researchmap.jp/yasuikeda/published_papers/45827841","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45827841]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"44313632","link":"https://api.researchmap.jp/yasuikeda/published_papers/44313632","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44313632]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"42962898","link":"https://api.researchmap.jp/yasuikeda/published_papers/42962898","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42962898]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"41903676","link":"https://api.researchmap.jp/yasuikeda/published_papers/41903676","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=41903676]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"40754243","link":"https://api.researchmap.jp/yasuikeda/published_papers/40754243","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=40754243]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"40154909","link":"https://api.researchmap.jp/yasuikeda/published_papers/40154909","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=40154909]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"37034545","link":"https://api.researchmap.jp/yasuikeda/published_papers/37034545","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=37034545]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"32635735","link":"https://api.researchmap.jp/yasuikeda/published_papers/32635735","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32635735]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"33322220","link":"https://api.researchmap.jp/yasuikeda/published_papers/33322220","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=33322220]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"35045098","link":"https://api.researchmap.jp/yasuikeda/published_papers/35045098","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=35045098]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"32553169","link":"https://api.researchmap.jp/yasuikeda/published_papers/32553169","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32553169]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"32234282","link":"https://api.researchmap.jp/yasuikeda/published_papers/32234282","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=32234282]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30702859","link":"https://api.researchmap.jp/yasuikeda/published_papers/30702859","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=30702859]。"}]} {"no":1,"line":14,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"32199538","link":"https://api.researchmap.jp/yasuikeda/published_papers/32199538","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32199538]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"31136365","link":"https://api.researchmap.jp/yasuikeda/published_papers/31136365","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=31136365]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"27559154","link":"https://api.researchmap.jp/yasuikeda/published_papers/27559154","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=27559154]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"27559164","link":"https://api.researchmap.jp/yasuikeda/published_papers/27559164","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=27559164]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"33233710","link":"https://api.researchmap.jp/yasuikeda/published_papers/33233710","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=33233710]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24571889","link":"https://api.researchmap.jp/yasuikeda/published_papers/24571889","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24571889]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24571891","link":"https://api.researchmap.jp/yasuikeda/published_papers/24571891","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24571891]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24571892","link":"https://api.researchmap.jp/yasuikeda/published_papers/24571892","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24571892]。"}]} {"no":1,"line":22,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376210","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376210","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=3879483]。"}]} {"no":1,"line":23,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24571893","link":"https://api.researchmap.jp/yasuikeda/published_papers/24571893","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24571893]。"}]} {"no":1,"line":24,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24571894","link":"https://api.researchmap.jp/yasuikeda/published_papers/24571894","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24571894]。"}]} {"no":1,"line":25,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376211","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376211","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=3879482]。"}]} {"no":1,"line":26,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"3879484","link":"https://api.researchmap.jp/yasuikeda/published_papers/3879484","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=3879484]。"}]} {"no":1,"line":27,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376212","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376212","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=3879488]。"}]} {"no":1,"line":28,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24571895","link":"https://api.researchmap.jp/yasuikeda/published_papers/24571895","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24571895]。"}]} {"no":1,"line":29,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376213","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376213","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=3879485]。"}]} {"no":1,"line":30,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"3879486","link":"https://api.researchmap.jp/yasuikeda/published_papers/3879486","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=3879486]。"}]} {"no":1,"line":31,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"3879489","link":"https://api.researchmap.jp/yasuikeda/published_papers/3879489","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=3879489]。"}]} {"no":1,"line":32,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376214","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376214","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=17986058]。"}]} {"no":1,"line":33,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30376215","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376215","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376215]。"}]} {"no":1,"line":34,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376216","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376216","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=17986060]。"}]} {"no":1,"line":35,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376217","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376217","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=16579192]。"}]} {"no":1,"line":36,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376218","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376218","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=16579193]。"}]} {"no":1,"line":37,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24878767","link":"https://api.researchmap.jp/yasuikeda/published_papers/24878767","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24878767]。"}]} {"no":1,"line":38,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790343","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790343","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790343]。"}]} {"no":1,"line":39,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"16579197","link":"https://api.researchmap.jp/yasuikeda/published_papers/16579197","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=16579197]。"}]} {"no":1,"line":40,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"16579196","link":"https://api.researchmap.jp/yasuikeda/published_papers/16579196","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=16579196]。"}]} {"no":1,"line":41,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790346","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790346","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790346]。"}]} {"no":1,"line":42,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790347","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790347","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790347]。"}]} {"no":1,"line":43,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376219","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376219","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=17986061]。"}]} {"no":1,"line":44,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790345","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790345","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790345]。"}]} {"no":1,"line":45,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790348","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790348","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790348]。"}]} {"no":1,"line":46,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790349","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790349","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790349]。"}]} {"no":1,"line":47,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105233","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105233","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105233]。"}]} {"no":1,"line":48,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24878792","link":"https://api.researchmap.jp/yasuikeda/published_papers/24878792","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24878792]。"}]} {"no":1,"line":49,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790352","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790352","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790352]。"}]} {"no":1,"line":50,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24878805","link":"https://api.researchmap.jp/yasuikeda/published_papers/24878805","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24878805]。"}]} {"no":1,"line":51,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790354","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790354","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790354]。"}]} {"no":1,"line":52,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24878823","link":"https://api.researchmap.jp/yasuikeda/published_papers/24878823","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24878823]。"}]} {"no":1,"line":53,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790356","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790356","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790356]。"}]} {"no":1,"line":54,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790358","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790358","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790358]。"}]} {"no":1,"line":55,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105243","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105243","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105243]。"}]} {"no":1,"line":56,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790360","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790360","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790360]。"}]} {"no":1,"line":57,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790361","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790361","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790361]。"}]} {"no":1,"line":58,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376220","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376220","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790363]。"}]} {"no":1,"line":59,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376221","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376221","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790362]。"}]} {"no":1,"line":60,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376222","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376222","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790366]。"}]} {"no":1,"line":61,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376223","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376223","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790364]。"}]} {"no":1,"line":62,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105260","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105260","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105260]。"}]} {"no":1,"line":63,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105265","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105265","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105265]。"}]} {"no":1,"line":64,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790368","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790368","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790368]。"}]} {"no":1,"line":65,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790370","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790370","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790370]。"}]} {"no":1,"line":66,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105287","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105287","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105287]。"}]} {"no":1,"line":67,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790372","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790372","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790372]。"}]} {"no":1,"line":68,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790373","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790373","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790373]。"}]} {"no":1,"line":69,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376224","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376224","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790374]。"}]} {"no":1,"line":70,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790375","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790375","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790375]。"}]} {"no":1,"line":71,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790380","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790380","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790380]。"}]} {"no":1,"line":72,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376225","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376225","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790377]。"}]} {"no":1,"line":73,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790378","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790378","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790378]。"}]} {"no":1,"line":74,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376226","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376226","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790379]。"}]} {"no":1,"line":75,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790376","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790376","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790376]。"}]} {"no":1,"line":76,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24878863","link":"https://api.researchmap.jp/yasuikeda/published_papers/24878863","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24878863]。"}]} {"no":1,"line":77,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376227","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376227","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790381]。"}]} {"no":1,"line":78,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790383","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790383","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790383]。"}]} {"no":1,"line":79,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790384","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790384","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790384]。"}]} {"no":1,"line":80,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105329","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105329","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105329]。"}]} {"no":1,"line":81,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105334","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105334","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105334]。"}]} {"no":1,"line":82,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790386","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790386","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790386]。"}]} {"no":1,"line":83,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30376228","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376228","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376228]。"}]} {"no":1,"line":84,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"25105337","link":"https://api.researchmap.jp/yasuikeda/published_papers/25105337","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=25105337]。"}]} {"no":1,"line":85,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376229","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376229","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790388]。"}]} {"no":1,"line":86,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790389","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790389","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790389]。"}]} {"no":1,"line":87,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790390","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790390","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790390]。"}]} {"no":1,"line":88,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790391","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790391","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790391]。"}]} {"no":1,"line":89,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790393","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790393","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790393]。"}]} {"no":1,"line":90,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790392","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790392","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790392]。"}]} {"no":1,"line":91,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790394","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790394","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790394]。"}]} {"no":1,"line":92,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30376230","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376230","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376230]。"}]} {"no":1,"line":93,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790395","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790395","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790395]。"}]} {"no":1,"line":94,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"30376231","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376231","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790396]。"}]} {"no":1,"line":95,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"30376232","link":"https://api.researchmap.jp/yasuikeda/published_papers/30376232","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376232]。"}]} {"no":1,"line":96,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"29103041","link":"https://api.researchmap.jp/yasuikeda/published_papers/29103041","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=29103041]。"}]} {"no":1,"line":97,"code":304,"action":"insert","action_type":"force","type":"published_papers","id":"32199539","link":"https://api.researchmap.jp/yasuikeda/published_papers/32199539","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32199539]。"}]} ====== BulkResult(B000241782, IcEv-I4B7kacV6CWWPVe) : End ====== ====== BulkResult(B000241782, KMEv-I4B7kacV6CWWfWf) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:06Z","end_datetime":"2024-04-19T21:14:06Z","estimated_end_datetime":"2024-04-19T21:14:07Z","total_items":22} --- success {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:06Z","end_datetime":"2024-04-19T21:14:06Z","estimated_end_datetime":"2024-04-19T21:14:07Z","total_items":22} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"44050684","link":"https://api.researchmap.jp/yasuikeda/misc/44050684","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44050684]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"43586166","link":"https://api.researchmap.jp/yasuikeda/misc/43586166","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43586166]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"43586167","link":"https://api.researchmap.jp/yasuikeda/misc/43586167","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43586167]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"force","type":"misc","id":"41903674","link":"https://api.researchmap.jp/yasuikeda/misc/41903674","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=41903674]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"force","type":"misc","id":"36868137","link":"https://api.researchmap.jp/yasuikeda/misc/36868137","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=36868137]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"force","type":"misc","id":"32244698","link":"https://api.researchmap.jp/yasuikeda/misc/32244698","messages":[{"code":304,"message":"not_modified","message_description":"本人相当が登録した既存データが存在したため、更新しませんでした[id=32244698]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30376240","link":"https://api.researchmap.jp/yasuikeda/misc/30376240","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376240]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30376241","link":"https://api.researchmap.jp/yasuikeda/misc/30376241","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376241]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"24571890","link":"https://api.researchmap.jp/yasuikeda/published_papers/24571890","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=24571890]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"1323176","link":"https://api.researchmap.jp/yasuikeda/misc/1323176","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=1323176]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"16579194","link":"https://api.researchmap.jp/yasuikeda/published_papers/16579194","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=16579194]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"force","type":"misc","id":"30376242","link":"https://api.researchmap.jp/yasuikeda/misc/30376242","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790344]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"1323166","link":"https://api.researchmap.jp/yasuikeda/misc/1323166","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=1323166]。"}]} {"no":1,"line":14,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"1323167","link":"https://api.researchmap.jp/yasuikeda/misc/1323167","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=1323167]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30376244","link":"https://api.researchmap.jp/yasuikeda/misc/30376244","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376244]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790357","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790357","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790357]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"1323170","link":"https://api.researchmap.jp/yasuikeda/misc/1323170","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=1323170]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790359","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790359","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790359]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"17138026","link":"https://api.researchmap.jp/yasuikeda/misc/17138026","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=17138026]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"misc","id":"1323171","link":"https://api.researchmap.jp/yasuikeda/misc/1323171","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=1323171]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"published_papers","id":"10790367","link":"https://api.researchmap.jp/yasuikeda/published_papers/10790367","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=10790367]。"}]} {"no":1,"line":22,"code":304,"action":"insert","action_type":"merge","type":"misc","id":"30376245","link":"https://api.researchmap.jp/yasuikeda/misc/30376245","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376245]。"}]} ====== BulkResult(B000241782, KMEv-I4B7kacV6CWWfWf) : End ====== ====== BulkResult(B000241782, K8Ev-I4B7kacV6CWWvVn) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:16Z","end_datetime":"2024-04-19T21:14:16Z","estimated_end_datetime":"2024-04-19T21:14:17Z","total_items":8} --- success {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:16Z","end_datetime":"2024-04-19T21:14:16Z","estimated_end_datetime":"2024-04-19T21:14:17Z","total_items":8} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"43609713","link":"https://api.researchmap.jp/yasuikeda/books_etc/43609713","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =43609713]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30376233","link":"https://api.researchmap.jp/yasuikeda/books_etc/30376233","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376233]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30376234","link":"https://api.researchmap.jp/yasuikeda/books_etc/30376234","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376234]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30376235","link":"https://api.researchmap.jp/yasuikeda/books_etc/30376235","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376235]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30386898","link":"https://api.researchmap.jp/yasuikeda/books_etc/30386898","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30386898]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30376238","link":"https://api.researchmap.jp/yasuikeda/books_etc/30376238","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376238]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30386899","link":"https://api.researchmap.jp/yasuikeda/books_etc/30386899","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30386899]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"merge","type":"books_etc","id":"30376239","link":"https://api.researchmap.jp/yasuikeda/books_etc/30376239","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376239]。"}]} ====== BulkResult(B000241782, K8Ev-I4B7kacV6CWWvVn) : End ====== ====== BulkResult(B000241782, L8Ev-I4B7kacV6CWW_U1) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:11Z","end_datetime":"2024-04-19T21:14:11Z","estimated_end_datetime":"2024-04-19T21:14:12Z","total_items":7} --- success {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:11Z","end_datetime":"2024-04-19T21:14:11Z","estimated_end_datetime":"2024-04-19T21:14:12Z","total_items":7} {"no":1,"line":1,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"awards","id":"2970983","link":"https://api.researchmap.jp/yasuikeda/awards/2970983","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=2970983]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"awards","id":"2970984","link":"https://api.researchmap.jp/yasuikeda/awards/2970984","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=2970984]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"awards","id":"2970985","link":"https://api.researchmap.jp/yasuikeda/awards/2970985","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=2970985]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"awards","id":"2970986","link":"https://api.researchmap.jp/yasuikeda/awards/2970986","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=2970986]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"awards","id":"2970987","link":"https://api.researchmap.jp/yasuikeda/awards/2970987","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=2970987]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"awards","id":"2970988","link":"https://api.researchmap.jp/yasuikeda/awards/2970988","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=2970988]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"awards","id":"2970989","link":"https://api.researchmap.jp/yasuikeda/awards/2970989","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=2970989]。"}]} ====== BulkResult(B000241782, L8Ev-I4B7kacV6CWW_U1) : End ====== ====== BulkResult(B000241782, QsEv-I4B7kacV6CWXvWR) : Begin ====== --- error {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:28Z","end_datetime":"2024-04-19T21:14:29Z","estimated_end_datetime":"2024-04-19T21:14:33Z","total_items":528} --- success {"code":304,"status":"completion","start_datetime":"2024-04-19T21:14:28Z","end_datetime":"2024-04-19T21:14:29Z","estimated_end_datetime":"2024-04-19T21:14:33Z","total_items":528} {"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"45512727","link":"https://api.researchmap.jp/yasuikeda/presentations/45512727","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45512727]。"}]} {"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"45512728","link":"https://api.researchmap.jp/yasuikeda/presentations/45512728","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45512728]。"}]} {"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"45529575","link":"https://api.researchmap.jp/yasuikeda/presentations/45529575","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45529575]。"}]} {"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376246","link":"https://api.researchmap.jp/yasuikeda/presentations/30376246","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376246]。"}]} {"no":1,"line":5,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376247","link":"https://api.researchmap.jp/yasuikeda/presentations/30376247","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376247]。"}]} {"no":1,"line":6,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376248","link":"https://api.researchmap.jp/yasuikeda/presentations/30376248","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376248]。"}]} {"no":1,"line":7,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426405","link":"https://api.researchmap.jp/yasuikeda/presentations/22426405","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426405]。"}]} {"no":1,"line":8,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376249","link":"https://api.researchmap.jp/yasuikeda/presentations/30376249","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376249]。"}]} {"no":1,"line":9,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376250","link":"https://api.researchmap.jp/yasuikeda/presentations/30376250","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376250]。"}]} {"no":1,"line":10,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426406","link":"https://api.researchmap.jp/yasuikeda/presentations/22426406","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426406]。"}]} {"no":1,"line":11,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426407","link":"https://api.researchmap.jp/yasuikeda/presentations/22426407","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426407]。"}]} {"no":1,"line":12,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426408","link":"https://api.researchmap.jp/yasuikeda/presentations/22426408","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426408]。"}]} {"no":1,"line":13,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426409","link":"https://api.researchmap.jp/yasuikeda/presentations/22426409","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426409]。"}]} {"no":1,"line":14,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426410","link":"https://api.researchmap.jp/yasuikeda/presentations/22426410","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426410]。"}]} {"no":1,"line":15,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426411","link":"https://api.researchmap.jp/yasuikeda/presentations/22426411","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426411]。"}]} {"no":1,"line":16,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426412","link":"https://api.researchmap.jp/yasuikeda/presentations/22426412","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426412]。"}]} {"no":1,"line":17,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426413","link":"https://api.researchmap.jp/yasuikeda/presentations/22426413","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426413]。"}]} {"no":1,"line":18,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426414","link":"https://api.researchmap.jp/yasuikeda/presentations/22426414","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426414]。"}]} {"no":1,"line":19,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426415","link":"https://api.researchmap.jp/yasuikeda/presentations/22426415","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426415]。"}]} {"no":1,"line":20,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426416","link":"https://api.researchmap.jp/yasuikeda/presentations/22426416","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426416]。"}]} {"no":1,"line":21,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426417","link":"https://api.researchmap.jp/yasuikeda/presentations/22426417","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426417]。"}]} {"no":1,"line":22,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426418","link":"https://api.researchmap.jp/yasuikeda/presentations/22426418","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426418]。"}]} {"no":1,"line":23,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426419","link":"https://api.researchmap.jp/yasuikeda/presentations/22426419","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426419]。"}]} {"no":1,"line":24,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426420","link":"https://api.researchmap.jp/yasuikeda/presentations/22426420","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426420]。"}]} {"no":1,"line":25,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426421","link":"https://api.researchmap.jp/yasuikeda/presentations/22426421","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426421]。"}]} {"no":1,"line":26,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426422","link":"https://api.researchmap.jp/yasuikeda/presentations/22426422","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426422]。"}]} {"no":1,"line":27,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426423","link":"https://api.researchmap.jp/yasuikeda/presentations/22426423","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426423]。"}]} {"no":1,"line":28,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426424","link":"https://api.researchmap.jp/yasuikeda/presentations/22426424","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426424]。"}]} {"no":1,"line":29,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426425","link":"https://api.researchmap.jp/yasuikeda/presentations/22426425","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426425]。"}]} {"no":1,"line":30,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426426","link":"https://api.researchmap.jp/yasuikeda/presentations/22426426","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426426]。"}]} {"no":1,"line":31,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426403","link":"https://api.researchmap.jp/yasuikeda/presentations/22426403","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426403]。"}]} {"no":1,"line":32,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426427","link":"https://api.researchmap.jp/yasuikeda/presentations/22426427","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426427]。"}]} {"no":1,"line":33,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426428","link":"https://api.researchmap.jp/yasuikeda/presentations/22426428","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426428]。"}]} {"no":1,"line":34,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426429","link":"https://api.researchmap.jp/yasuikeda/presentations/22426429","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426429]。"}]} {"no":1,"line":35,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426430","link":"https://api.researchmap.jp/yasuikeda/presentations/22426430","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426430]。"}]} {"no":1,"line":36,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426431","link":"https://api.researchmap.jp/yasuikeda/presentations/22426431","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426431]。"}]} {"no":1,"line":37,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426432","link":"https://api.researchmap.jp/yasuikeda/presentations/22426432","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426432]。"}]} {"no":1,"line":38,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426433","link":"https://api.researchmap.jp/yasuikeda/presentations/22426433","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426433]。"}]} {"no":1,"line":39,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426434","link":"https://api.researchmap.jp/yasuikeda/presentations/22426434","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426434]。"}]} {"no":1,"line":40,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426435","link":"https://api.researchmap.jp/yasuikeda/presentations/22426435","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426435]。"}]} {"no":1,"line":41,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426436","link":"https://api.researchmap.jp/yasuikeda/presentations/22426436","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426436]。"}]} {"no":1,"line":42,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426437","link":"https://api.researchmap.jp/yasuikeda/presentations/22426437","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426437]。"}]} {"no":1,"line":43,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426438","link":"https://api.researchmap.jp/yasuikeda/presentations/22426438","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426438]。"}]} {"no":1,"line":44,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426439","link":"https://api.researchmap.jp/yasuikeda/presentations/22426439","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426439]。"}]} {"no":1,"line":45,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426440","link":"https://api.researchmap.jp/yasuikeda/presentations/22426440","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426440]。"}]} {"no":1,"line":46,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426441","link":"https://api.researchmap.jp/yasuikeda/presentations/22426441","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426441]。"}]} {"no":1,"line":47,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426442","link":"https://api.researchmap.jp/yasuikeda/presentations/22426442","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426442]。"}]} {"no":1,"line":48,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426443","link":"https://api.researchmap.jp/yasuikeda/presentations/22426443","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426443]。"}]} {"no":1,"line":49,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426444","link":"https://api.researchmap.jp/yasuikeda/presentations/22426444","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426444]。"}]} {"no":1,"line":50,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426445","link":"https://api.researchmap.jp/yasuikeda/presentations/22426445","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426445]。"}]} {"no":1,"line":51,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426446","link":"https://api.researchmap.jp/yasuikeda/presentations/22426446","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426446]。"}]} {"no":1,"line":52,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426447","link":"https://api.researchmap.jp/yasuikeda/presentations/22426447","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426447]。"}]} {"no":1,"line":53,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426448","link":"https://api.researchmap.jp/yasuikeda/presentations/22426448","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426448]。"}]} {"no":1,"line":54,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426799","link":"https://api.researchmap.jp/yasuikeda/presentations/22426799","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426799]。"}]} {"no":1,"line":55,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426450","link":"https://api.researchmap.jp/yasuikeda/presentations/22426450","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426450]。"}]} {"no":1,"line":56,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426451","link":"https://api.researchmap.jp/yasuikeda/presentations/22426451","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426451]。"}]} {"no":1,"line":57,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426452","link":"https://api.researchmap.jp/yasuikeda/presentations/22426452","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426452]。"}]} {"no":1,"line":58,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426453","link":"https://api.researchmap.jp/yasuikeda/presentations/22426453","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426453]。"}]} {"no":1,"line":59,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426447","link":"https://api.researchmap.jp/yasuikeda/presentations/22426447","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426447]。"}]} {"no":1,"line":60,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426454","link":"https://api.researchmap.jp/yasuikeda/presentations/22426454","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426454]。"}]} {"no":1,"line":61,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426799","link":"https://api.researchmap.jp/yasuikeda/presentations/22426799","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426799]。"}]} {"no":1,"line":62,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426455","link":"https://api.researchmap.jp/yasuikeda/presentations/22426455","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426455]。"}]} {"no":1,"line":63,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426456","link":"https://api.researchmap.jp/yasuikeda/presentations/22426456","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426456]。"}]} {"no":1,"line":64,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426457","link":"https://api.researchmap.jp/yasuikeda/presentations/22426457","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426457]。"}]} {"no":1,"line":65,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426458","link":"https://api.researchmap.jp/yasuikeda/presentations/22426458","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426458]。"}]} {"no":1,"line":66,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426459","link":"https://api.researchmap.jp/yasuikeda/presentations/22426459","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426459]。"}]} {"no":1,"line":67,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426460","link":"https://api.researchmap.jp/yasuikeda/presentations/22426460","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426460]。"}]} {"no":1,"line":68,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426461","link":"https://api.researchmap.jp/yasuikeda/presentations/22426461","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426461]。"}]} {"no":1,"line":69,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426462","link":"https://api.researchmap.jp/yasuikeda/presentations/22426462","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426462]。"}]} {"no":1,"line":70,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426463","link":"https://api.researchmap.jp/yasuikeda/presentations/22426463","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426463]。"}]} {"no":1,"line":71,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426464","link":"https://api.researchmap.jp/yasuikeda/presentations/22426464","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426464]。"}]} {"no":1,"line":72,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426800","link":"https://api.researchmap.jp/yasuikeda/presentations/22426800","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426800]。"}]} {"no":1,"line":73,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426465","link":"https://api.researchmap.jp/yasuikeda/presentations/22426465","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426465]。"}]} {"no":1,"line":74,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426466","link":"https://api.researchmap.jp/yasuikeda/presentations/22426466","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426466]。"}]} {"no":1,"line":75,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426467","link":"https://api.researchmap.jp/yasuikeda/presentations/22426467","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426467]。"}]} {"no":1,"line":76,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426468","link":"https://api.researchmap.jp/yasuikeda/presentations/22426468","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426468]。"}]} {"no":1,"line":77,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426469","link":"https://api.researchmap.jp/yasuikeda/presentations/22426469","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426469]。"}]} {"no":1,"line":78,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426470","link":"https://api.researchmap.jp/yasuikeda/presentations/22426470","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426470]。"}]} {"no":1,"line":79,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426471","link":"https://api.researchmap.jp/yasuikeda/presentations/22426471","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426471]。"}]} {"no":1,"line":80,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426801","link":"https://api.researchmap.jp/yasuikeda/presentations/22426801","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426801]。"}]} {"no":1,"line":81,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426472","link":"https://api.researchmap.jp/yasuikeda/presentations/22426472","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426472]。"}]} {"no":1,"line":82,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426473","link":"https://api.researchmap.jp/yasuikeda/presentations/22426473","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426473]。"}]} {"no":1,"line":83,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426474","link":"https://api.researchmap.jp/yasuikeda/presentations/22426474","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426474]。"}]} {"no":1,"line":84,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426475","link":"https://api.researchmap.jp/yasuikeda/presentations/22426475","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426475]。"}]} {"no":1,"line":85,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426476","link":"https://api.researchmap.jp/yasuikeda/presentations/22426476","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426476]。"}]} {"no":1,"line":86,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426477","link":"https://api.researchmap.jp/yasuikeda/presentations/22426477","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426477]。"}]} {"no":1,"line":87,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426478","link":"https://api.researchmap.jp/yasuikeda/presentations/22426478","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426478]。"}]} {"no":1,"line":88,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426479","link":"https://api.researchmap.jp/yasuikeda/presentations/22426479","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426479]。"}]} {"no":1,"line":89,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426480","link":"https://api.researchmap.jp/yasuikeda/presentations/22426480","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426480]。"}]} {"no":1,"line":90,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426481","link":"https://api.researchmap.jp/yasuikeda/presentations/22426481","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426481]。"}]} {"no":1,"line":91,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426802","link":"https://api.researchmap.jp/yasuikeda/presentations/22426802","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426802]。"}]} {"no":1,"line":92,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426482","link":"https://api.researchmap.jp/yasuikeda/presentations/22426482","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426482]。"}]} {"no":1,"line":93,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426803","link":"https://api.researchmap.jp/yasuikeda/presentations/22426803","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426803]。"}]} {"no":1,"line":94,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426804","link":"https://api.researchmap.jp/yasuikeda/presentations/22426804","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426804]。"}]} {"no":1,"line":95,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426483","link":"https://api.researchmap.jp/yasuikeda/presentations/22426483","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426483]。"}]} {"no":1,"line":96,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426484","link":"https://api.researchmap.jp/yasuikeda/presentations/22426484","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426484]。"}]} {"no":1,"line":97,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426485","link":"https://api.researchmap.jp/yasuikeda/presentations/22426485","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426485]。"}]} {"no":1,"line":98,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426486","link":"https://api.researchmap.jp/yasuikeda/presentations/22426486","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426486]。"}]} {"no":1,"line":99,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426487","link":"https://api.researchmap.jp/yasuikeda/presentations/22426487","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426487]。"}]} {"no":1,"line":100,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376251","link":"https://api.researchmap.jp/yasuikeda/presentations/30376251","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376251]。"}]} {"no":1,"line":101,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426488","link":"https://api.researchmap.jp/yasuikeda/presentations/22426488","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426488]。"}]} {"no":1,"line":102,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426489","link":"https://api.researchmap.jp/yasuikeda/presentations/22426489","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426489]。"}]} {"no":1,"line":103,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426490","link":"https://api.researchmap.jp/yasuikeda/presentations/22426490","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426490]。"}]} {"no":1,"line":104,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426491","link":"https://api.researchmap.jp/yasuikeda/presentations/22426491","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426491]。"}]} {"no":1,"line":105,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426492","link":"https://api.researchmap.jp/yasuikeda/presentations/22426492","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426492]。"}]} {"no":1,"line":106,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426493","link":"https://api.researchmap.jp/yasuikeda/presentations/22426493","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426493]。"}]} {"no":1,"line":107,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426494","link":"https://api.researchmap.jp/yasuikeda/presentations/22426494","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426494]。"}]} {"no":1,"line":108,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46023528","link":"https://api.researchmap.jp/yasuikeda/presentations/46023528","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46023528]。"}]} {"no":1,"line":109,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46023529","link":"https://api.researchmap.jp/yasuikeda/presentations/46023529","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46023529]。"}]} {"no":1,"line":110,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"45587319","link":"https://api.researchmap.jp/yasuikeda/presentations/45587319","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =45587319]。"}]} {"no":1,"line":111,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46023530","link":"https://api.researchmap.jp/yasuikeda/presentations/46023530","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46023530]。"}]} {"no":1,"line":112,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44542750","link":"https://api.researchmap.jp/yasuikeda/presentations/44542750","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44542750]。"}]} {"no":1,"line":113,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44542751","link":"https://api.researchmap.jp/yasuikeda/presentations/44542751","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44542751]。"}]} {"no":1,"line":114,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44287793","link":"https://api.researchmap.jp/yasuikeda/presentations/44287793","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44287793]。"}]} {"no":1,"line":115,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44287794","link":"https://api.researchmap.jp/yasuikeda/presentations/44287794","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44287794]。"}]} {"no":1,"line":116,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44287795","link":"https://api.researchmap.jp/yasuikeda/presentations/44287795","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44287795]。"}]} {"no":1,"line":117,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44268481","link":"https://api.researchmap.jp/yasuikeda/presentations/44268481","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44268481]。"}]} {"no":1,"line":118,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46023531","link":"https://api.researchmap.jp/yasuikeda/presentations/46023531","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46023531]。"}]} {"no":1,"line":119,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46023532","link":"https://api.researchmap.jp/yasuikeda/presentations/46023532","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46023532]。"}]} {"no":1,"line":120,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46023533","link":"https://api.researchmap.jp/yasuikeda/presentations/46023533","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46023533]。"}]} {"no":1,"line":121,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46023534","link":"https://api.researchmap.jp/yasuikeda/presentations/46023534","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46023534]。"}]} {"no":1,"line":122,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44268482","link":"https://api.researchmap.jp/yasuikeda/presentations/44268482","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44268482]。"}]} {"no":1,"line":123,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44268483","link":"https://api.researchmap.jp/yasuikeda/presentations/44268483","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44268483]。"}]} {"no":1,"line":124,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44268484","link":"https://api.researchmap.jp/yasuikeda/presentations/44268484","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44268484]。"}]} {"no":1,"line":125,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44268485","link":"https://api.researchmap.jp/yasuikeda/presentations/44268485","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44268485]。"}]} {"no":1,"line":126,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44268486","link":"https://api.researchmap.jp/yasuikeda/presentations/44268486","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44268486]。"}]} {"no":1,"line":127,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"44268487","link":"https://api.researchmap.jp/yasuikeda/presentations/44268487","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =44268487]。"}]} {"no":1,"line":128,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"42249451","link":"https://api.researchmap.jp/yasuikeda/presentations/42249451"} {"no":1,"line":129,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42249452","link":"https://api.researchmap.jp/yasuikeda/presentations/42249452","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42249452]。"}]} {"no":1,"line":130,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42249453","link":"https://api.researchmap.jp/yasuikeda/presentations/42249453","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42249453]。"}]} {"no":1,"line":131,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42249454","link":"https://api.researchmap.jp/yasuikeda/presentations/42249454","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42249454]。"}]} {"no":1,"line":132,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"42249455","link":"https://api.researchmap.jp/yasuikeda/presentations/42249455"} {"no":1,"line":133,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42412550","link":"https://api.researchmap.jp/yasuikeda/presentations/42412550","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42412550]。"}]} {"no":1,"line":134,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"40615749","link":"https://api.researchmap.jp/yasuikeda/presentations/40615749","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =40615749]。"}]} {"no":1,"line":135,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42991600","link":"https://api.researchmap.jp/yasuikeda/presentations/42991600","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42991600]。"}]} {"no":1,"line":136,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42412551","link":"https://api.researchmap.jp/yasuikeda/presentations/42412551","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42412551]。"}]} {"no":1,"line":137,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"38625525","link":"https://api.researchmap.jp/yasuikeda/presentations/38625525","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =38625525]。"}]} {"no":1,"line":138,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37579754","link":"https://api.researchmap.jp/yasuikeda/presentations/37579754","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37579754]。"}]} {"no":1,"line":139,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37241242","link":"https://api.researchmap.jp/yasuikeda/presentations/37241242","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37241242]。"}]} {"no":1,"line":140,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"40241751","link":"https://api.researchmap.jp/yasuikeda/presentations/40241751","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =40241751]。"}]} {"no":1,"line":141,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"37241243","link":"https://api.researchmap.jp/yasuikeda/presentations/37241243","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =37241243]。"}]} {"no":1,"line":142,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39491398","link":"https://api.researchmap.jp/yasuikeda/presentations/39491398","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39491398]。"}]} {"no":1,"line":143,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"36868138","link":"https://api.researchmap.jp/yasuikeda/presentations/36868138","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =36868138]。"}]} {"no":1,"line":144,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"42921399","link":"https://api.researchmap.jp/yasuikeda/presentations/42921399","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =42921399]。"}]} {"no":1,"line":145,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39491399","link":"https://api.researchmap.jp/yasuikeda/presentations/39491399","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39491399]。"}]} {"no":1,"line":146,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39491400","link":"https://api.researchmap.jp/yasuikeda/presentations/39491400","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39491400]。"}]} {"no":1,"line":147,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39491401","link":"https://api.researchmap.jp/yasuikeda/presentations/39491401","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39491401]。"}]} {"no":1,"line":148,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39491402","link":"https://api.researchmap.jp/yasuikeda/presentations/39491402","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39491402]。"}]} {"no":1,"line":149,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"39491403","link":"https://api.researchmap.jp/yasuikeda/presentations/39491403","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =39491403]。"}]} {"no":1,"line":150,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33127477","link":"https://api.researchmap.jp/yasuikeda/presentations/33127477","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33127477]。"}]} {"no":1,"line":151,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31837422","link":"https://api.researchmap.jp/yasuikeda/presentations/31837422","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31837422]。"}]} {"no":1,"line":152,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31837423","link":"https://api.researchmap.jp/yasuikeda/presentations/31837423","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31837423]。"}]} {"no":1,"line":153,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"33428529","link":"https://api.researchmap.jp/yasuikeda/presentations/33428529","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =33428529]。"}]} {"no":1,"line":154,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376252","link":"https://api.researchmap.jp/yasuikeda/presentations/30376252","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376252]。"}]} {"no":1,"line":155,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376253","link":"https://api.researchmap.jp/yasuikeda/presentations/30376253","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376253]。"}]} {"no":1,"line":156,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31973234","link":"https://api.researchmap.jp/yasuikeda/presentations/31973234","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31973234]。"}]} {"no":1,"line":157,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376254","link":"https://api.researchmap.jp/yasuikeda/presentations/30376254","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376254]。"}]} {"no":1,"line":158,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376255","link":"https://api.researchmap.jp/yasuikeda/presentations/30376255","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376255]。"}]} {"no":1,"line":159,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376256","link":"https://api.researchmap.jp/yasuikeda/presentations/30376256","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376256]。"}]} {"no":1,"line":160,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376257","link":"https://api.researchmap.jp/yasuikeda/presentations/30376257","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376257]。"}]} {"no":1,"line":161,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376258","link":"https://api.researchmap.jp/yasuikeda/presentations/30376258","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376258]。"}]} {"no":1,"line":162,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376259","link":"https://api.researchmap.jp/yasuikeda/presentations/30376259","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376259]。"}]} {"no":1,"line":163,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376260","link":"https://api.researchmap.jp/yasuikeda/presentations/30376260","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376260]。"}]} {"no":1,"line":164,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376261","link":"https://api.researchmap.jp/yasuikeda/presentations/30376261","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376261]。"}]} {"no":1,"line":165,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376262","link":"https://api.researchmap.jp/yasuikeda/presentations/30376262","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376262]。"}]} {"no":1,"line":166,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376263","link":"https://api.researchmap.jp/yasuikeda/presentations/30376263","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376263]。"}]} {"no":1,"line":167,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376264","link":"https://api.researchmap.jp/yasuikeda/presentations/30376264","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376264]。"}]} {"no":1,"line":168,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"30496236","link":"https://api.researchmap.jp/yasuikeda/presentations/30496236"} {"no":1,"line":169,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376267","link":"https://api.researchmap.jp/yasuikeda/presentations/30376267","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376267]。"}]} {"no":1,"line":170,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376268","link":"https://api.researchmap.jp/yasuikeda/presentations/30376268","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376268]。"}]} {"no":1,"line":171,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376269","link":"https://api.researchmap.jp/yasuikeda/presentations/30376269","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376269]。"}]} {"no":1,"line":172,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376270","link":"https://api.researchmap.jp/yasuikeda/presentations/30376270","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376270]。"}]} {"no":1,"line":173,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376271","link":"https://api.researchmap.jp/yasuikeda/presentations/30376271","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376271]。"}]} {"no":1,"line":174,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376272","link":"https://api.researchmap.jp/yasuikeda/presentations/30376272","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376272]。"}]} {"no":1,"line":175,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376273","link":"https://api.researchmap.jp/yasuikeda/presentations/30376273","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376273]。"}]} {"no":1,"line":176,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376274","link":"https://api.researchmap.jp/yasuikeda/presentations/30376274","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376274]。"}]} {"no":1,"line":177,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"30496237","link":"https://api.researchmap.jp/yasuikeda/presentations/30496237"} {"no":1,"line":178,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"30496238","link":"https://api.researchmap.jp/yasuikeda/presentations/30496238"} {"no":1,"line":179,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376277","link":"https://api.researchmap.jp/yasuikeda/presentations/30376277","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376277]。"}]} {"no":1,"line":180,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376278","link":"https://api.researchmap.jp/yasuikeda/presentations/30376278","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376278]。"}]} {"no":1,"line":181,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376279","link":"https://api.researchmap.jp/yasuikeda/presentations/30376279","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376279]。"}]} {"no":1,"line":182,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376280","link":"https://api.researchmap.jp/yasuikeda/presentations/30376280","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376280]。"}]} {"no":1,"line":183,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376281","link":"https://api.researchmap.jp/yasuikeda/presentations/30376281","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376281]。"}]} {"no":1,"line":184,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376282","link":"https://api.researchmap.jp/yasuikeda/presentations/30376282","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376282]。"}]} {"no":1,"line":185,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376283","link":"https://api.researchmap.jp/yasuikeda/presentations/30376283","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376283]。"}]} {"no":1,"line":186,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376284","link":"https://api.researchmap.jp/yasuikeda/presentations/30376284","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376284]。"}]} {"no":1,"line":187,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376285","link":"https://api.researchmap.jp/yasuikeda/presentations/30376285","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376285]。"}]} {"no":1,"line":188,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"30496240","link":"https://api.researchmap.jp/yasuikeda/presentations/30496240"} {"no":1,"line":189,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376288","link":"https://api.researchmap.jp/yasuikeda/presentations/30376288","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376288]。"}]} {"no":1,"line":190,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376289","link":"https://api.researchmap.jp/yasuikeda/presentations/30376289","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376289]。"}]} {"no":1,"line":191,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376290","link":"https://api.researchmap.jp/yasuikeda/presentations/30376290","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376290]。"}]} {"no":1,"line":192,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376291","link":"https://api.researchmap.jp/yasuikeda/presentations/30376291","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376291]。"}]} {"no":1,"line":193,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376292","link":"https://api.researchmap.jp/yasuikeda/presentations/30376292","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376292]。"}]} {"no":1,"line":194,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376293","link":"https://api.researchmap.jp/yasuikeda/presentations/30376293","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376293]。"}]} {"no":1,"line":195,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376294","link":"https://api.researchmap.jp/yasuikeda/presentations/30376294","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376294]。"}]} {"no":1,"line":196,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376295","link":"https://api.researchmap.jp/yasuikeda/presentations/30376295","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376295]。"}]} {"no":1,"line":197,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376296","link":"https://api.researchmap.jp/yasuikeda/presentations/30376296","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376296]。"}]} {"no":1,"line":198,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376297","link":"https://api.researchmap.jp/yasuikeda/presentations/30376297","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376297]。"}]} {"no":1,"line":199,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376298","link":"https://api.researchmap.jp/yasuikeda/presentations/30376298","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376298]。"}]} {"no":1,"line":200,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376299","link":"https://api.researchmap.jp/yasuikeda/presentations/30376299","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376299]。"}]} {"no":1,"line":201,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376300","link":"https://api.researchmap.jp/yasuikeda/presentations/30376300","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376300]。"}]} {"no":1,"line":202,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376301","link":"https://api.researchmap.jp/yasuikeda/presentations/30376301","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376301]。"}]} {"no":1,"line":203,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376302","link":"https://api.researchmap.jp/yasuikeda/presentations/30376302","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376302]。"}]} {"no":1,"line":204,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376303","link":"https://api.researchmap.jp/yasuikeda/presentations/30376303","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376303]。"}]} {"no":1,"line":205,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376304","link":"https://api.researchmap.jp/yasuikeda/presentations/30376304","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376304]。"}]} {"no":1,"line":206,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376305","link":"https://api.researchmap.jp/yasuikeda/presentations/30376305","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376305]。"}]} {"no":1,"line":207,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376306","link":"https://api.researchmap.jp/yasuikeda/presentations/30376306","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376306]。"}]} {"no":1,"line":208,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376307","link":"https://api.researchmap.jp/yasuikeda/presentations/30376307","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376307]。"}]} {"no":1,"line":209,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376308","link":"https://api.researchmap.jp/yasuikeda/presentations/30376308","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376308]。"}]} {"no":1,"line":210,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376309","link":"https://api.researchmap.jp/yasuikeda/presentations/30376309","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376309]。"}]} {"no":1,"line":211,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426495","link":"https://api.researchmap.jp/yasuikeda/presentations/22426495","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426495]。"}]} {"no":1,"line":212,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376310","link":"https://api.researchmap.jp/yasuikeda/presentations/30376310","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376310]。"}]} {"no":1,"line":213,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376311","link":"https://api.researchmap.jp/yasuikeda/presentations/30376311","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376311]。"}]} {"no":1,"line":214,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31973235","link":"https://api.researchmap.jp/yasuikeda/presentations/31973235","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31973235]。"}]} {"no":1,"line":215,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376312","link":"https://api.researchmap.jp/yasuikeda/presentations/30376312","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376312]。"}]} {"no":1,"line":216,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"31973236","link":"https://api.researchmap.jp/yasuikeda/presentations/31973236","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =31973236]。"}]} {"no":1,"line":217,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376313","link":"https://api.researchmap.jp/yasuikeda/presentations/30376313","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376313]。"}]} {"no":1,"line":218,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426496","link":"https://api.researchmap.jp/yasuikeda/presentations/22426496","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426496]。"}]} {"no":1,"line":219,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426497","link":"https://api.researchmap.jp/yasuikeda/presentations/22426497","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426497]。"}]} {"no":1,"line":220,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426498","link":"https://api.researchmap.jp/yasuikeda/presentations/22426498","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426498]。"}]} {"no":1,"line":221,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426499","link":"https://api.researchmap.jp/yasuikeda/presentations/22426499","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426499]。"}]} {"no":1,"line":222,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426500","link":"https://api.researchmap.jp/yasuikeda/presentations/22426500","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426500]。"}]} {"no":1,"line":223,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426501","link":"https://api.researchmap.jp/yasuikeda/presentations/22426501","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426501]。"}]} {"no":1,"line":224,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426502","link":"https://api.researchmap.jp/yasuikeda/presentations/22426502","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426502]。"}]} {"no":1,"line":225,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426503","link":"https://api.researchmap.jp/yasuikeda/presentations/22426503","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426503]。"}]} {"no":1,"line":226,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426504","link":"https://api.researchmap.jp/yasuikeda/presentations/22426504","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426504]。"}]} {"no":1,"line":227,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426505","link":"https://api.researchmap.jp/yasuikeda/presentations/22426505","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426505]。"}]} {"no":1,"line":228,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426506","link":"https://api.researchmap.jp/yasuikeda/presentations/22426506","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426506]。"}]} {"no":1,"line":229,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426507","link":"https://api.researchmap.jp/yasuikeda/presentations/22426507","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426507]。"}]} {"no":1,"line":230,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426508","link":"https://api.researchmap.jp/yasuikeda/presentations/22426508","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426508]。"}]} {"no":1,"line":231,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426509","link":"https://api.researchmap.jp/yasuikeda/presentations/22426509","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426509]。"}]} {"no":1,"line":232,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426510","link":"https://api.researchmap.jp/yasuikeda/presentations/22426510","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426510]。"}]} {"no":1,"line":233,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426511","link":"https://api.researchmap.jp/yasuikeda/presentations/22426511","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426511]。"}]} {"no":1,"line":234,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426512","link":"https://api.researchmap.jp/yasuikeda/presentations/22426512","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426512]。"}]} {"no":1,"line":235,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426513","link":"https://api.researchmap.jp/yasuikeda/presentations/22426513","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426513]。"}]} {"no":1,"line":236,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426514","link":"https://api.researchmap.jp/yasuikeda/presentations/22426514","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426514]。"}]} {"no":1,"line":237,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376314","link":"https://api.researchmap.jp/yasuikeda/presentations/30376314","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376314]。"}]} {"no":1,"line":238,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426516","link":"https://api.researchmap.jp/yasuikeda/presentations/22426516","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426516]。"}]} {"no":1,"line":239,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426517","link":"https://api.researchmap.jp/yasuikeda/presentations/22426517","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426517]。"}]} {"no":1,"line":240,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426518","link":"https://api.researchmap.jp/yasuikeda/presentations/22426518","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426518]。"}]} {"no":1,"line":241,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426519","link":"https://api.researchmap.jp/yasuikeda/presentations/22426519","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426519]。"}]} {"no":1,"line":242,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426520","link":"https://api.researchmap.jp/yasuikeda/presentations/22426520","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426520]。"}]} {"no":1,"line":243,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426521","link":"https://api.researchmap.jp/yasuikeda/presentations/22426521","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426521]。"}]} {"no":1,"line":244,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426522","link":"https://api.researchmap.jp/yasuikeda/presentations/22426522","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426522]。"}]} {"no":1,"line":245,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426523","link":"https://api.researchmap.jp/yasuikeda/presentations/22426523","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426523]。"}]} {"no":1,"line":246,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426524","link":"https://api.researchmap.jp/yasuikeda/presentations/22426524","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426524]。"}]} {"no":1,"line":247,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426525","link":"https://api.researchmap.jp/yasuikeda/presentations/22426525","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426525]。"}]} {"no":1,"line":248,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426526","link":"https://api.researchmap.jp/yasuikeda/presentations/22426526","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426526]。"}]} {"no":1,"line":249,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426527","link":"https://api.researchmap.jp/yasuikeda/presentations/22426527","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426527]。"}]} {"no":1,"line":250,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426528","link":"https://api.researchmap.jp/yasuikeda/presentations/22426528","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426528]。"}]} {"no":1,"line":251,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426530","link":"https://api.researchmap.jp/yasuikeda/presentations/22426530","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426530]。"}]} {"no":1,"line":252,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426531","link":"https://api.researchmap.jp/yasuikeda/presentations/22426531","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426531]。"}]} {"no":1,"line":253,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426532","link":"https://api.researchmap.jp/yasuikeda/presentations/22426532","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426532]。"}]} {"no":1,"line":254,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426533","link":"https://api.researchmap.jp/yasuikeda/presentations/22426533","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426533]。"}]} {"no":1,"line":255,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426534","link":"https://api.researchmap.jp/yasuikeda/presentations/22426534","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426534]。"}]} {"no":1,"line":256,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426535","link":"https://api.researchmap.jp/yasuikeda/presentations/22426535","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426535]。"}]} {"no":1,"line":257,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426536","link":"https://api.researchmap.jp/yasuikeda/presentations/22426536","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426536]。"}]} {"no":1,"line":258,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426537","link":"https://api.researchmap.jp/yasuikeda/presentations/22426537","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426537]。"}]} {"no":1,"line":259,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426538","link":"https://api.researchmap.jp/yasuikeda/presentations/22426538","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426538]。"}]} {"no":1,"line":260,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426539","link":"https://api.researchmap.jp/yasuikeda/presentations/22426539","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426539]。"}]} {"no":1,"line":261,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426540","link":"https://api.researchmap.jp/yasuikeda/presentations/22426540","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426540]。"}]} {"no":1,"line":262,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426541","link":"https://api.researchmap.jp/yasuikeda/presentations/22426541","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426541]。"}]} {"no":1,"line":263,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426542","link":"https://api.researchmap.jp/yasuikeda/presentations/22426542","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426542]。"}]} {"no":1,"line":264,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376315","link":"https://api.researchmap.jp/yasuikeda/presentations/30376315","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376315]。"}]} {"no":1,"line":265,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426543","link":"https://api.researchmap.jp/yasuikeda/presentations/22426543","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426543]。"}]} {"no":1,"line":266,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426544","link":"https://api.researchmap.jp/yasuikeda/presentations/22426544","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426544]。"}]} {"no":1,"line":267,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426545","link":"https://api.researchmap.jp/yasuikeda/presentations/22426545","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426545]。"}]} {"no":1,"line":268,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426546","link":"https://api.researchmap.jp/yasuikeda/presentations/22426546","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426546]。"}]} {"no":1,"line":269,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426547","link":"https://api.researchmap.jp/yasuikeda/presentations/22426547","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426547]。"}]} {"no":1,"line":270,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426548","link":"https://api.researchmap.jp/yasuikeda/presentations/22426548","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426548]。"}]} {"no":1,"line":271,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426549","link":"https://api.researchmap.jp/yasuikeda/presentations/22426549","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426549]。"}]} {"no":1,"line":272,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426550","link":"https://api.researchmap.jp/yasuikeda/presentations/22426550","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426550]。"}]} {"no":1,"line":273,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426551","link":"https://api.researchmap.jp/yasuikeda/presentations/22426551","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426551]。"}]} {"no":1,"line":274,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426552","link":"https://api.researchmap.jp/yasuikeda/presentations/22426552","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426552]。"}]} {"no":1,"line":275,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426553","link":"https://api.researchmap.jp/yasuikeda/presentations/22426553","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426553]。"}]} {"no":1,"line":276,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426554","link":"https://api.researchmap.jp/yasuikeda/presentations/22426554","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426554]。"}]} {"no":1,"line":277,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426555","link":"https://api.researchmap.jp/yasuikeda/presentations/22426555","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426555]。"}]} {"no":1,"line":278,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426556","link":"https://api.researchmap.jp/yasuikeda/presentations/22426556","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426556]。"}]} {"no":1,"line":279,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426557","link":"https://api.researchmap.jp/yasuikeda/presentations/22426557","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426557]。"}]} {"no":1,"line":280,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426558","link":"https://api.researchmap.jp/yasuikeda/presentations/22426558","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426558]。"}]} {"no":1,"line":281,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426559","link":"https://api.researchmap.jp/yasuikeda/presentations/22426559","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426559]。"}]} {"no":1,"line":282,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426560","link":"https://api.researchmap.jp/yasuikeda/presentations/22426560","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426560]。"}]} {"no":1,"line":283,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426561","link":"https://api.researchmap.jp/yasuikeda/presentations/22426561","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426561]。"}]} {"no":1,"line":284,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426562","link":"https://api.researchmap.jp/yasuikeda/presentations/22426562","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426562]。"}]} {"no":1,"line":285,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426563","link":"https://api.researchmap.jp/yasuikeda/presentations/22426563","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426563]。"}]} {"no":1,"line":286,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426564","link":"https://api.researchmap.jp/yasuikeda/presentations/22426564","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426564]。"}]} {"no":1,"line":287,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426565","link":"https://api.researchmap.jp/yasuikeda/presentations/22426565","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426565]。"}]} {"no":1,"line":288,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426566","link":"https://api.researchmap.jp/yasuikeda/presentations/22426566","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426566]。"}]} {"no":1,"line":289,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426567","link":"https://api.researchmap.jp/yasuikeda/presentations/22426567","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426567]。"}]} {"no":1,"line":290,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426568","link":"https://api.researchmap.jp/yasuikeda/presentations/22426568","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426568]。"}]} {"no":1,"line":291,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426569","link":"https://api.researchmap.jp/yasuikeda/presentations/22426569","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426569]。"}]} {"no":1,"line":292,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426570","link":"https://api.researchmap.jp/yasuikeda/presentations/22426570","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426570]。"}]} {"no":1,"line":293,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426571","link":"https://api.researchmap.jp/yasuikeda/presentations/22426571","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426571]。"}]} {"no":1,"line":294,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426572","link":"https://api.researchmap.jp/yasuikeda/presentations/22426572","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426572]。"}]} {"no":1,"line":295,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426573","link":"https://api.researchmap.jp/yasuikeda/presentations/22426573","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426573]。"}]} {"no":1,"line":296,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426574","link":"https://api.researchmap.jp/yasuikeda/presentations/22426574","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426574]。"}]} {"no":1,"line":297,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426575","link":"https://api.researchmap.jp/yasuikeda/presentations/22426575","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426575]。"}]} {"no":1,"line":298,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426576","link":"https://api.researchmap.jp/yasuikeda/presentations/22426576","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426576]。"}]} {"no":1,"line":299,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426577","link":"https://api.researchmap.jp/yasuikeda/presentations/22426577","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426577]。"}]} {"no":1,"line":300,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426578","link":"https://api.researchmap.jp/yasuikeda/presentations/22426578","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426578]。"}]} {"no":1,"line":301,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426579","link":"https://api.researchmap.jp/yasuikeda/presentations/22426579","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426579]。"}]} {"no":1,"line":302,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426580","link":"https://api.researchmap.jp/yasuikeda/presentations/22426580","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426580]。"}]} {"no":1,"line":303,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426581","link":"https://api.researchmap.jp/yasuikeda/presentations/22426581","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426581]。"}]} {"no":1,"line":304,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426582","link":"https://api.researchmap.jp/yasuikeda/presentations/22426582","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426582]。"}]} {"no":1,"line":305,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426583","link":"https://api.researchmap.jp/yasuikeda/presentations/22426583","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426583]。"}]} {"no":1,"line":306,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426584","link":"https://api.researchmap.jp/yasuikeda/presentations/22426584","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426584]。"}]} {"no":1,"line":307,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426585","link":"https://api.researchmap.jp/yasuikeda/presentations/22426585","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426585]。"}]} {"no":1,"line":308,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426586","link":"https://api.researchmap.jp/yasuikeda/presentations/22426586","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426586]。"}]} {"no":1,"line":309,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426587","link":"https://api.researchmap.jp/yasuikeda/presentations/22426587","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426587]。"}]} {"no":1,"line":310,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426588","link":"https://api.researchmap.jp/yasuikeda/presentations/22426588","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426588]。"}]} {"no":1,"line":311,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426589","link":"https://api.researchmap.jp/yasuikeda/presentations/22426589","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426589]。"}]} {"no":1,"line":312,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426590","link":"https://api.researchmap.jp/yasuikeda/presentations/22426590","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426590]。"}]} {"no":1,"line":313,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426591","link":"https://api.researchmap.jp/yasuikeda/presentations/22426591","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426591]。"}]} {"no":1,"line":314,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426592","link":"https://api.researchmap.jp/yasuikeda/presentations/22426592","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426592]。"}]} {"no":1,"line":315,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426593","link":"https://api.researchmap.jp/yasuikeda/presentations/22426593","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426593]。"}]} {"no":1,"line":316,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426594","link":"https://api.researchmap.jp/yasuikeda/presentations/22426594","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426594]。"}]} {"no":1,"line":317,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426595","link":"https://api.researchmap.jp/yasuikeda/presentations/22426595","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426595]。"}]} {"no":1,"line":318,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426596","link":"https://api.researchmap.jp/yasuikeda/presentations/22426596","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426596]。"}]} {"no":1,"line":319,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426597","link":"https://api.researchmap.jp/yasuikeda/presentations/22426597","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426597]。"}]} {"no":1,"line":320,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426598","link":"https://api.researchmap.jp/yasuikeda/presentations/22426598","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426598]。"}]} {"no":1,"line":321,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426599","link":"https://api.researchmap.jp/yasuikeda/presentations/22426599","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426599]。"}]} {"no":1,"line":322,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426600","link":"https://api.researchmap.jp/yasuikeda/presentations/22426600","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426600]。"}]} {"no":1,"line":323,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426601","link":"https://api.researchmap.jp/yasuikeda/presentations/22426601","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426601]。"}]} {"no":1,"line":324,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426602","link":"https://api.researchmap.jp/yasuikeda/presentations/22426602","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426602]。"}]} {"no":1,"line":325,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426603","link":"https://api.researchmap.jp/yasuikeda/presentations/22426603","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426603]。"}]} {"no":1,"line":326,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426604","link":"https://api.researchmap.jp/yasuikeda/presentations/22426604","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426604]。"}]} {"no":1,"line":327,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426605","link":"https://api.researchmap.jp/yasuikeda/presentations/22426605","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426605]。"}]} {"no":1,"line":328,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426606","link":"https://api.researchmap.jp/yasuikeda/presentations/22426606","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426606]。"}]} {"no":1,"line":329,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426607","link":"https://api.researchmap.jp/yasuikeda/presentations/22426607","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426607]。"}]} {"no":1,"line":330,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426608","link":"https://api.researchmap.jp/yasuikeda/presentations/22426608","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426608]。"}]} {"no":1,"line":331,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426609","link":"https://api.researchmap.jp/yasuikeda/presentations/22426609","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426609]。"}]} {"no":1,"line":332,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426610","link":"https://api.researchmap.jp/yasuikeda/presentations/22426610","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426610]。"}]} {"no":1,"line":333,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426611","link":"https://api.researchmap.jp/yasuikeda/presentations/22426611","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426611]。"}]} {"no":1,"line":334,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426612","link":"https://api.researchmap.jp/yasuikeda/presentations/22426612","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426612]。"}]} {"no":1,"line":335,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426613","link":"https://api.researchmap.jp/yasuikeda/presentations/22426613","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426613]。"}]} {"no":1,"line":336,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426614","link":"https://api.researchmap.jp/yasuikeda/presentations/22426614","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426614]。"}]} {"no":1,"line":337,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426615","link":"https://api.researchmap.jp/yasuikeda/presentations/22426615","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426615]。"}]} {"no":1,"line":338,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426615","link":"https://api.researchmap.jp/yasuikeda/presentations/22426615","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426615]。"}]} {"no":1,"line":339,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426616","link":"https://api.researchmap.jp/yasuikeda/presentations/22426616","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426616]。"}]} {"no":1,"line":340,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426617","link":"https://api.researchmap.jp/yasuikeda/presentations/22426617","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426617]。"}]} {"no":1,"line":341,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426618","link":"https://api.researchmap.jp/yasuikeda/presentations/22426618","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426618]。"}]} {"no":1,"line":342,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426619","link":"https://api.researchmap.jp/yasuikeda/presentations/22426619","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426619]。"}]} {"no":1,"line":343,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426620","link":"https://api.researchmap.jp/yasuikeda/presentations/22426620","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426620]。"}]} {"no":1,"line":344,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426621","link":"https://api.researchmap.jp/yasuikeda/presentations/22426621","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426621]。"}]} {"no":1,"line":345,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426622","link":"https://api.researchmap.jp/yasuikeda/presentations/22426622","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426622]。"}]} {"no":1,"line":346,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426623","link":"https://api.researchmap.jp/yasuikeda/presentations/22426623","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426623]。"}]} {"no":1,"line":347,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426624","link":"https://api.researchmap.jp/yasuikeda/presentations/22426624","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426624]。"}]} {"no":1,"line":348,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426625","link":"https://api.researchmap.jp/yasuikeda/presentations/22426625","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426625]。"}]} {"no":1,"line":349,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426626","link":"https://api.researchmap.jp/yasuikeda/presentations/22426626","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426626]。"}]} {"no":1,"line":350,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426627","link":"https://api.researchmap.jp/yasuikeda/presentations/22426627","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426627]。"}]} {"no":1,"line":351,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426628","link":"https://api.researchmap.jp/yasuikeda/presentations/22426628","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426628]。"}]} {"no":1,"line":352,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426629","link":"https://api.researchmap.jp/yasuikeda/presentations/22426629","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426629]。"}]} {"no":1,"line":353,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426630","link":"https://api.researchmap.jp/yasuikeda/presentations/22426630","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426630]。"}]} {"no":1,"line":354,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426631","link":"https://api.researchmap.jp/yasuikeda/presentations/22426631","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426631]。"}]} {"no":1,"line":355,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426632","link":"https://api.researchmap.jp/yasuikeda/presentations/22426632","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426632]。"}]} {"no":1,"line":356,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426633","link":"https://api.researchmap.jp/yasuikeda/presentations/22426633","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426633]。"}]} {"no":1,"line":357,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426634","link":"https://api.researchmap.jp/yasuikeda/presentations/22426634","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426634]。"}]} {"no":1,"line":358,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426635","link":"https://api.researchmap.jp/yasuikeda/presentations/22426635","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426635]。"}]} {"no":1,"line":359,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426636","link":"https://api.researchmap.jp/yasuikeda/presentations/22426636","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426636]。"}]} {"no":1,"line":360,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426637","link":"https://api.researchmap.jp/yasuikeda/presentations/22426637","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426637]。"}]} {"no":1,"line":361,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426638","link":"https://api.researchmap.jp/yasuikeda/presentations/22426638","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426638]。"}]} {"no":1,"line":362,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426639","link":"https://api.researchmap.jp/yasuikeda/presentations/22426639","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426639]。"}]} {"no":1,"line":363,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426640","link":"https://api.researchmap.jp/yasuikeda/presentations/22426640","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426640]。"}]} {"no":1,"line":364,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426641","link":"https://api.researchmap.jp/yasuikeda/presentations/22426641","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426641]。"}]} {"no":1,"line":365,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376316","link":"https://api.researchmap.jp/yasuikeda/presentations/30376316","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376316]。"}]} {"no":1,"line":366,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426643","link":"https://api.researchmap.jp/yasuikeda/presentations/22426643","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426643]。"}]} {"no":1,"line":367,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426644","link":"https://api.researchmap.jp/yasuikeda/presentations/22426644","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426644]。"}]} {"no":1,"line":368,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426645","link":"https://api.researchmap.jp/yasuikeda/presentations/22426645","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426645]。"}]} {"no":1,"line":369,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426646","link":"https://api.researchmap.jp/yasuikeda/presentations/22426646","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426646]。"}]} {"no":1,"line":370,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426647","link":"https://api.researchmap.jp/yasuikeda/presentations/22426647","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426647]。"}]} {"no":1,"line":371,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426648","link":"https://api.researchmap.jp/yasuikeda/presentations/22426648","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426648]。"}]} {"no":1,"line":372,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426649","link":"https://api.researchmap.jp/yasuikeda/presentations/22426649","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426649]。"}]} {"no":1,"line":373,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426650","link":"https://api.researchmap.jp/yasuikeda/presentations/22426650","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426650]。"}]} {"no":1,"line":374,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426651","link":"https://api.researchmap.jp/yasuikeda/presentations/22426651","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426651]。"}]} {"no":1,"line":375,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426652","link":"https://api.researchmap.jp/yasuikeda/presentations/22426652","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426652]。"}]} {"no":1,"line":376,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426653","link":"https://api.researchmap.jp/yasuikeda/presentations/22426653","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426653]。"}]} {"no":1,"line":377,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426654","link":"https://api.researchmap.jp/yasuikeda/presentations/22426654","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426654]。"}]} {"no":1,"line":378,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426655","link":"https://api.researchmap.jp/yasuikeda/presentations/22426655","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426655]。"}]} {"no":1,"line":379,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426656","link":"https://api.researchmap.jp/yasuikeda/presentations/22426656","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426656]。"}]} {"no":1,"line":380,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426657","link":"https://api.researchmap.jp/yasuikeda/presentations/22426657","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426657]。"}]} {"no":1,"line":381,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426658","link":"https://api.researchmap.jp/yasuikeda/presentations/22426658","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426658]。"}]} {"no":1,"line":382,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426659","link":"https://api.researchmap.jp/yasuikeda/presentations/22426659","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426659]。"}]} {"no":1,"line":383,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426660","link":"https://api.researchmap.jp/yasuikeda/presentations/22426660","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426660]。"}]} {"no":1,"line":384,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376317","link":"https://api.researchmap.jp/yasuikeda/presentations/30376317","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376317]。"}]} {"no":1,"line":385,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376318","link":"https://api.researchmap.jp/yasuikeda/presentations/30376318","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376318]。"}]} {"no":1,"line":386,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426663","link":"https://api.researchmap.jp/yasuikeda/presentations/22426663","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426663]。"}]} {"no":1,"line":387,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376319","link":"https://api.researchmap.jp/yasuikeda/presentations/30376319","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376319]。"}]} {"no":1,"line":388,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426665","link":"https://api.researchmap.jp/yasuikeda/presentations/22426665","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426665]。"}]} {"no":1,"line":389,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376320","link":"https://api.researchmap.jp/yasuikeda/presentations/30376320","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376320]。"}]} {"no":1,"line":390,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376321","link":"https://api.researchmap.jp/yasuikeda/presentations/30376321","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376321]。"}]} {"no":1,"line":391,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426668","link":"https://api.researchmap.jp/yasuikeda/presentations/22426668","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426668]。"}]} {"no":1,"line":392,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426669","link":"https://api.researchmap.jp/yasuikeda/presentations/22426669","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426669]。"}]} {"no":1,"line":393,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426670","link":"https://api.researchmap.jp/yasuikeda/presentations/22426670","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426670]。"}]} {"no":1,"line":394,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426671","link":"https://api.researchmap.jp/yasuikeda/presentations/22426671","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426671]。"}]} {"no":1,"line":395,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426672","link":"https://api.researchmap.jp/yasuikeda/presentations/22426672","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426672]。"}]} {"no":1,"line":396,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426673","link":"https://api.researchmap.jp/yasuikeda/presentations/22426673","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426673]。"}]} {"no":1,"line":397,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426674","link":"https://api.researchmap.jp/yasuikeda/presentations/22426674","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426674]。"}]} {"no":1,"line":398,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426675","link":"https://api.researchmap.jp/yasuikeda/presentations/22426675","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426675]。"}]} {"no":1,"line":399,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426676","link":"https://api.researchmap.jp/yasuikeda/presentations/22426676","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426676]。"}]} {"no":1,"line":400,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426677","link":"https://api.researchmap.jp/yasuikeda/presentations/22426677","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426677]。"}]} {"no":1,"line":401,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426678","link":"https://api.researchmap.jp/yasuikeda/presentations/22426678","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426678]。"}]} {"no":1,"line":402,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426679","link":"https://api.researchmap.jp/yasuikeda/presentations/22426679","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426679]。"}]} {"no":1,"line":403,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426680","link":"https://api.researchmap.jp/yasuikeda/presentations/22426680","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426680]。"}]} {"no":1,"line":404,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426681","link":"https://api.researchmap.jp/yasuikeda/presentations/22426681","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426681]。"}]} {"no":1,"line":405,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426682","link":"https://api.researchmap.jp/yasuikeda/presentations/22426682","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426682]。"}]} {"no":1,"line":406,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426683","link":"https://api.researchmap.jp/yasuikeda/presentations/22426683","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426683]。"}]} {"no":1,"line":407,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426684","link":"https://api.researchmap.jp/yasuikeda/presentations/22426684","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426684]。"}]} {"no":1,"line":408,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426685","link":"https://api.researchmap.jp/yasuikeda/presentations/22426685","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426685]。"}]} {"no":1,"line":409,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426686","link":"https://api.researchmap.jp/yasuikeda/presentations/22426686","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426686]。"}]} {"no":1,"line":410,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426687","link":"https://api.researchmap.jp/yasuikeda/presentations/22426687","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426687]。"}]} {"no":1,"line":411,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376322","link":"https://api.researchmap.jp/yasuikeda/presentations/30376322","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376322]。"}]} {"no":1,"line":412,"code":200,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"30376323","link":"https://api.researchmap.jp/yasuikeda/presentations/30376323"} {"no":1,"line":413,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376323","link":"https://api.researchmap.jp/yasuikeda/presentations/30376323","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376323]。"}]} {"no":1,"line":414,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426690","link":"https://api.researchmap.jp/yasuikeda/presentations/22426690","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426690]。"}]} {"no":1,"line":415,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426691","link":"https://api.researchmap.jp/yasuikeda/presentations/22426691","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426691]。"}]} {"no":1,"line":416,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426692","link":"https://api.researchmap.jp/yasuikeda/presentations/22426692","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426692]。"}]} {"no":1,"line":417,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426693","link":"https://api.researchmap.jp/yasuikeda/presentations/22426693","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426693]。"}]} {"no":1,"line":418,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426694","link":"https://api.researchmap.jp/yasuikeda/presentations/22426694","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426694]。"}]} {"no":1,"line":419,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426695","link":"https://api.researchmap.jp/yasuikeda/presentations/22426695","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426695]。"}]} {"no":1,"line":420,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426696","link":"https://api.researchmap.jp/yasuikeda/presentations/22426696","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426696]。"}]} {"no":1,"line":421,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376324","link":"https://api.researchmap.jp/yasuikeda/presentations/30376324","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376324]。"}]} {"no":1,"line":422,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376325","link":"https://api.researchmap.jp/yasuikeda/presentations/30376325","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376325]。"}]} {"no":1,"line":423,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426699","link":"https://api.researchmap.jp/yasuikeda/presentations/22426699","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426699]。"}]} {"no":1,"line":424,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376326","link":"https://api.researchmap.jp/yasuikeda/presentations/30376326","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376326]。"}]} {"no":1,"line":425,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426701","link":"https://api.researchmap.jp/yasuikeda/presentations/22426701","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426701]。"}]} {"no":1,"line":426,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426702","link":"https://api.researchmap.jp/yasuikeda/presentations/22426702","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426702]。"}]} {"no":1,"line":427,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376327","link":"https://api.researchmap.jp/yasuikeda/presentations/30376327","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376327]。"}]} {"no":1,"line":428,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426704","link":"https://api.researchmap.jp/yasuikeda/presentations/22426704","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426704]。"}]} {"no":1,"line":429,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426705","link":"https://api.researchmap.jp/yasuikeda/presentations/22426705","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426705]。"}]} {"no":1,"line":430,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426706","link":"https://api.researchmap.jp/yasuikeda/presentations/22426706","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426706]。"}]} {"no":1,"line":431,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426707","link":"https://api.researchmap.jp/yasuikeda/presentations/22426707","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426707]。"}]} {"no":1,"line":432,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426708","link":"https://api.researchmap.jp/yasuikeda/presentations/22426708","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426708]。"}]} {"no":1,"line":433,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426709","link":"https://api.researchmap.jp/yasuikeda/presentations/22426709","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426709]。"}]} {"no":1,"line":434,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426710","link":"https://api.researchmap.jp/yasuikeda/presentations/22426710","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426710]。"}]} {"no":1,"line":435,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426711","link":"https://api.researchmap.jp/yasuikeda/presentations/22426711","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426711]。"}]} {"no":1,"line":436,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426712","link":"https://api.researchmap.jp/yasuikeda/presentations/22426712","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426712]。"}]} {"no":1,"line":437,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426713","link":"https://api.researchmap.jp/yasuikeda/presentations/22426713","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426713]。"}]} {"no":1,"line":438,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426714","link":"https://api.researchmap.jp/yasuikeda/presentations/22426714","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426714]。"}]} {"no":1,"line":439,"code":200,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"30376330","link":"https://api.researchmap.jp/yasuikeda/presentations/30376330"} {"no":1,"line":440,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426715","link":"https://api.researchmap.jp/yasuikeda/presentations/22426715","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426715]。"}]} {"no":1,"line":441,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"30496241","link":"https://api.researchmap.jp/yasuikeda/presentations/30496241"} {"no":1,"line":442,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426717","link":"https://api.researchmap.jp/yasuikeda/presentations/22426717","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426717]。"}]} {"no":1,"line":443,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426718","link":"https://api.researchmap.jp/yasuikeda/presentations/22426718","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426718]。"}]} {"no":1,"line":444,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426715","link":"https://api.researchmap.jp/yasuikeda/presentations/22426715","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426715]。"}]} {"no":1,"line":445,"code":200,"action":"insert","action_type":"force","type":"presentations","id":"30496242","link":"https://api.researchmap.jp/yasuikeda/presentations/30496242"} {"no":1,"line":446,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376330","link":"https://api.researchmap.jp/yasuikeda/presentations/30376330","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376330]。"}]} {"no":1,"line":447,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426720","link":"https://api.researchmap.jp/yasuikeda/presentations/22426720","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426720]。"}]} {"no":1,"line":448,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426721","link":"https://api.researchmap.jp/yasuikeda/presentations/22426721","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426721]。"}]} {"no":1,"line":449,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426722","link":"https://api.researchmap.jp/yasuikeda/presentations/22426722","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426722]。"}]} {"no":1,"line":450,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426723","link":"https://api.researchmap.jp/yasuikeda/presentations/22426723","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426723]。"}]} {"no":1,"line":451,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426724","link":"https://api.researchmap.jp/yasuikeda/presentations/22426724","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426724]。"}]} {"no":1,"line":452,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426725","link":"https://api.researchmap.jp/yasuikeda/presentations/22426725","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426725]。"}]} {"no":1,"line":453,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426726","link":"https://api.researchmap.jp/yasuikeda/presentations/22426726","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426726]。"}]} {"no":1,"line":454,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426727","link":"https://api.researchmap.jp/yasuikeda/presentations/22426727","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426727]。"}]} {"no":1,"line":455,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426728","link":"https://api.researchmap.jp/yasuikeda/presentations/22426728","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426728]。"}]} {"no":1,"line":456,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376331","link":"https://api.researchmap.jp/yasuikeda/presentations/30376331","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376331]。"}]} {"no":1,"line":457,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426730","link":"https://api.researchmap.jp/yasuikeda/presentations/22426730","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426730]。"}]} {"no":1,"line":458,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426731","link":"https://api.researchmap.jp/yasuikeda/presentations/22426731","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426731]。"}]} {"no":1,"line":459,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426732","link":"https://api.researchmap.jp/yasuikeda/presentations/22426732","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426732]。"}]} {"no":1,"line":460,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426733","link":"https://api.researchmap.jp/yasuikeda/presentations/22426733","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426733]。"}]} {"no":1,"line":461,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426734","link":"https://api.researchmap.jp/yasuikeda/presentations/22426734","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426734]。"}]} {"no":1,"line":462,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376332","link":"https://api.researchmap.jp/yasuikeda/presentations/30376332","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376332]。"}]} {"no":1,"line":463,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426736","link":"https://api.researchmap.jp/yasuikeda/presentations/22426736","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426736]。"}]} {"no":1,"line":464,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426737","link":"https://api.researchmap.jp/yasuikeda/presentations/22426737","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426737]。"}]} {"no":1,"line":465,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426738","link":"https://api.researchmap.jp/yasuikeda/presentations/22426738","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426738]。"}]} {"no":1,"line":466,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426739","link":"https://api.researchmap.jp/yasuikeda/presentations/22426739","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426739]。"}]} {"no":1,"line":467,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426740","link":"https://api.researchmap.jp/yasuikeda/presentations/22426740","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426740]。"}]} {"no":1,"line":468,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426741","link":"https://api.researchmap.jp/yasuikeda/presentations/22426741","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426741]。"}]} {"no":1,"line":469,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426742","link":"https://api.researchmap.jp/yasuikeda/presentations/22426742","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426742]。"}]} {"no":1,"line":470,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426743","link":"https://api.researchmap.jp/yasuikeda/presentations/22426743","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426743]。"}]} {"no":1,"line":471,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426744","link":"https://api.researchmap.jp/yasuikeda/presentations/22426744","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426744]。"}]} {"no":1,"line":472,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426745","link":"https://api.researchmap.jp/yasuikeda/presentations/22426745","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426745]。"}]} {"no":1,"line":473,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426746","link":"https://api.researchmap.jp/yasuikeda/presentations/22426746","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426746]。"}]} {"no":1,"line":474,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426747","link":"https://api.researchmap.jp/yasuikeda/presentations/22426747","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426747]。"}]} {"no":1,"line":475,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426748","link":"https://api.researchmap.jp/yasuikeda/presentations/22426748","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426748]。"}]} {"no":1,"line":476,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426749","link":"https://api.researchmap.jp/yasuikeda/presentations/22426749","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426749]。"}]} {"no":1,"line":477,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426750","link":"https://api.researchmap.jp/yasuikeda/presentations/22426750","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426750]。"}]} {"no":1,"line":478,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426751","link":"https://api.researchmap.jp/yasuikeda/presentations/22426751","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426751]。"}]} {"no":1,"line":479,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426752","link":"https://api.researchmap.jp/yasuikeda/presentations/22426752","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426752]。"}]} {"no":1,"line":480,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426753","link":"https://api.researchmap.jp/yasuikeda/presentations/22426753","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426753]。"}]} {"no":1,"line":481,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426754","link":"https://api.researchmap.jp/yasuikeda/presentations/22426754","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426754]。"}]} {"no":1,"line":482,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426755","link":"https://api.researchmap.jp/yasuikeda/presentations/22426755","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426755]。"}]} {"no":1,"line":483,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426756","link":"https://api.researchmap.jp/yasuikeda/presentations/22426756","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426756]。"}]} {"no":1,"line":484,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426757","link":"https://api.researchmap.jp/yasuikeda/presentations/22426757","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426757]。"}]} {"no":1,"line":485,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426758","link":"https://api.researchmap.jp/yasuikeda/presentations/22426758","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426758]。"}]} {"no":1,"line":486,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426759","link":"https://api.researchmap.jp/yasuikeda/presentations/22426759","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426759]。"}]} {"no":1,"line":487,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426760","link":"https://api.researchmap.jp/yasuikeda/presentations/22426760","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426760]。"}]} {"no":1,"line":488,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426761","link":"https://api.researchmap.jp/yasuikeda/presentations/22426761","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426761]。"}]} {"no":1,"line":489,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426762","link":"https://api.researchmap.jp/yasuikeda/presentations/22426762","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426762]。"}]} {"no":1,"line":490,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426763","link":"https://api.researchmap.jp/yasuikeda/presentations/22426763","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426763]。"}]} {"no":1,"line":491,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426764","link":"https://api.researchmap.jp/yasuikeda/presentations/22426764","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426764]。"}]} {"no":1,"line":492,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426765","link":"https://api.researchmap.jp/yasuikeda/presentations/22426765","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426765]。"}]} {"no":1,"line":493,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426766","link":"https://api.researchmap.jp/yasuikeda/presentations/22426766","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426766]。"}]} {"no":1,"line":494,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426767","link":"https://api.researchmap.jp/yasuikeda/presentations/22426767","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426767]。"}]} {"no":1,"line":495,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426768","link":"https://api.researchmap.jp/yasuikeda/presentations/22426768","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426768]。"}]} {"no":1,"line":496,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426769","link":"https://api.researchmap.jp/yasuikeda/presentations/22426769","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426769]。"}]} {"no":1,"line":497,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426770","link":"https://api.researchmap.jp/yasuikeda/presentations/22426770","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426770]。"}]} {"no":1,"line":498,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426771","link":"https://api.researchmap.jp/yasuikeda/presentations/22426771","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426771]。"}]} {"no":1,"line":499,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426772","link":"https://api.researchmap.jp/yasuikeda/presentations/22426772","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426772]。"}]} {"no":1,"line":500,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426773","link":"https://api.researchmap.jp/yasuikeda/presentations/22426773","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426773]。"}]} {"no":1,"line":501,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426774","link":"https://api.researchmap.jp/yasuikeda/presentations/22426774","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426774]。"}]} {"no":1,"line":502,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426775","link":"https://api.researchmap.jp/yasuikeda/presentations/22426775","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426775]。"}]} {"no":1,"line":503,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426776","link":"https://api.researchmap.jp/yasuikeda/presentations/22426776","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426776]。"}]} {"no":1,"line":504,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426777","link":"https://api.researchmap.jp/yasuikeda/presentations/22426777","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426777]。"}]} {"no":1,"line":505,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426778","link":"https://api.researchmap.jp/yasuikeda/presentations/22426778","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426778]。"}]} {"no":1,"line":506,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426779","link":"https://api.researchmap.jp/yasuikeda/presentations/22426779","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426779]。"}]} {"no":1,"line":507,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426780","link":"https://api.researchmap.jp/yasuikeda/presentations/22426780","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426780]。"}]} {"no":1,"line":508,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426781","link":"https://api.researchmap.jp/yasuikeda/presentations/22426781","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426781]。"}]} {"no":1,"line":509,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426782","link":"https://api.researchmap.jp/yasuikeda/presentations/22426782","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426782]。"}]} {"no":1,"line":510,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"41349373","link":"https://api.researchmap.jp/yasuikeda/presentations/41349373","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =41349373]。"}]} {"no":1,"line":511,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376333","link":"https://api.researchmap.jp/yasuikeda/presentations/30376333","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376333]。"}]} {"no":1,"line":512,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376334","link":"https://api.researchmap.jp/yasuikeda/presentations/30376334","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376334]。"}]} {"no":1,"line":513,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"30376335","link":"https://api.researchmap.jp/yasuikeda/presentations/30376335","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =30376335]。"}]} {"no":1,"line":514,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426783","link":"https://api.researchmap.jp/yasuikeda/presentations/22426783","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426783]。"}]} {"no":1,"line":515,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426784","link":"https://api.researchmap.jp/yasuikeda/presentations/22426784","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426784]。"}]} {"no":1,"line":516,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426785","link":"https://api.researchmap.jp/yasuikeda/presentations/22426785","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426785]。"}]} {"no":1,"line":517,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426786","link":"https://api.researchmap.jp/yasuikeda/presentations/22426786","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426786]。"}]} {"no":1,"line":518,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426787","link":"https://api.researchmap.jp/yasuikeda/presentations/22426787","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426787]。"}]} {"no":1,"line":519,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426788","link":"https://api.researchmap.jp/yasuikeda/presentations/22426788","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426788]。"}]} {"no":1,"line":520,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426789","link":"https://api.researchmap.jp/yasuikeda/presentations/22426789","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426789]。"}]} {"no":1,"line":521,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426790","link":"https://api.researchmap.jp/yasuikeda/presentations/22426790","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426790]。"}]} {"no":1,"line":522,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426791","link":"https://api.researchmap.jp/yasuikeda/presentations/22426791","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426791]。"}]} {"no":1,"line":523,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426792","link":"https://api.researchmap.jp/yasuikeda/presentations/22426792","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426792]。"}]} {"no":1,"line":524,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426793","link":"https://api.researchmap.jp/yasuikeda/presentations/22426793","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426793]。"}]} {"no":1,"line":525,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426794","link":"https://api.researchmap.jp/yasuikeda/presentations/22426794","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426794]。"}]} {"no":1,"line":526,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426795","link":"https://api.researchmap.jp/yasuikeda/presentations/22426795","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426795]。"}]} {"no":1,"line":527,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426796","link":"https://api.researchmap.jp/yasuikeda/presentations/22426796","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426796]。"}]} {"no":1,"line":528,"code":304,"action":"insert","action_type":"similar_merge","priority":"input_data","type":"presentations","id":"22426797","link":"https://api.researchmap.jp/yasuikeda/presentations/22426797","messages":[{"code":304,"message":"not_similar_modified","message_description":"本人相当が登録した類似の業績が存在したため、更新しませんでした[id=22426797]。"}]} ====== BulkResult(B000241782, QsEv-I4B7kacV6CWXvWR) : End ======